335116	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

9	O
.	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
27	I-temporal
2007	I-temporal
]	O

-	O
The	O
patient	O
had	O
a	O
colonoscopy	O
on	O
Monday	B-temporal
11	B-temporal
-	I-temporal
05	I-temporal
but	O
unfortunately	O
,	O
was	O
unable	O
to	O
complete	O
the	O
study	O
as	O
his	O
bowel	O

Colace	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

PROCEDURE	O
DURING	O
THIS	O
HOSPITALIZATION	O
:	O

Sex	O
:	O

Atrovent	O
nebulizers	B-form
0	B-strength
.	I-strength
5	I-strength
mg	I-strength
mixed	O
with	O
albuterol	O
,	O
nebulizer	B-form
is	O
given	O
every	B-frequency
six	I-frequency
hours	I-frequency
.	O

As	O
above	O
.	O

Positive	B-labvalue
bowel	O
sounds	O
.	O

)	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

Perform	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O
(	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
18	I-temporal
2007	I-temporal
]	O
12	B-temporal
:	I-temporal
05	I-temporal
)	O

Hgb	O
stable	B-labvalue
.	O

Chart	O
and	O
labs	O
reviewed	O
.	O

01/26/92	B-temporal

CONDITION	O
ON	O
DISCHARGE	O
:	O

Colace	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-duration
.	I-duration
i	I-duration
.	I-duration
d	I-duration
.	I-duration

2014-04-23	B-temporal
03	B-temporal
:	I-temporal
56	I-temporal
PM	I-temporal

Cerebellar	O
function	O
was	O
intact	O
.	O

-	O
check	O
Stool	O
occult	O
:	O
neg	B-labvalue
on	O
1	B-temporal
/	I-temporal
19	I-temporal
.	O

07/26/1999	B-temporal

142995994	O
SC	O

Lyrica	O
25	B-strength
mg	I-strength
daily	B-frequency

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

The	O
patient	O
is	O
medically	O
cleared	O
for	O
a	O
flight	O
to	O
return	O
to	O
her	O
home	O
in	O
the	O
United	O
Kingdom	O
.	O

CTMC	O

Per	O
Cardiology	O
,	O
it	O
was	O
felt	O
that	O
the	O
patient	O
had	O
no	B-negation
clinical	O
evidence	O
of	O
any	O
CHF	O
by	O
physical	O
examination	O
or	O
x	O
-	O
ray	O
;	O
however	O
,	O
the	O
patient	O
did	O
improve	O
subjectively	O
on	O
Lasix	O
,	O
prednisone	O
as	O
well	O
as	O
doxycycline	O
.	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Kisha	O
Jones	O
on	O
:	O
Jose	O
2010-07-01	B-temporal
8	B-temporal
:	I-temporal
27	I-temporal
AM	I-temporal

BUN	O
10	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

Neck	O

*	O
*	O
NAME	O
[	O
YYY	O
]	O

LABORATORY	O
DATA	O
:	O

GLUCOSE	O
-	O
116	B-labvalue
*	O
UREA	O
N	O
-	O
14	B-labvalue
CREAT	O
-	O
1	B-labvalue
.	I-labvalue
0	I-labvalue
SODIUM	O
-	O
137	B-labvalue
POTASSIUM	O
-	O
4	B-labvalue
.	I-labvalue
5	I-labvalue
CHLORIDE	O
-	O
105	B-labvalue
TOTAL	O
CO2	O
-	O
20	B-labvalue
*	O
ANION	O
GAP	O
-	O
17	B-labvalue

There	O
is	O
no	B-negation
edema	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
12	I-temporal
2007	I-temporal
]	O
06:37:11	B-temporal

She	O
will	O
be	O
given	O
iron	O
therapy	O
as	O
well	O
.	O

1	O
.	O

IMPRESSION	O
:	O
Increased	O
tracer	O
activity	O
demonstrated	O
within	O
the	O
left	O
lower	O
quadrant	O
,	O
most	O
likely	O
sigmoid	B-bodyloc
colonic	I-bodyloc
loops	I-bodyloc
of	I-bodyloc
bowel	I-bodyloc
,	O
consistent	O
with	O
active	O
bleeding	O
.	O

Results	O
to	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
,	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
,	O
and	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
,	O
and	O
he	O
is	O
to	O
go	O
to	O
*	O
*	O
INSTITUTION	O
ER	O
Ambulatory	O
Detox	O
Unit	O
for	O
Librium	O
refill	O
as	B-frequency
needed	I-frequency
.	O

At	O
the	O
time	O
of	O
her	O
discharge	O
,	O
she	O
is	O
afebrile	O
,	O
vital	O
signs	O
are	O
stable	B-labvalue
,	O
H	O
and	O
H	O
are	O
within	B-labvalue
normal	I-labvalue
limits	I-labvalue
,	O
and	O
her	O
INR	O
is	O
therapeutic	O
.	O

*	O
*	O
AGE	O
[	O
in	O
30s	O
]	O
years	O

I	O
instructed	O
the	O
bedside	O
nurses	O
to	O
follow	O
cardiac	O
outputs	O
on	O
a	O
q	O
.	O
2	O
hourly	O
basis	O
with	O
mixed	O
venous	O
oxygen	O
saturations	O
.	O

The	O
patient	O
was	O
also	O
noted	O
to	O
have	O
a	O
lot	O
of	O
musculoskeletal	O
component	O
of	O
her	O
pain	O
.	O

2	O
.	O

Followup	O
radiograph	O
suggested	O

PT	O
refused	O
to	O
answere	O
my	O
questions	O
:	O
where	O
we	O
are	O
at	O
?	O

DISCHARGE	O
MEDICATIONS	O
:	O

thiamine	O
(	O
THIAMINE	O
HCL	O
100	B-strength
MG	I-strength
TABLET	B-duration
)	O
,	O
100	B-strength
mg	I-strength
,	O
Tab	B-form
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Routine	O
,	O

Senna	O

Examination	O
was	O
guaiac	O
negative	B-labvalue
with	O
good	O
rectal	O
tone	O
.	O

The	O
patient	O
will	O
be	O
continued	O
on	O
medications	O
per	O
Discharge	O
Summary	O
with	O
the	O
addition	O
of	O
captopril	O
ACE	O
inhibitor	O
since	O
the	O
patient	O
'	O
s	O
blood	O
pressure	O
is	O
stable	B-labvalue
.	O

1	O
.	O

The	O
nephrologist	O
recommended	O
use	O
of	O
Clonidine	O
0	B-strength
.	I-strength
5	I-strength
mg	I-strength
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
and	O
0	B-strength
.	I-strength
1	I-strength
mg	I-strength
q	B-frequency
2	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency

At	O
this	O
time	O
,	O
she	O
is	O
afebrile	O
,	O
hemodynamically	O
stable	O
with	O
a	O
WBC	O
count	O
within	B-labvalue
normal	I-labvalue
limits	I-labvalue
and	O
she	O
is	O
being	O
discharged	O
to	O
the	O
same	O
skilled	O
nursing	O
home	O
facility	O
where	O
she	O
came	O
from	O
.	O

7	O
.	O

Cyclosporin	O
microemulsion	O
.	O

During	O
the	O
course	O
of	O
the	O
hospital	O
stay	O
,	O
the	O
patient	O
was	O
afebrile	O
.	O

She	O
denies	O
smoking	O
and	O
alcohol	O
.	O

3	O
.	O

To	O
see	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
in	O
1	O
week	O
.	O

The	O
patient	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
medical	O
issues	O
resolve	B-course
.	O

His	O
HCT	O
had	O
dropped	O
from	O
36	B-labvalue
.	I-labvalue
7	I-labvalue
to	I-labvalue
30	I-labvalue
.	I-labvalue
8	I-labvalue
despite	O
2U	O
PRBC	O
and	O
3	O
U	O
FFP	O
.	O

Followup	O
Instructions	O
:	O

CARDIAC	O
:	O

The	O
plan	O
is	O
for	O
him	O
to	O
continue	O
with	O
fluconazole	O
for	O
at	B-temporal
least	I-temporal
2	I-temporal
weeks	I-temporal
.	O

White	O
blood	O
cell	O
12	B-labvalue
.	I-labvalue
9	I-labvalue
,	O
hemoglobin	O
11	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
hematocrit	O
32	B-labvalue
.	I-labvalue
8	I-labvalue
,	O
platelet	O
count	O
197	B-labvalue
,	I-labvalue
000	I-labvalue
,	O
sodium	O
141	B-labvalue
,	O
potassium	O
3	B-labvalue
.	I-labvalue
6	I-labvalue
,	O
chloride	O
110	B-labvalue
,	O
bicarbonate	O
21	B-labvalue
,	O
BUN	O
20	B-labvalue
,	O
creatinine	O
0	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
glucose	O
189	B-labvalue
,	O
PT	O
13	B-labvalue
.	I-labvalue
3	I-labvalue
,	O
INR	O
1	B-labvalue
.	I-labvalue
2	I-labvalue
,	O
PTT	O
30	B-labvalue
.	I-labvalue
0	I-labvalue
,	O
amylase	O
57	B-labvalue
,	O
arterial	O
blood	O
gas	O
7	B-labvalue
.	I-labvalue
32	I-labvalue
,	O
35	B-labvalue
,	O
159	B-labvalue
,	O
19	B-labvalue
,	O
-	B-labvalue
7	I-labvalue
.	O

*	O
*	O
ID	O
-	O
NUM	O

CT	O
of	O
the	O
C	O
spine	O
was	O
negative	B-labvalue
and	O
her	O
cervical	O
spine	O
was	O
cleared	B-labvalue
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
24	I-temporal
2007	I-temporal
]	O
02:26:22	B-temporal

RR	O
.	O

Dictated	O
By	O
:	O

CONSULTS	O
:	O

The	O
patient	O
continued	O
to	O
do	O
well	O
and	O
did	O
not	B-negation
require	O
restraints	O
after	O
that	O
event	O
.	O

ACTIVITY	O
:	O

3	O
.	O

Troponin	O
was	O
less	B-labvalue
than	I-labvalue
0	I-labvalue
.	I-labvalue
1	I-labvalue
.	O

A	O
small	O
right	B-bodyloc
occipital	I-bodyloc
lobe	I-bodyloc
chronic	B-course
infarction	O
is	O
also	O
evident	O
.	O

-	O
Continue	O
Bactrim	O
DS	O
BID	B-frequency
,	O
per	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
'	O
s	O
recommendation	O

DILATED	O
CARDIOMYOPATHY	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
regular	O
floor	O
.	O

None	O
.	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
25	I-temporal
2007	I-temporal
]	O
16:46:42	B-temporal

PMH	O
:	O

Current	O
Medications	O
:	O
medication	O
administration	O
orders	O
(	O
selected	O
)	O

Patient	O
on	O
day	O
2	O
of	O
Avelox	O
.	O

Amitriptyline	O
50	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
h	I-frequency
.	I-frequency
s	I-frequency
.	I-frequency

-	O
PT	O
/	O
OT	O

6	B-labvalue
.	I-labvalue
3	I-labvalue
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
15	I-temporal
07	I-temporal
]	O

He	O
has	O
had	O
no	B-negation
fevers	O
or	O
chills	O
.	O

Hypotension	O
:	O
The	O
patient	O
'	O
d	O
pm	O
BP	O
meds	O
were	O
held	O
11	B-temporal
-	I-temporal
14	I-temporal
and	O
she	O
was	O
administered	O
1	O
.	O
5L	O
NS	O
over	O
the	O
course	O
of	O
the	O
day	O
with	O
subsequent	O
SBP	O
s	O
in	O
the	O
high	O
90	O
s	O
,	O
low	O
100	O
s	O
,	O
.	O

4	B-strength
mg	I-strength
daily	B-frequency
,	O
Today	O
INR	O
2	B-labvalue
.	I-labvalue
4	I-labvalue

Age	O
:	O

She	O
will	O
likely	O
improve	O
.	O

ACHASTHA	O
N	O
.	O

The	O
patient	O
'	O
s	O
multiple	O
myeloma	O
was	O
worked	O
up	O
because	O
of	O
her	O
renal	B-bodyloc
failure	O
.	O

His	B-bodyloc
left	I-bodyloc
ventricle	I-bodyloc
ejection	O
showed	O
diffuse	O
hypokinesis	O
.	O

No	B-negation
gross	O
deformities	O
.	O

VS	O
98	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
62	B-labvalue
,	O
103	B-labvalue
/	I-labvalue
37	I-labvalue
,	O
15	B-labvalue
97	I-labvalue
%	I-labvalue
2L	I-labvalue

D	O
:	O
2016-06-15	B-temporal

Service	O
:	O

Calcium	O
carbonate	O
125	B-strength
.	I-strength
0	I-strength
mg	I-strength
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Cardiac	O
exam	O
showed	O
a	O
normal	B-labvalue
PMI	O
,	O
regular	B-labvalue
rate	O
and	O
rhythm	O
,	O
normal	B-labvalue
S1	O
,	O
physiologically	O
split	O
S2	O
.	O

He	O
was	O
febrile	O
in	O
the	O
Intensive	O
Care	O
Unit	O
to	O
101	O
.	O
0	O
F	O
.	O
;	O
yet	O
,	O
chest	O
x	O
-	O
ray	O
,	O
blood	O
cultures	O
,	O
urinalysis	O
and	O
urine	O
cultures	O
were	O
all	O
negative	B-labvalue
for	O
sources	O
.	O

The	O
patient	O
developed	O
the	O
syndrome	O
after	O
her	O
thoracic	O
aortic	O
aneurysm	O
repair	O
.	O

72	O
year	O
old	O
man	O
with	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
9:00:00	B-temporal

She	O
was	O
transferred	O
to	O
the	O
Coronary	O
Care	O
Unit	O
in	O
stable	O
condition	O
and	O
still	O
intubated	O
.	O

Fever	O
.	O

When	O
he	O
was	O
seen	O
on	O
2	B-temporal
/	I-temporal
3	I-temporal
in	O
the	O
Transplant	O
Clinic	O
,	O
his	O
incision	O
was	O
noted	O
to	O
be	O
more	O
erythematous	O
.	O

She	O
had	O
a	O
white	O
count	O
of	O
64	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
H	O
and	O
H	O
12	B-labvalue
.	I-labvalue
1	I-labvalue
and	O
37	B-labvalue
,	O
platelets	O
280	B-labvalue
,	O
and	O
INR	O
was	O
2	B-labvalue
.	I-labvalue
4	I-labvalue
.	O

Her	O
EOMs	O
are	O
intact	O
.	O

72	O
male	O
s	O
/	O
p	O
fall	O
down	O
20	O
stairs	O

*	O
*	O
*	O
2	B-strength
.	I-strength
5	I-strength
mg	I-strength
ALBUTEROL	O
+	O
0	B-strength
.	I-strength
5	I-strength
mg	I-strength
ATROVENT	O
*	O
*	O
*	O

Colistin	O
30	B-strength
mg	I-strength
nebulizer	B-form
twice	B-frequency
a	I-frequency
day	I-frequency
,	O
give	O
30	O
minutes	O
post	O
albuterol	O
and	O
Atrovent	O
.	O

He	O
had	O
progressive	O
symptoms	O
of	O
congestive	O
heart	B-bodyloc
failure	O
which	O
led	O
to	O
his	O
evaluation	O
of	O
his	O
cardiac	O
transplant	O
in	O
March	B-temporal
of	I-temporal
1991	I-temporal
.	O

ATRIAL	B-bodyloc
FIBRILLATION	O
(	O
ICD9	O
427	O
.	O
31	O
,	O
Working	O
,	O
Problem	O
)	O

Date	O
of	O
Birth	O
:	O

Sign	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O
(	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
18	I-temporal
2007	I-temporal
]	O
12	B-temporal
:	I-temporal
05	I-temporal
)	O

Patient	O
denies	B-negation
fever	O
,	O
chills	O
,	O
SOB	O
and	O
chest	B-bodyloc
pain	O
.	O

Otherwise	O
no	B-negation
acute	B-course
cardiopulmonary	O
changes	O
.	O

He	O
has	O
had	O
no	B-negation
recent	B-temporal
weight	O
loss	O
,	O
no	B-negation
light	O
-	O
headedness	O
or	O
dizziness	O
.	O

The	O
patient	O
was	O
also	O
administered	O
adaptive	O
training	O
for	O
activities	O
of	O
daily	O
life	O
and	O
advised	O
regarding	O
wound	O
care	O
.	O

D	O
:	O

3	O
.	O

HOSPITAL	O
COURSE	O
:	O

Stool	O
for	O
C	O
.	O
diff	O
toxin	O
was	O
sent	O
x	O
1	O
and	O
was	O
negative	B-labvalue
.	O

Coumadin	O
2	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
once	B-frequency
a	I-frequency
day	I-frequency
.	O

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

The	B-bodyloc
left	I-bodyloc
forearm	I-bodyloc
and	O
right	B-bodyloc
lower	I-bodyloc
leg	I-bodyloc
wound	O
should	O
be	O
kept	O
clean	O
and	O
dry	O
with	O
regular	O
dressing	O
changes	O
with	O
dry	O
gauze	O
once	O
per	O
day	O
.	O

The	O
patient	O
still	O
had	O
transcutaneous	O
pacing	O
wires	O
in	O
place	O
.	O

9	O
.	O
)	O
Ritalin	O
20	B-strength
mg	I-strength
daily	B-frequency

*	O
*	O
ID	O
-	O
NUM	O

Right	B-bodyloc
anterior	I-bodyloc
tibial	I-bodyloc
laceration	O
.	O

11	O
.	O

4	O
.	O

Abdomen	O
:	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

?	O
related	O
to	O
UTI	O
and	O
conjunctivitis	O
.	O

Signed	O

Neurological	O
:	O

7	O
.	O
)	O
H	O
/	O
O	O
DVT	O
(	O
right	O
sided	O
)	O
and	O
subsequent	O
PE	O
,	O
put	O
onto	O
lifetime	B-duration
warfarin	O

There	O
is	O
diffuse	O
brain	O
atrophy	O
and	O
chronic	B-course
microvascular	O
infarction	O
throughout	O
the	O
white	O
matter	O
.	O

GH	O

Intubated	O
and	O
sedated	O
for	O
desats	O
on	O
2014-10-27	B-temporal
.	O

He	O
is	O
to	O
see	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
the	O
second	O
week	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

Obesity	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

Status	O
post	O
transient	O
ischemic	O
attack	O
.	O

2	O
Paraplegia	O
.	O

There	O
he	O
was	O
given	O
3	B-dosage
doses	O
of	O
8	B-strength
mg	I-strength
of	O
Dilaudid	O
with	O
marginal	O
control	O
of	O
his	O
pain	O
.	O

PHYSICAL	O
EXAMINATION	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

2012-10-31	B-temporal

*	O
*	O
DATE	O
[	O
Jan	B-temporal
23	I-temporal
2008	I-temporal
]	O
02:37:54	B-temporal
PM	I-temporal

Current	O
weight	O
conversion	O
122	O
.	O
9	O
kg	O

During	O
hospitalization	O
the	O
patient	O
showed	O
evidence	O
of	O
labile	O
hypertension	O
.	O

ADMISSION	O
DIAGNOSIS	O
:	O

There	O
was	O
slightly	O
thickened	O
mitral	B-bodyloc
valve	I-bodyloc
leaflets	O
and	O
mild	B-severity
regurgitation	O
,	O
a	O
normal	O
aortic	O
valve	O
,	O
normal	O
right	O
ventricular	O
size	O
and	O
function	O
and	O
no	B-negation
pericardial	O
effusion	O
.	O

Anion	O
Gap	O
3	B-labvalue
.	I-labvalue
0	I-labvalue
Low	B-labvalue

T	O
:	O

This	O
was	O
done	O
on	O
*	O
*	O
DATE	O
[	O
Aug	B-temporal
23	I-temporal
2007	I-temporal
]	O
.	O

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

Also	O
in	O
the	O
Intensive	O
Care	O
Unit	O
,	O
O2	O
saturation	O
was	O
closely	O
monitored	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

Good	O
.	O

The	O
patient	O
continues	O
to	O
improve	O
with	O
regard	O
to	O
his	B-bodyloc
scrotal	I-bodyloc
and	O
lower	B-bodyloc
extremity	I-bodyloc
edema	O
.	O

Bibasilar	B-bodyloc
crackles	O
.	O

A	O
sample	O
was	O
also	O
sent	O
to	O
pathology	O
laboratory	O
to	O
look	O
for	O
any	O
malignant	O
cells	O
.	O

Due	O
to	O
her	O
satisfactory	O
evolution	O
,	O
she	O
is	O
being	O
sent	O
home	O
with	O
followup	O
in	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
'	O
s	O
office	O
in	O
2	O
weeks	O
from	O
today	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

JOB	O
#	O
:	O
10027	O

He	O
will	O
start	O
prednisone	O
40	B-strength
mg	I-strength
per	B-frequency
day	I-frequency
x	O
4	B-duration
weeks	I-duration
,	O
then	O
1	B-duration
week	I-duration
rapid	O
taper	O
as	O
outlined	O
by	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
'	O
s	O
note	O
.	O

Hypertension	O
.	O

ADMISSION	O
DATE	O
:	O

?	O
related	O
to	O
UTI	O
and	O
conjunctivitis	O
.	O

From	O
2/17/00	B-temporal
to	O
2/21/00	B-temporal
,	O
the	O
patient	O
complained	O
of	O
persistent	B-course
and	O
occasionally	O
severe	B-severity
epigastric	B-bodyloc
pain	O
.	O

Exacerbation	O
of	O
chronic	B-severity
obstructive	O
pulmonary	B-bodyloc
disease	O
.	O

DD	O
:	O

Allowing	O
for	O
the	O
limitations	O
,	O
the	O
vertebral	O
bodies	O
are	O
normal	O
in	O
height	O
and	O
normally	O
aligned	O
.	O

Dilutional	O
hyponatremia	O
(	O
SNMCT	O
*	O
*	O
ID	O
-	O
NUM	O
,	O
Working	O
,	O
Diagnosis	O
)	O
improved	O
with	O
fluid	O
restriction	O
and	O
low	O
na	O
diet	O

Dr	O
*	O
*	O
NAME	O
[	O
VVV	O
]	O
and	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
from	O
Renal	O
.	O

Prealbumin	O
&	O
lt	O
;	O
7	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

*	O
*	O
ID	O
-	O
NUM	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

9175227	O

HOSPITAL	O
COURSE	O
:	O

HA1C	O
is	O
5	B-labvalue
.	I-labvalue
3	I-labvalue
.	O

Basophils	O
0	B-labvalue
%	I-labvalue

ETOH	O
:	O
according	O
to	O
her	O
POA	O
,	O
she	O
is	O
not	O
heavy	O
drinker	O
.	O

.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
Dr	O
.	O
Kayschird	O
to	O
schedule	O
for	O
the	O
epidural	O
pump	O
.	O

Soft	O
,	O
nondistended	O
,	O
nontender	O
.	O

Follow	O
up	O
Instructions	O
:	O

ALLERGIES	O
:	O

Metoprolol	O
Tartrate	O
25	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
TID	B-frequency
(	O
3	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
.	O

16	O
.	O

The	O
patient	O
did	O
well	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
04	B-temporal
-	I-temporal
02	I-temporal
.	O

With	O
regard	O
to	O
the	B-bodyloc
left	I-bodyloc
ventricular	I-bodyloc
thrombus	O
,	O
her	O
goal	O
INR	O
remained	O
2	B-labvalue
.	I-labvalue
5	I-labvalue
to	I-labvalue
3	I-labvalue
;	O
and	O
the	O
goal	O
was	O
to	O
start	O
heparin	O
once	O
the	O
patient	O
was	O
stable	O
from	O
a	O
thoracotomy	O
and	O
chest	O
tube	O

The	O
patient	O
ambulating	O
three	O
to	O
four	O
times	O
per	O
day	O
and	O
able	O
to	O
get	O
out	O
of	O
bed	O
using	O
a	O
walker	O
.	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
25	I-temporal
2007	I-temporal
]	O
17:02:27	B-temporal
/	O
lc	O

Signal	O
average	O
EKG	O
.	O

3133	O
W	O
.	O

She	O
was	O
admitted	O
to	O
the	O
Medical	O
Surgical	O
Unit	O
,	O
regular	O
bed	O
,	O
with	O
a	O
diagnosis	O
of	O
weakness	O
and	O
inability	O
to	O
ambulate	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
6	B-temporal
:	I-temporal
15	I-temporal
AM	I-temporal

6	O
Baclofen	O
20	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

*	O
*	O
DATE	O
[	O
Jul	B-temporal
18	I-temporal
2007	I-temporal
]	O
6	B-temporal
:	I-temporal
00	I-temporal
AM	I-temporal

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

EVALUATION	O
DATE	O
:	O

2012-06-07	B-temporal
09	B-temporal
:	I-temporal
55	I-temporal
PM	I-temporal
BLOOD	O
Albumin	O
-	O
3	B-labvalue
.	I-labvalue
9	I-labvalue
Calcium	O
-	O
8	B-labvalue
.	I-labvalue
5	I-labvalue
Phos	O
-	O
4	B-labvalue
.	I-labvalue
2	I-labvalue
Mg	O
-	O
2	B-labvalue
.	I-labvalue
0	I-labvalue

2011-11-18	B-temporal

Soft	O
and	O
nontender	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

She	O
states	O
that	O
she	O
actually	O
feels	O
little	O
bit	O
better	O
.	O

She	O
has	O
no	O
current	O
legal	O
issues	O
.	O

ABS	O
Lymphs	O
0	B-labvalue
.	I-labvalue
6	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

FOLLOW	O
-	O
UP	O
INSTRUCTIONS	O
:	O

*	O
*	O
ID	O
-	O
NUM	O

The	O
patient	O
was	O
admitted	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
6	I-temporal
2007	I-temporal
]	O
.	O

ADMISSION	O
DATE	O
:	O

6	O
.	O

Ophthlologist	O
:	O

Cardiology	O
.	O

Endo	O
-	O
DM	O
:	O

She	O
had	O
peripheral	B-bodyloc
edema	O
with	O
2	B-labvalue
+	I-labvalue
peripheral	O
pulses	O
bilaterally	O
.	O

He	O
also	O
is	O
hesitant	O
to	O
go	O
to	O
out	O
patient	O
rehab	O
as	O
he	O
may	O
be	O
called	O
back	O
to	O
work	O
.	O

Credentials	O
and	O
Title	O
of	O
Author	O
*	O
*	O
NAME	O
[	O
VVV	O
]	O
Signing	O
this	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
:	O

Once	O
the	O
patient	O
was	O
titrated	O
off	O
dopamine	O
,	O
the	O
beta	O
blocker	O
and	O
ACE	O
inhibitor	O
were	O
restarted	O
.	O

5	O
.	O

Chest	O
x	O
-	O
ray	O
shows	O
a	O
pulmonary	O
artery	O
catheter	O
and	O
endotracheal	O
tube	O
in	O
reasonable	O
position	O
.	O

Two	O
sisters	O
with	O
h	O
/	O
o	O
depression	O
and	O
suicidality	O
.	O

8	O
.	O

M	O

He	O
was	O
seen	O
in	O
the	O
emergency	O
room	O
on	O
the	B-temporal
evening	I-temporal
of	O
*	O
*	O
DATE	O
[	O
Dec	B-temporal
5	I-temporal
2007	I-temporal
]	O
.	O

Russell	O
2011-03-24	B-temporal
7	B-temporal
:	I-temporal
54	I-temporal
AM	I-temporal

Date	O
:	O

Phos	O
3	B-labvalue
.	I-labvalue
3	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

Lipitor	O
10	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency

No	B-negation
autopsy	O
was	O
performed	O
.	O

FINDINGS	O
:	O

RDW	O
14	B-labvalue
.	I-labvalue
3	I-labvalue
%	I-labvalue

Abdomen	O
was	O
nontender	O
.	O

Hamby	O
,	O
M	O
.	O
D	O
.	O

Health	O
Status	O

Ovoid	O
18	O
-	O
mm	O
density	O
within	B-bodyloc
the	I-bodyloc
atrium	I-bodyloc
of	O
the	B-bodyloc
right	I-bodyloc
lateral	I-bodyloc
ventricle	I-bodyloc
.	O

Acct	O
#	O
:	O

Winchester	O
filter	O
.	O

Call	O
(	O
909	O
)	O
566	O
-	O
1185	O
to	O
schedule	O
appointment	O
in	O
Trauma	O
Clinic	O
in	O
3	O
-	O
4	O
weeks	O
.	O

On	O
date	O
of	O
admission	O
,	O
the	O
patient	O
'	O
s	O
sodium	O
was	O
134	B-labvalue
,	O
his	O
chloride	O
was	O
98	B-labvalue
,	O
CO2	O
28	B-labvalue
,	O
BUN	O
5	B-labvalue
,	O
creatinine	O
0	B-labvalue
.	I-labvalue
06	I-labvalue
with	O
a	O
glucose	O
of	O
104	B-labvalue
.	O

Constitutional	O
:	O
hydration	O
:	O
clinically	O
slightly	O
dry	O
.	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O

Dermatology	O
and	O
plastic	O
surgery	O
were	O
consulted	O
who	O
felt	O
that	O
symptoms	O
were	O
due	O
to	O
trauma	O
;	O
it	O
was	O
not	O
felt	O
that	O
patient	O
had	O
compartment	O
syndrome	O
.	O

Microscopic	O
exam	O
showed	O
4	O
+	O
Staph	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Acct	O
#	O
:	O

COPD	O
-	O
Patient	O
started	O
on	O
IV	B-route
steroids	O
(	O
methylprednisolone	O
)	O
.	O

PATIENT	O
NAME	O
:	O

White	O
count	O
this	O
morning	O
was	O
9200	B-labvalue
.	O

07/30/93	B-temporal
:	O

Liver	O
function	O
tests	O
were	O
checked	O
,	O
only	O
total	O
bilirubin	O
was	O
slightly	B-labvalue
elevated	I-labvalue
at	O
1	B-labvalue
.	I-labvalue
6	I-labvalue
.	O

Blood	O
pressure	O
140	B-labvalue
/	I-labvalue
100	I-labvalue
,	O
phosphorus	O
94	B-labvalue
,	O
weight	O
181	B-labvalue
lb	I-labvalue
.	O

He	O
responded	O
to	O
intravenous	O
Lasix	O
with	O
3	B-labvalue
.	I-labvalue
2	I-labvalue
liters	I-labvalue
of	O
urine	O
output	O
as	O
well	O
as	O
marked	O
clinical	O
improvement	O
.	O

Disp	O
:	O
*	O
90	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O

She	O
had	O
evaluation	O
of	O
PT	O
/	O
OT	O
that	O
I	O
recommended	O
the	O
patient	O
having	O
1	O
to	O
2	O
hours	O
of	O
physical	O
therapy	O
in	O
order	O
to	O
regain	O
autotomy	O
.	O

12	O
.	O

We	O
will	O
get	O
an	O
EMG	O
and	O
nerve	O
conduction	O
study	O
.	O

If	O
the	O
patient	O
develops	O
and	O
additional	O
problems	O
with	O
her	B-bodyloc
right	I-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
such	O
as	O
increased	O
erythema	O
,	O
pain	O
,	O
numbness	O
,	O
or	O
tingling	O
or	O
other	O
problems	O
,	O
she	O
should	O
contact	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
'	O
s	O
office	O
immediately	O
.	O

INR	O
3	B-labvalue
.	I-labvalue
3	I-labvalue
today	O
,	O
continue	O
to	O
Hold	O
coumadin	O
now	O
.	O

Renal	B-bodyloc
-	O
ESRD	O
on	O
HD	O
.	O

*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
YYY	O
]	O

Hypertension	O
-	O
-	O
the	O
patient	O
was	O
placed	O
on	O
nifedipine	O
and	O
continued	O
on	O
her	O
level	O
of	O
atenolol	O
and	O
blood	O
pressure	O
remained	O
stable	O
.	O

The	O
patient	O
has	O
no	B-negation
lower	B-bodyloc
extremity	I-bodyloc
ulcers	O
,	O
and	O
all	O
former	O
leg	B-bodyloc
excoriations	O
are	O
healing	O
well	O
.	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
12	I-temporal
2008	I-temporal
]	O
04:32:44	B-temporal

On	O
the	O
evening	O
of	O
the	O
22nd	O
,	O
the	O
patient	O
became	O
acutely	B-course
agitated	O
,	O
threatening	O
to	O
leave	O
,	O
and	O
also	O
threatening	O
to	O
harm	O
those	O
nurses	O
and	O
physicians	O
that	O
were	O
attempting	O
to	O
prevent	O
him	O
from	O
leaving	O
.	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Abdomen	O
:	O

Epidural	B-bodyloc
site	I-bodyloc
is	O
without	B-negation
erythema	O
,	O
drainage	O
or	O
tenderness	O
.	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

YYY	O
M	O
ZZZ	O
]	O

Overnight	B-temporal
in	O
the	O
ICU	O
patient	O
was	O
noticed	O
to	O
have	O
painful	O
bullae	O
on	O
hands	B-bodyloc
and	I-bodyloc
arm	I-bodyloc
along	O
with	O
swelling	O
.	O

Skin	O
:	O

Skin	O
:	O
normal	O

Dilaudid	O
1	B-strength
mg	I-strength
intravenous	B-route
q	B-frequency
4	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
pain	O
.	O

Please	O
take	O
all	O
medications	O
as	O
prescribed	O
.	O

HEENT	O
Exam	O
:	O

Creatinine	O
upon	O
admission	O
was	O
3	B-labvalue
.	I-labvalue
5	I-labvalue
and	O
over	O
the	O
next	O
several	O
days	O
continued	O
to	O
increase	O
to	O
4	O
.	O
7	O
.	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
17	I-temporal
2007	I-temporal
]	O
18	B-temporal
:	I-temporal
17	I-temporal

No	B-negation
calf	B-bodyloc
tenderness	O
.	O

Blood	O
coagulation	O
started	O
due	O
to	O
liver	B-bodyloc
disease	O
.	O

Going	O
to	O
UMass	O
Memorial	O
Medical	O
Center	O
4	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
9:00:00	B-temporal

Cards	O
consulted	O
-	O
planned	O
for	O
cath	O
in	O
am	O
.	O

THERE	O
HAS	O
BEEN	O
A	O
FURTHER	O
REDUCTION	O
IN	O
SYSTOLIC	O
FUNCTION	O
.	O

Hypertension	O
and	O
low	O
back	B-bodyloc
pain	O
.	O

9	O
.	O

COMPARED	O
TO	O
A	O
PRIOR	O
STUDY	O
OF	O
*	O
*	O
DATE	O
[	O
Sep	O
2006	O
]	O
,	O
AT	O
THAT	O
TIME	O
THE	O
AORTIC	O
VALVE	O
AREA	O
WAS	O
1	B-labvalue
.	I-labvalue
4	I-labvalue
CM	I-labvalue
SQUARED	I-labvalue
WHICH	O
IS	O
LIKELY	O
ACCURATE	O
.	O

Back	O
MRI	O
was	O
negative	B-labvalue
.	O

Male	O

2	O
.	O

Neck	O
was	O
without	O
bruits	O
.	O

(	O
End	O
of	O
Report	O
)	O

A	O
family	O
discussion	O
was	O
then	O
held	O
on	O
*	O
*	O
DATE	O
[	O
Aug	B-temporal
26	I-temporal
2007	I-temporal
]	O
,	O
for	O
which	O
the	O
patient	O
'	O
s	O
family	O
decided	O
to	O
discontinue	O
care	O
.	O

Subjective	O

Norvasc	O
10	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
daily	B-frequency
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

72	O
yo	O
M	O
with	O
rib	O
fx	O
s	O
/	O
p	O
trauma	O
,	O
failure	O
on	O
previous	B-temporal
CXR	O
,	O
now	O
with	O
fever	O
.	O

WBC	O
-	O
6	B-labvalue
.	I-labvalue
5	I-labvalue
RBC	O
-	O
3	B-labvalue
.	I-labvalue
68	I-labvalue
*	O
HGB	O
-	O
11	B-labvalue
.	I-labvalue
6	I-labvalue
*	O
HCT	O
-	O
32	B-labvalue
.	I-labvalue
5	I-labvalue
*	O
MCV	O
-	O
88	B-labvalue
MCH	O
-	O
31	B-labvalue
.	I-labvalue
5	I-labvalue
MCHC	O
-	O
35	B-labvalue
.	I-labvalue
6	I-labvalue
*	O
RDW	O
-	O
13	B-labvalue
.	I-labvalue
6	I-labvalue

(	O
End	O
of	O
Report	O
)	O

Now	O
living	O
at	O
the	O
DBT	O
House	O
on	O
Treva	O
Williamson	O
in	O
Westborough	O
.	O

-	O
T	O
/	O
C	O
increase	O
Lantus	O

2	O
.	O

His	O
immunosuppressive	O
therapy	O
was	O
continued	O
throughout	O
his	O
stay	O
;	O
his	O
creatinine	O
remained	O
approximately	O
2	B-labvalue
.	I-labvalue
3	I-labvalue
to	I-labvalue
2	I-labvalue
.	I-labvalue
4	I-labvalue
;	O
he	O
has	O
a	O
baseline	O
renal	B-bodyloc
insufficiency	O
.	O

CTA	O
ant	O
/	O
lat	O

H	O
/	O
O	O
GI	B-bodyloc
bleeding	O
.	O

The	O
patient	O
began	O
to	O
feel	O
more	O
comfortable	O
by	O
the	O
second	O
day	O
.	O

Female	O

Patient	O
had	O
CTA	O
which	O
showed	O
bilateral	O
pulmonary	B-bodyloc
embolisms	O
.	O

*	O
*	O
INITIALS	O

Imaging	O
studies	O
:	O

*	O
*	O
INSTITUTION	O

My	O
plan	O
is	O
to	O
leave	O
him	O
sedated	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
17	I-temporal
2007	I-temporal
]	O
19	B-temporal
:	I-temporal
30	I-temporal

Tiotropium	O
Bromide	O
18	B-strength
mcg	I-strength
Capsule	B-form
,	I-form
w	I-form
/	I-form
Inhalation	I-form
Device	I-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Cap	B-form
Inhalation	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

A	O
chest	O
x	O
-	O
ray	O
revealed	O
an	O
enlarged	O
mediastinum	B-bodyloc
with	O
clear	O
lung	O
fields	O
bilaterally	O
.	O

During	O
initial	O
evaluation	O
for	O
a	O
coronary	O
artery	O
bypass	O
graft	O
,	O
80	O
%	O
to	O
90	O
%	O
of	O
the	B-bodyloc
right	I-bodyloc
coronary	I-bodyloc
artery	I-bodyloc
stenosis	O
was	O
found	O
;	O
for	O
which	O
she	O
underwent	O
a	O
right	O
internal	O
carotid	O
artery	O
stent	O
.	O

The	O
cytology	O
showed	O
samples	O
satisfactory	O
for	O
interpretation	O
.	O

2012-10-31	B-temporal
12	B-temporal
:	I-temporal
20PM	I-temporal

Stable	O

13	B-temporal
:	I-temporal
01	I-temporal

#	O
*	O
*	O
ACCESSION	O
-	O
NUMBER	O
[	O
1	O
]	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

She	O
had	O
a	O
cardiac	O
catheterization	O
which	O
revealed	O
3	B-bodyloc
-	I-bodyloc
vessel	I-bodyloc
disease	O
with	O
normal	O
left	O
main	O
,	O
mid	O
left	O
anterior	O
descending	O
artery	O
60	O
%	O
,	O
diffuse	O
90	O
%	O
mid	B-bodyloc
distal	I-bodyloc
stenosis	O
at	O
the	O
origin	O
of	O
the	O
diagonal	O
,	O
serial	O
70	O
%	O
and	O
90	O
%	O
left	B-bodyloc
circumflex	I-bodyloc
lesions	O
,	O
and	O
90	O
%	O
first	O
obtuse	O
marginal	O
,	O
and	O
mid	O
right	O
coronary	O
artery	O
60	O
%	O
.	O

F	O

-	O
*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
SSS	O
M	O
]	O
.	O

No	B-negation
history	O
of	O
head	B-bodyloc
trauma	O
or	O
seizure	O
disorder	O

Has	O
BM	O
daily	O
.	O

.	O
.	O

I	O
personally	O
interviewed	O
and	O
examined	O
the	O
patient	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
23	I-temporal
2007	I-temporal
]	O
.	O

Lymphs	O
9	B-labvalue
%	I-labvalue
Low	B-labvalue

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

2014-10-21	B-temporal
9	B-temporal
:	I-temporal
42	I-temporal
AM	I-temporal

Allergies	O
:	O

Improving	O

Male	O

The	O
stabbing	O
,	O
sharp	O
pain	O
that	O
she	O
occasionally	O
has	O
on	O
the	O
left	O
chest	O
wall	O
was	O
significantly	O
diminished	O
and	O
she	O
also	O
noticed	O
periods	O
of	O
time	O
when	O
she	O
did	O
not	O
have	O
any	O
of	O
that	O
pain	O
.	O

T	O
37	B-labvalue
.	I-labvalue
2	I-labvalue
,	O
HR	O
72	B-labvalue
,	O
BP	O
130	B-labvalue
/	I-labvalue
70	I-labvalue

2	O
.	O

71624078	O

Mood	O
-	O
incongruent	O
.	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
10	I-temporal
2007	I-temporal
]	O

X	O
-	O
ray	O
of	O
the	O
hands	O
and	O
wrist	O
were	O
obtained	O
which	O
were	O
negative	B-labvalue
.	O

Neurosurgery	O

1	O
.	O

GI	O
BLEEDING	O
STUDY	O

Basophils	O
0	B-labvalue
%	I-labvalue

Mahoney	O
had	O
been	O
following	O
with	O
their	O
appreciated	O
recommendations	O
on	O
glucose	O
control	O
.	O

-	O
SSI	O
cover	O

He	O
was	O
hemodynamically	O
stable	O
and	O
sent	O
up	O
to	O
the	O
floor	O
on	O
*	O
*	O
DATE	O
[	O
Aug	B-temporal
24	I-temporal
2007	I-temporal
]	O
.	O

FOLLOWUP	O
:	O

Pt	O
compliants	O
of	O
R	O
shooulder	B-bodyloc
and	O
elbow	B-bodyloc
pain	O
since	O
"	O
she	O
had	O
surgery	O
yesterday	B-temporal
afternoon	I-temporal
.	O

Sex	O
:	O

The	O
patient	O
is	O
alert	O
today	O
and	O
not	B-negation
agitated	O
.	O

1	O
.	O

He	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Nutrition	O
Service	O
,	O
who	O
followed	O
him	O
for	O
dietary	O
management	O
of	O
his	O
diabetes	O
mellitus	O
.	O

DISPOSITION	O
:	O

As	O
tolerated	O
.	O

The	O
patient	O
was	O
treated	O
with	O
p	B-route
.	I-route
o	I-route
.	I-route

General	O
Exam	O

R	O
shoulder	O
,	O
elbow	B-bodyloc
pain	O
geting	O
better	B-course
,	O
Pt	O
can	O
lifts	O
her	O
R	O
arms	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

No	B-negation
edema	O
.	O

08-09-93	B-temporal

This	O
patient	O
is	O
doing	O
well	O
.	O

D	O
:	O

The	O
patient	O
was	O
also	O
treated	O
for	O
presumptively	O
for	O
her	O
COPD	O
exacerbation	O
,	O
was	O
started	O
on	O
a	O
10	B-duration
-	I-duration
day	I-duration
course	I-duration
of	O
doxycycline	O
as	O
well	O
as	O
started	O
on	O
oral	B-route
prednisone	O
.	O

Attending	O
:	O
Christopher	O
KJ	O
Cater	O
,	O
M	O
.	O
D	O
.	O

Trauma	O
series	O
demonstrated	O
no	B-negation
evidence	O
of	O
a	B-bodyloc
pelvic	I-bodyloc
fracture	O
.	O

3	O
.	O

HPI	O
:	O

It	O
was	O
not	O
associated	O
with	O
any	O
nausea	O
or	O
vomiting	O
.	O

R	O
:	O

2012-06-08	B-temporal

She	O
came	O
from	O
Czech	O
Republic	O
14	O
years	O
ago	O
.	O

PROCEDURE	O
:	O

rifaximin	O
,	O
400	B-strength
mg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
TID	B-frequency
,	O
Drug	O
Form	O
:	O
Tab	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
14:00:00	B-temporal

PAST	O
GYNECOLOGIC	O
HISTORY	O
:	O

On	O
admission	O
revealed	O
a	O
middle	O
aged	O
man	O
in	O
no	B-negation
distress	O
.	O

3	O
Vertigo	O
.	O

Interoperatively	O
,	O
he	O
was	O
positive	O
two	O
liters	O
with	O
a	O
stable	O
blood	O
pressure	O
and	O
heart	O
rate	O
,	O
although	O
requiring	O
some	O
neo	O
-	O
synephrine	O
interoperatively	O
.	O

2	O
.	O

This	O
was	O
especially	O
associated	O
with	O
anxiety	O
in	O
anticipation	O
of	O
procedures	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
was	O
afebrile	O
.	O

CONDITION	O
:	O

2	O
.	O

Later	O
patient	O
told	O
CMED	O
CCU	O
that	O
she	O
was	O
feeling	O
down	O
and	O
impulsively	O
ingested	O
5	O
days	O
worth	O
of	O
medications	O
,	O
she	O
states	O
that	O
her	O
intent	O
at	O
that	O
time	O
was	O
to	O
end	O
her	O
life	O
.	O

Plavix	O
75	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

1941-03-23	B-temporal

Discharge	O
Summary	O

Lamictal	O
100	B-strength
mg	I-strength
po	B-route
bid	B-frequency

10	O
.	O

CHEST	O
(	O
PORTABLE	O
AP	O
)	O

She	O
is	O
currently	O
on	O
Zosyn	O
and	O
vancomycin	O
for	O
approximately	O
8	B-duration
more	I-duration
days	I-duration
.	O

MC0	O

Neuro	O
:	O

Date	O
of	O
Birth	O
:	O

PATIENT	O
NAME	O
:	O

She	O
was	O
out	O
of	O
bed	O
ambulating	O
,	O
tolerating	O
a	O
regular	O
diet	O
,	O
voiding	O
spontaneously	O
.	O

Abdomen	O
:	O
bowel	O
sounds	O
:	O
normal	B-labvalue
.	O

SSI	O
and	O
accuchecks	O
.	O

D	O
:	O

Abs	O
Eos	O
,	O
auto	O
0	B-labvalue
.	I-labvalue
2	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

Dilantin	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-duration
.	I-duration
i	I-duration
.	I-duration
d	I-duration
.	I-duration

ATTENDING	O
PHYSICIAN	O
:	O

(	O
1	O
)	O
GERD	O
;	O
(	O
2	O
)	O
Pneumonia	O
with	O
partially	O
collapsed	O
lung	B-bodyloc
in	O
1999	B-temporal
.	O

his	O
risk	O
of	O
bleeding	O
.	O

07-30-93	B-temporal

NKA	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
.	O

He	O
refused	O
an	O
NG	O
lavage	O
.	O

ONCLUSIONS	O
:	O

His	O
iron	O
saturation	O
was	O
greater	B-labvalue
than	I-labvalue
87	I-labvalue
%	I-labvalue
.	O

Coronary	B-bodyloc
artery	I-bodyloc
disease	O
(	O
as	O
noted	O
previously	O
)	O
.	O

2014-10-21	B-temporal

CBC	O
-	O
White	O
blood	O
cell	O
count	O
8	B-labvalue
.	I-labvalue
82	I-labvalue
,	O
hemoglobin	O
15	B-labvalue
.	I-labvalue
2	I-labvalue
,	O
hematocrit	O
43	B-labvalue
,	O
and	O
platelets	O
322	B-labvalue
.	O

#	O
CAD	O
/	O
CHF	O
-	O
The	O
patient	O
was	O
restarted	O
on	O
his	O
home	O
regimen	O
prior	O
to	O
discharge	O
as	O
it	O
was	O
held	O
temporarily	O
given	O
his	O
acute	B-course
GI	B-bodyloc
bleed	O
.	O

MEDICATIONS	O
AT	O
THE	O
TIME	O
OF	O
DISCHARGE	O
:	O

Sacral	B-bodyloc
decubitus	O
ulcer	O
.	O

Physical	O
Examination	O

2012-06-07	B-temporal

Her	O
BNP	O
was	O
elevated	B-labvalue
at	O
920	B-labvalue
.	O

2	O
.	O

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

Nitroglycerin	O
SR	O
2	B-strength
.	I-strength
5	I-strength
mg	I-strength
twice	B-frequency
a	I-frequency
day	I-frequency
.	O

Repeat	O
hcts	O
were	O
stable	O
.	O

He	O
had	O
a	O
urine	O
C	O
and	O
S	O
which	O
was	O
detailed	O
as	O
above	O
.	O

*	O
*	O
AGE	O
[	O
in	O
30s	O
]	O
years	O

There	O
was	O
stranding	O
along	O
the	O
pancreas	B-bodyloc
,	O
but	O
no	B-negation
necrosis	O
,	O
abscess	O
,	O
or	O
pseudocyst	O
.	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
06	I-temporal
2007	I-temporal
]	O
13:28:35	B-temporal

Calcified	O
tendoniti	O
?	B-uncertain

INDICATION	O
:	O
Intraparenchymal	B-bodyloc
hemorrhage	O
after	O
fall	O
.	O

KP91	O
KX681	O
/	O
6848	O

Avascular	O
necrosis	O
and	O
degenerative	O
joint	B-bodyloc
disease	O
,	O
osteoarthrosis	O
secondary	O
to	O
the	B-bodyloc
left	I-bodyloc
hip	I-bodyloc
joint	I-bodyloc
now	O
status	O
post	O
left	O
total	O
hip	O
arthroplasty	O
.	O

Opacified	O
and	O
sclerotic	O
left	B-bodyloc
mastoid	I-bodyloc
air	I-bodyloc
cells	I-bodyloc
are	O
noted	O
.	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
30	I-temporal
2007	I-temporal
]	O

HOSPITAL	O
COURSE	O
:	O

Her	B-bodyloc
abdomen	I-bodyloc
was	O
notable	O
for	O
voluntary	O
guarding	O
but	O
no	B-negation
involuntary	O
guarding	O
or	O
rebound	O
,	O
mild	B-severity
right	B-bodyloc
lower	I-bodyloc
quadrant	I-bodyloc
tenderness	O
greater	O
than	O
left	O
lower	O
quadrant	O
,	O
nondistended	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Course	O

General	O
Results	O

Gentamicin	O
,	O
and	O
ibuprofen	O
.	O

When	O
his	O
O2	O
saturation	O
was	O
monitored	O
,	O
his	O
pulse	O
oximetry	O
remained	O
in	O
the	O
90s	O
during	O
his	O
stay	O
.	O

Coumadin	O
was	O
initially	O
held	O
.	O

She	O
has	O
had	O
a	O
procedure	O
for	O
left	O
lumbar	O
sympathetic	O
block	O
under	O
fluoroscopy	O
.	O

Supple	O
with	O
no	B-negation
evidence	O
of	O
adenopathy	O
.	O
.	O

This	O
is	O
a	O
49	O
-	O
year	O
-	O
old	O
gravida	O
III	O
,	O
para	O
II	O
,	O
status	O
post	O
uterine	O
artery	O
embolization	O
on	O
2009-01-07	B-temporal
due	O
to	O
uterine	B-bodyloc
fibroids	O
,	O
with	O
continued	B-course
abdominal	B-bodyloc
pain	O
and	O
CT	O
scan	O
revealing	O
fluid	O
and	O
gas	O
in	O
the	O
endometrial	B-bodyloc
cavity	O
.	O

11	O
.	O

He	O
will	O
be	O
discharged	O
on	O
Trental	O
400	B-strength
mg	I-strength
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

CXR	O
:	O

Cardiovascular	O
:	O

Chemistry	O
-	O
7	O
was	O
unremarkable	O
.	O

Given	O
the	O
elevated	O
stroke	O
risk	O
of	O
aortic	O
cross	O
-	O
clamping	O
in	O
the	O
setting	O
of	O
this	O
finding	O
,	O
the	O
plan	O
for	O
a	O
bypass	O
graft	O
was	O
aborted	O
.	O

His	O
coumadin	O
was	O
held	O
during	O
his	O
stay	O
given	O
his	O
acute	B-course
bleed	O
but	O
restarted	O
per	O
his	O
PCP	O
with	O
the	O
guidance	O
of	O
GI	O
on	O
the	O
day	O
of	O
discharge	O
.	O

*	O
*	O
NAME	O
[	O
VVV	O
UUU	O
]	O
will	O
call	O
with	O
any	O
adjustments	O
to	O
Coumadin	O
dosing	O
as	O
needed	O
.	O

She	O
has	O
no	B-negation
visible	O
rashes	O
on	O
skin	O
exam	O
.	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

TECHNIQUE	O
:	O
Axial	O
noncontrast	O
CT	O
scans	O
of	O
the	O
brain	O
were	O
obtained	O
.	O

FEN	O
-	O
Low	O
Na	O
+	O
will	O
fluid	O
restrict	O
and	O
check	O
electrolyte	O
status	O
in	O
the	O
AM	O
.	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
11	I-temporal
2008	I-temporal
]	O

Benign	B-severity
essential	O
hypertension	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
22	I-temporal
2007	I-temporal
]	O
09	B-temporal
:	I-temporal
00	I-temporal
)	O

MRN	O
-	O
*	O
*	O
ID	O
-	O
NUM	O
-	O
MPACCOMMMRN	O

Advair	O
Diskus	O
250	B-strength
/	I-strength
50	I-strength
1	B-dosage
puff	B-form
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Social	O
History	O
:	O

Vital	O
signs	O

Patient	O
was	O
found	O
at	O
group	O
home	O
in	B-temporal
am	I-temporal
laying	O
on	O
floor	O
by	O
bed	O
unresponsive	O
,	O
last	O
seen	O
awake	O
8	O
hours	O
prior	O
at	O
dinner	O
.	O

Family	O
history	O
is	O
not	O
significant	O
for	O
any	O
early	O
history	O
of	O
coronary	B-bodyloc
artery	I-bodyloc
disease	O
.	O

4	O
.	O

Weight	O
Method	O
Bedscale	O

75	O
-	O
285	O

She	O
will	O
need	O
to	O
have	O
a	O
close	O
followup	O
to	O
monitor	O
her	O
glucose	O
given	O
high	B-dosage
doses	I-dosage
of	O
steroid	O
therapy	O
.	O

R	O
:	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
08	I-temporal
2007	I-temporal
]	O
22:36:23	B-temporal
/	I-temporal
rec	I-temporal

(	O
End	O
of	O
Report	O
)	O

Derm	O
.	O

CMED	O
CSRU	O
Course	O
:	O

2	O
)	O
You	O
are	O
scheduled	O
to	O
have	O
your	O
staples	O
removed	O
on	O
2013-11-20	B-temporal
3	B-temporal
:	I-temporal
00	I-temporal
with	O
provider	O
:	O
Leah	O
,	O
Paula	O
G	O
.	O

Dr	O
.	O
*	O
*	O
NAME	O
[	O
VVV	O
]	O
on	O
*	O
*	O
DATE	O
[	O
Dec	B-temporal
7	I-temporal
2007	I-temporal
]	O
,	O
at	O
the	O
*	O
*	O
INSTITUTION	O
office	O
at	O
2	B-temporal
p	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal

Dictated	O
By	O
:	O
Catherine	O
K	O
Thomas	O
,	O
M	O
.	O
D	O
.	O

5	O
.	O

Past	O
Medical	O
History	O
:	O

*	O
*	O
AGE	O
[	O
in	O
70s	O
]	O
years	O

S1	O
:	O
normal	B-labvalue
,	O
S2	O
:	O
normal	B-labvalue
.	O

Cc	O
:	O

2011-03-23	B-temporal

*	O
*	O
NAME	O
[	O
YYY	O
]	O

2010-08-26	B-temporal

ABS	O
Basophils	O
0	B-labvalue
.	I-labvalue
0	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

The	O
epidural	O
was	O
placed	O
in	O
the	O
L1	O
-	O
2	O
region	O
and	O
the	O
catheter	O
was	O
placed	O
in	O
the	O
T7	O
region	O
using	O
fluoroscope	O
to	O
guide	O
the	O
catheter	O
.	O

left	O
internal	O
mammary	O
artery	O
to	O
anterior	O
descending	O
artery	O
x	O
1	O
.	O

Job	O
ID	O
:	O

Actonel	O
35	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
weekly	B-frequency
a	O
.	O
c	O
.	O

Admission	O
Date	O
:	O

Alcohlism	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

Mild	B-severity
swelling	O
was	O
noted	O
in	O
the	B-bodyloc
left	I-bodyloc
hand	I-bodyloc
.	O

Admission	O
Date	O
:	O

VERIFY	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
L	O

*	O
*	O
INSTITUTION	O

Discharge	O
Date	O
:	O

XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

7	O
.	O

347071	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

Addendum	O
:	O

Results	O
to	O
return	O
in	O
approximately	O
1	O
week	O
.	O

The	O
lateral	O
masses	O
of	O
C1	O
articulate	O
normally	O
about	O
the	O
odontoid	O
process	O
.	O

MD	O

T	O
:	O

At	O
that	B-temporal
time	I-temporal
,	O
she	O
denied	B-negation
any	O
significant	O
dyspnea	O
or	O
chest	B-bodyloc
pain	O
or	O
coughing	O
or	O
sputum	O
.	O

MRSA	O
conjunctivitis	O
,	O
*	O
*	O
DATE	O
[	O
Jan	O
]	O
attribute	O
to	O
chronic	B-course
dry	O
eyes	B-bodyloc
(	O
eyelid	B-bodyloc
problems	O
and	O
tear	B-bodyloc
duct	I-bodyloc
problem	O
)	O
PT	O
can	O
close	O
her	O
eyes	O
normally	O
.	O

3	O
.	O

Batch	O
:	O

Plavix	O
75	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency

No	B-negation
other	O
abnormalities	O
were	O
noted	O
.	O

She	O
was	O
raised	O
in	O
multiple	O
foster	O
care	O
homes	O
because	O
her	O
mother	O
could	O
not	O
care	O
for	O
her	O
.	O

The	O
patient	O
is	O
a	O
comfort	O
measures	O
.	O

Atenolol	O
25	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
0	B-dosage
.	I-dosage
5	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

2	O
.	O
)	O
Atenolol	O
12	B-strength
.	I-strength
5mg	I-strength
daily	B-frequency

CV	O
-	O
SVT	O
:	O
serial	O
tropnins	O
neg	B-labvalue
/	O
EKG	O
(	O
-	B-labvalue
)	O
.	O

spironolactone	O
(	O
SPIRONOLACTONE	O
25	B-strength
MG	I-strength
TABLET	B-form
)	O
,	O
100	B-strength
mg	I-strength
,	O
Tab	B-form
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Routine	O
,	O

No	B-negation
further	O
intervention	O
was	O
done	O
.	O

Status	O
post	O
laparotomy	O
for	O
an	O
ovarian	B-bodyloc
cyst	O
in	O
1988	B-temporal
.	O

MRI	O
of	O
the	O
head	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
8	I-temporal
2007	I-temporal
]	O
,	O
showed	O
extensive	O
presumed	O
small	B-bodyloc
-	I-bodyloc
vessel	I-bodyloc
ischemic	O
changes	O
within	O
the	O
brainstem	O
.	O

He	O
did	O
have	O
runs	O
of	O
nonsustained	O
ventricular	B-bodyloc
tachycardia	O
,	O
which	O
were	O
clinically	O
stable	O
.	O

The	O
patient	O
was	O
discharged	O
in	O
stable	O
conditionand	O
will	O
follow	O
up	O
for	O
(	O
1	O
)	O
sacral	O
decubitus	O
closure	O
,	O
and	O
(	O
2	O
)	O
placement	O
of	O
epidural	O
pump	O
in	O
the	O
future	O
.	O

Temperature	O
98	B-labvalue
.	I-labvalue
4	I-labvalue
Deg	I-labvalue
F	I-labvalue

*	O
*	O
DATE	O
[	O
Mar	B-temporal
11	I-temporal
2007	I-temporal
]	O

-	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
VVV	O
M	O
]	O
.	O

There	O
is	O
a	O
remote	O
right	B-bodyloc
frontal	I-bodyloc
infarct	O
.	O

9	O
.	O

Good	O
.	O

Labs	O
on	O
admit	O
:	O

In	O
general	O
,	O
she	O
was	O
sedated	O
at	O
the	O
time	O
,	O
responsive	O
to	O
stimuli	O
,	O
and	O
was	O
following	O
commands	O
.	O

*	O
*	O
*	O

GENERAL	O
MEDICINE	O

Heart	O
,	O
regular	B-labvalue
rhythm	O
.	O

Heparin	O
5000	B-strength
units	I-strength
subcu	B-route
q	B-frequency
.	I-frequency
8h	I-frequency
.	I-frequency

CV	O
:	O

Right	B-bodyloc
bundle	I-bodyloc
branch	I-bodyloc
block	O
.	O

Extremities	O
:	O

Social	O
History	O
:	O

insulin	O
glargine	O
,	O
22	B-dosage
Unit	I-dosage
(	I-dosage
s	I-dosage
)	I-dosage
,	O
subQ	B-route
,	O
At	B-frequency
Bedtime	I-frequency
,	O
Drug	O
Form	O
:	O
Injection	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
21:00:00	B-temporal

The	O
back	B-bodyloc
was	O
notable	O
for	O
tenderness	O
at	O
the	O
level	O
of	O
L3	B-bodyloc
-	I-bodyloc
L5	I-bodyloc
.	O

Clearly	O
her	O
hypertension	O
was	O
labile	O
and	O
anxiety	O
related	O
.	O

Os	O
-	O
Cal	O
with	O
vitamin	O
D	O
500	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Prednisone	O
10	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
x	O
3	B-duration
days	I-duration
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
3	B-duration
days	I-duration
.	O

-	O
-	O
2	O
/	O
6	O
SEM	O
LLSB	O
-	O
-	O
&	O
gt	O
;	O
t	O
/	O
c	O
ECHO	O

Health	O
Status	O

The	O
patient	O
asked	O
to	O
come	O
back	O
as	O
C	O
.	O
diff	O
culture	O
was	O
positive	B-labvalue
.	O

2	O
.	O

-	O
Warm	O
compress	O
for	O
the	O
R	O
arm	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
13	I-temporal
2007	I-temporal
]	O
02:39:59	B-temporal

RBC	O
2	B-labvalue
.	I-labvalue
92	I-labvalue
X10E	I-labvalue
+	I-labvalue
12	I-labvalue
/	I-labvalue
L	I-labvalue
Low	B-labvalue

Our	O
assessment	O
is	O
that	O
this	O
is	O
secondary	O
to	O
drug	O
intoxication	O
and	O
underlying	O
psychiatric	O
illness	O
.	O

Service	O
:	O

1	O
.	O

This	O
morning	O
he	O
has	O
done	O
much	O
better	O
off	O
the	O
BiPAP	O
with	O
comfortable	O
respiratory	O
rate	O
between	O
18	B-labvalue
and	I-labvalue
24	I-labvalue
breaths	I-labvalue
per	I-labvalue
minute	I-labvalue
,	O
oxygen	O
saturations	O
in	O
the	O
mid	O
-	O
90s	O
on	O
the	O
6	O
liter	O
oximyzer	O
.	O

1	O
.	O

Arthritis	O
.	O

Cardiomegaly	O
.	O

MEDICINE	O

From	O
2	B-temporal
/	I-temporal
25	I-temporal
-	O
2/27/00	B-temporal
,	O
the	O
patient	O
&apos;s	O
fever	O
defervesced	O
and	O
his	O
abdominal	B-bodyloc
pain	O
gradually	O
subsided	O
.	O

He	O
had	O
a	O
history	O
of	O
gout	O
.	O

Discharge	O
Instructions	O
:	O

Completed	O
by	O
:	O
Jill	O
Kelly	O
MD	O
47	O
-	O
482	O
2013-11-16	B-temporal
@	O
1550	B-temporal

MRN	O
:	O

CT	O
HEAD	O
W	O
/	O
O	O
CONTRAST	O

Lungs	O
were	O
clear	O
bilaterally	O
.	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
23	I-temporal
1963	I-temporal
]	O

Transfer	O
Summary	O

Patient	O
:	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

ABG	O
revealed	O
widened	O
A	O
-	O
a	O
gradient	O
so	O
a	O
d	O
-	O
dimer	O
was	O
sent	O
which	O
was	O
elevated	O
.	O

5	O
.	O

1	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
16	I-temporal
2008	I-temporal
]	O
11	B-temporal
:	I-temporal
40	I-temporal
AM	I-temporal

PAST	O
MEDICAL	O
HISTORY	O
:	O

ALLRESLTSECT	O

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

He	O
remained	O
in	O
normal	O
sinus	O
rhythm	O
.	O

Discharge	O
Condition	O
:	O

4	O
.	O

Gen	O
:	O
caucasian	O
man	O
lying	O
in	O
bed	O
,	O
NAD	O

Her	O
lungs	O
were	O
clear	B-labvalue
to	O
auscultation	O
anteriorly	O
.	O

Modifinal	O
100	B-strength
mg	I-strength
po	B-route
qd	B-frequency

*	O
*	O
NAME	O
[	O
TTT	O
M	O
SSS	O
]	O

08-10-93	B-temporal

ADMISSION	O
DATE	O
:	O

NEURO	O
:	O

Levofloxacin	O
500	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
Q24H	B-frequency
(	O
every	B-frequency
24	I-frequency
hours	I-frequency
)	O
for	O
3	B-duration
days	I-duration
.	O

HPI	O
:	O
Pt	O
is	O
a	O
71	O
y	O
/	O
o	O
male	O
with	O
h	O
/	O
o	O
dm2	O
,	O
cad	O
s	O
/	O
p	O
cabg	O
,	O
DVT	O
/	O
PE	O
on	O
long	O
term	O
anti	O
-	O
coagulation	O
,	O
ulcerative	O
colitis	O
on	O
Asacol	O
presents	O
with	O
brbpr	O
starting	O
at	O
9am	B-temporal
of	I-temporal
the	I-temporal
morning	I-temporal
of	O
admission	O
.	O

Extended	O
Care	O

Per	O
report	O
,	O
there	O
were	O
empty	O
bottles	O
of	O
Inderal	O
and	O
Klonopin	O
found	O
at	O
bedside	O
,	O
as	O
well	O
as	O
02	O
-	O
26	O
full	O
bottles	O
of	O
geodon	O
,	O
gabapentin	O
,	O
Lescol	O
and	O
paroxitine	O
.	O

EVALUATION	O
DATE	O
:	O

PHYSICAL	O
EXAM	O
:	O

I	O
have	O
asked	O
Wound	O
Care	O
to	O
come	O
by	O
and	O
see	O
that	O
.	O

DOB	O
:	O

Cl	O
101	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

She	O
went	O
to	O
her	O
primary	O
care	O
physician	O
'	O
s	O
office	O
on	O
the	O
day	O
of	O
admission	O
complaining	O
of	O
abdominal	B-bodyloc
pain	O
,	O
which	O
she	O
stated	O
was	O
constant	O
but	O
intermittently	O
sharper	O
at	O
times	O
.	O

MRN	O
:	O

Periods	O
regular	O
.	O

The	O
patient	O
remained	O
comfortable	O
.	O

The	O
right	B-bodyloc
leg	I-bodyloc
was	O
with	O
decreased	B-course
range	O
of	O
motion	O
of	O
thigh	O
flexion	O
and	O
extension	O
.	O

Insertion	O
of	O
intra	O
-	O
aortic	O
balloon	O
pump	O
.	O

Extremities	O

*	O
*	O
INITIALS	O

Respiratory	O
Rate	O
20	B-labvalue

The	O
patient	O
has	O
a	O
50	O
%	O
mortality	O
risk	O
the	O
next	O
month	O
.	O

Patient	O
seen	O
by	O
PT	O
and	O
OT	O
who	O
recommended	O
hand	O
exercises	O
and	O
splints	O
for	O
patient	O
.	O

ADMISSION	O
DATE	O
:	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
21	I-temporal
2007	I-temporal
]	O
09:06:44	B-temporal
PM	I-temporal

However	O
,	O
he	O
was	O
awake	O
and	O
alert	O
and	O
able	O
to	O
answer	O
questions	O
.	O

The	O
patient	O
'	O
s	O
actual	O
date	O
of	O
discharge	O
was	O
2011-03-21	B-temporal
.	O

Loud	O
S4	O
and	O
a	O
II	O
/	O
VI	O
regurgitant	O
murmur	O
.	O

MCV	O
74	B-labvalue
.	I-labvalue
6	I-labvalue
fL	I-labvalue
Low	B-labvalue

If	O
the	O
patient	O
does	O
not	O
have	O
a	O
history	O
of	O
a	O
primary	O
malignancy	O
,	O
followup	O
CT	O
of	O
the	O
chest	O
in	B-temporal
1	I-temporal
year	I-temporal
is	O
recommended	O
to	O
evaluate	O
for	O
stability	O
of	O
this	O
finding	O
.	O

PLT	O
COUNT	O
-	O
102	B-labvalue
*	I-labvalue

Progress	O
Note	O

General	O
Exam	O

Liver	O
function	O
tests	O
were	O
significant	O
for	O
an	O
ALT	O
41	B-labvalue
,	O
AST	O
31	B-labvalue
,	O
alk	O
phos	O
76	B-labvalue
,	O
T	O
.	O
bili	O
0	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
D	O
.	O
bili	O
0	B-labvalue
.	I-labvalue
2	I-labvalue
,	O
amylase	O
345	B-labvalue
,	O
lipase	O
2510	B-labvalue
,	O
T	O
.	O
protein	O
8	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
albumin	O
4	B-labvalue
.	I-labvalue
9	I-labvalue
,	O
globulin	O
3	B-labvalue
.	I-labvalue
2	I-labvalue
,	O
Ca	O
9	B-labvalue
.	I-labvalue
9	I-labvalue
.	O

The	O
patient	O
did	O
spike	O
fevers	O
postoperatively	O
on	O
multiple	O
occasions	O
.	O

Signed	O

Thus	O
,	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

*	O
*	O
ROOM	O

EXTREMITIES	O
:	O

No	B-negation
abscess	O
or	O
pseudocyst	O
.	O

Patient	O
:	O

SOCIAL	O
HISTORY	O
:	O

By	O
report	O
,	O
the	O
patient	O
was	O
ejected	O
from	O
the	O
vehicle	O
on	O
impact	O
and	O
found	O
curled	O
in	O
the	O
fetal	O
position	O
at	O
the	O
rear	O
of	O
the	O
vehicle	O
at	O
the	O
scene	O
.	O

Rectal	O
bleeding	O
from	O
inferior	B-bodyloc
mesenteric	I-bodyloc
artery	I-bodyloc
tributaries	O
supplying	O
sigmoid	B-bodyloc
colon	I-bodyloc
.	O

The	O
patient	O
was	O
alert	O
but	O
in	O
mild	B-severity
discomfort	O
.	O

Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
on	O
Tuesday	O
,	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
16	I-temporal
2007	I-temporal
]	O
,	O
at	O
10	B-temporal
:	I-temporal
45	I-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal

Prolong	O
QT	O
/	O
Lone	O
Afib	O
-	O
cardiology	O
consult	O
.	O

The	O
patient	O
'	O
s	O
pelvis	O
was	O
stable	O
to	O
AP	O
and	O
lateral	O
compression	O
.	O

He	O
currently	O
drinks	O
10	O
beers	O
every	O
other	O
day	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

Traumatic	O
/	O
pressure	O
bullae	O

Echocardiogram	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
6	I-temporal
2007	I-temporal
]	O
,	O
showed	O
ejection	O
fraction	O
of	O
55	B-labvalue
%	I-labvalue
,	O
mild	B-course
mitral	B-bodyloc
insufficiency	O
,	O
and	O
1	O
+	O
tricuspid	B-bodyloc
insufficiency	O
with	O
mild	B-course
pulmonary	B-bodyloc
hypertension	O
.	O

He	O
was	O
then	O
transferred	O
to	O
the	O
general	O
medicine	O
service	O
for	O
further	O
management	O
.	O

DAIZSMAELLILLE	O
,	O
M	O
.	O
D	O
.	O

Mr	O
.	O
Vazquez	O
is	O
a	O
48	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
hepatitis	O
C	O
,	O
bipolar	O
disorder	O
with	O
suicide	O
attempts	O
in	O
the	O
past	O
,	O
recent	O
CMED	O
admit	O
earlier	O
in	O
4	B-temporal
/	I-temporal
05	I-temporal
who	O
was	O
found	O
alert	O
approximately	O
one	B-temporal
hour	I-temporal
after	I-temporal
taking	O
an	O
unspecified	O
number	O
of	O
pills	O
.	O

Labs	O
are	O
detailed	O
in	O
the	O
resident	O
note	O
and	O
reviewed	O
by	O
me	O
in	O
their	O
entirety	O
.	O

3	O
.	O

2	O
.	O

BP	O
Site	O
Left	O
Arm	O

Continue	O
nebs	O
.	O

Hgb	O
10	B-labvalue
.	I-labvalue
6	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

ABS	O
Neutrophils	O
2	B-labvalue
.	I-labvalue
50	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

Atrial	B-bodyloc
fibrillation	O
(	O
on	O
Coumadin	O
)	O

-	O
-	O
INR	O
therapeutic	O
;	O
follow	O

Please	O
f	O
/	O
u	O
with	O
PCP	O
D	O
2	O
weeks	O
.	O

Admitted	O
:	O

2012-10-31	B-temporal
05	B-temporal
:	I-temporal
47PM	I-temporal
URINE	O

Acute	B-course
alcoholic	O
hepatitis	O
.	O

Fluticasone	O
50	B-strength
mcg	I-strength
/	O
Actuation	B-form
Aerosol	I-form
,	I-form
Spray	I-form
Sig	O
:	O
Two	B-dosage
(	O
2	O
)	O
Spray	O
Nasal	O
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

While	O
in	O
the	O
PACU	O
,	O
Anesthesia	O
was	O
called	O
because	O
the	O
patient	O
became	O
dyspneic	O
and	O
tachypneic	O
and	O
his	O
SAO2	O
dropped	O
to	O
89	B-labvalue
%	I-labvalue
.	O

STRUCTURALLY	O
NORMAL	O
MITRAL	O
AND	O
TRICUSPID	O
VALVE	O
.	O

She	O
is	O
not	O
a	O
smoker	O
.	O

Pt	O
may	O
not	O
be	O
good	O
candidate	O
for	O
Surgery	O
.	O

Benzodiazapine	O
Overdose	O

Smokes	O
1ppd	O
.	O

Hypothyroidism	O

He	O
did	O
not	O
remember	O
some	O
of	O
the	O
conversations	O
that	O
I	O
had	O
with	O
him	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
22	I-temporal
2007	I-temporal
]	O
.	O

By	O
04	B-temporal
-	I-temporal
03	I-temporal
,	O
captopril	O
and	O
atenolol	O
were	O
started	O
,	O
and	O
the	O
patient	O
'	O
s	O
leg	O
bandage	O
from	O
the	O
vein	O
harvest	O
was	O
removed	O
.	O

Full	O
range	O
of	O
motion	O
with	O
no	B-negation
lymphadenopathy	O
.	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
19	I-temporal
2008	I-temporal
]	O
02:55:22	B-temporal
PM	I-temporal

There	O
is	O
no	B-negation
atlantoaxial	B-bodyloc
subluxation	O
.	O

Matebolic	O
:	O

T	O
:	O

6	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

His	O
glucose	O
is	O
109	B-labvalue
.	O

3	O
.	O

ATRIAL	B-bodyloc
FIBRILLATION	O
(	O
ICD9	O
427	O
.	O
31	O
,	O
Working	O
,	O
Problem	O
)	O

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

calcium	O
acetate	O
,	O
667	B-strength
mg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
TID	B-frequency
meals	I-frequency
,	O
Drug	O
Form	O
:	O
Cap	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
7:00:00	B-temporal

CORRECTED	O
REPORT	O
-	O
DATE	O

05	O
-	O
383	O

Blood	O
pressure	O
132	B-labvalue
/	I-labvalue
48	I-labvalue
.	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

HOSPITAL	O
COURSE	O
:	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
15	I-temporal
2007	I-temporal
]	O
15:40:01	B-temporal

Other	O
concerns	O
during	O
his	O
stay	O
was	O
his	O
kidney	O
function	O
,	O
due	O
to	O
his	O
renal	O
transplant	O
in	O
2003	B-temporal
.	O

He	O
was	O
also	O
given	O
5mg	B-strength
of	O
glucagon	O
and	O
started	O
on	O
a	O
glucagon	O
drip	O
with	O
good	O
response	O
.	O

3	O
.	O

D	O
:	O

Occipital	B-bodyloc
scalp	I-bodyloc
laceration	O
.	O

5	O
.	O

Date	O
of	O
Birth	O
:	O

4	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Author	O
:	O

His	O
intra	O
-	O
aortic	O
balloon	O
pump	O
was	O
weaned	O
the	O
following	O
day	O
and	O
he	O
was	O
transferred	O
out	O
of	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
.	O

FOMAIRE	O
KOTEKOTEJESCDREWE	O
,	O
M	O
.	O
D	O
.	O

ALLERGIES	O
:	O

Surgery	O
was	O
consulted	O
and	O
followed	O
him	O
while	O
he	O
was	O
in	O
house	O
.	O

Metoprolol	O
100	B-strength
mg	I-strength
twice	B-frequency
a	I-frequency
day	I-frequency
.	O

Her	O
heart	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
faint	O
second	O
heart	B-bodyloc
sound	O
and	O
second	O
heart	O
sound	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

CRNP	O

Quality	O
Measures	O

Admission	O
Date	O
:	O

*	O
*	O
INSTITUTION	O

She	O
complained	O
of	O
a	O
sore	O
throat	B-bodyloc
which	O
was	O
likely	O
the	O
etiology	O
of	O
her	O
atypical	O
chest	B-bodyloc
complaints	O
.	O

Chest	O
with	O
clear	O
respiratory	O
sounds	O
bilaterally	O
.	O

Home	O
Care	O
.	O

There	O
is	O
no	B-negation
skull	B-bodyloc
fracture	O
.	O

Sats	O
96	B-labvalue
%	I-labvalue
on	O
room	O
air	O
.	O

Her	O
vital	O
signs	O
were	O
stable	B-labvalue
.	O

CT	O
C	O
-	O
SPINE	O
W	O
/	O
O	O
CONTRAST	O
;	O
CT	O
RECONSTRUCTION	O

Had	O
a	O
normal	O
sinus	O
rhythm	O
.	O

Hgb	O
12	B-labvalue
.	I-labvalue
4	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

The	O
patient	O
is	O
to	O
follow	O
up	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
in	O
2	O
to	O
3	O
weeks	O
.	O

ATTENDING	O
PHYSICIAN	O
:	O

Labs	O
today	B-temporal
:	O

Provider	O
:	O
Greg	O
CLINIC	O
Phone	O
:	O
(	O
212	O
)	O
442	O
0438	O
Date	O
/	O
Time	O
:	O
2013-01-11	B-temporal
1	B-temporal
:	I-temporal
30	I-temporal

PORTAL	O
HYPERTENSION	O
(	O
ICD9	O
572	O
.	O
3	O
,	O
Working	O
,	O
Diagnosis	O
)	O

Decision	O
to	O
continue	O
Dobhoff	O
at	O
rehab	O
given	O
continued	O
clinical	O
improvement	O
and	O
his	O
poor	O
candidacy	O
for	O
G	O
/	O
J	O
tube	O
.	O

347338	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

CXR	O
:	O

DISCHARGE	O
SUMMARY	O

*	O
*	O
ID	O
-	O
NUM	O

T	O
:	O
2012-05-01	B-temporal
08	B-temporal
:	I-temporal
13	I-temporal

*	O
*	O
NAME	O
[	O
ZZZ	O
YYY	O
]	O
,	O
M	O
.	O
D	O
.	O

Poss	O
.	O
d	O
/	O
c	O
to	O
NH	O
for	O
physical	O
therapy	O
soon	O

Appropriate	O
laboratory	O
studies	O
were	O
taken	O
to	O
include	O
a	O
urinalysis	O
,	O
which	O
on	O
*	O
*	O
DATE	O
[	O
Oct	B-temporal
30	I-temporal
07	I-temporal
]	O
showed	O
positive	O
leukocyte	O
esterase	O
and	O
bacteria	O
indicative	O
of	O
a	O
urinary	B-bodyloc
tract	I-bodyloc
infection	O
.	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
15	I-temporal
2007	I-temporal
]	O

No	B-negation
rashes	O
or	O
petechiae	O
,	O
linear	O
and	O
burn	O
scars	O
as	O
above	O

Admission	O
Date	O
:	O

The	O
patient	O
does	O
have	O
a	O
history	O
of	O
renal	B-bodyloc
insufficiency	O
status	O
post	O
left	O
nephrectomy	O
due	O
to	O
renal	B-bodyloc
cell	O
carcinoma	O
.	O

3	O
.	O

IMPRESSION	O
:	O

Lungs	O
:	O
?	B-uncertain
decreased	B-course
BS	O
over	O
left	B-bodyloc
middle	I-bodyloc
lung	I-bodyloc
,	O
otherwise	O
CTA	O

History	O
of	O
placement	O
of	O
a	O
right	O
ureteral	O
stent	O
.	O

Eosinophils	O
0	B-labvalue
%	I-labvalue

Claude	O
U	O
Bolanos	O
,	O
M	O
.	O
D	O
.	O

PATIENT	O
NAME	O
:	O

will	O
check	O
his	O
hr	O
,	O
bp	O
after	O
that	O
.	O

6	O
.	O

If	O
it	O
comes	O
back	O
negative	B-negation
for	O
MRSA	O
,	O
we	O
can	O
likely	O
discontinue	O
the	O
vancomycin	O
;	O
although	O
,	O
with	O
vancomycin	O
we	O
will	O
check	O
the	O
trough	O
prior	O
to	O
referring	O
for	O
dose	O
.	O

Docusate	O
Sodium	O
150	B-strength
mg	I-strength
/	I-strength
15	I-strength
mL	I-strength
Liquid	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
PO	B-route
BID	B-frequency
(	O
2	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
.	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
16	I-temporal
2007	I-temporal
]	O
16	B-temporal
:	I-temporal
37	I-temporal

Admitted	O
:	O

There	O
,	O
his	O
vitals	O
were	O
intially	O
stable	O
with	O
a	O
hct	O
of	O
36	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
though	O
he	O
was	O
felt	O
to	O
be	O
hypovolemic	O
and	O
this	O
hemoconcentrated	O
;	O
his	O
previous	B-temporal
hct	O
was	O
39	B-labvalue
about	O
five	B-temporal
months	I-temporal
ago	I-temporal
.	O

He	O
does	O
have	O
two	O
monitors	O
at	O
home	O
and	O
he	O
says	O
old	O
glucometer	O
strips	O
.	O

12	O
.	O

Extremities	O

2012-06-08	B-temporal
09	B-temporal
:	I-temporal
30	I-temporal
AM	I-temporal
BLOOD	O
WBC	O
-	O
10	B-labvalue
.	I-labvalue
1	I-labvalue
RBC	O
-	O
4	B-labvalue
.	I-labvalue
35	I-labvalue
*	O
Hgb	O
-	O
14	B-labvalue
.	I-labvalue
2	I-labvalue
Hct	O
-	O
39	B-labvalue
.	I-labvalue
9	I-labvalue
*	O
MCV	O
-	O
92	B-labvalue
MCH	O
-	O
32	B-labvalue
.	I-labvalue
6	I-labvalue
*	O
MCHC	O
-	O
35	B-labvalue
.	I-labvalue
6	I-labvalue
*	O
RDW	O
-	O
12	B-labvalue
.	I-labvalue
4	I-labvalue
Plt	O
Ct	O
-	O
151	B-labvalue

PERSONAL	O
HISTORY	O
:	O

No	B-negation
m	O
/	O
r	O
/	O
g	O
'	O
s	O
appreciated	O
.	O
.	O

Condition	O
on	O
discharge	O
was	O
stable	O
.	O

The	O
patient	O
had	O
headache	O
that	O
was	O
relieved	O
only	O
with	O
oxycodone	O
.	O

Brief	O
Hospital	O
Course	O
:	O

4	O
.	O

Telephone	O
#	O
:	O

7	O
Ambien	O
10	B-strength
mg	I-strength
nightly	B-frequency
.	O

Course	O

Substance	O
abuse	O
in	O
mother	O
and	O
brother	O
.	O

Ativan	O
0	B-strength
.	I-strength
5	I-strength
mg	I-strength
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
anxiety	O
.	O

Acct	O
#	O
:	O

Zinc	O
sulfate	O
220	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
day	I-frequency
.	O

The	O
spinal	O
cord	O
stimulator	O
was	O
programmed	O
with	O
setting	O
of	O
a	O
rate	O
of	O
80	O
,	O
power	O
450	O
and	O
4	O
.	O
0	O
amps	O
.	O

Medicine	O
Progress	O

PAIN	O
IN	O
JOINT	B-bodyloc
INVOLVING	O
SHOULDER	B-bodyloc
REGION	O
(	O
ICD9	O
719	O
.	O
41	O
,	O
Working	O
,	O
Problem	O
)	O

4	O
.	O
)	O
Furosemide	O
10	B-strength
mg	I-strength
every	B-frequency
other	I-frequency
day	I-frequency

4	O
.	O

Abdomen	O
.	O

For	O
her	B-bodyloc
coronary	I-bodyloc
artery	I-bodyloc
disease	O
,	O
status	O
post	O
catheterization	O
,	O
she	O
was	O
given	O
Integrilin	O
for	O
18	B-duration
hours	I-duration
.	O

T	O
:	O

SHY	O
#	O
*	O
*	O
ID	O
-	O
NUM	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Suzanne	O
Simpson	O
on	O
:	O
FRI	O
2009-04-24	B-temporal
12	B-temporal
:	I-temporal
48	I-temporal
PM	I-temporal

Intubated	O
and	O
sedated	O

Her	O
mood	O
is	O
good	O
.	O

GENERAL	O
MEDICINE	O

01909607	O

9	O
.	O

The	O
patient	O
was	O
instructed	O
to	O
contact	O
her	O
primary	O
care	O
physician	O
and	O
/	O
or	O
contact	O
the	O
emergency	O
room	O
if	O
she	O
had	O
any	O
symptoms	O
including	O
but	O
not	O
limited	O
to	O
prolonged	O
fever	O
,	O
nausea	O
,	O
vomiting	O
,	O
chills	O
,	O
night	O
sweats	O
,	O
chest	B-bodyloc
pain	O
,	O
shortness	O
of	O
breath	O
,	O
palpitations	O
or	O
any	O
other	O
serious	O
complaints	O
.	O

1	O
.	O

Aluminum	O
-	O
Magnesium	O
Hydroxide	O
225	B-strength
-	I-strength
200	I-strength
mg	I-strength
/	I-strength
5	I-strength
mL	I-strength
Suspension	I-strength
Sig	O
:	O
15	B-dosage
-	I-dosage
30	I-dosage
ML	I-dosage
s	I-dosage
PO	B-route
PRN	B-frequency
(	O
as	B-frequency
needed	I-frequency
)	O
.	O

D	O
:	O

This	O
patient	O
is	O
going	O
to	O
be	O
followed	O
by	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
at	O
the	O
skilled	O
nursing	O
home	O
facility	O
and	O
after	O
this	O
intensive	O
therapy	O
,	O
she	O
might	O
be	O
able	O
to	O
go	O
home	O
.	O

His	O
ferritin	O
was	O
1530	B-labvalue
.	O

1	O
.	O

1	O
.	O

ATTENDING	O
PHYSICIAN	O
:	O

By	O
report	O
,	O
the	O
patient	O
has	O
an	O
outside	O
study	O
.	O

The	O
patient	O
'	O
s	O
trachea	O
was	O
noted	O
to	O
be	O
midline	O
.	O

Albuterol	O
Sulfate	O
0	B-strength
.	I-strength
083	I-strength
%	I-strength
Solution	I-strength
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
puff	O
Inhalation	B-route
Q6H	B-frequency
(	O
every	B-frequency
6	I-frequency
hours	I-frequency
)	O
as	B-frequency
needed	I-frequency
for	O
shortness	O
of	O
breath	O
or	O
wheezing	O
.	O

SV7	O

2	O
.	O

DIS	O

56	O
-	O
333	O

HOSPITAL	O
COURSE	O
:	O

Chest	O
was	O
clear	B-labvalue
to	O
auscultation	O
bilaterally	O
.	O

Small	O
amount	O
of	O
intraventricular	B-bodyloc
hemorrhage	O
.	O

Atenolol	O
25	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

She	O
noted	O
that	O
he	O
was	O
actively	O
working	O
full	O
time	O
and	O
was	O
a	O
sales	O
representative	O
at	O
the	O
Leigh	O
and	O
lives	O
at	O
home	O
with	O
her	O
and	O
his	O
daughter	O
,	O
age	O
18	O
.	O

The	O
patient	O
requested	O
an	O
outside	O
second	O
opinion	O
,	O
as	O
she	O
was	O
reluctant	O
to	O
undergo	O
hysterectomy	O
at	O
this	O
time	O
.	O

GERD	O

There	O
were	O
no	B-negation
rashes	O
.	O

Some	O
interstitial	B-bodyloc
edema	O
still	O
persists	O
,	O
but	O
there	O
is	O
no	B-negation
central	B-bodyloc
pulmonary	I-bodyloc
vascular	I-bodyloc
congestion	O
.	O

*	O
*	O
INSTITUTION	O

-	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
OOO	O
]	O
*	O
*	O
*	O

5	O
.	O

Condition	O
on	O
discharge	O
was	O
stable	O
and	O
asymptomatic	O
.	O

Sex	O
:	O

Alcohol	O
abuse	O
NOS	O
(	O
ICD9	O
305	O
.	O
00	O
,	O
Working	O
,	O
Diagnosis	O
)	O
cont	O
Thiamine	O
,	O
folic	O
acid	O
suppl	O

*	O
*	O
INSTITUTION	O

Discharge	O
Date	O
:	O

Atrial	O
fibrillation	O
.	O

MEDICINE	O

BP	O
stable	B-labvalue

Perform	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O
(	O
on	O
*	O
*	O
DATE	O
[	O
Dec	O
07	O
2007	O
]	O
15	B-temporal
:	I-temporal
16	I-temporal
)	O

Indeed	O
,	O
he	O
was	O
treated	O
with	O
diuretics	O
and	O
nitrates	O
along	O
with	O
cessation	O
of	O
his	O
aspirin	O
,	O
and	O
he	O
was	O
put	O
on	O
IV	B-route
Heparin	O
.	O

Initial	O
A	O
/	O
P	O
:	O

An	O
angiography	O
showed	O
bleeding	O
in	O
two	O
vessels	B-bodyloc
off	O
of	O
the	O
Minnie	O
supplying	O
the	O
sigmoid	B-bodyloc
that	O
were	O
succesfully	O
embolized	O
.	O

*	O
*	O
DATE	O
[	O
May	B-temporal
21	I-temporal
2007	I-temporal
]	O
10:46:42	B-temporal
PM	I-temporal

PAST	O
SURGICAL	O
HISTORY	O
:	O

Results	O
were	O
discussed	O
with	O
Dr	O
.	O
Leanne	O
Vazquez	O
in	O
the	O
early	B-temporal
afternoon	I-temporal
on	O
2014-10-21	B-temporal
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

DOB	O
:	O

10	O
.	O

SUSHA	O
I	O
.	O

ABS	O
Monocytes	O
1	B-labvalue
.	I-labvalue
0	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

On	O
2010-07-01	B-temporal
,	O
the	O
patient	O
was	O
discharged	O
from	O
the	O
hospital	O
with	O
instructions	O
for	O
follow	O
up	O
care	O
on	O
return	O
to	O
the	O
United	O
Kingdom	O
.	O

8	O
.	O

R	B-bodyloc
hand	I-bodyloc
and	I-bodyloc
arm	I-bodyloc
shoulder	I-bodyloc
no	B-negation
redness	O
,	O
no	B-negation
edema	O
,	O
no	B-negation
bony	O
diformity	O
.	O

10	O
.	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

Repeat	O
head	O
CT	O
showed	O
stable	B-course
bleed	O
.	O

She	O
had	O
moist	O
mucous	O
membranes	O
.	O

-	O
Continue	O
Bactrim	O
DS	O
BID	B-frequency
,	O
per	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
'	O
s	O
recommendation	O

History	O
of	O
renal	B-bodyloc
cell	O
carcinoma	O
status	O
post	O
left	O
nephrectomy	O
with	O
chronic	B-course
renal	B-bodyloc
insufficiency	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

ABS	O
Monocytes	O
0	B-labvalue
.	I-labvalue
50	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

TECHNIQUE	O
:	O
Noncontrast	O
cervical	O
spine	O
CT	O
.	O

Past	O
Medical	O
History	O
:	O

Credentials	O
and	O
Title	O
of	O
Author	O
*	O
*	O
NAME	O
[	O
VVV	O
]	O
Signing	O
this	O
Document	O
:	O

-	O
OOB	O
with	O
assisstent	O

Patient	O
recorded	O
as	O
having	O
No	B-negation
Known	O
Allergies	O
to	O
Drugs	O

INDICATION	O
:	O
72	O
-	O
year	O
-	O
old	O
male	O
with	O
altered	O
mental	O
status	O
.	O

Discharged	O
:	O

(	O
End	O
of	O
Report	O
)	O

Oxycodone	O
5	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
Q4H	B-frequency
(	O
every	B-frequency
4	I-frequency
hours	I-frequency
)	O
as	B-frequency
needed	I-frequency
for	O
pain	O
.	O

Propanolol	O
XL	O
80	B-strength
mg	I-strength
qd	B-frequency

Percocet	O
one	B-dosage
to	I-dosage
two	I-dosage
tablets	B-form
PO	B-route
q	B-frequency
.	I-frequency
4h	I-frequency
.	I-frequency
to	I-frequency
6h	I-frequency
.	I-frequency
p	I-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
pain	O
.	O

MEDICATIONS	O
:	O

Abdomen	O

For	O
that	O
reasons	O
,	O
we	O
performed	O
thoracentesis	O
that	O
showed	O
an	O
exudate	O
without	B-negation
signs	O
of	O
malignancy	O
on	O
the	O
cytological	O
examination	O
.	O

Dr	O
.	O
Thorebreutz	O
,	O
E	O
2	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
10:21:00	B-temporal
,	O

Cr	O
0	B-labvalue
.	I-labvalue
5	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

Sign	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

The	O
ultrasound	O
showed	O
biliary	B-bodyloc
sludge	O
and	O
swelling	O
of	O
the	O
body	O
and	O
tail	O
of	O
the	O
pancreas	B-bodyloc
.	O

This	O
was	O
accomplished	O
on	O
the	O
first	O
hospital	O
day	O
.	O

NS	O
-	O
bolus	O
-	O
250ml	B-dosage
to	O
be	O
given	O
.	O

*	O
*	O
NAME	O
[	O
ZZZ	O
]	O

No	B-negation
evidence	O
of	O
extension	O
into	O
the	O
foramina	B-bodyloc
transversaria	I-bodyloc
.	O

6	O
.	O

Joseph	O
Judy	O
MD	O
35	O
-	O
943	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
11	I-temporal
2007	I-temporal
]	O
01:39:05	B-temporal

Neurologic	O
examination	O
was	O
nonfocal	B-labvalue
.	O

Right	O
upper	O
extremity	O
examination	O
demonstrated	O
intact	O
motor	O
,	O
sensory	O
,	O
and	O
vascular	O
function	O
.	O

Unsigned	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
3:59:00	B-temporal

Automated	O
Differential	O

Discharge	O
Disposition	O
:	O

ADMITTING	O
DIAGNOSIS	O
:	O

MEDQUIST36	O

-	O
*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
XXX	O
M	O
]	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

Mesenteric	O
angiograpm	O
w	O
/	O
coil	O
embolization	O
of	O
bleeding	O
vessel	O
.	O

Albumin	O
3	B-labvalue
.	I-labvalue
1	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

Renal	B-bodyloc
failure	O
secondary	O
to	O
#	O
2	O
.	O

MPV	O
6	B-labvalue
.	I-labvalue
5	I-labvalue
fL	I-labvalue
Low	B-labvalue

HOSPITAL	O
COURSE	O
:	O

Anion	O
Gap	O
6	B-labvalue
.	I-labvalue
0	I-labvalue
Low	B-labvalue

No	B-negation
edema	O
.	O

The	O
care	O
plan	O
was	O
discussed	O
with	O
the	O
Resident	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Her	O
carotids	O
were	O
2	O
+	O
bilaterally	O
.	O

She	O
will	O
need	O
outpatient	O
follow	O
up	O
for	O
her	O
guiac	O
pos	O
stools	O
with	O
endoscopy	O
vs	O
EGD	O
+	O
/	O
-	O
H	O
.	O
pylori	O
serologies	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
9:29:00	B-temporal

5	O
Wellbutrin	O
75	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

R	O
:	O

Discharge	O
Medications	O
:	O

No	B-negation
m	O
/	O
r	O
/	O
g	O
'	O
s	O
appreciated	O
.	O

4	O
.	O

The	O
patient	O
had	O
a	O
head	O
CT	O
which	O
showed	O
no	B-negation
acute	B-course
abnormality	O
.	O

3	O
.	O

Psych	O
-	O
Patient	O
on	O
Librium	O
for	O
alcohol	O
withdrawal	O
.	O

Fe	O
Sat	O
%	O
60	B-labvalue
%	I-labvalue
High	B-labvalue

As	O
stated	O
on	O
*	O
*	O
DATE	O
[	O
Oct	O
29	O
07	O
]	O
the	O
patient	O
underwent	O
successful	O
left	O
total	O
hip	O
arthroplasty	O
.	O

6	O
.	O

-	O
Feeding	O
well	O
.	O

Pertinent	O
Results	O
:	O

LMB	O
/	O
fp	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
04	I-temporal
2007	I-temporal
]	O
08:50:52	B-temporal
PM	I-temporal

2	O
.	O

CCU	O

(	O
End	O
of	O
Report	O
)	O

If	O
his	O
WBC	O
count	O
increases	B-labvalue
on	O
steroids	O
he	O
should	O
have	O
a	O
blood	O
culture	O
,	O
urine	O
C	O
and	O
S	O
every	B-temporal
week	I-temporal
.	O

The	O
patient	O
the	O
next	O
two	O
days	O
did	O
not	O
notice	O
any	O
significant	O
change	O
in	O
her	O
pain	O
pattern	O
.	O

Author	O
:	O

The	O
patient	O
presents	O
with	O
complaint	O
of	O

He	O
will	O
then	O
follow	O
up	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
and	O
have	O
another	O
scan	O
done	O
.	O

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

Displacement	O
of	O
cervical	B-bodyloc
intervertebral	I-bodyloc
disks	O
without	B-negation
myelopathy	O
.	O

PATIENT	O
NAME	O
:	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

His	O
vitamin	O
B12	O
was	O
1838	B-labvalue
.	O

DATE	O
OF	O
DISCHARGE	O
:	O

D	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

TOTAL	O
CRITICAL	O
CARE	O
TIME	O
EQUALS	O
40	O
MINUTES	O
.	O

2	O
.	O

Lungs	O

ATTENDING	O
PHYSICIAN	O
:	O

MEDQUIST36	O

2	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Norvasc	O
2	B-strength
.	I-strength
5	I-strength
mg	I-strength
p	O
.	O
o	O
.	O
q	B-frequency
day	I-frequency
.	O

Professional	O
Services	O

DATE	O
OF	O
DISCHARGE	O
:	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
11	I-temporal
2007	I-temporal
]	O
01:39:05	B-temporal
/	O
mbi	O

Temp	O
:	O

COMPARED	O
TO	O
A	O
PRIOR	O
STUDY	O
OF	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
2006	I-temporal
]	O
,	O
AT	O
THAT	O
TIME	O
THE	O
AORTIC	O
VALVE	O
AREA	O
WAS	O
1	O
.	O
4	O
CM	O
SQUARED	O
WHICH	O
IS	O
LIKELY	O
ACCURATE	O
.	O

4	O
.	O

This	O
was	O
obtained	O
on	O
the	O
day	O
of	O
discharge	O
,	O
however	O
,	O
due	O
to	O
residual	O
contrast	O
in	O
the	O
colon	B-bodyloc
from	O
the	O
patient	O
&apos;s	O
prior	B-temporal
abdominal	O
CT	O
scan	O
,	O
the	O
exam	O
was	O
postponed	O
after	O
a	O
scout	O
film	O
was	O
obtained	O
.	O

There	O
is	O
no	B-negation
evidence	O
of	O
any	O
cranial	O
neuropathy	O
.	O

Matthews	O
,	O
M	O
.	O
D	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

Bipolar	O
disorder	O
.	O

The	O
fluid	O
removed	O
was	O
yellow	O
clear	O
in	O
color	O
.	O

The	O
official	O
result	O
was	O
not	O
yet	O
in	O
.	O

Na	O
133	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue
Low	B-labvalue

The	O
patient	O
'	O
s	O
M	O
spike	O
was	O
not	B-labvalue
elevated	I-labvalue
.	O

Nystatin	O
100	B-strength
,	I-strength
000	I-strength
unit	I-strength
/	I-strength
mL	I-strength
Suspension	I-strength
Sig	O
:	O
Ten	B-dosage
(	I-dosage
10	I-dosage
)	I-dosage
ML	I-dosage
PO	B-route
QID	B-frequency
(	O
4	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
for	O
7	B-duration
days	I-duration
.	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
16	I-temporal
1930	I-temporal
]	O

The	O
patient	O
had	O
iron	O
studies	O
which	O
showed	O
iron	O
-	O
deficiency	O
anemia	O
and	O
was	O
started	O
on	O
iron	O
therapy	O
upon	O
discharge	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
]	O

Report	O
Status	O
:	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
23	I-temporal
2007	I-temporal
]	O
14:45:38	B-temporal

9	O
.	O

Her	O
vital	O
signs	O
were	O
stable	B-labvalue
,	O
and	O
she	O
had	O
no	B-negation
significant	O
complaints	O
.	O

She	O
will	O
followup	O
in	O
the	O
Wardca	O
Presiew	O
Hospital	O
in	O
one	O
week	O
.	O

2	O
.	O

3	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Neurology	O
evaluated	O
the	O
patient	O
on	O
*	O
*	O
DATE	O
[	O
Mar	O
05	O
07	O
]	O
.	O

Heparin	O
5	B-strength
,	I-strength
000	I-strength
units	I-strength
subcu	B-route
q	B-frequency
12	I-frequency
hours	I-frequency

*	O
*	O
*	O
Dictated	O
By	O
:	O

RPR	O
evaluating	O
for	O
possible	O
neurologic	O
syphilis	O
was	O
also	O
checked	O
.	O

NEUROPATHIC	O
PAIN	O

ACTIVITY	O
:	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

Chest	O
tube	O
showed	O
30	O
cc	O
per	O
hour	O
over	O
the	O
last	O
four	O
hours	O
.	O

D	O
:	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
08	I-temporal
2007	I-temporal
]	O
15:06:01	B-temporal

BS	O
is	O
not	O
well	O
controoled	O
:	O
beside	O
Lantus	O
22	B-dosage
units	I-dosage
daily	B-frequency
,	O
she	O
also	O
had	O
14	B-dosage
units	I-dosage
covered	O
by	O
ISS	O
.	O

Additionally	O
on	O
the	O
night	O
before	O
discharge	O
,	O
flexion	O
and	O
extension	O
views	O
of	O
the	O
lumbosacral	O
spine	O
were	O
obtained	O
,	O
and	O
showed	O
no	B-negation
fracture	O
or	O
instability	O
.	O

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

Cardiac	O
size	O
is	O
unchanged	O
.	O

3	O
.	O

*	O
*	O
NAME	O
[	O
VVV	O
WWW	O
]	O
,	O
M	O
.	O
D	O
.	O

HEENT	O
exam	O
was	O
within	B-labvalue
normal	I-labvalue
limits	I-labvalue
.	O

Hypercholesterolemia	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Oct	B-temporal
14	I-temporal
2007	I-temporal
]	O
20	B-temporal
:	I-temporal
15	I-temporal
)	O

JOB	O
#	O
:	O

Right	O
-	O
sided	O
electrocardiograms	O
showed	O
1	O
-	O
mm	O
ST	O
elevations	O
in	O
V4	O
;	O
consistent	O
with	O
a	B-bodyloc
right	I-bodyloc
ventricular	I-bodyloc
infarct	O
.	O

Discharge	O
Date	O
:	O

9	O
.	O

bowel	O
sounds	O
:	O
normal	B-labvalue
.	O

restraints	O
,	O
for	O
the	O
safety	O
of	O
both	O
the	O
patient	O
and	O
the	O
staff	O
of	O
the	O
hospital	O
.	O

*	O
*	O
AGE	O
[	O
in	O
70s	O
]	O
years	O

Each	O
progressive	O
day	O
,	O
Mr	O
.	O
Donald	O
delirium	O
abated	O
with	O
return	O
to	O
baseline	O
mental	O
status	O
early	O
on	O
09	B-temporal
-	I-temporal
01	I-temporal
.	O

Bipolar	O
D	O
/	O
O	O
with	O
one	O
suicide	O
attempt	O
by	O
overdose	O
several	B-temporal
years	I-temporal
ago	I-temporal

4	O
.	O

7	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Feb	B-temporal
10	I-temporal
2007	I-temporal
]	O
16	B-temporal
:	I-temporal
25	I-temporal
)	O

3	O
.	O

I	O
have	O
started	O
him	O
on	O
a	O
Lasix	O
infusion	O
in	O
order	O
to	O
try	O
and	O
get	O
some	O
excess	O
fluid	O
off	O
him	O
after	O
his	O
operation	O
.	O

This	O
is	O
a	O
*	O
*	O
AGE	O
[	O
90	O
+	O
]	O
-	O
year	O
-	O
old	O
Caucasian	O
female	O
that	O
only	O
speaks	O
Greek	O
who	O
was	O
admitted	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
24	I-temporal
2007	I-temporal
]	O
,	O
after	O
approximately	O
1	B-temporal
to	I-temporal
2	I-temporal
weeks	I-temporal
of	O
chest	B-bodyloc
discomfort	O
described	O
as	O
a	O
pressure	O
/	O
bulging	O
sensation	O
on	O
the	O
left	B-bodyloc
chest	I-bodyloc
.	O

*	O
*	O
INSTITUTION	O

6	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Oct	B-temporal
14	I-temporal
2007	I-temporal
]	O
20	B-temporal
:	I-temporal
15	I-temporal
)	O

Anion	O
Gap	O
4	B-labvalue
.	I-labvalue
0	I-labvalue
Low	B-labvalue

SHY	O
#	O
*	O
*	O
ID	O
-	O
NUM	O

The	O
patient	O
is	O
a	O
61	O
-	O
year	O
-	O
old	O
Caucasian	O
-	O
speaking	O
woman	O
with	O
a	O
history	O
of	O
hypercholesterolemia	O
and	O
tobacco	O
use	O
who	O
developed	O
waxing	O
and	O
waning	O
left	B-bodyloc
substernal	I-bodyloc
chest	I-bodyloc
pain	O
with	O
radiation	O
to	O
the	B-bodyloc
left	I-bodyloc
shoulder	I-bodyloc
on	O
2011-11-17	B-temporal
which	O
lasted	O
that	O
entire	O
day	O
.	O

This	O
patient	O
was	O
admitted	O
to	O
the	O
Cardiology	O
Service	O
and	O
workup	O
was	O
performed	O
on	O
this	O
patient	O
.	O

possible	O
drainage	O
of	O
the	O
abscess	O
vs	O
.	O
hysterectomy	O
.	O

They	O
lives	O
together	O
for	O
19	O
years	O
.	O

Abd	O
:	O

He	O
had	O
some	O
further	O
anterolateral	O
ST	O
segment	O
changes	O
.	O

OP303	O
/	O
0134	O
NARI	O
BLACK	O
,	O
M	O
.	O
D	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

HEENT	O
:	O

Pt	O
home	O
regimen	O
as	O
Lopressor	O
and	O
Lisinopril	O
.	O

His	O
pain	O
medication	O
was	O
then	O
changed	O
to	O
Dilaudid	O
IV	B-route
in	O
an	O
attempt	O
to	O
better	O
alleviate	O
his	O
symptoms	O
.	O

Further	O
adjustment	O
of	O
medications	O
will	O
be	O
done	O
as	O
outpatient	O
.	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
,	O
CCC	O
]	O

3	O
.	O

Admitted	O
:	O

Brief	O
Hospital	O
Course	O
:	O

Vital	O
signs	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
07	I-temporal
2007	I-temporal
]	O
01:19:40	B-temporal
/	O
ss	O

2	O
.	O

Job	O
ID	O
:	O

COMPARISON	O
:	O
No	B-negation
prior	O
studies	O
are	O
available	O
.	O

Chronic	B-course
constipation	O
from	O
laxative	O
abuse	O
.	O

Admission	O
Date	O
:	O

sclera	O
anicteric	O

She	O
then	O
became	O
bradycardic	O
which	O
responded	O
to	O
atropine	O
and	O
intravenous	O
fluids	O
.	O

Signed	O

1	O
.	O

Temp	O
98	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
heart	O
rate	O
74	B-labvalue
,	O
BP	O
140	B-labvalue
/	I-labvalue
90	I-labvalue
,	O
respiratory	O
rate	O
18	B-labvalue
,	O
O2	O
sat	O
98	B-labvalue
%	I-labvalue
.	O

Left	O
costophrenic	O
angle	O
has	O
been	O
excluded	O
from	O
the	O
study	O
and	O
cannot	O
be	O
assessed	O
.	O

LABORATORY	O
DATA	O
:	O

Brief	O
Hospital	O
Course	O
:	O

Neck	O
:	O
supple	O
,	O
no	B-negation
LAD	O
,	O
no	B-negation
JVD	O

Following	O
this	O
ECT	O
,	O
she	O
had	O
progressively	O
increased	O
work	O
of	O
breathing	O
followed	O
by	O
extubation	O
after	O
her	O
procedure	O
.	O

DOB	O
:	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

lisinopril	O
40	B-strength
mg	I-strength
1	B-dosage
tab	B-form
(	I-form
s	I-form
)	I-form
,	O
40	B-strength
mg	I-strength
,	O
Tab	B-form
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Routine	O
,	O

Status	O
post	O
abdominal	O
aortic	O
aneurysm	O
repair	O
.	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
07	I-temporal
2008	I-temporal
]	O
11:44:17	B-temporal

*	O
*	O
AGE	O
[	O
in	O
70s	O
]	O
years	O

R	O
:	O

INR	O
1	B-labvalue
.	I-labvalue
7	I-labvalue
High	B-labvalue

Case	O
management	O
/	O
discharge	O
planning	O
/	O
social	O
services	O
re	O
:	O
transportation	O
to	O
HD	O
as	O
this	O
was	O
an	O
insurance	O
/	O
financial	O
issue	O
previous	O
admission	O
,	O
HD	O
arrangements	O
and	O
DME	O
.	O

Regular	B-labvalue
rate	O
and	O
rhythm	O
,	O
normal	B-labvalue
S1	O
,	O
S2	O
,	O
no	B-negation
murmurs	O
,	O
rubs	O
,	O
or	O
gallops	O
.	O

Amiodarone	O
drip	B-route
.	O

Service	O
:	O
SURGERY	O

Discharged	O
:	O

Discharge	O
Diagnosis	O
:	O

Author	O
:	O

Skin	O
:	O

MEDQUIST36	O

Hypertension	O
.	O

Chest	O
is	O
clear	O
.	O

Hematocrit	O
on	O
admission	O
was	O
43	B-labvalue
%	I-labvalue
with	O
a	O
white	O
blood	O
count	O
of	O
6600	B-labvalue
.	O

There	O
does	O
not	O
appear	O
to	O
be	O
anything	O
else	O
reasonably	O
that	O
we	O
can	O
do	O
at	O
this	O
point	O
.	O

For	O
this	O
,	O
eye	O
examination	O
was	O
done	O
and	O
no	B-negation
papilledema	O
was	O
seen	O
and	O
troponins	O
were	O
checked	O
for	O
a	O
chest	B-bodyloc
pain	O
and	O
she	O
had	O
2	O
negative	B-labvalue
troponins	O
as	O
well	O
as	O
no	B-negation
further	O
chest	B-bodyloc
pain	O
after	O
being	O
admitted	O
to	O
the	O
hospital	O
.	O

The	O
patient	O
is	O
to	O
maintain	O
her	O
figure	O
-	O
of	O
-	O
eight	O
clavicular	O
splint	O
and	O
left	O
posterior	O
forearm	O
splint	O
in	O
place	O
for	O
fourteen	B-temporal
days	I-temporal
following	O
discharge	O
.	O

1	O
.	O

CARDIOVASCULAR	O
SYSTEM	O
:	O

The	O
patient	O
was	O
started	O
on	O
hemodialysis	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
6	I-temporal
2006	I-temporal
]	O
,	O
after	O
a	O
tunneled	O
dialysis	O
catheter	O
was	O
placed	O
in	O
the	O
right	O
internal	O
jugular	O
vein	O
by	O
general	O
surgery	O
.	O

There	O
is	O
a	O
small	O
amount	O
of	O
blood	O
layering	O
in	O
both	B-bodyloc
lateral	I-bodyloc
ventricles	I-bodyloc
,	O
and	O
this	O
has	O
decreased	O
since	O
the	O
previous	O
study	O
.	O

Report	O
Status	O
:	O

1	O
.	O

Ri	O
Strength	O
is	O
a	O
40	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
GERD	O
,	O
who	O
presents	O
with	O
abdominal	B-bodyloc
pain	O
of	O
seven	B-temporal
days	I-temporal
duration	O
.	O

Requires	O
pre	O
-	O
medication	O
as	O
well	O
.	O

On	O
exam	O
,	O
his	B-bodyloc
toes	I-bodyloc
although	O
not	B-negation
cold	O
and	O
reasonably	O
well	O
-	O
perfused	O
with	O
reasonable	O
distal	O
pulses	O
in	O
the	O
dorsalis	O
pedis	O
and	O
other	O
extremities	O
are	O
reasonably	O
well	O
-	O
perfused	O
as	O
well	O
.	O

Ca	O
7	B-labvalue
.	I-labvalue
7	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

On	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
01	I-temporal
07	I-temporal
]	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
TTT	O
]	O
was	O
consulted	O
with	O
regards	O
to	O
her	O
urinary	B-bodyloc
tract	I-bodyloc
infection	O
and	O
her	O
history	O
of	O
stent	O
and	O
he	O
concurred	O
with	O
the	O
patient	O
being	O
placed	O
on	O
Cipro	O
.	O

altered	O
mental	O
status	O

Insulin	O
45	B-strength
NPH	O
in	B-frequency
am	I-frequency
with	O
33	B-strength
NPH	O
at	B-frequency
bedtime	I-frequency

Chief	O
Complaint	O
:	O

BENIGN	B-severity
ESSENTIAL	O
HYPERTENSION	O
(	O
ICD9	O
401	O
.	O
1	O
,	O
Working	O
,	O
Problem	O
)	O

Dictated	O
By	O
:	O
William	O
MP	O
Lajoie	O
,	O
M	O
.	O
D	O
.	O

DR	O
.	O
Shirley	O
X	O
Schaack	O
on	O
:	O

Dictated	O
By	O
:	O

Home	O
Care	O
consults	O
were	O
obtained	O
for	O
the	O
patient	O
to	O
have	O
PT	O
/	O
INR	O
/	O
BMP	O
checks	O
weekly	O
as	O
well	O
as	O
to	O
ensure	O
the	O
patient	O
had	O
an	O
appropriate	O
home	O
O2	O
therapy	O
.	O

ACCOUNT	O
#	O
:	O

Norvasc	O
10	B-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

She	O
was	O
continued	O
on	O
her	O
outpatient	O
medications	O
Spiriva	O
and	O
Advair	O
as	O
well	O
as	O
given	O
DuoNeb	O
as	B-frequency
needed	I-frequency
for	O
any	O
shortness	O
of	O
breath	O
.	O

Refuse	O
long	O
term	O
NH	O
placement	O
.	O

I	O
also	O
talked	O
to	O
the	O
patient	O
'	O
s	O
wife	O
about	O
his	O
clinical	O
situation	O
.	O

Skin	O

ADMISSION	O
DATE	O
:	O

-	O
Renal	O
function	O
back	O
to	O
normal	B-labvalue
,	O
resume	O
lisinopril	O
.	O

Pantoprazole	O
40	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
PO	B-route
twice	B-frequency
a	I-frequency
day	I-frequency
.	O

I	O
agree	O
with	O
their	O
note	O
as	O
written	O
.	O

Dict	O
:	O

Perform	O
by	O
*	O
*	O
NAME	O
[	O
VVV	O
,	O
UUU	O
]	O

01/26/1992	B-temporal

He	O
was	O
admitted	O
to	O
the	O
CMED	O
,	O
intubated	O
for	O
airway	O
protection	O
and	O
started	O
on	O
both	O
a	O
calcium	O
and	O
glucagon	O
drip	B-route
.	O

RRR	O
.	O

2	O
.	O

F	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

The	O
cardiac	O
catheterization	O
revealed	O
a	O
total	O
occlusion	O
of	O
the	B-bodyloc
proximal	I-bodyloc
right	I-bodyloc
coronary	I-bodyloc
artery	I-bodyloc
and	O
diffuse	O
right	B-bodyloc
coronary	I-bodyloc
artery	I-bodyloc
disease	O
.	O

2011-03-21	B-temporal

Spironolactone	O
25	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
0	B-dosage
.	I-dosage
5	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Pulse	O
normal	B-labvalue
.	O

XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

Allopurinol	O
100	B-strength
mg	I-strength
tablet	B-form
one	B-dosage
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
Norvasc	O
5	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
;	O
Lotensin	O
20	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
;	O
Lipitor	O
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
h	I-frequency
.	I-frequency
s	I-frequency
.	I-frequency
;	O
Cipro	O
500	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
to	O
be	O
given	O
separate	O
from	O
ferrous	O
sulfate	O
dose	O
by	O
at	O
least	O
two	O
hours	O
this	O
should	O
continue	O
for	O
at	O
least	O
seven	B-duration
days	I-duration
;	O
Colace	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
hold	O
for	O
loose	O
stools	O
;	O
Lovenox	O
30	B-strength
mg	I-strength
subcutaneously	B-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
for	O
an	O
additional	O
ten	B-duration
days	I-duration
,	O
this	O
can	O
be	O
changed	O
to	O
40	B-strength
mg	I-strength
once	O
daily	O
subcutaneous	O
injection	O
administered	O
at	O
home	O
if	O
the	O
patient	O
is	O
discharged	O
prior	O

Supporting	O
lines	O
and	O
tubes	O
in	O
unchanged	O
position	O
.	O

In	O
general	O
,	O
she	O
was	O
in	O
no	B-negation
acute	B-course
distress	O
.	O

Attending	O
:	O
Robert	O
E	O
Goldschmidt	O
,	O
M	O
.	O
D	O
.	O

I	O
will	O
send	O
him	O
out	O
on	O
Librium	O
as	B-frequency
needed	I-frequency
for	O
alcohol	O
withdrawal	O
.	O

By	O
04	B-temporal
-	I-temporal
01	I-temporal
,	O
on	O
postoperative	O
day	O
two	O
,	O
the	O
patient	O
was	O
doing	O
well	O
and	O
the	O
chest	O
tube	O
was	O
discontinued	O
.	O

Hypoxia	O
:	O

7/30/1993	B-temporal
12:00:00	B-temporal
AM	I-temporal

2	O
.	O

26532	O

*	O
*	O
NAME	O
[	O
ZZZ	O
]	O

The	O
does	O
was	O
titrated	O
to	O
the	O
patient	O
&apos;s	O
need	O
for	O
comfort	O
and	O
was	O
eventually	O
tapered	O
.	O

There	O
was	O
evidence	O
of	O
possible	O
aspiration	O
pneumonia	O
on	O
CXR	O
,	O
though	O
he	O
was	O
extubated	O
without	O
incident	O
on	O
the	O
AM	O
of	O
transfer	O
to	O
the	O
medicine	O
floor	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
is	O
awake	O
.	O

He	O
has	O
a	O
history	O
of	O
peripheral	B-bodyloc
neuropathy	O
,	O
kidney	O
transplantation	O
in	O
2003	B-temporal
secondary	O
to	O
diabetic	O
nephropathy	O
,	O
as	O
well	O
as	O
throat	B-bodyloc
cancer	O
in	O
2004	B-temporal
treated	O
with	O
local	O
resection	O
and	O
radical	O
neck	O
dissection	O
on	O
the	O
left	O
as	O
well	O
as	O
postoperative	O
radiation	O
.	O

CC	O
:	O

1	O
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

An	O
EEG	O
was	O
then	O
performed	O
which	O
showed	O
periodic	O
epileptic	O
strokes	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Feb	B-temporal
10	I-temporal
2007	I-temporal
]	O
16	B-temporal
:	I-temporal
25	I-temporal
)	O

CRITICAL	O
CARE	O
MEDICINE	O

She	O
received	O
dialysis	O
today	B-temporal
on	O
*	O
*	O
DATE	O
[	O
Oct	B-temporal
19	I-temporal
2007	I-temporal
]	O
.	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
19	I-temporal
2007	I-temporal
]	O

SHY	O
#	O
*	O
*	O
ID	O
-	O
NUM	O

Digoxin	O
125	B-strength
mcg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

A5B	O
/	O
539	O

D	O
/	O
C	O
Ambienm	O
today	B-temporal

GAEHS07465	O

Per	O
OMR	O
,	O
h	O
/	O
o	O
sporadic	O
marijuana	O
use	O
.	O

The	O
patient	O
was	O
on	O
moxifloxacin	O
for	O
sinusitis	O
and	O
fever	O
subsided	O
.	O

Course	O

Blood	O
pressure	O
was	O
152	B-labvalue
/	I-labvalue
88	I-labvalue
.	O

*	O
*	O
NAME	O
[	O
VVV	O
,	O
UUU	O
]	O

Rhonchi	O
with	O
bibasilar	B-bodyloc
rales	O
.	O

5	O
.	O

Portal	O
hypertension	O
.	O

Dict	O
:	O

Date	O
of	O
Birth	O
:	O

PRINCIPAL	O
DIAGNOSES	O
:	O

Temperature	O
Site	O
Oral	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Immediately	O
prior	O
to	O
transfer	O
to	O
Worcester	O
State	O
Hospital	O
,	O
she	O
went	O
into	O
ventricular	O
fibrillation	O
arrest	O
at	O
12	B-temporal
:	I-temporal
30	I-temporal
p	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal
,	O
at	O
which	O
time	O
she	O
was	O
intubated	O
and	O
defibrillated	O
back	O
to	O
sinus	O
rhythm	O
after	O
five	O
shocks	O
.	O

8	O
.	O

As	O
for	O
his	O
diabetes	O
mellitus	O
,	O
the	O
Mahoney	O
Team	O
provided	O
updated	O
recommendations	O
each	O
day	O
,	O
adjusting	O
for	O
the	O
changing	O
p	O
.	O
o	O
.	O
intake	O
.	O

Last	O
menstrual	O
period	O
2009-02-21	B-temporal
.	O

She	O
still	O
compliants	O
of	O
R	B-bodyloc
shoulder	I-bodyloc
and	O
elbow	B-bodyloc
pain	O
and	O
could	O
not	O
move	O
her	O
R	O
arm	O

10	O
.	O

Patient	O
is	O
alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
and	O
date	O
.	O

Sex	O
:	O

On	O
2/24/00	B-temporal
,	O
the	O
patient	O
had	O
an	O
episode	O
of	O
exacerbation	O
of	O
epigastric	B-bodyloc
pain	O
with	O
radiation	O
to	O
the	O
left	B-bodyloc
upper	I-bodyloc
quadrant	I-bodyloc
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Plan	O

*	O
*	O
INSTITUTION	O

Vitals	O
:	O
99	B-labvalue
.	I-labvalue
3	I-labvalue
67	B-labvalue
(	O
60	O
-	O
70	O
)	O
99	B-labvalue
/	I-labvalue
53	I-labvalue
(	O
90	O
-	O
100	O
s	O
)	O
96	B-labvalue
%	I-labvalue
on	O
RA	O
3	O
.	O
7L	O
+	O
LOS	O

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

Her	O
white	O
blood	O
cell	O
count	O
was	O
12	B-labvalue
.	I-labvalue
8	I-labvalue
,	O
with	O
a	O
normal	B-labvalue
differential	O
.	O

Clear	O
.	O

No	O
smoking	O
,	O
alcohol	O
or	O
drugs	O
.	O

7	O
.	O

Hypothyroidism	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Left	O
forearm	O
and	O
wrist	O
series	O
demonstrated	O
transverse	B-bodyloc
mid	I-bodyloc
shaft	I-bodyloc
radial	I-bodyloc
fracture	O
with	O
ulnar	B-bodyloc
displacement	O
.	O

Patient	O
was	O
admitted	O
through	O
the	O
emergency	O
department	O
with	O
chief	O
complaint	O
of	O
weakness	O
,	O
general	O
diffuse	O
weakness	O
,	O
decreased	B-course
ability	O
to	O
stand	O
or	O
walk	O
.	O

(	O
No	O
improving	O
from	O
yesterday	O
.	O

The	O
assay	O
was	O
nonreactive	O
.	O

12	O
.	O

He	O
was	O
noted	O
to	O
have	O
some	O
ventricular	B-bodyloc
ectopy	O
on	O
Holter	O
monitor	O
.	O

HEENT	O
:	O

It	O
also	O
helped	O
of	O
course	O
to	O
clear	O
her	O
lungs	O
.	O

Physical	O
Examination	O

Was	O
called	O
to	O
see	O
patient	O
because	O
pt	O
was	O
c	O
/	O
o	O
sob	O
&	O
amp	O
;	O
his	O
HR	O
was	O
in	O
40s	B-labvalue
,	O
B	O
.	O
p	O
.	O
90	B-labvalue
/	I-labvalue
47	I-labvalue
.	O

HR	O
is	O
blow	O
60	B-labvalue
.	O

As	O
mentioned	O
earlier	O
,	O
the	O
patient	O
'	O
s	O
creatinine	O
improved	O
nicely	O
and	O
at	O
the	O
time	O
of	O
discharge	O
was	O
1	B-labvalue
.	I-labvalue
3	I-labvalue
.	O

Back	O
:	O

Cholesterol	O
197	B-labvalue
,	O
triglycerides	O
118	B-labvalue
,	O
HDL	O
31	B-labvalue
,	O
LDL	O
142	B-labvalue
,	O
total	O
protein	O
6	B-labvalue
.	I-labvalue
2	I-labvalue
,	O
bilirubin	O
1	B-labvalue
.	I-labvalue
0	I-labvalue
,	O
alkaline	O
phosphatase	O
72	B-labvalue
,	O
SGOT	O
23	B-labvalue
.	O

*	O
*	O
ID	O
-	O
NUM	O

Social	O
History	O
:	O

Since	O
the	O
patient	O
'	O
s	O
total	O
protein	O
in	O
the	O
ascites	O
was	O
less	B-labvalue
than	I-labvalue
1	I-labvalue
we	O
will	O
start	O
him	O
on	O
Cipro	O
750	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
weekly	B-frequency
x	O
4	B-duration
weeks	I-duration
for	O
his	O
[	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
]	O
*	O
*	O
*	O
prophylaxis	O
.	O

Just	O
prior	O
to	O
discharge	O
on	O
11	B-temporal
-	I-temporal
14	I-temporal
,	O
pt	O
'	O
s	O
BP	O
was	O
found	O
to	O
be	O
70	B-labvalue
/	I-labvalue
40	I-labvalue
P70	O
s	O
just	O
after	O
receiving	O
her	O
am	O
BP	O
meds	O
.	O

2013-11-16	B-temporal

WBC	O
10	B-labvalue
.	I-labvalue
5	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	O

Stable	O
appearance	O
of	O
hypodense	O
lesion	O
within	O
the	B-bodyloc
caudate	I-bodyloc
lobe	I-bodyloc
of	I-bodyloc
the	I-bodyloc
liver	I-bodyloc
,	O
too	O
small	O
to	O
fully	O
characterize	O
.	O

1	O
.	O

GYNECOLOGY	O

Diastolic	O
BP	O
47	B-labvalue
mmHg	I-labvalue

Today	B-temporal
,	O
on	O
exam	O
,	O
she	O
is	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
x	O
3	O
.	O

The	O
patient	O
is	O
status	O
post	O
uterine	O
artery	O
embolization	O
on	O
2009-01-07	B-temporal
secondary	O
to	O
fibroids	O
.	O

Physical	O
Exam	O
:	O

Intubation	O
for	O
airway	O
protection	O

Patient	O
was	O
admitted	O
to	O
rehab	O
,	O
PT	O
/	O
OT	O
to	O
be	O
provided	O
there	O
.	O

Sitting	O
on	O
edge	O
of	O
bed	O
without	O
c	O
/	O
o	O
.	O

Bilateral	O
pleural	B-bodyloc
effusion	O
were	O
seen	O
with	O
associated	O
compression	O
atelectasis	O
.	O

3	O
.	O

MOPAIGEIT	O
S	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
XXX	O
ZZZ	O
]	O

No	B-negation
clubbing	O
,	O
cyanosis	O
or	O
edema	O
.	O

HS	O
Job	O
#	O
849436	O
/	O
37260	O
/	O

1	O
.	O

LABORATORY	O
DATA	O
:	O

2014-11-21	B-temporal

Respiratory	O
rate	O
was	O
17	B-labvalue
.	O

bleed	O
?	B-uncertain

Bronchoscopy	O
2014-11-05	B-temporal

She	O
got	O
a	O
chest	O
x	O
-	O
ray	O
at	O
that	O
time	O
which	O
showed	O
right	B-bodyloc
-	I-bodyloc
sided	I-bodyloc
opacities	O
suspicious	B-uncertain
for	O
pneumonia	O
.	O

-	O
-	O
looks	O
better	O
today	O

Job	O
ID	O
:	O

Batch	O
:	O

Course	O

His	O
folic	O
acid	O
was	O
5	B-labvalue
.	I-labvalue
7	I-labvalue
.	O

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

Repeat	O
blood	O
cultures	O
were	O
sent	O
.	O

She	O
was	O
also	O
started	O
on	O
Norvasc	O
.	O

5	O
.	O

VERIFY	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
for	O
urinary	B-bodyloc
tract	I-bodyloc
infection	O
with	O
regards	O
to	O
prior	O
placement	O
of	O
right	O
ureteral	O
stent	O
.	O

2012-04-27	B-temporal

Neck	O
:	O

A	O
thallium	O
stress	O
test	O
showed	O
tachycardia	O
and	O
severe	B-bodyloc
dyspnea	O
as	O
well	O
as	O
a	O
fall	O
in	O
blood	O
pressure	O
with	O
low	O
level	O
exercise	O
.	O

In	O
addition	O
,	O
he	O
also	O
complained	O
of	O
difficulty	O
with	O
swallowing	O
,	O
necessitating	O
only	O
soft	O
and	O
liquid	O
diet	O
.	O

4	O
.	O

Ms	O
.	O
*	O
*	O
NAME	O
[	O
AAA	O
]	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
60s	O
]	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
history	O
of	O
smoldering	O
multiple	O
myeloma	O
and	O
membranoproliferative	O
glomerulonephritis	O
who	O
presented	O
from	O
her	O
office	O
visit	O
with	O
anemia	O
and	O
thrombocytopenia	O
and	O
epistaxis	O
.	O

Disposition	O
.	O

Left	B-bodyloc
transverse	I-bodyloc
mid	I-bodyloc
shaft	I-bodyloc
radial	I-bodyloc
fracture	O
with	O
ulnar	B-bodyloc
displacement	O
status	O
post	O
left	O
radial	O
open	O
reduction	O
and	O
internal	O
fixation	O
.	O

-	O
Biopsies	O
were	O
obtained	O
during	O
his	O
colonoscopy	O
and	O
he	O
should	O
follow	O
up	O
with	O
gastroenterology	O
for	O
the	O
results	O
.	O

His	O
urine	O
and	O
serum	O
tox	O
screens	O
were	O
notable	O
only	O
for	O
benzos	O
,	O
otherwise	O
negative	O
.	O

7	O
.	O

Gen	O
:	O

ABS	O
Basophils	O
0	B-labvalue
.	I-labvalue
0	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

Subjective	O
/	O
Events	O
Overnight	O
:	O
labs	O
/	O
events	O
reviewed	O

Female	O

Continue	O
spironalactone	O
.	O

Multivitamin	O
,	O
one	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
day	I-frequency
.	O

No	O
current	O
relationship	O
.	O

Family	O
History	O
:	O

Coronary	B-bodyloc
Artery	I-bodyloc
Disease	O

However	O
,	O
she	O
has	O
no	B-negation
vomiting	O
and	O
only	O
mild	B-severity
nausea	O
with	O
medications	O
.	O

Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
is	O
going	O
to	O
follow	O
her	O
up	O
at	O
the	O
facility	O
.	O

5	O
.	O
)	O
Aspirin	O
81	B-strength
mg	I-strength
daily	B-frequency

Supple	O
.	O

She	O
was	O
afebrile	O
.	O

Regular	O
insulin	O
5	B-strength
units	I-strength
q	B-frequency
.	I-frequency
a	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency
and	O
3	B-dosage
to	I-dosage
5	I-dosage
units	I-dosage
q	B-frequency
.	I-frequency
p	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency

Blood	O
cultures	O
pending	O
.	O

Service	O
:	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

Cl	O
101	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

History	O
of	O
herpes	O
simplex	O
virus	O
,	O
last	O
outbreak	O
in	O
2000	B-temporal
.	O

Course	O

1	O
.	O

T	O
:	O

His	O
goal	O
INR	O
should	O
be	O
1	O
.	O
6	O
-	O
2	O
.	O

4	O
.	O

(	O
End	O
of	O
Report	O
)	O

8	O
.	O

Impression	O
and	O
Plan	O

Discharged	O
:	O

3	O
.	O

5	O
.	O

11	O
.	O
)	O
Asacol	O
400	B-strength
mg	I-strength
3	B-frequency
,	I-frequency
TID	I-frequency

7	O
.	O

The	O
patient	O
was	O
ambulating	O
appropriately	O
and	O
tolerating	O
a	O
p	O
.	O
o	O
.	O
diet	O
.	O

GERD	O
-	O
continue	O
Protonix	O

Protonix	O
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

On	O
exam	O
:	O

Disposition	O
-	O
patient	O
thinks	O
she	O
can	O
live	O
at	O
home	O
with	O
HHC	O
.	O

refuse	O
to	O
move	O
due	O
to	O
pain	O
.	O

General	O
results	O

She	O
was	O
also	O
placed	O
on	O
on	O
low	B-dosage
dose	I-dosage
spironolactone	O
as	O
a	O
K	O
sparing	O
diuretic	O
and	O
for	O
BP	O
control	O
in	O
addition	O
to	O
Toprol	O
XL	O
25	B-strength
mg	I-strength
QD	B-frequency
for	O
her	O
coronary	B-bodyloc
disease	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
smoldering	O
multiple	O
myeloma	O
with	O
treatments	O
with	O
Cytoxan	O
and	O
steroids	O
and	O
had	O
a	O
bone	O
marrow	O
transplant	O
in	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
2007	I-temporal
]	O
.	O

She	O
was	O
physically	O
abused	O
and	O
severely	O
neglected	O
as	O
a	O
child	O
and	O
been	O
sexually	O
assaulted	O
.	O

Lisinopril	O
15	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Reason	O
:	O
Fever	O
,	O
f	O
/	O
u	O
infiltrte	O

Disp	O
:	O
*	O
1	O
inhaler	O
*	O
Refills	O
:	O
*	O
1	O
*	O

Boston	O
Coma	O
Scale	O
of	O
15	B-labvalue
.	O

Head	O
CT	O
showed	O
a	O
front	O
focal	O
hemorrhage	O
in	O
the	B-bodyloc
left	I-bodyloc
occipital	I-bodyloc
lobe	I-bodyloc
adjacent	O
to	O
the	O
falx	O
with	O
intraparenchymal	B-bodyloc
hemorrhage	O
or	O
epidural	B-bodyloc
or	I-bodyloc
subdural	I-bodyloc
hemorrhage	O
near	O
the	B-bodyloc
falx	I-bodyloc
with	O
no	B-negation
shift	O
.	O

Third	O
Ave	O
.	O

He	O
was	O
given	O
4	O
amps	O
of	O
calcium	O
gluconate	O
,	O
and	O
started	O
on	O
a	O
Calcium	O
gtt	O
.	O

Vital	O
signs	O
are	O
stable	B-labvalue
.	O

It	O
was	O
felt	O
that	O
,	O
because	O
of	O
the	O
evidence	O
of	O
congestive	O
heart	B-bodyloc
failure	O
and	O
the	O
critical	O
left	O
main	O
lesion	O
,	O
he	O
should	O
be	O
admitted	O
for	O
further	O
evaluation	O
.	O

Middle	O
aged	O
female	O
in	O
NAD	O
.	O

Stable	O
.	O

36	B-labvalue
.	I-labvalue
9	I-labvalue
degrees	I-labvalue
Celsius	I-labvalue
.	O

Low	O
Ca	O
+	O
-	O
will	O
replete	O
with	O
IV	B-route
calcium	O

INR	O
was	O
1	B-labvalue
.	I-labvalue
2	I-labvalue
,	O
partial	O
thromboplastin	O
time	O
was	O
23	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
and	O
prothrombin	O
time	O
was	O
13	B-labvalue
.	I-labvalue
4	I-labvalue
.	O

SU1	O

She	O
was	O
receiving	O
physical	O
therapy	O
and	O
occupational	O
therapy	O
at	O
that	O
time	O
.	O

He	O
has	O
insulin	O
dependent	O
diabetes	O
mellitus	O
and	O
a	O
history	O
of	O
a	O
dilated	O
cardiomyopathy	O
.	O

Followup	O
Instructions	O
:	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Enteric	O
coated	O
aspirin	O
81	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

CCU	O

The	O
patient	O
has	O
an	O
appointment	O
to	O
initiate	O
primary	O
care	O
,	O
as	O
she	O
no	O
longer	O
had	O
a	O
primary	O
care	O
physician	O
.	O

*	O
*	O
INSTITUTION	O

Blood	O
cultures	O
drawn	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
24	I-temporal
2007	I-temporal
]	O
,	O
that	O
showed	O
no	B-negation
growth	O
after	O
6	B-temporal
days	I-temporal
of	O
culture	O
.	O

Cardiac	O
index	O
is	O
around	O
2	B-labvalue
.	I-labvalue
2	I-labvalue
with	O
a	O
mixed	O
venous	O
oxygen	O
saturation	O
of	O
around	O
58	B-labvalue
%	I-labvalue
.	O

Eosinophils	O
1	B-labvalue
%	I-labvalue

Ca	O
8	B-labvalue
.	I-labvalue
8	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

Accucheck	O
this	B-temporal
am	I-temporal
80	B-labvalue
,	O
yesterday	B-temporal
'	O
s	O
100	B-labvalue
-	I-labvalue
106	I-labvalue
-	O
off	O
unit	O
-	O
94	B-labvalue
.	O

DIET	O
:	O

Soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Hemodialysis	O
on	O
*	O
*	O
DATE	O
[	O
Oct	B-temporal
19	I-temporal
2007	I-temporal
]	O
.	O

MEDQUIST36	O

She	O
is	O
continuing	O
to	O
have	O
some	O
hallucinations	O
and	O
delusions	O
.	O

3	O
.	O

EKG	O
:	O

5	O
.	O

SOLID	O
,	O
M	O
.	O
D	O
.	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Tracey	O
Mccourtney	O
on	O
:	O
MON	B-temporal
2014-05-05	B-temporal
10	B-temporal
:	I-temporal
26	I-temporal
PM	I-temporal

*	O
*	O
*	O
Dictated	O
By	O
:	O

Patient	O
was	O
doing	O
well	O
.	O

Lidoderm	O
patch	B-form
5	B-strength
%	I-strength
topically	B-route
one	B-dosage
patch	B-form
daily	B-frequency

Please	O
call	O
your	O
gastroenterologist	O
to	O
schedule	O
a	O
follow	O
up	O
appointment	O
in	O
2	O
weeks	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

He	O
also	O
had	O
a	O
blood	O
work	O
,	O
which	O
showed	O
hemoglobin	O
of	O
6	B-labvalue
.	I-labvalue
6	I-labvalue
with	O
a	O
white	O
count	O
of	O
11	B-labvalue
.	I-labvalue
5	I-labvalue
.	O

Course	O

3	O
.	O

She	O
will	O
need	O
follow	O
up	O
with	O
her	O
PCP	O
within	O
B	O
week	O
after	O
discharge	O
from	O
the	O
extended	O
care	O
facility	O
for	O
further	O
BP	O
titration	O
and	O
monitoring	O
of	O
her	O
electrolytes	O
.	O

A	O
head	O
and	O
neck	O
CT	O
scan	O
,	O
non	O
-	O
contrast	O
,	O
were	O
ordered	O
though	O
to	O
evaluate	O
for	O
such	O
processes	O
.	O

14	B-temporal
:	I-temporal
42	I-temporal

While	O
on	O
the	O
floor	O
patient	O
'	O
s	O
hands	O
improved	O
with	O
good	O
range	O
of	O
motion	O
of	O
left	O
hand	O
,	O
however	O
Jones	O
some	O
poor	O
range	O
of	O
motion	O
of	O
right	O
.	O

*	O
*	O
INSTITUTION	O

The	O
staples	O
will	O
be	O
removed	O
at	O
her	O
already	O
scheduled	O
postoperative	O
visit	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
XXX	O
]	O
in	O
the	O
office	O
two	O
weeks	O
postoperatively	O
.	O

He	O
was	O
able	O
to	O
be	O
rapidly	O
weaned	O
and	O
extubated	O
.	O

Attend	O
:	O

D	O
:	O

Insulin	O
drip	B-route
at	O
2	O
.	O

#	O
Access	O
-	O
-	O
2	O
large	O
bore	O
PIV	O
'	O
s	O

Extremities	O
:	O

HOSPITAL	O
COURSE	O
:	O

Discharged	O
:	O

Patient	O
denies	B-negation
symptoms	O
of	O
alcohol	O
withdrawal	O
including	O
tactile	O
hallucinations	O
and	O
history	O
of	O
seizures	O
and	O
DT	O
'	O
s	O
.	O
.	O
.	O

He	O
was	O
also	O
put	O
on	O
Lopressor	O
150	B-strength
mg	I-strength
twice	B-frequency
a	I-frequency
day	I-frequency
.	O

Pancreatitis	O
:	O

Discharge	O
Summary	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

3	O
.	O

Improving	O

He	O
continues	O
to	O
be	O
on	O
high	O
Fi02	O
and	O
PEEP	O
.	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

The	O
patient	O
afterward	O
however	O
responded	O
quite	O
nicely	O
and	O
her	O
blood	O
pressure	O
dropped	O
to	O
104	B-labvalue
/	I-labvalue
80	I-labvalue
.	O

Lansoprazole	O
30	B-strength
mg	I-strength
Susp	B-form
,	I-form
Delayed	I-form
Release	I-form
for	O
Recon	O
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Normal	B-labvalue
active	I-labvalue
bowel	O
sounds	O
.	O
.	O

8	O
.	O

Hydrochlorothiazide	O
25	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Given	O
this	O
,	O
it	O
was	O
advised	O
that	O
the	O
patient	O
have	O
a	O
colonoscopy	O
to	O
rule	B-uncertain
out	I-uncertain
further	O
bleeding	O
.	O

insulin	O
regular	O
(	O
Regular	O
Insulin	O
Sliding	B-dosage
Scale	I-dosage
Low	O
)	O
(	O
INSULIN	O
HUMAN	O
REG	O
100	B-strength
U	I-strength
/	O
ML	O
10	B-dosage
ML	I-dosage
VIAL	O
)	O
,	O
2	B-dosage
-	I-dosage
12	I-dosage
Unit	I-dosage
(	I-dosage
s	I-dosage
)	I-dosage
,	O
Injection	B-form
,	O
subQ	B-route
,	O
ACandHS	O
,	O
Routine	O
,	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

Temperature	O
Conversion	O
36	B-labvalue
.	I-labvalue
4	I-labvalue
Deg	I-labvalue
C	I-labvalue

cipro	O
and	O
Pepcid	O
have	O
been	O
off	O
4	O
days	O
.	O

Right	B-bodyloc
hemiparesis	O
and	O
paraparesis	O
.	O

MRN	O
-	O
*	O
*	O
ID	O
-	O
NUM	O
-	O
MPACCOMMMRN	O

2	O
.	O

Transfer	O
Summary	O

Protonix	O
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

EKG	O
done	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
24	I-temporal
2007	I-temporal
]	O
,	O
that	O
showed	O
sinus	O
bradycardia	O
with	O
sinus	O
arrhythmia	O
.	O

*	O
*	O
DATE	O
[	O
Oct	B-temporal
17	I-temporal
2007	I-temporal
]	O

Claire	O
was	O
to	O
see	O
Dr	O
.	O
Michael	O
Majerowski	O
at	O
the	O
Sturdy	O
Memorial	O
Clinic	O
on	O
the	O
east	O
campus	O
,	O
on	O
Bissonette	O
Six	O
,	O
in	O
the	O
South	O
Suite	O
,	O
on	O
31-05-03	B-temporal
at	O
11	B-temporal
:	I-temporal
30	I-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal

Type	O
of	O
Differential	O

6	O
.	O

She	O
had	O
good	O
post	O
percutaneous	O
coronary	O
intervention	O
angiographic	O
results	O
.	O

5	O
.	O

Lungs	O
:	O
bilateral	O
:	O
no	B-negation
crackles	O
present	O
,	O
no	B-negation
wheezes	O
present	O
.	O

Please	O
call	O
physician	O
if	B-condition
you	O
develop	O
shortness	O
of	O
breath	O
,	O
weakness	O
in	O
your	O
legs	B-bodyloc
or	O
arms	B-bodyloc
,	O
sudden	O
blurry	O
vision	O
or	O
slurred	O
speech	O
,	O
chest	B-bodyloc
pain	O
,	O
faintness	O
,	O
or	O
significant	O
unexplained	O
weight	O
loss	O
.	O

T	O
:	O

Vitamin	O
C	O
500	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

This	O
lowered	O
with	O
IV	B-route
nitroglycerin	O
.	O

This	O
is	O
a	O
64	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
history	O
of	O
hypertension	O
,	O
hypercholesterolemia	O
,	O
diabetes	O
mellitus	O
,	O
and	O
dilated	O
cardiomyopathy	O
(	O
with	O
a	O
transthoracic	O
echocardiogram	O
in	O
2016-01-13	B-temporal
showing	O
an	O
ejection	O
fraction	O
of	O
40	B-labvalue
%	I-labvalue
,	O
posterior	B-bodyloc
and	I-bodyloc
inferior	I-bodyloc
apical	I-bodyloc
akinesis	O
,	O
and	O
large	O
left	B-bodyloc
ventricular	I-bodyloc
thrombus	O
)	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

We	O
are	O
OK	O
.	O

HOSPITAL	O
COURSE	O
:	O

Vital	O
Signs	O
:	O

LABORATORY	O
DATA	O
:	O

There	O
was	O
no	B-negation
splenomegaly	O
or	O
hepatosplenomegaly	O
.	O

It	O
is	O
characterized	O
by	O
Abdominal	B-bodyloc
distension	O
.	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Platelet	O
count	O
improved	O
with	O
transfusion	O
,	O
however	O
,	O
they	O
continued	O
to	O
improve	O
spontaneously	O
and	O
remained	O
in	O
the	O
60	O
,	O
000	O
range	O
.	O

In	O
addition	O
,	O
she	O
was	O
given	O
aspirin	O
,	O
Plavix	O
,	O
heparin	O
,	O
and	O
morphine	O
.	O

Young	O
on	O
:	O
FRI	O
2013-12-20	B-temporal
4	B-temporal
:	I-temporal
59	I-temporal
PM	I-temporal

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Aspirin	O
325	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

He	O
was	O
made	O
NPO	O
and	O
was	O
resuscitated	O
with	O
IV	O
fluids	O
.	O

Also	O
noted	O
on	O
the	O
day	O
of	O
11	O
-	O
20	O
,	O
the	O
patient	O
self	O
-	O
extubated	O
herself	O
.	O

Once	O
on	O
the	O
floor	O
patient	O
stable	O
.	O

The	O
patient	O
will	O
see	O
endocrine	O
before	O
discharge	O
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

Continue	O
.	O

The	O
patient	O
was	O
in	O
general	O
good	O
health	O
until	O
seven	O
days	O
ago	O
(	O
2/11/00	B-temporal
)	O
,	O
when	O
he	O
had	O
a	O
sudden	B-course
onset	I-course
of	O
sharp	O
left	B-bodyloc
flank	I-bodyloc
pain	O
with	O
radiation	O
to	O
the	O
lower	B-bodyloc
abdomen	I-bodyloc
and	O
then	O
to	O
the	B-bodyloc
epigastrium	I-bodyloc
.	O

T	O
:	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
30	I-temporal
2007	I-temporal
]	O
11	B-temporal
:	I-temporal
43	I-temporal

5	O
.	O

HRR	O
S1	O
-	O
S2	O
.	O

IMPRESSION	O
AND	O
PLAN	O
:	O

VERIFY	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O
(	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
18	I-temporal
2007	I-temporal
]	O
12	B-temporal
:	I-temporal
05	I-temporal
)	O

The	O
patient	O
was	O
kept	O
an	O
additional	O
two	O
days	O
to	O
follow	O
her	O
hcts	O
and	O
titrate	O
her	O
BP	O
meds	O
.	O

On	O
postoperative	O
day	B-temporal
#	I-temporal
1	I-temporal
,	O
2010-06-30	B-temporal
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
clinically	O
stable	O
,	O
tolerating	O
oral	O
intake	O
,	O
and	O
expressive	O
of	O
adequate	O
amounts	O
of	O
urine	O
independent	O
of	O
a	O
Foley	O
catheter	O
.	O

Respiratory	O
rate	O
14	B-labvalue
.	O

1	O
.	O

T	O
:	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
08	I-temporal
2007	I-temporal
]	O
22:36:23	B-temporal

It	O
is	O
of	O
note	O
that	O
this	O
fluid	O
had	O
a	O
high	B-labvalue
content	O
of	O
lymphocytes	O
up	O
to	O
81	B-labvalue
%	I-labvalue
and	O
a	O
low	B-labvalue
neutrophil	O
count	O
with	O
5	B-labvalue
%	I-labvalue
of	O
the	O
total	O
WBC	O
s	O
.	O

Plavix	O
75	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

The	O
patient	O
is	O
actually	O
doing	O
well	O
at	O
this	O
time	O
,	O
although	O
he	O
is	O
complaining	O
of	O
a	O
variety	O
of	O
issues	O
including	O
some	O
urinary	B-bodyloc
tract	I-bodyloc
bleeding	O
and	O
persistent	B-course
mild	O
fever	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

Completed	O
by	O
:	O
Simon	O
Claudine	O
Audrey	O
MD	O
82	O
-	O
812	O
2014-04-28	B-temporal
@	O
1227	O

Her	O
laboratories	O
at	O
the	O
time	O
of	O
transfer	O
to	O
Saint	O
Vincent	O
Hospital	O
revealed	O
white	O
blood	O
cell	O
count	O
was	O
11	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
hematocrit	O
was	O
42	B-labvalue
on	O
admission	O
,	O
platelets	O
were	O
242	B-labvalue
.	O

Course	O

She	O
presented	O
to	O
*	O
*	O
INSTITUTION	O
complaining	O
of	O
nausea	O
and	O
absence	O
of	O
the	O
bowel	B-bodyloc
movement	O
.	O

She	O
was	O
continued	O
on	O
aspirin	O
,	O
Plavix	O
,	O
and	O
Lipitor	O
.	O

2	O
.	O

The	O
patient	O
was	O
encouraged	O
to	O
take	O
PO	O
liquids	O
to	O
prevent	O
volume	O
depletion	O
.	O

She	O
has	O
completed	O
up	O
to	O
the	O
tenth	O
grade	O
of	O
high	O
school	O
.	O

In	O
no	B-negation
apparent	O
distress	O
and	O
denied	B-negation
pain	O
.	O

ATTENDING	O
PHYSICIAN	O
:	O

6	O
.	O

7	O
.	O

Folate	O
1	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
day	I-frequency
.	O

Procrit	O
20	B-dosage
,	I-dosage
000	I-dosage
units	I-dosage
IV	B-route
q	B-frequency
.	I-frequency
hemodialysis	I-frequency
.	O

3	O
.	O

818603	O

SCHAUMANN	O
,	O
M	O
.	O
D	O
.	O

Pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

History	O
of	O
peripheral	O
vascular	B-bodyloc
disease	O
.	O

PT	O
19	B-labvalue
.	I-labvalue
9	I-labvalue
sec	I-labvalue
High	B-labvalue

Bisacodyl	O
5	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
Sig	O
:	O
Two	B-dosage
(	O
2	O
)	O
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
as	O
needed	O
for	O
constipation	O
.	O

The	O
patient	O
is	O
a	O
48	O
-	O
year	O
-	O
old	O
white	O
man	O
who	O
is	O
20	O
days	O
status	O
post	O
orthotopic	O
cardiac	O
transplant	O
who	O
was	O
readmitted	O
for	O
sternal	B-bodyloc
wound	O
infection	O
.	O

Then	O
move	O
back	O
her	O
home	O
after	O
her	O
strong	O
enough	O
.	O

2016-04-03	B-temporal

7	O
.	O

Theophylline	O
&	O
lt	O
;	O
2	B-labvalue
.	I-labvalue
0	I-labvalue
ug	I-labvalue
/	I-labvalue
mL	I-labvalue

Nursing	O
staff	O
feels	O
patient	O
should	O
be	O
moving	O
more	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
on	O
2/29/00	B-temporal
,	O
with	O
much	O
improvement	B-course
of	O
his	O
symptoms	O
.	O

There	O
is	O
opacification	O
of	O
the	B-bodyloc
mastoid	I-bodyloc
air	I-bodyloc
cells	I-bodyloc
,	O
greater	O
on	O
the	O
left	O
than	O
the	O
right	O
.	O

Finger	O
sticks	O
were	O
in	O
the	O
150	O
s	O
when	O
acutely	O
agitated	O
,	O
therefore	O
,	O
it	O
was	O
not	O
determined	O
that	O
glucose	O
levels	O
were	O
contributory	O
.	O

A	O
small	O
gallstone	O
was	O
noted	O
in	O
the	O
gallbladder	B-bodyloc
neck	I-bodyloc
.	O

IS	O
/	O
fp	O

EVALUATION	O
DATE	O
:	O

1960-03-06	B-temporal

She	O
was	O
admitted	O
from	O
a	O
skilled	O
nursing	O
home	O
facility	O
where	O
she	O
was	O
started	O
on	O
moxifloxacin	O
empirically	O
for	O
a	O
possible	O
pneumonia	O
aAs	O
per	O
the	O
chest	O
x	O
-	O
ray	O
and	O
the	O
very	O
unspecific	O
symptoms	O
.	O

3	O
.	O

NSR	O
R	O
60	B-labvalue
Normal	O
axis	O
,	O
intervals	O
,	O
incomplete	O
RBBB	O
,	O
flat	O
T	O
aVL	O
,	O
V2	O
,	O
TWI	O
V1	O

The	O
patient	O
also	O
complained	O
of	O
some	O
restless	O
leg	B-bodyloc
syndrome	O
while	O
in	O
the	O
hospital	O
at	O
night	O
,	O
and	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
recommended	O
starting	O
Klonopin	O
at	O
a	O
low	O
dose	O
as	O
above	O
and	O
we	O
did	O
it	O
.	O

Therefore	O
he	O
was	O
able	O
to	O
be	O
discharged	O
home	O
.	O

He	O
was	O
treated	O
with	O
vancomycin	O
and	O
ceftazidime	O
while	O
awaiting	O
wound	O
cultures	O
.	O

The	O
patient	O
did	O
not	B-negation
have	O
any	O
worsening	B-course
of	O
her	O
condition	O
.	O

For	O
pump	O
,	O
once	O
transferred	O
out	O
of	O
the	O
Coronary	O
Care	O
Unit	O
on	O
2011-11-20	B-temporal
,	O
a	O
beta	O
blocker	O
was	O
begun	O
at	O
12	B-strength
.	I-strength
5	I-strength
mg	I-strength
of	O
Lopressor	O
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
which	O
was	O
titrated	O
to	O
25	B-strength
mg	I-strength
at	O
the	O
time	O
of	O
discharge	O
.	O

Physical	O
Exam	O
:	O

Fe	O
53	B-labvalue
ug	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

*	O
*	O
INSTITUTION	O

Case	O
discussed	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
VVV	O
]	O
.	O

RDW	O
16	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue
High	B-labvalue

No	B-negation
edema	O
noted	O
.	O

Headache	O
.	O

Discharged	O
to	O
home	O
.	O

*	O
*	O
DATE	O
[	O
May	B-temporal
02	I-temporal
2007	I-temporal
]	O
01:02:07	B-temporal
/	O
vm	O

97368061	O

ABS	O
Neutrophils	O
9	B-labvalue
.	I-labvalue
4	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O
R	O

She	O
was	O
taken	O
to	O
the	O
OR	O
and	O
due	O
to	O
her	O
reflux	O
,	O
a	O
Nissen	O
fundoplication	O
with	O
gastroduodenoscopy	O
was	O
performed	O
.	O

08/02/93	B-temporal
:	O

HISTORY	O
:	O

Initial	O
radiologic	O
evaluation	O
showed	O
negative	B-labvalue
C	I-labvalue
-	I-labvalue
spine	I-labvalue
,	I-labvalue
thoracic	I-labvalue
spine	I-labvalue
,	I-labvalue
and	I-labvalue
lumbosacral	I-labvalue
spine	I-labvalue
films	I-labvalue
.	O

In	O
the	O
hospital	O
she	O
was	O
found	O
to	O
have	O
right	B-bodyloc
sided	I-bodyloc
weakness	O
and	O
bilateral	B-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
weakness	O
of	O
uncertain	O
etiology	O
.	O

MRN	O
-	O
*	O
*	O
ID	O
-	O
NUM	O
-	O
MPACCOMMMRN	O

MCH	O
24	B-labvalue
.	I-labvalue
6	I-labvalue
pg	I-labvalue
Low	B-labvalue

Left	O
lower	O
extremity	O
examination	O
demonstrated	O
no	B-negation
gross	O
deformities	O
and	O
intact	B-labvalue
motor	O
,	O
sensory	O
,	O
and	O
vascular	O
examinations	O
in	O
all	O
distributions	O
.	O

Dr	O
*	O
*	O
NAME	O
[	O
PPP	O
]	O
for	O
Psychiatry	O
.	O

BENIGN	B-severity
ESSENTIAL	O
HYPERTENSION	O
(	O
ICD9	O
401	O
.	O
1	O
,	O
Working	O
,	O
Problem	O
)	O

R	O
:	O

1951-08-19	B-temporal

LIST	O
OF	O
CONSULTANTS	O
:	O

ORTHOPEDIC	O

Thus	O
,	O
the	O
beta	O
blocker	O
and	O
ACE	O
inhibitor	O
were	O
started	O
to	O
be	O
titrated	O
up	O
.	O

4	O
.	O

Urine	O
output	O
of	O
30	B-labvalue
cc	I-labvalue
to	I-labvalue
100	I-labvalue
cc	I-labvalue
per	I-labvalue
hour	I-labvalue
over	O
the	B-temporal
last	I-temporal
four	I-temporal
hours	I-temporal
.	O

Patient	O
started	O
on	O
Zosyn	O
.	O

D	O
:	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
11	I-temporal
2007	I-temporal
]	O
13	B-temporal
:	I-temporal
56	I-temporal

MRN	O
-	O
*	O
*	O
ID	O
-	O
NUM	O
-	O
MPACCOMMMRN	O

Nortriptyline	O
10	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
h	I-frequency
.	I-frequency
s	I-frequency
.	I-frequency
;	O
Flomax	O
0	B-strength
.	I-strength
4	I-strength
mg	I-strength
q	B-frequency
.	I-frequency
h	I-frequency
.	I-frequency
s	I-frequency
.	I-frequency
;	O
Neurontin	O
600	B-strength
mg	I-strength
three	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
.	O

Serial	O
CT	O
head	O
revealed	O
decreased	B-course
blood	O
through	O
2014-11-14	B-temporal
.	O

Dr	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
and	O
his	O
group	O
from	O
Pulmonary	O
.	O

8	O
.	O

4	O
.	O

Bili	O
,	O
Delta	O
&	O
lt	O
;	O
0	B-labvalue
.	I-labvalue
1	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

*	O
*	O
ID	O
-	O
NUM	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
17	I-temporal
2007	I-temporal
]	O
09:06:21	B-temporal
AM	I-temporal

*	O
*	O
ID	O
-	O
NUM	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
20	I-temporal
2007	I-temporal
]	O
14	B-temporal
:	I-temporal
55	I-temporal

SHY	O
#	O
*	O
*	O
ID	O
-	O
NUM	O

2	O
.	O

Dr	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
from	O
surgery	O
.	O

-	O
Xray	O
R	O
shoulder	O
and	O
elbow	O
No	B-negation
BOny	O
Fx	O
.	O

Gastroenteritis	O
is	O
possible	O
but	O
she	O
has	O
no	B-negation
vomiting	O
and	O
only	O
occ	O
nausea	O
with	O
meds	O
.	O

There	O
was	O
no	B-negation
effusion	O
.	O

Blood	O
coagulation	O
disorder	O
due	O
to	O
liver	B-bodyloc
disease	O
(	O
SNMCT	O
*	O
*	O
ID	O
-	O
NUM	O
,	O
Working	O
,	O
Diagnosis	O
)	O
no	B-negation
evidence	O
of	O
bleeding	O
follow	O
PT	O
/	O
INR	O

Tender	O
to	O
palpation	O
at	O
the	O
left	B-bodyloc
lower	I-bodyloc
quadrant	I-bodyloc
and	O
especially	O
at	O
the	B-bodyloc
epigastrium	I-bodyloc
.	O

4	O
.	O
)	O
Right	B-bodyloc
parietal	I-bodyloc
intracranial	I-bodyloc
bleeding	O
following	O
1996	B-labvalue
cardiac	O
cath	O

Infectious	O
causes	O
were	O
evaluated	O
.	O

028200	O
-	O
Painter	O
,	O
M	O
.	O
D	O
.	O

6	O
.	O

He	O
is	O
a	O
little	O
bit	O
dry	O
intervascularly	B-bodyloc
and	O
I	O
have	O
decreased	O
his	O
Lasix	O
dose	O
.	O

No	B-negation
further	O
dressings	O
are	O
required	O
when	O
there	O
is	O
no	B-negation
further	O
drainage	O
of	O
the	O
left	O
hip	B-bodyloc
wound	O
.	O

10	O
.	O

8	O
.	O

Can	O
not	O
move	O
her	O
R	O
arm	O
.	O

Left	B-bodyloc
rib	I-bodyloc
fractures	O
05	B-temporal
-	I-temporal
22	I-temporal

1	O
.	O

Alk	O
Phos	O
117	B-labvalue
IntUnit	I-labvalue
/	I-labvalue
L	I-labvalue

Questions	O
regarding	O
follow	O
up	O
may	O
be	O
referred	O
to	O
Dr	O
.	O
Ronda	O
Lopez	O
at	O
the	O
Ayer	O
Orthopedic	O
Group	O
.	O

The	O
epidural	O
catheter	O
had	O
a	O
morphine	O
infusion	B-form
initially	O
started	O
at	O
1	B-strength
mg	I-strength
a	B-frequency
day	I-frequency
and	O
increased	O
to	O
3	B-strength
mg	I-strength
a	B-frequency
day	I-frequency
in	O
a	O
period	O
of	O
three	B-duration
days	I-duration
.	O

His	O
memory	O
seemed	O
to	O
be	O
slightly	O
impaired	O
today	O
.	O

Findings	O
were	O
discussed	O
with	O
Dr	O
.	O
Leanne	O
Vazquez	O
at	O
the	O
time	O
this	O
study	O
was	O
performed	O
,	O
but	O
the	O
study	O
was	O
not	O
dictated	O
until	O
the	B-temporal
morning	I-temporal
of	O
2014-10-22	B-temporal
,	O
due	O
to	O
PACS	O
malfunction	O
.	O

CABG	O
x4	O
was	O
performed	O
on	O
*	O
*	O
DATE	O
[	O
Aug	B-temporal
23	I-temporal
2007	I-temporal
]	O
.	O

This	O
*	O
*	O
AGE	O
[	O
in	O
60s	O
]	O
year	O
old	O
,	O
married	O
,	O
white	O
female	O
with	O
h	O
/	O
o	O
ESRD	O
on	O
HD	O
,	O
presented	O
to	O
ED	O
after	O
a	O
presyncopal	O
episode	O
on	O
HD	O
,	O
lightheadedness	O
and	O
substernal	B-bodyloc
chestpain	O
.	O

4	O
.	O

Throughout	O
his	O
stay	O
,	O
Chem	O
-	O
10	O
was	O
monitored	O
.	O

Multivitamin	O

5	O
.	O

Z	O
.	O

Osteoporosis	O
.	O

2	O
.	O

As	O
tolerated	O
,	O
regular	O
diet	O
.	O

Potassium	O
at	O
the	O
time	O
of	O
admission	O
was	O
low	B-labvalue
and	O
she	O
required	O
vigorous	O
potassium	O
replacement	O
.	O

Accordingly	O
he	O
was	O
referred	O
for	O
further	O
evaluation	O
.	O

Multivitamin	O
Capsule	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Cap	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Aspirin	O
325	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

On	O
the	O
night	O
of	O
admission	O
,	O
the	O
patient	O
experienced	O
post	O
catheterization	O
hypotension	O
which	O
required	O
intravenous	O
fluids	O
and	O
dopamine	O
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

3	O
.	O

HOSPITAL	O
COURSE	O
:	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
12	I-temporal
2007	I-temporal
]	O

Discharge	O
Date	O
:	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
7	I-temporal
2007	I-temporal
]	O
8	B-temporal
:	I-temporal
00	I-temporal
AM	I-temporal

We	O
are	O
going	O
to	O
discharge	O
her	O
home	O
with	O
close	O
outpatient	O
followup	O
.	O

Leukocytosis	O
NOS	O
(	O
ICD9	O
288	O
.	O
8	O
,	O
Working	O
,	O
Diagnosis	O
)	O

*	O
*	O
NAME	O
[	O
VVV	O
WWW	O
]	O
,	O
R	O
.	O
N	O
.	O

Atorvastatin	O
10	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

1	O
.	O

6	O
.	O

T	O
:	O

CONCLUSION	O
:	O
Improvement	B-course
in	O
congestion	O
from	O
edema	O
with	O
no	O
worsening	O
,	O
but	O
no	O
significant	O
improvement	O
,	O
in	O
the	B-bodyloc
right	I-bodyloc
upper	I-bodyloc
lobe	I-bodyloc
pneumonia	O
.	O

She	O
did	O
have	O
anasarca	O
at	O
the	O
time	O
of	O
admission	O
,	O
but	O
the	O
use	O
of	O
Lasix	O
and	O
the	O
single	O
dialysis	O
session	O
that	O
she	O
had	O
early	O
during	O
hospitalization	O
helped	O
mobilize	O
that	O
fluid	O
.	O

None	O
.	O

Postoperatively	O
,	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
.	O

Post	O
thoracotomy	O
syndrome	O
.	O

Patient	O
:	O

Milk	O
of	O
magnesia	O
30	B-dosage
mL	I-dosage
p	B-form
.	I-form
o	I-form
.	I-form
at	B-frequency
bedtime	I-frequency
for	O
constipation	O
.	O

Respiratory	O
Rate	O
18	B-labvalue

ACUTE	B-course
ALCOHOLIC	O
HEPATITIS	O
(	O
ICD9	O
571	O
.	O
1	O
,	O
Working	O
,	O
Diagnosis	O
)	O

This	O
resolved	O
with	O
Tylenol	O
and	O
as	O
needed	O
doses	O
of	O
oxycodone	O
.	O

No	B-negation
cyanosis	O
.	O

8	O
.	O

1	O
.	O

ALT	O
/	O
SGPT	O
35	B-labvalue
IU	I-labvalue
/	I-labvalue
L	I-labvalue

T	O
:	O

Further	O
identification	O
revealed	O
staphylococcus	O
coag	O
-	O
negative	B-labvalue
,	O
which	O
was	O
sensitive	O
to	O
gentamicin	O
and	O
clindamycin	O
.	O

Pulse	O
:	O

Ionized	O
Calcium	O
1	B-labvalue
.	I-labvalue
12	I-labvalue
mMol	I-labvalue
/	I-labvalue
L	I-labvalue
Low	B-labvalue

1950-04-21	B-temporal

D	O
:	O
2012-04-30	B-temporal
11	B-temporal
:	I-temporal
30	I-temporal

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

Temperature	O
100	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
pulse	O
108	B-labvalue
,	O
respirations	O
20	B-labvalue
,	O
blood	O
pressure	O
110	B-labvalue
/	I-labvalue
70	I-labvalue
,	O
oxygen	O
saturation	O
100	B-labvalue
%	I-labvalue
on	O
room	O
air	O
.	O

Denies	O
any	O
recent	O
use	O
of	O
EtOH	O
or	O
illicit	O
drugs	O
.	O

Peripheral	O
pulses	O
intact	O
.	O

GLUCOSE	O
-	O
NEG	B-labvalue
KETONE	O
-	O
NEG	B-labvalue
BILIRUBIN	O
-	O
NEG	B-labvalue
UROBILNGN	O
-	O
NEG	B-labvalue
PH	O
-	O
7	B-labvalue
.	I-labvalue
0	I-labvalue
LEUK	O
-	O
NEG	B-labvalue

CT	O
scan	O
of	O
the	O
chest	O
without	O
contrast	O
done	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
26	I-temporal
2007	I-temporal
]	O
,	O
that	O
showed	O
left	B-bodyloc
lower	I-bodyloc
lobe	I-bodyloc
pneumonia	O
with	O
trace	B-severity
left	O
parapneumonic	O
effusion	O
,	O
moderate	B-course
cardiomegaly	O
,	O
and	O
large	O
hiatal	O
hernia	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

1	O
.	O

PATIENT	O
NAME	O
:	O

D	O
:	O
2010-09-02	B-temporal
18	B-temporal
:	I-temporal
23	I-temporal

She	O
also	O
denies	B-negation
any	O
tiredness	O
or	O
fever	O
or	O
malaise	O
.	O

This	O
was	O
consistent	O
with	O
severe	B-course
anoxic	O
encephalopathy	O
.	O

7	O
.	O

It	O
was	O
unclear	O
at	O
first	O
as	O
to	O
why	O
the	O
patient	O
required	O
life	B-duration
-	I-duration
long	I-duration
anticoagulation	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Sex	O
:	O

ALLRESLTSECT	O

Articulation	O
and	O
speech	O

Lungs	O
:	O

ACUTE	B-course
PANCREATITIS	O
.	O

VITAL	O
SIGNS	O
:	O

FEN	O
:	O
house	O
diet	O

My	O
note	O
should	O
be	O
considered	O
as	O
linked	O
.	O

Monocytes	O
9	B-labvalue
%	I-labvalue

Unemployed	O
and	O
on	O
disability	O
.	O

Completed	O
by	O
:	O
Bertha	O
Janice	O
Motta	O
MD	O
52	O
-	O
860	O
2012-11-07	B-temporal
@	O
1207	O

MRN	O
-	O
*	O
*	O
ID	O
-	O
NUM	O
-	O
MPACCOMMMRN	O

ABDOMEN	O
:	O

Alk	O
Phos	O
137	B-labvalue
IU	I-labvalue
/	I-labvalue
L	I-labvalue
High	B-labvalue

Pulmonary	B-bodyloc
hypertension	O
.	O

She	O
had	O
the	O
temporal	O
artery	O
biopsies	O
come	O
back	O
positive	O
.	O

Cyclosporin	O
levels	O
were	O
followed	O
and	O
his	O
sugars	O
were	O
followed	O
with	O
a	O
sliding	O
scale	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

D	O
:	O
2011-11-22	B-temporal
14	B-temporal
:	I-temporal
09	I-temporal

Continue	O
home	O
medications	O
and	O
Flagyl	O
500	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
for	O
10	B-duration
days	I-duration
,	O
dispensed	O
#	O
40	O
.	O

Health	O
Status	O

Attending	O
:	O

DIS	O

1	O
.	O

She	O
can	O
shower	O
.	O

1	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
will	O
have	O
SMH	O
Service	O
that	O
comes	O
to	O
her	O
home	O
once	O
a	O
day	O
for	O
adressing	O
change	O
.	O

Cervical	O
spine	O
imaging	O
demonstrated	O
no	B-negation
evidence	O
of	O
cervical	B-bodyloc
spine	I-bodyloc
injury	O
.	O

7	O
.	O

Acute	B-course
delirium	O
.	O

Medications	O
on	O
Admission	O
:	O

A	O
chest	O
x	O
-	O
ray	O
was	O
done	O
,	O
which	O
revealed	O
no	B-negation
infiltrate	O
or	O
effusion	O
.	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
7	I-temporal
2007	I-temporal
]	O
6	B-temporal
:	I-temporal
35	I-temporal
AM	I-temporal

Allergies	O
:	O

ABS	O
Basophils	O
0	B-labvalue
.	I-labvalue
00	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
7:00:00	B-temporal

Blood	O
pressure	O
will	O
need	O
to	O
be	O
followed	O
because	O
of	O
variability	O
,	O
but	O
she	O
is	O
breathing	O
quite	O
comfortably	O
.	O

*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
YYY	O
]	O

ABS	O
Monocytes	O
1	B-labvalue
.	I-labvalue
3	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

DIAGNOSES	O
:	O

2011-03-21	B-temporal

4	O
.	O

5	O
.	O

SaO2	O
has	O
been	O
stable	O
overall	O
96	B-labvalue
%	I-labvalue
/	O
ra	O
and	O
hgb	O
&	O
gt	O
;	O
10	O
.	O

Extended	O
Care	O

WBC	O
s	O
in	O
the	O
fluid	O
was	O
300	B-labvalue
,	O
RBC	O
s	O
in	O
the	O
fluid	O
were	O
within	B-labvalue
normal	I-labvalue
limits	I-labvalue
,	O
neutrophils	O
in	O
the	O
fluid	O
were	O
5	B-labvalue
%	I-labvalue
,	O
and	O
lymphocytes	O
in	O
the	O
fluid	O
were	O
81	B-labvalue
%	I-labvalue
.	O

DISCHARGE	O
DATE	O
:	O

Chest	O
:	O

No	B-negation
wheezes	O
auscultated	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

RWRF75BSI	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

Impression	O
and	O
Plan	O

Pulse	O
92	B-labvalue
BPM	I-labvalue

GI	O
-	O
ESLD	O
-	O
patient	O
having	O
7	O
-	O
10	O
BM	O
s	O
daily	O
.	O

2	O
.	O

4	O
.	O

Acute	B-course
inferior	B-bodyloc
myocardial	I-bodyloc
infarction	O
and	O
right	B-bodyloc
ventricular	I-bodyloc
infarction	O
.	O

General	O
Internal	O
Medicine	O

Her	O
strength	O
was	O
unchanged	O
.	O

They	O
are	O
stable	O
and	O
normal	O
.	O

Increased	O
sedimentation	O
rate	O
,	O
white	O
count	O
,	O
and	O
CRP	O
which	O
is	O
being	O
worked	O
up	O
at	O
this	O
point	O
for	O
rheumatologic	O
evaluation	O
.	O

Discussed	O
with	O
the	O
FHC	O
Residents	O
*	O
*	O
NAME	O
[	O
QQQ	O
]	O
PharmD	O
on	O
Rounds	O
.	O

She	O
was	O
therefore	O
admitted	O
to	O
the	O
hospital	O
for	O
acute	O
care	O
.	O

1990-02-01	B-temporal

Barium	O
swallow	O
with	O
a	O
reflux	O
study	O
was	O
performed	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
19	I-temporal
2007	I-temporal
]	O
.	O

Follow	O
up	O
for	O
hemodialysis	O
tomorrow	B-temporal
.	O

Medication	O
:	O

The	O
wounds	O
were	O
clean	O
,	O
dry	O
and	O
intact	O
,	O
and	O
flat	O
.	O

2	O
.	O

PATIENT	O
NAME	O
:	O

CC	O
:	O
Antonio	O
M	O
.	O

SHAZA	O
C	O
.	O

This	O
in	O
the	O
setting	O
of	O
ischemic	O
heart	B-bodyloc
disease	O
with	O
some	O
moderate	B-severity
systolic	O
and	O
diastolic	O
dysfunction	O
as	O
well	O
as	O
hypertension	O
and	O
history	O
of	O
mechanical	O
mitral	O
valve	O
.	O

*	O
*	O
AGE	O
[	O
in	O
70s	O
]	O
years	O

At	O
the	O
time	O
of	O
discharge	O
the	O
patient	O
is	O
doing	O
quite	O
well	O
.	O

nutritional	O
status	O
:	O
normal	O
.	O

Summary	O
of	O
Hospitalization	O
:	O

MCV	O
105	B-labvalue
.	I-labvalue
2	I-labvalue
fL	I-labvalue
High	B-labvalue

Patient	O
seen	O
at	O
bedside	O
.	O

SOCIAL	O
HISTORY	O
:	O

There	O
was	O
an	O
S4	O
.	O

Scalp	B-bodyloc
laceration	O
should	O
be	O
kept	O
clean	O
and	O
dry	O
for	O
five	O
days	O
following	O
discharge	O
after	O
which	O
point	O
the	O
patient	O
may	O
once	O
wash	O
her	O
hair	O
.	O

STATUS	O
POST	O
MOTORVEHICLE	O
ACCIDENT	O
WITH	O
TRANSIENT	O
PARAPLEGIA	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

NONCONTRAST	O
CERVICAL	O
SPINE	O
CT	O
:	O
There	O
are	O
minimally	O
displaced	O
and	O
comminuted	O
fractures	O
through	O
the	O
left	B-bodyloc
C7	I-bodyloc
and	I-bodyloc
T1	I-bodyloc
transverse	I-bodyloc
processes	I-bodyloc
.	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Pantoprazole	O
Sodium	O
40	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
PO	B-route
Q24H	B-frequency
(	O
every	B-frequency
24	I-frequency
hours	I-frequency
)	O
.	O

PUOMC	O

Ultram	O
50	B-strength
mg	I-strength
q	B-frequency
12	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
pain	O

*	O
*	O
DATE	O
[	O
Oct	B-temporal
19	I-temporal
2007	I-temporal
]	O

His	O
course	O
has	O
been	O
complicated	O
by	O
an	O
SMA	O
aneurysm	O
,	O
status	O
post	O
repair	O
,	O
as	O
well	O
as	O
an	O
infected	O
phlegmon	O
,	O
status	O
post	O
debridement	O
,	O
with	O
ARDS	O
and	O
subsequent	O
respiratory	O
insufficiency	O
.	O

Addendum	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
19	I-temporal
2007	I-temporal
]	O
4	B-temporal
:	I-temporal
43	I-temporal
PM	I-temporal

There	O
is	O
evidence	O
of	O
passage	O
of	O
oral	O
contrast	O
throughout	O
all	O
the	O
stomach	O
and	O
the	O
small	O
bowel	O
.	O

Acetaminophen	O
325	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
Q4	B-frequency
-	I-frequency
6H	I-frequency
(	O
every	B-frequency
4	I-frequency
to	I-frequency
6	I-frequency
hours	I-frequency
)	O
as	B-frequency
needed	I-frequency
.	O

This	O
pattern	O
continued	O
throughout	O
her	O
hospital	O
stay	O
on	O
her	O
current	B-temporal
medication	O
regimen	O
.	O

1	O
.	O

DISPOSITION	O
:	O

Physical	O
therapy	O
and	O
Occupational	O
Therapy	O
were	O
consulted	O
for	O
standard	O
total	O
hip	O
arthroplasty	O
protocol	O
.	O

This	O
slowed	O
and	O
eventually	O
stopped	O
by	O
postoperative	O
day	O
7	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Tracheostomy	O
2014-11-11	B-temporal

CT	O
head	O
remained	O
stable	O
for	O
SAH	O
.	O

RBC	O
2	B-labvalue
.	I-labvalue
90	I-labvalue
X10E	I-labvalue
+	I-labvalue
12	I-labvalue
/	I-labvalue
L	I-labvalue
Low	B-labvalue

CC	O
:	O

4	O
.	O

ACUTE	B-course
PANCREATITIS	O

8	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

*	O
*	O
ROOM	O

3	O
.	O

The	O
patient	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
70s	O
]	O
-	O
year	O
-	O
old	O
man	O
who	O
was	O
admitted	O
as	O
an	O
outpatient	O
secondary	O
to	O
increased	B-course
blood	O
pressure	O
,	O
increased	B-course
hypertension	O
of	O
240	O
/	O
140	O
,	O
and	O
associated	O
chest	B-bodyloc
pain	O
.	O

The	O
patient	O
&apos;s	O
paraplegia	O
resolved	B-course
by	O
the	B-temporal
morning	I-temporal
of	O
her	O
second	O
hospital	O
day	O
,	O
and	O
she	O
maintained	O
5	B-labvalue
/	I-labvalue
5	I-labvalue
motor	O
strength	O
in	O
all	O
groups	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
10	I-temporal
2007	I-temporal
]	O

Chest	O
x	O
-	O
ray	O
done	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
25	I-temporal
2007	I-temporal
]	O
,	O
that	O
showed	O
moderate	O
-	O
sized	O
left	O
pleural	O
effusions	O
.	O

DIAGNOSES	O
AT	O
TIME	O
OF	O
DEATH	O
:	O

Occasionally	O
required	O
Haldol	O
/	O
ativan	O
at	B-temporal
night	I-temporal
for	O
agitation	O
.	O

03/01/00	B-temporal

Patient	O
has	O
a	O
history	O
of	O
suicidal	O
ideations	O
and	O
self	O
mutilation	O
.	O

History	O
of	O
transient	O
ischemic	O
attack	O
/	O
cerebrovascular	O
accident	O
.	O

*	O
*	O
AGE	O
[	O
in	O
30s	O
]	O
year	O
old	O
SWM	O
with	O
a	O
history	O
of	O
alcoholism	O
,	O
DM	O
,	O
HTN	O
,	O
Lone	O
A	O
-	O
Fib	O
who	O
was	O
admitted	O
for	O
ascites	O
.	O

2012-10-31	B-temporal
12	B-temporal
:	I-temporal
20PM	I-temporal

BRIEF	O
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O

IMPRESSION	O
:	O
Minimally	O
displaced	O
,	O
comminuted	O
fractures	O
of	O
the	O
left	B-bodyloc
C7	I-bodyloc
and	I-bodyloc
T1	I-bodyloc
transverse	I-bodyloc
processes	I-bodyloc
.	O

Paraphimosis	O
.	O

DISPOSITION	O
:	O

Sodium	O
133	B-labvalue
,	O
potassium	O
4	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
chloride	O
101	B-labvalue
,	O
CO2	O
28	B-labvalue
,	O
BUN	O
7	B-labvalue
,	O
creatinine	O
0	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
and	O
glucose	O
99	B-labvalue
.	O

He	O
had	O
triglycerides	O
on	O
*	O
*	O
DATE	O
[	O
May	B-temporal
8	I-temporal
2006	I-temporal
]	O
,	O
of	O
112	B-labvalue
.	O

-	O
Check	O
microalbumin	O
.	O

ABS	O
Eosinophils	O
0	B-labvalue
.	I-labvalue
30	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

anxiety	O
improved	B-course
no	B-negation
CP	O
,	O
SOB	O

The	O
patient	O
was	O
admitted	O
for	O
acute	B-course
alcoholic	O
hepatitis	O
.	O

Quality	O
Measures	O

LIST	O
OF	O
CONSULTANTS	O
:	O

3	O
.	O
)	O
Insulin	O
45N	B-strength
/	I-strength
8R	I-strength
qAM	B-frequency
and	O
33N	B-strength
qPM	B-frequency

Fair	O
control	O
at	O
this	O
time	O
Observe	O
.	O

2	O
.	O

JOB	O
#	O
:	O
15087	O

General	O
Results	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
11	I-temporal
07	I-temporal
]	O

His	O
hemoglobin	O
A1c	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
2007	I-temporal
]	O
,	O
was	O
5	B-labvalue
.	I-labvalue
3	I-labvalue
.	O

Lower	B-bodyloc
extremity	I-bodyloc
pain	O
with	O
inability	O
to	O
ambulate	O
.	O

DOB	O
:	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
22	I-temporal
2007	I-temporal
]	O
04	B-temporal
:	I-temporal
16	I-temporal

Quality	O
Measures	O

The	O
patient	O
wears	O
dentures	O
.	O

A	O
followup	O
MRI	O
which	O
also	O
showed	O
similar	O
changes	O
.	O

Ascites	O
-	O
GI	O
consult	O
.	O

darbepoetin	O
alfa	O
,	O
100	B-strength
mcg	I-strength
,	O
subQ	B-route
,	O
Q	B-frequency
Saturday	I-frequency
,	O
Drug	O
Form	O
:	O
Solution	O
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
9:00:00	B-temporal

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

Discharge	O
Condition	O
:	O

*	O
*	O
ROOM	O

DOB	O
:	O

Dictator	O
:	O

None	O
.	O

Discharge	O
Date	O
:	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O

The	O
patient	O
had	O
an	O
episode	O
of	O
shortness	O
of	O
breath	O
and	O
was	O
most	O
likely	O
related	O
to	O
some	O
pulmonary	B-bodyloc
edema	O
,	O
however	O
,	O
an	O
echocardiogram	O
was	O
performed	O
which	O
showed	O
a	O
normal	B-labvalue
EF	O
.	O

COLOR	O
-	O
Straw	B-labvalue
APPEAR	O
-	O
Clear	B-labvalue
SP	O
Marquez	O
-	O
1	B-labvalue
.	I-labvalue
021	I-labvalue

The	O
patient	O
is	O
well	O
-	O
appearing	O
in	O
no	B-negation
acute	B-course
distress	O
.	O

Acute	B-course
rhabdomyolysis	O
secondary	O
to	O
#	O
5	O
.	O

Nicotine	O
14	B-dosage
mg	I-dosage
/	I-dosage
24	I-dosage
hr	I-dosage
Patch	B-form
24	I-form
HR	I-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Patch	B-form
24	I-form
HR	I-form
Transdermal	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Low	O
magnesium	O
-	O
will	O
replete	O
with	O
IV	B-route
magnesium	O

ATTENDING	O
PHYSICIAN	O
:	O

5	O
.	O

Unsigned	O

Signed	O

Abdomen	O
:	O

General	O
results	O

5	O
.	O

She	O
was	O
sent	O
for	O
a	O
CT	O
scan	O
of	O
her	O
abdomen	O
,	O
which	O
revealed	O
fluid	O
and	O
question	O
of	O
gas	O
in	O
the	O
endometrial	B-bodyloc
cavity	O
,	O
and	O
she	O
was	O
sent	O
to	O
Pinewood	O
,	O
Norfolk	O
for	O
treatment	O
and	O
admission	O
.	O

CRITICAL	O
CARE	O
MEDICINE	O

The	O
patient	O
'	O
s	O
head	B-bodyloc
wound	O
laceration	O
was	O
noted	O
to	O
be	O
clean	O
and	O
dry	O
with	O
intact	O
staples	O
.	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Sandra	O
BURGER	O
on	O
:	O
WED	B-temporal
2011-11-30	B-temporal
9	B-temporal
:	I-temporal
46	I-temporal
AM	I-temporal

*	O
*	O
NAME	O
[	O
XXX	O
M	O
ZZZ	O
YYY	O
]	O

Depression	O
.	O

5	O
.	O

Some	O
spotting	O
on	O
the	O
day	O
prior	O
to	O
admission	O
,	O
but	O
not	O
a	O
normal	O
period	O
.	O

Ext	O
:	O

The	O
patient	O
was	O
to	O
have	O
a	O
repeat	O
CT	O
scan	O
in	O
one	B-temporal
week	I-temporal
.	O

Age	O
:	O

Discharge	O
Disposition	O
:	O

He	O
is	O
on	O
Heparin	O
dose	O
for	O
his	O
SMA	O
repair	O
,	O
but	O
he	O
has	O
had	O
some	O
bleeding	O
from	O
the	O
lower	O
aspect	O
of	O
the	O
wound	O
.	O

Course	O

Signed	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

Possible	O
due	O
to	O
celebrex	O
insult	O

342924	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

2012-10-31	B-temporal
12	B-temporal
:	I-temporal
20PM	I-temporal

The	O
patient	O
will	O
be	O
ready	O
for	O
insulin	O
therapy	O
if	O
needed	O
during	O
his	O
course	O
of	O
steroids	O
.	O

All	O
cultures	O
were	O
negative	B-labvalue
.	O

Pyelonephritis	O
.	O

He	O
is	O
9	O
.	O
4	O
and	O
27	O
.	O
3	O
this	B-temporal
morning	I-temporal
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
amount	O
of	O
fluid	O
layering	O
at	O
the	B-bodyloc
apices	I-bodyloc
and	O
the	O
pleural	B-bodyloc
spaces	O
appear	O
slightly	O
decreased	B-course
.	O

I	O
personally	O
interviewed	O
and	O
examined	O
the	O
patient	O
.	O

ACCOUNT	O
#	O
:	O

Venous	O
Doppler	O
studies	O
were	O
negative	B-labvalue
for	O
any	O
evidence	O
to	O
suggest	O
deep	O
vein	O
thrombosis	O
of	O
the	B-bodyloc
lower	I-bodyloc
extremities	I-bodyloc
.	O

Date	O
of	O
Birth	O
:	O

HOSPITAL	O
COURSE	O
:	O

Enteric	O
-	O
coated	O
aspirin	O
325	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

ALLERGIES	O
:	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
29	I-temporal
2007	I-temporal
]	O

A	O
copy	O
of	O
this	O
dc	O
summary	O
will	O
be	O
faxed	O
to	O
her	O
PCP	O
to	O
ensure	O
proper	O
follow	O
up	O
.	O

PATIENT	O
NAME	O
:	O

2014-10-21	B-temporal
08	B-temporal
:	I-temporal
10	I-temporal
PM	I-temporal

Admission	O
Date	O
:	O

Colace	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
twice	B-frequency
per	I-frequency
day	I-frequency
.	O

3	O
.	O

Discharge	O
Date	O
:	O

*	O
*	O
*	O

3	O
.	O

lorazepam	O
,	O
0	B-strength
.	I-strength
5	I-strength
mg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
BID	B-frequency
,	O
Drug	O
Form	O
:	O
Tab	B-form
,	O
PRN	B-frequency
,	O
For	O
Anxiety	O
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
14	I-temporal
08	I-temporal
]	O
14:58:00	B-temporal

MPV	O
7	B-labvalue
.	I-labvalue
7	I-labvalue
fL	I-labvalue

His	O
abdominal	O
CT	O
showed	O
progressive	O
cirrhotic	O
change	O
within	O
the	O
liver	B-bodyloc
with	O
new	O
evidence	O
of	O
portal	O
hypertension	O
including	O
large	O
abdominal	B-bodyloc
ascites	O
,	O
perigastric	B-bodyloc
,	O
and	O
paraesophageal	B-bodyloc
varices	O
,	O
and	O
reconstituted	O
periumbilical	B-bodyloc
vein	I-bodyloc
.	O

Children	O
'	O
s	O
Hospital	O
of	O
Waltham	O

Resp	O
:	O

Patient	O
did	O
not	O
receive	O
the	O
pneumococcal	O
vaccine	O
,	O
but	O
she	O
did	O
receive	O
the	O
inactivated	O
influenza	O
vaccine	O
.	O

Discharge	O
Disposition	O
:	O

At	O
this	O
point	O
,	O
it	O
was	O
determined	O
that	O
the	O
patient	O
would	O
not	O
receive	O
percutaneous	O
coronary	O
intervention	O
on	O
this	O
admission	O
and	O
would	O
likely	O
be	O
discharged	O
to	O
the	O
floor	O
for	O
stabilization	O
with	O
followup	O
.	O

Wilson	O
SURGERY	O
(	O
NHB	O
)	O

Located	O
within	O
the	B-bodyloc
atrium	I-bodyloc
of	I-bodyloc
the	I-bodyloc
right	I-bodyloc
lateral	I-bodyloc
ventricle	I-bodyloc
is	O
an	O
18	O
x	O
10	O
mm	O
nodular	O
area	O
of	O
increased	B-course
density	O
which	O
is	O
separate	O
from	O
the	O
choroid	O
plexus	O
.	O

Clostridium	O
difficile	O
diarrhea	O
infection	O
.	O

In	O
the	O
St	O
.	O

Toxicology	O
consulted	O
and	O
felt	O
that	O
patient	O
most	O
likely	O
had	O
benzo	O
overdose	O
.	O

Sign	O
by	O
*	O
*	O
NAME	O
[	O
VVV	O
,	O
UUU	O
]	O

Eye	O
:	O

As	O
tolerated	O
.	O

345005	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

ATTENDING	O
:	O

OO63	O

ID	O
-	O
H	O
&	O
amp	O
;	O
H	O
trending	O
down	O
.	O

The	O
likely	O
cause	O
of	O
the	O
delirium	O
was	O
a	O
combination	O
of	O
surgery	O
and	O
Intensive	O
Care	O
Unit	O
stay	O
in	O
addition	O
to	O
poly	O
-	O
pharmacy	O
.	O

The	O
abdomen	O
is	O
soft	O
,	O
he	O
is	O
tolerating	O
his	O
tube	O
feeds	O
at	O
his	O
goal	O
rate	O
and	O
clinically	O
he	O
seems	O
to	O
be	O
improving	O
.	O

Date	O
of	O
Birth	O
:	O

SECONDARY	O
DIAGNOSES	O
:	O

52175844	O

Service	O
:	O

ACCOUNT	O
#	O
:	O

If	O
he	O
needs	O
further	O
Librium	O
then	O
he	O
should	O
go	O
to	O
*	O
*	O
INSTITUTION	O
Ambulatory	O
Division	O
for	O
further	O
care	O
.	O

Penicillins	O
/	O
Sulfonamides	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

ACCOUNT	O
#	O
:	O

10	O
.	O

Pupils	O
are	O
equal	O
and	O
reactive	O
to	O
light	O
.	O

CT	O
HEAD	O
W	O
/	O
O	O
CONTRAST	O

4	O
.	O

The	O
patient	O
'	O
s	O
spiked	O
a	O
fever	O
on	O
hospital	O
day	B-temporal
7	I-temporal
of	O
38	O
.	O
1	O
.	O

Chemistry	O
was	O
normal	B-labvalue
.	O

insulin	O
regular	O
,	O
6	B-dosage
Unit	I-dosage
(	I-dosage
s	I-dosage
)	I-dosage
,	O
subQ	B-route
,	O
TID	B-frequency
meals	I-frequency
,	O
Drug	O
Form	O
:	O
Injection	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
12:00:00	B-temporal

Dr	O
.	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
was	O
consulted	O
for	O
rehab	O
management	O
.	O

The	O
patient	O
received	O
hydralazine	O
and	O
labetalol	O
in	O
the	O
ED	O
with	O
good	O
effect	O
and	O
her	O
blood	O
pressure	O
started	O
to	O
come	O
under	O
control	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

K7798E74	O

Special	O
Instructions	O
:	O

Respiratory	O
Rate	O
16	B-labvalue

Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
was	O
consulted	O
for	O
medical	O
management	O
.	O

D	O
:	O
2009-04-02	B-temporal
22	B-temporal
:	I-temporal
09	I-temporal

2014-04-23	B-temporal
01	B-temporal
:	I-temporal
38	I-temporal
PM	I-temporal

Job	O
ID	O
:	O

Patient	O
states	O
he	O
is	O
"	O
breathing	O
easier	O
.	O
"	O
.	O

-	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
QQQ	O
M	O
]	O
.	O

Need	O
carefully	O
to	O
investigae	O
her	O
home	O
meds	O
to	O
see	O
if	O
there	O
any	O
she	O
has	O
been	O
taking	O
but	O
we	O
did	O
not	O
give	O
to	O
her	O
.	O

CVA	O
2012	O
w	O
/	O
right	B-bodyloc
sided	I-bodyloc
weakness	O

He	O
was	O
instructed	O
to	O
hold	O
the	O
following	O
three	O
medications	O
that	O
he	O
took	O
prior	O
to	O
admission	O
:	O

MEDICATIONS	O
ON	O
ADMISSION	O
TO	O
CORONARY	O
CARE	O
0408398	O
.	O

Transfer	O
Summary	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Disposition	O

She	O
was	O
discharged	O
on	O
Coumadin	O
for	O
a	O
goal	O
INR	O
of	O
2	B-labvalue
.	I-labvalue
5	I-labvalue
to	I-labvalue
3	I-labvalue
.	O

Lisinopril	O
5	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

Diet	O
as	O
tolerated	O
.	O

The	O
patient	O
had	O
intubation	O
attempted	O
.	O

He	O
is	O
being	O
tube	O
fed	O
at	O
his	O
goal	O
rate	O
.	O

ASSESSMENT	O
AND	O
PLAN	O

*	O
*	O
ROOM	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Electrophysiology	O
service	O
,	O
Dr	O
.	O
Slusslashgodle	O
,	O
who	O
said	O
that	O
he	O
had	O
no	B-negation
indication	I-negation
for	O
patch	O
placement	O
at	O
the	O
time	O
of	O
surgery	O
.	O

SERVICE	O
OF	O
:	O

*	O
*	O
CARBON	O
-	O
COPY	O

She	O
was	O
breathing	O
rapidly	O
and	O
working	O
to	O
breath	O
.	O

She	O
has	O
therapeutic	O
INR	O
of	O
2	B-labvalue
.	I-labvalue
4	I-labvalue
.	O

Electrocardiogram	O
status	O
post	O
percutaneous	O
coronary	O
intervention	O
revealed	O
a	O
normal	O
sinus	O
rhythm	O
at	O
84	O
,	O
with	O
a	O

Stable	O
.	O

1	O
.	O

RADIOLOGY	O
/	O
IMAGING	O
:	O

Postoperative	O
physical	O
examination	O
demonstrated	O
that	O
he	O
was	O
afebrile	O
at	O
97	O
degrees	O
;	O
blood	O
pressure	O
145	B-labvalue
/	I-labvalue
80	I-labvalue
;	O
pulse	O
60	B-labvalue
;	O
respiratory	O
rate	O
10	B-labvalue
;	O
100	O
%	O
on	O
a	O
non	O
-	O
rebreather	O
.	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Lee	O
V	O
.	O

The	O
patient	O
was	O
evaluated	O
for	O
TTP	O
with	O
peripheral	O
blood	O
smear	O
and	O
checking	O
for	O
hemolysis	O
;	O
however	O
,	O
the	O
patient	O
did	O
not	O
have	O
altered	O
mental	O
status	O
and	O
did	O
not	O
spike	O
fevers	O
and	O
blood	O
smear	O
showed	O
very	O
few	O
histocytes	O
.	O

Later	O
in	O
the	B-temporal
morning	I-temporal
on	O
08	B-temporal
-	I-temporal
31	I-temporal
,	O
the	O
patient	O
was	O
more	O
oriented	O
and	O
alert	O
,	O
and	O
asked	O
to	O
have	O
the	O
restraints	O
removed	O
.	O

Ambien	O
10	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
h	I-frequency
.	I-frequency
s	I-frequency
.	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
insomnia	O

Linezolid	O
600	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
Q12H	B-frequency
(	O
every	B-frequency
12	I-frequency
hours	I-frequency
)	O
:	O
Last	O
dose	O
2014-11-20	B-temporal
.	O

01/27/92	B-temporal

On	O
the	O
last	O
hospital	O
day	O
the	O
patient	O
underwent	O
successful	O
left	O
lumbar	O
sympathetic	O
block	O
under	O
fluoroscopy	O
by	O
Pain	O
Management	O
and	O
yet	O
at	O
the	O
time	O
of	O
the	O
preprocedure	O
period	O
her	O
blood	O
pressure	O
was	O
elevated	B-labvalue
at	O
154	B-labvalue
/	I-labvalue
118	I-labvalue
.	O

Discharge	O
Date	O
:	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
XXX	O
ZZZ	O
]	O

*	O
*	O
ROOM	O

Date	O
of	O
Birth	O
:	O

Regular	B-labvalue
rate	O
and	O
rhythm	O
with	O
normal	B-labvalue
S1	O
and	O
S2	O
.	O

Soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

Hydrocodone	O
5	B-strength
mg	I-strength
with	O
Tylenol	O
,	O
one	B-dosage
to	I-dosage
two	I-dosage
tablets	B-form
every	B-frequency
four	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
pain	O
.	O

bradycardia	O
&	O
amp	O
;	O
hypotension	O
could	O
be	O
secondary	O
to	O
meds	O
.	O

She	O
had	O
a	O
thoracic	B-bodyloc
aortic	I-bodyloc
aneurysm	O
repaired	O
in	O
the	O
past	O
and	O
subsequently	O
developed	O
neuropathic	O
pain	O
at	O
the	O
incision	O
site	O
.	O

2010-07-01	B-temporal

Social	O
history	O
is	O
positive	O
for	O
smoking	O
.	O

11	O
.	O

Pulse	O
78	B-labvalue
BPM	I-labvalue

with	O
Dr	O
.	O
Gunter	O
for	O
an	O
eventual	O
percutaneous	O
coronary	O
intervention	O
,	O
and	O
her	O
surgeon	O
(	O
Dr	O
.	O
Halcomb	O
)	O
following	O
her	O
thoracotomy	O
.	O

Supratentorial	O
brain	O
and	O
left	O
cerebellar	O
hemisphere	O
.	O

Pt	O
seen	O
and	O
examined	O
.	O

The	O
patient	O
is	O
to	O
followup	O
with	O
an	O
orthopedist	O
in	O
the	O
United	O
Kingdom	O
fourteen	O
days	O
following	O
discharge	O
at	O
which	O
point	O
repeat	O
x	O
-	O
rays	O
of	O
her	O
left	O
forearm	O
should	O
be	O
obtained	O
and	O
her	O
left	O
forearm	O
scalp	O
and	O
right	O
lower	O
leg	O
sutures	O
and	O
staples	O
may	O
be	O
removed	O
.	O

Specific	O
gravity	O
was	O
1	B-labvalue
.	I-labvalue
023	I-labvalue
.	O

Flaccid	O
paralysis	O
of	O
bilateral	B-bodyloc
lower	I-bodyloc
extremities	I-bodyloc
.	O

CC	O
:	O

CLinically	O
stable	O
at	O
this	O
time	O
.	O

R	O
:	O

Clopidogrel	O
75	B-strength
mg	I-strength
Tablet	O
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

The	O
patient	O
underwent	O
an	O
echocardiogram	O
which	O
showed	O
normal	O
left	O
ventricular	O
size	O
and	O
function	O
with	O
an	O
LVEF	O
of	O
25	B-labvalue
%	I-labvalue
.	O

CMED	O
was	O
made	O
aware	O
,	O
and	O
they	O
are	O
actively	O
involved	O
in	O
his	O
care	O
.	O

Ct	O
scan	O
the	O
head	O
r	O
/	O
o	O
ICH	O
.	O

I	O
am	O
managing	O
this	O
critically	O
ill	O
*	O
*	O
AGE	O
[	O
in	O
60s	O
]	O
-	O
year	O
-	O
old	O
male	O
,	O
who	O
is	O
status	O
post	O
laparoscopic	O
colectomy	O
for	O
colonic	B-bodyloc
polys	O
.	O

Sigmoidoscopy	O
.	O

History	O
of	O
anxiety	O
.	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
25	I-temporal
2007	I-temporal
]	O
17:02:27	B-temporal
mz	O
/	O
lc	O
/	O
362018	O
/	O
*	O
*	O
ID	O
-	O
NUM	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

ATNC	O
,	O
Pupils	B-bodyloc
dialted	O
at	O
5	O
mm	O
but	O
minimally	O
reactive	O
,	O
anicteric	O

DISPOSITION	O
:	O

DATE	O
OF	O
DEATH	O
:	O

Admitted	O
:	O

BP	O
stable	B-labvalue

WBC	O
13	B-labvalue
.	I-labvalue
3	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue
High	B-labvalue

Subjectively	O
,	O
the	O
patient	O
was	O
seen	O
lying	O
in	O
bed	O
.	O

3	O
.	O

2012-06-07	B-temporal
09	B-temporal
:	I-temporal
55	I-temporal
PM	I-temporal
BLOOD	O
Plt	O
Ct	O
-	O
175	B-labvalue

-	O
Check	O
microalbumin	O
pending	O
.	O

Discharge	O
Date	O
:	O

*	O
*	O
CARBON	O
-	O
COPY	O

(	O
End	O
of	O
Report	O
)	O

Sex	O
:	O

-	O
*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
SSS	O
M	O
]	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
general	O
medicine	O
floor	O
.	O

The	O
patient	O
presented	O
to	O
the	O
Sloan	O
-	O
Center	O
Emergency	O
Department	O
,	O
where	O
he	O
was	O
resuscitated	O
with	O
normal	O
saline	O
and	O
received	O
morphine	O
for	O
pain	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
11	I-temporal
2007	I-temporal
]	O
23:17:32	B-temporal

No	B-negation
active	O
issues	O
.	O

Mesalamine	O
400	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
Sig	O
:	O
Three	B-dosage
(	I-dosage
3	I-dosage
)	I-dosage
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
PO	B-route
TID	B-frequency
(	O
3	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
as	B-frequency
needed	I-frequency
for	O
ulcerative	O
colitis	O
w	O
/	O
o	O
recent	O
severe	O
flares	O
.	O

Clomipramine	O
100	B-strength
mg	I-strength
po	B-route
qhs	B-frequency

No	B-negation
tenderness	O
.	O

Her	O
pelvic	O
examination	O
was	O
notable	O
for	O
some	O
brownish	O
discharge	O
.	O

3	O
.	O

Date	O
/	O
Time	O
:	O
2013-11-20	B-temporal
3	B-temporal
:	I-temporal
00	I-temporal
.	O

Agoraphobia	O

Stable	O

M	O

She	O
is	O
on	O
Coumadin	O
and	O
Pepcid	O
.	O

Free	O
calcium	O
was	O
0	B-labvalue
.	I-labvalue
95	I-labvalue
on	O
03	B-temporal
-	I-temporal
30	I-temporal
.	O

Her	O
temperature	O
was	O
97	B-labvalue
.	I-labvalue
6	I-labvalue
.	O

DISCHARGE	O
DATE	O
:	O

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

Job	O
ID	O
:	O

*	O
*	O
*	O

"	O
Flumaran	O
"	O
for	O
circulatory	O
problems	O
.	O

The	O
patient	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
20s	O
]	O
year	O
old	O
right	O
handed	O
white	O
female	O
with	O
history	O
of	O
polysubstance	O
drug	O
abuse	O
who	O
was	O
found	O
unresponsive	O
after	O
last	O
having	O
been	O
seen	O
18	O
hours	O
earlier	O
.	O

*	O
*	O
INSTITUTION	O

She	O
talks	O
something	O
which	O
is	O
not	O
related	O
to	O
my	O
questoions	O

*	O
*	O
INSTITUTION	O

PHYSICAL	O
EXAMINATION	O
:	O

D	O
:	O

-	O
T	O
/	O
C	O
Ophthlologist	O
.	O

4	O
.	O

7	O
.	O

Seen	O
in	O
ED	O
with	O
SVT	O
200	O
'	O
s	O
-	O
responded	O
well	O
to	O
Adenosine	O
.	O

cv	B-bodyloc
-	O
rrr	O
,	O
s1s2	O
,	O
no	B-negation
m	O
/	O
r	O
/	O
g	O

PERRL	O
,	O
EOMI	O
,	O
oropharynx	O
clear	O
,	O
moist	O
buccal	O
mucosa	O
.	O

standpoint	O
.	O

A	O
lumbar	O
puncture	O
was	O
considered	O
,	O
although	O
not	O
performed	O
due	O
to	O
the	O
fact	O
that	O
the	O
cerebrospinal	O
fluid	O
was	O
not	O
breached	O
during	O
the	O
procedure	O
.	O

Discharged	O
:	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
07	I-temporal
2007	I-temporal
]	O

His	O
PT	O
was	O
19	B-labvalue
.	I-labvalue
9	I-labvalue
with	O
an	O
INR	O
of	O
1	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
PTT	O
of	O
45	B-labvalue
.	I-labvalue
3	I-labvalue
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
18	I-temporal
2007	I-temporal
]	O
.	O

Lines	O
included	O
a	O
right	O
antecubital	O
peripheral	O
intravenous	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

The	O
patient	O
had	O
a	O
follow	O
-	O
up	O
chest	O
x	O
-	O
ray	O
,	O
which	O
was	O
essentially	O
unchanged	O
from	O
previously	O
,	O
showing	O
a	O
normal	O
heart	O
and	O
lungs	B-bodyloc
without	B-negation
infiltrate	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
where	O
his	O
respiratory	O
and	O
cardiac	O
status	O
was	O
monitored	O
carefully	O
.	O

T	O
:	O

Her	O
heart	O
was	O
regular	O
.	O

Abdominal	O
ultrasound	O
on	O
2/23/00	B-temporal
-	O
This	O
study	O
revealed	O
gallbladder	B-bodyloc
sludge	O
but	O
no	B-negation
cholelithiasis	O
.	O

﻿Admission	O
Date	O
:	O

The	O
exception	O
is	O
that	O
per	O
his	O
PCP	O
,	O
Jason	O
aspirin	O
will	O
be	O
held	O
for	O
2	O
weeks	O
given	O
that	O
he	O
was	O
restarted	O
on	O
coumadin	O
with	O

1	O
.	O

4	O
.	O

T	O
:	O

Perform	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

*	O
*	O
ID	O
-	O
NUM	O

Course	O

1	O
.	O

Dilatation	O
and	O
curettage	O
x	O
1	O
for	O
SAB	O
.	O

2	O
.	O

13	O
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
able	O
to	O
wiggle	O
her	O
fingers	O
with	O
intact	O
flexor	O
,	O
extensor	O
,	O
abductor	O
,	O
and	O
adductor	O
function	O
.	O

Male	O

The	O
patient	O
was	O
subsequently	O
admitted	O
to	O
the	O
Trauma	O
Service	O
on	O
2010-06-28	B-temporal
under	O
the	O
direction	O
of	O
Dr	O
.	O
Lowery	O
.	O

The	O
patient	O
also	O
complained	O
of	O
back	B-bodyloc
pain	O
which	O
he	O
had	O
managed	O
as	O
an	O
outpatient	O
and	O
the	O
above	O
MRI	O
was	O
obtained	O
because	O
her	O
back	B-bodyloc
pain	O
was	O
not	O
responding	O
to	O
musculoskeletal	O
treatment	O
.	O

Portable	O
chest	O
on	O
2/23/00	B-temporal
-	O
Lungs	O
were	O
clear	B-labvalue
.	O

2	O
Anemia	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

-	O
Check	O
Echo	O
:	O

GENERAL	O
MEDICINE	O

Age	O
:	O

Diabetes	O
mellitus	O
.	O

ACCOUNT	O
#	O
:	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
20	I-temporal
2007	I-temporal
]	O

D	O
:	O

folic	O
acid	O
(	O
FOLIC	O
ACID	O
1	B-strength
MG	I-strength
TABLET	B-form
)	O
,	O
1	B-strength
mg	I-strength
,	O
Tab	B-form
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Routine	O
,	O

Given	O
the	O
fluid	O
overload	O
on	O
the	O
chest	O
x	O
-	O
ray	O
,	O
the	O
central	O
venous	O
pressure	O
in	O
the	O
mid	B-labvalue
20s	I-labvalue
and	O
the	O
pulmonary	B-bodyloc
hypertension	O
,	O
I	O
have	O
elected	O
to	O
start	O
empiric	O
diuresis	O
this	O
evening	O
while	O
maintaining	O
an	O
adequate	O
cardiac	O
output	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Diastolic	O
BP	O
72	B-labvalue
mmHg	I-labvalue

*	O
*	O
ID	O
-	O
NUM	O

On	O
initial	O
exam	O
,	O
her	O
left	B-bodyloc
shoulder	I-bodyloc
was	O
tender	O
to	O
palpation	O
over	O
the	O
proximal	O
humerus	O
with	O
decreased	B-course
range	O
of	O
motion	O
.	O

PT	O
/	O
OT	O
asked	O
if	O
they	O
deem	O
this	O
patient	O
safe	O
for	O
d	O
/	O
c	O
to	O
home	O
with	O
HHC	O
-	O
PT	O
.	O

Dictator	O
:	O

His	O
PA	O
catheter	O
is	O
showing	O
pressures	O
of	O
about	O
55	B-labvalue
/	I-labvalue
30	I-labvalue
and	O
I	O
suspect	O
that	O
he	O
has	O
chronic	B-course
pulmonary	B-bodyloc
hypertension	O
,	O
given	O
these	O
numbers	O
.	O

Gastroesophageal	B-bodyloc
reflux	O
disease	O
.	O

He	O
denies	B-negation
abdominal	B-bodyloc
pain	O
,	O
nausea	O
or	O
vomiting	O
,	O
diarrhea	O
or	O
constipation	O
.	O

2012-06-07	B-temporal
09	B-temporal
:	I-temporal
55	I-temporal
PM	I-temporal
BLOOD	O
ASA	O
-	O
NEG	B-labvalue
Ethanol	O
-	O
NEG	B-labvalue
Acetmnp	O
-	O
NEG	B-labvalue
Bnzodzp	O
-	O
NEG	B-labvalue
Barbitr	O
-	O
NEG	B-labvalue
Tricycl	O
-	O
NEG	B-labvalue

D	O
:	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
30	I-temporal
2007	I-temporal
]	O
11	B-temporal
:	I-temporal
21	I-temporal

Attending	O
:	O

The	O
patient	O
has	O
what	O
is	O
considered	O
a	O
hospital	O
-	O
acquired	O
pneumonia	O
.	O

ALTERED	O
MENTAL	O
STATUS	O
(	O
ICD9	O
780	O
.	O
97	O
,	O
Working	O
,	O
Problem	O
)	O

6	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Tran	O
:	O

Discharge	O
Diagnosis	O
:	O

Her	O
sedimentation	O
rate	O
was	O
elevated	O
at	O
110	B-labvalue
.	O

Admission	O
Date	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
pancultured	O
.	O

SaO2	O
has	O
been	O
stable	O
overall	O
96	B-labvalue
%	I-labvalue
/	O
ra	O
and	O
hgb	O
&	O
gt	O
;	O
10	O
.	O

Attend	O
:	O

Dilated	O
cardiomyopathy	O
(	O
also	O
as	O
noted	O
above	O
)	O
.	O

Her	O
Hct	O
dropped	O
from	O
Hct	O
38	B-labvalue
.	I-labvalue
9	I-labvalue
before	O
fluids	O
to	O
35	B-dosage
.	I-dosage
5	I-dosage
s	I-dosage
/	I-dosage
p	I-dosage
1	O
.	O
5L	O
NS	O
and	O
was	O
thought	O
to	O
be	O
dilutional	O
.	O

Sex	O
:	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
22	I-temporal
2007	I-temporal
]	O
09	B-temporal
:	I-temporal
00	I-temporal
)	O

5	O
.	O

There	O
were	O
no	B-negation
murmurs	O
or	O
rubs	O
.	O

Mental	O
status	O
.	O

12	O
.	O

1	O
.	O

Professional	O
Services	O

This	O
was	O
reviewed	O
with	O
the	O
attending	O
physician	O
,	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O
,	O
who	O
agreed	O
that	O
a	O
spiral	O
CT	O
should	O
not	O
be	O
performed	O
.	O

We	O
will	O
continue	O
with	O
her	O
current	O
Coumadin	O
dose	O
.	O

nystatin	O
,	O
By	B-route
Mouth	I-route
,	O
QID	B-frequency
,	O
Drug	O
Form	O
:	O
Susp	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
21:00:00	B-temporal

7505	O

Overdose	O

Lungs	O
are	O
diminished	O
at	O
bases	O
but	O
otherwise	O
clear	O
.	O

T	O
:	O

Fingers	O
were	O
warm	O
and	O
well	O
perfused	O
with	O
capillary	O
refill	O
less	O
than	O
3	O
seconds	O
.	O

She	O
has	O
complained	O
about	O
mild	B-severity
pain	O
in	O
the	O
right	B-bodyloc
costal	I-bodyloc
angle	I-bodyloc
.	O

1	O
.	O

We	O
have	O
instructed	O
that	O
he	O
follow	O
up	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
.	O

*	O
*	O
INSTITUTION	O

Film	O
of	O
the	O
left	O
humerus	O
was	O
also	O
negative	B-labvalue
.	O

Abdomen	O
was	O
benign	O
.	O

Discharge	O
Disposition	O
:	O

SERVICE	O
OF	O
:	O

CC	O
:	O

Right	O
lower	O
extremity	O
examination	O
demonstrated	O
mild	B-course
swelling	O
and	O
ecchymosis	O
of	O
the	B-bodyloc
right	I-bodyloc
posterior	I-bodyloc
thigh	I-bodyloc
and	O
approximately	O
a	O
3	O
cm	O
laceration	O
in	O
the	B-bodyloc
lower	I-bodyloc
leg	I-bodyloc
,	O
expressive	O
of	O
moderate	O
amounts	O
of	O
standard	O
sterile	O

He	O
had	O
a	O
transient	O
episode	O
of	O
headache	O
and	O
disorientation	O
at	O
that	O
time	O
.	O

Lungs	O
:	O
bilateral	O
:	O
no	B-negation
crackles	O
present	O
,	O
no	B-negation
wheezes	O
present	O
.	O

CC	O
:	O

08/02/93	B-temporal
:	O

4	O
.	O

RBC	O
-	O
21	O
-	O
50	O
*	O
WBC	O
-	O
0	O
-	O
2	O
BACTERIA	O
-	O
FEW	B-labvalue

Flagyl	O
.	O

BP	O
:	O
systolic	O
127	B-labvalue
,	O
diastolic	O
42	B-labvalue
.	O

-	O
Consult	O
skin	O
care	O
for	O
heels	B-bodyloc
sore	O
.	O

ACCOUNT	O
#	O
:	O

chlordiazepoxide	O
(	O
Librium	O
)	O
(	O
CHLORDIAZEPOXIDE	O
25	B-strength
MG	I-strength
CAP	B-form
)	O
,	O
25	B-strength
mg	I-strength
,	O
Cap	B-form
,	O
By	B-route
Mouth	I-route
,	O
QID	B-frequency
,	O
PRN	B-frequency
,	O
For	O
Withdrawal	O
(	O
Alcohol	O
)	O
,	O
Routine	O
,	O

He	O
has	O
had	O
this	O
in	O
the	O
past	O
and	O
has	O
not	O
worked	O
and	O
he	O
is	O
very	O
much	O
against	O
outpatient	O
rehabilitation	O
,	O
although	O
,	O
he	O
is	O
now	O
willing	O
to	O
consider	O
it	O
after	O
we	O
have	O
spoken	O
to	O
the	O
patient	O
at	O
length	O
.	O

1980-02-05	B-temporal

There	O
is	O
opacification	O
of	O
the	O
posterior	B-bodyloc
nasal	I-bodyloc
cavity	I-bodyloc
and	O
nasopharynx	B-bodyloc
but	O
an	O
NG	O
tube	O
is	O
present	O
,	O
and	O
the	O
patient	O
is	O
intubated	O
.	O

Dr	O
*	O
*	O
NAME	O
[	O
XXX	O
]	O
and	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
WWW	O
]	O
from	O
Pain	O
Management	O
.	O

CARDIOTHORACIC	O
SURGERY	O

He	O
has	O
been	O
a	O
construction	O
worker	O
for	O
the	O
past	O
20	O
years	O
.	O

08/02/93	B-temporal
:	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
07	I-temporal
2007	I-temporal
]	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
16	I-temporal
2007	I-temporal
]	O
02:52:53	B-temporal
PM	I-temporal

Laboratory	O
studies	O
on	O
discharge	O
:	O

Prophylaxis	O
.	O

Protonix	O
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
.	O

Aspirin	O
325	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
15	I-temporal
2007	I-temporal
]	O
12:20:27	B-temporal

At	O
no	O
point	O
did	O
she	O
develop	O
significant	O
respiratory	O
difficulties	O
.	O

HISTORY	O
:	O
Trauma	O
,	O
congestive	O
heart	B-bodyloc
failure	O
,	O
fever	O
,	O
pneumonia	O
.	O

6	O
.	O

Albumin	O
1	B-labvalue
.	I-labvalue
5	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

ATTENDING	O
PHYSICIAN	O
:	O

Therefore	O
,	O
the	O
cause	O
of	O
her	O
mild	B-severity
diarrhea	O
(	O
few	O
loose	O
BM	O
/	O
liquid	O
stool	O
/	O
night	O
)	O
may	O
be	O
either	O
viral	O
or	O
secondary	O
to	O
resolving	O
abdominal	B-bodyloc
hematoma	O
with	O
resultant	O
irritation	O
of	O
GI	B-bodyloc
system	O
.	O

balsam	O
Peru	O
/	O
castor	O
oil	O
/	O
trypsin	O
topical	O
,	O
1	B-dosage
Application	I-dosage
,	O
Topically	B-route
,	O
Q8HRS	B-frequency
,	O
Drug	O
Form	O
:	O
Oint	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
22:00:00	B-temporal

Extremities	O
:	O

2014-11-14	B-temporal
12	B-temporal
:	I-temporal
34	I-temporal
PM	I-temporal

Today	O
'	O
s	O
results	O
:	O

Her	O
uterus	O
and	O
adnexa	O
were	O
difficult	O
to	O
assess	O
secondary	O
to	O
voluntary	O
tensing	O
of	O
her	B-bodyloc
abdomen	I-bodyloc
.	O

Home	O

1	O
.	O

A	O
/	O
P	O
:	O
48yo	O
man	O
with	O
h	O
/	O
o	O
HCV	O
,	O
bipolar	O
DO	O
,	O
h	O
/	O
o	O
suicide	O
attempts	O
,	O
a	O
/	O
w	O
overdose	O
of	O
Inderal	O
,	O
Klonopin	O
,	O
Geodon	O
,	O
s	O
/	O
T	O
Jackson	O
stay	O
with	O
intubation	O
for	O
airway	O
protection	O
,	O
with	O
question	O
of	O
L	B-bodyloc
retrocardiac	I-bodyloc
infiltrate	O
,	O
now	O
doing	O
well	O
.	O

The	O
infection	O
has	O
been	O
well	O
controlled	O
and	O
improving	O
.	O

ASPIRIN	O
.	O

1	O
.	O

Current	O
Medications	O
:	O
medication	O
administration	O
orders	O
magnesium	O
oxide	O
(	O
MAGNESIUM	O
OXIDE	O
400	B-strength
MG	I-strength
TABLET	B-form
)	O
,	O
400	B-strength
mg	I-strength
,	O
Tab	B-form
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Routine	O
,	O

98	B-labvalue
beats	I-labvalue
per	I-labvalue
min	I-labvalue
.	O

ONCLUSIONS	O
:	O

Hospital	O
medical	O
optimization	O
and	O
management	O
following	O
an	O
aborted	O
coronary	O
artery	O
bypass	O
graft	O
when	O
a	O
mobile	O
aortic	B-bodyloc
atheroma	O
was	O
noted	O
.	O

Dict	O
:	O

MRN	O
-	O
*	O
*	O
ID	O
-	O
NUM	O
-	O
MPACCOMMMRN	O

She	O
will	O
have	O
urology	O
followup	O
after	O
her	O
IVP	O
.	O

T	O
/	O
C	O
study	O
of	O
sleep	O
apnea	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

PRINCIPAL	O
PROCEDURES	O
AND	O
TESTS	O
:	O

Patient	O
is	O
a	O
79	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
history	O
of	O
cataracts	O
,	O
glaucoma	O
,	O
and	O
diabetes	O
,	O
who	O
fell	O
and	O
tripped	O
over	O
a	O
wheelchair	O
of	O
a	O
friend	O
with	O
no	B-negation
loss	O
of	O
consciousness	O
,	O
no	B-negation
dizziness	O
,	O
no	B-negation
chest	B-bodyloc
pain	O
,	O
and	O
no	B-negation
shortness	O
of	O
breath	O
.	O

Cc	O
:	O

Abs	O
Eos	O
,	O
auto	O
0	B-labvalue
.	I-labvalue
1	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

RESIDENTS	O
:	O

THE	O
LEFT	B-bodyloc
VENTRICLE	I-bodyloc
IS	O
DILATED	O
WITH	O
GLOBAL	O
HYPOKINESIS	O
WITH	O
A	O
RESIDUAL	O
EJECTION	O
FRACTION	O
OF	O
25	B-labvalue
-	I-labvalue
30	I-labvalue
%	I-labvalue
.	O

HS	O
Job	O
#	O
123616	O
/	O
41427	O
/	O
40215	O

Cc	O
:	O

07/26/99	B-temporal

2014-10-21	B-temporal
08	B-temporal
:	I-temporal
10	I-temporal
PM	I-temporal

I	O
personally	O
interviewed	O
and	O
examined	O
the	O
patient	O
today	O
.	O

1	O
.	O

You	O
must	O
take	O
your	O
aspirin	O
and	O
plavix	O
every	O
day	O
to	O
prevent	O
failure	O
of	O
these	O
stents	O
which	O
could	O
be	O
life	O
threatening	O
.	O

Cr	O
0	B-labvalue
.	I-labvalue
5	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

The	O
margins	O
do	O
not	O
appear	O
to	O
extend	O
into	O
the	O
foramina	O
transversaria	O
.	O

Troponin	O
wnl	B-labvalue
.	O

PENICILLIN	O
.	O

The	O
patient	O
lives	O
alone	O
in	O
Woburn	O
.	O

MRN	O
:	O

The	O
patient	O
had	O
a	O
chest	O
x	O
-	O
ray	O
which	O
showed	O
no	B-negation
evidence	O
of	O
active	O
cardiopulmonary	B-bodyloc
disease	O
.	O

She	O
said	O
these	O
things	O
again	O
?	O

*	O
*	O
ROOM	O

*	O
*	O
CARBON	O
-	O
COPY	O

1	O
.	O

Accordingly	O
,	O
she	O
was	O
transfused	O
with	O
two	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
and	O
by	O
date	O
of	O
transfer	O
she	O
was	O
stable	O
with	O
hemoglobin	O
of	O
9	B-labvalue
.	I-labvalue
4	I-labvalue
and	O
28	B-labvalue
.	I-labvalue
3	I-labvalue
hematocrit	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
12	I-temporal
2007	I-temporal
]	O
06:37:11	B-temporal
/	O
fp	O

JOFREDD	O
N	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
29	I-temporal
2007	I-temporal
]	O
09	B-temporal
:	I-temporal
22	I-temporal

8	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

For	O
her	O
rhythm	O
,	O
amiodarone	O
was	O
discontinued	O
as	O
she	O
was	O
maintained	O
in	O
sinus	O
rhythm	O
after	O
moving	O
to	O
the	O
floor	O
.	O

RR	O
nl	B-labvalue
S1	O
S2	O
no	B-negation
m	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

*	O
*	O
INSTITUTION	O

*	O
*	O
INSTITUTION	O

PATIENT	O
NAME	O
:	O

Has	O
a	O
history	O
of	O
cocaine	O
abuse	O
-	O
in	O
remission	O
for	O
6	O
years	O
,	O
with	O
one	O
relapse	O
2	O
.	O
5	O
years	O
ago	O
.	O

Left	O
upper	O
extremity	O
examination	O
demonstrated	O
no	B-negation
gross	O
deformities	O
,	O
tenderness	O
to	O
palpation	O
in	O
the	O
mid	O
forearm	O
,	O
intact	B-labvalue
motor	O
function	O
in	O
the	O
median	O
,	O
radial	O
,	O
and	O
ulnar	O
nerve	O
distributions	O
,	O
intact	B-labvalue
sensation	O
to	O
light	O
touch	O
in	O
the	O
median	O
and	O
radial	O
nerve	O
distributions	O
,	O
decreased	B-course
sensation	O
in	O
the	B-bodyloc
ulnar	I-bodyloc
-	I-bodyloc
nerve	I-bodyloc
distribution	O
,	O
warm	O
and	O
well	O
perfused	O
limb	O
with	O
2	B-labvalue
+	I-labvalue
radial	O
pulses	O
.	O

13	O
.	O

*	O
*	O
INSTITUTION	O

Admitted	O
:	O

Reason	O
:	O
altered	O
mental	O
status	O

Raymond	O
William	O
MD	O
50	O
-	O
154	O

Security	O
was	O
notified	O
who	O
then	O
arrived	O
to	O
the	O
room	O
and	O
helped	O
to	O
place	O
the	O
patient	O
in	O
four	O
-	O
point	O

SECONDARY	O
DIAGNOSES	O
:	O

Discharge	O
Date	O
:	O

PRIMARY	O
DIAGNOSES	O
:	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

(	O
End	O
of	O
Report	O
)	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
17	I-temporal
2007	I-temporal
]	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O

#	O
Ulcerative	O
colitis	O
-	O
-	O
The	O
patient	O
'	O
s	O
Asacol	O
was	O
originally	O
held	O
but	O
restarted	O
the	O
day	O
prior	O
to	O
discharge	O
per	O
GI	O
.	O

PATIENT	O
NAME	O
:	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Bipolar	O
disorder	O
:	O

Skin	O
exam	O
is	O
unchanged	O
.	O

On	O
06	B-temporal
-	I-temporal
28	I-temporal
,	O
the	O
patient	O
was	O
also	O
cleared	O
for	O
removal	O
of	O
her	O
C	O
-	O
spine	O
collar	O
and	O
deemed	O
stable	O
for	O
transfer	O
to	O
the	O
Orthopedic	O
Service	O
under	O
the	O
direction	O
of	O
Dr	O
.	O
Ronda	O
Lopez	O
.	O

*	O
*	O
NAME	O
[	O
WWW	O
VVV	O
XXX	O
]	O

Therefore	O
,	O
he	O
did	O
have	O
unstable	B-course
angina	O
with	O
his	O
critical	O
coronary	O
anatomy	O
.	O

ASSESSMENT	O
AND	O
PLAN	O
:	O

Cataract	O
.	O

2	O
.	O

No	B-negation
audible	O
murmurs	O
.	O

Acute	B-course
pulmonary	O
edema	O
with	O
acute	B-course
respiratory	O
failure	O
.	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
16	I-temporal
2008	I-temporal
]	O
6:00:00	B-temporal
AM	I-temporal
.	O

Credentials	O
and	O
Title	O
of	O
Author	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
Signing	O
this	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
:	O
CRNP	O

Atorvastatin	O
40	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

A	O
5	O
cm	O
laceration	O
was	O
noted	O
over	O
the	O
patient	O
'	O
s	O
occiput	B-bodyloc
on	O
further	O
inspection	O
with	O
no	B-negation
exposed	O
underlying	O
bone	O
.	O

1	O
.	O

08/10/93	B-temporal

Discharge	O
Diagnosis	O
:	O

His	O
WBC	O
count	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
,	O
was	O
10	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
hemoglobin	O
10	B-labvalue
.	I-labvalue
6	I-labvalue
,	O
hematocrit	O
30	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
and	O
MCV	O
105	B-labvalue
.	I-labvalue
2	I-labvalue
,	O
and	O
platelets	O
162	B-labvalue
.	O

10	O
.	O

Good	O
.	O

Detrol	O
LA	O
4	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

Improving	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
TTT	O
UUU	O
]	O
for	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
XXX	O
]	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
16	I-temporal
2007	I-temporal
]	O
09:01:29	B-temporal
AM	I-temporal

End	O
-	O
stage	O
renal	B-bodyloc
disease	O
secondary	O
to	O
type	O
1	O
diabetes	O
mellitus	O
;	O
status	O
post	O
renal	O
transplant	O
in	O
2003	B-temporal
.	O

He	O
still	O
is	O
against	O
rehab	O
.	O

Author	O
:	O

ALT	O
/	O
SGPT	O
65	B-labvalue
IntUnit	I-labvalue
/	I-labvalue
L	I-labvalue

Service	O
:	O

Name	O
:	O

Zocor	O
60	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
day	I-frequency
.	I-frequency

Percocet	O
for	O
pain	O
as	B-frequency
needed	I-frequency
.	O

MCHC	O
33	B-labvalue
.	I-labvalue
0	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue

2012-10-31	B-temporal
12	B-temporal
:	I-temporal
20PM	I-temporal

Hgb	O
10	B-labvalue
.	I-labvalue
6	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
YYY	O
]	O

History	O
of	O
lone	O
atrial	B-bodyloc
fibrillation	O
.	O

lansoprazole	O
,	O
30	B-strength
mg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Drug	O
Form	O
:	O
Cap	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
9:00:00	B-temporal

Digoxin	O
,	O
.	B-strength
25	I-strength
mg	I-strength
PO	B-route
QD	B-frequency
;	O
Ecotrin	O
,	O
325	B-strength
mg	I-strength
QD	B-frequency
;	O
Coumadin	O
,	O
2	B-strength
.	I-strength
5	I-strength
mg	I-strength
PO	B-route
QD	B-frequency
;	O
Lisinopril	O
,	O
2	B-strength
.	I-strength
5	I-strength
mg	I-strength
PO	B-route
QD	B-frequency
;	O
Micronase	O
,	O
5	B-strength
mg	I-strength
PO	B-route
BID	B-frequency
.	O

Accuchecks	O
ranging	O
106	B-labvalue
-	I-labvalue
150	I-labvalue
.	O

bnzodzpn	O
-	O
NEG	B-labvalue
barbitrt	O
-	O
NEG	B-labvalue
opiates	O
-	O
NEG	B-labvalue
cocaine	O
-	O
NEG	B-labvalue
amphetmn	O
-	O
NEG	B-labvalue
mthdone	O
-	O
NEG	B-labvalue

The	O
patient	O
will	O
be	O
discharged	O
to	O
rehabilitation	O
in	O
Brain	O
Tree	O
Maryland	O
.	O

*	O
*	O
INITIALS	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
06	I-temporal
2007	I-temporal
]	O

Hct	O
32	B-labvalue
.	I-labvalue
1	I-labvalue
%	I-labvalue
Low	B-labvalue

Discharge	O
Date	O
:	O

We	O
will	O
see	O
what	O
the	O
biopsy	O
results	O
show	O
.	O

Pertinent	O
Results	O
:	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

R	O
:	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
Dr	O
*	O
*	O
NAME	O
[	O
PPP	O
]	O
from	O
psychiatry	O
.	O

Admission	O
Date	O
:	O

ssx	O
/	O
bmot	O

THE	O
AORTIC	B-bodyloc
VALVE	I-bodyloc
APPEARS	O
MILDLY	O
SCLEROTIC	O
HOWEVER	O
,	O
THE	O
DOPPLER	O
ASSESSMENT	O
OF	O
DEGREE	O
OF	O
AORTIC	B-bodyloc
STENOSIS	O
IS	O
INACCURATE	O
.	O

2011-03-06	B-temporal

In	O
addition	O
,	O
as	O
stated	O
above	O
,	O
Dr	O
.	O
Hastings	O
office	O
from	O
Cardiothoracic	O
Surgery	O
will	O
be	O
in	O
contact	O
with	O
Ms	O
.	O
Williams	O
to	O
arrange	O
followup	O
for	O
her	B-bodyloc
ascending	I-bodyloc
aortic	I-bodyloc
aneurysm	O
in	O
approximately	O
one	B-temporal
month	I-temporal
.	O

Also	O
noted	O
is	O
sclerosis	O
and	O
opacification	O
of	O
the	O
visualized	O
left	B-bodyloc
mastoid	I-bodyloc
air	I-bodyloc
cells	I-bodyloc
and	O
mastoid	B-bodyloc
tip	I-bodyloc
,	O
likely	O
chronic	O
inflammatory	O

Admitted	O
:	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

5	O
.	O

.	O
.	O

There	O
was	O
no	B-negation
erythema	O
or	O
purulence	O
.	O

11	O
.	O

Heart	O
was	O
normal	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

T	O
:	O

Modify	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O

He	O
feels	O
he	O
can	O
quit	O
etoh	O
on	O
his	O
own	O
because	O
he	O
knows	O
he	O
will	O
otherwise	O
die	O
.	O

Preoperatively	O
,	O
he	O
had	O
a	O
severely	O
dilated	O
left	B-bodyloc
ventricle	I-bodyloc
with	O
markedly	O
diminished	O
function	O
.	O

s	O
/	O
p	O
TURP	O

ATTENDING	O
PHYSICIAN	O
:	O

NOted	O
to	O
have	O
(	O
+	B-labvalue
)	O
D	O
-	O
dimer	O
/	O
VQ	O
scan	O
(	O
-	B-labvalue
)	O
.	O

.	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

The	O
patient	O
is	O
doing	O
okay	O
today	O
.	O

Thyroid	O
:	O
normal	O

Mental	O
status	O
improved	O
with	O
the	O
discontinuation	O
of	O
his	O
bensodiazapines	O
.	O

Reports	O
that	O
he	O
has	O
suffered	O
from	O
anxiety	O
since	O
childhood	O
and	O
needed	O
to	O
drop	O
out	O
of	O
college	O
.	O

Community	O
-	O
acquired	O
pneumonia	O
.	O

Shortness	O
of	O
breath	O
:	O

Awake	O
,	O
alert	O
,	O
and	O
oriented	O
.	O

3	O
.	O

LFT	O
s	O
Normal	B-labvalue
at	O
this	O
addmison	O
.	O

fashion	O
.	O

11	O
.	O

Per	O
OMR	O
,	O
the	O
patient	O
is	O
currently	O
not	O
in	O
contact	O
with	O
her	O
family	O
.	O

Would	O
not	O
to	O
increase	O
her	O
lantus	O
.	O

PATIENT	O
NAME	O
:	O

*	O
*	O
INSTITUTION	O

Status	O
post	O
carotid	O
endarterectomy	O
.	O

WBC	O
4	B-labvalue
.	I-labvalue
7	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

*	O
*	O
DATE	O
[	O
Jan	B-temporal
09	I-temporal
2008	I-temporal
]	O

She	O
is	O
to	O
continue	O
with	O
aggressive	O
physical	O
therapy	O
under	O
the	O
care	O
of	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
at	O
*	O
*	O
NAME	O
[	O
QQQ	O
]	O
Rehab	O
for	O
standard	O
post	O
total	O
hip	O
arthroplasty	O
.	O

Trauma	O
was	O
also	O
considered	O
.	O

ATTENDING	O
PHYSICIAN	O
:	O

*	O
*	O
*	O

MPV	O
6	B-labvalue
.	I-labvalue
7	I-labvalue
fL	I-labvalue
Low	B-labvalue

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

Cc	O
:	O

7	O
.	O

Total	O
Protein	O
6	B-labvalue
.	I-labvalue
3	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

General	O
Appearance	O
:	O
no	B-negation
distress	O
.	O

A	O
question	O
of	O
a	O
SULFA	O
allergy	O
.	O

Activated	O
PTT	O
45	B-labvalue
.	I-labvalue
3	I-labvalue
sec	I-labvalue
High	B-labvalue

Will	O
follow	O
up	O
on	O
the	O
results	O
.	O

During	O
her	O
hospital	O
stay	O
,	O
the	O
patient	O
'	O
s	O
renal	O
function	O
did	O
not	O
show	O
signs	O
of	O
improvement	O
and	O
patient	O
was	O
discharged	O
with	O
hemodialysis	O
followup	O
.	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

The	O
patient	O
also	O
had	O
thoracentesis	O
.	O

In	O
general	O
,	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

The	O
patient	O
was	O
admitted	O
on	O
07/20/99	B-temporal
for	O
a	O
history	O
of	O
left	O
chest	B-bodyloc
wall	I-bodyloc
pain	O
from	O
postthoracotomy	O
syndrome	O
.	O

9	O
.	O

Neoral	O
100	B-strength
mg	I-strength
twice	B-frequency
a	I-frequency
day	I-frequency
.	O

FLUIDS	O
/	O
ELECTROLYTES	O
/	O
NUTRITION	O
:	O

BP	O
:	O
systolic	O
122	B-labvalue
,	O
diastolic	O
81	B-labvalue
.	O

C7	B-bodyloc
&	I-bodyloc
T1	I-bodyloc
mimimally	O
displaced	O
transverse	B-bodyloc
process	I-bodyloc
fracture	O

IMPRESSION	O
:	O

Subcentimeter	O
attenuation	O
lesion	O
within	O
the	B-bodyloc
lower	I-bodyloc
pole	I-bodyloc
of	I-bodyloc
the	I-bodyloc
right	I-bodyloc
kidney	I-bodyloc
,	O
too	O
small	O
to	O
characterize	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
21	I-temporal
2007	I-temporal
]	O
09:06:39	B-temporal
PM	I-temporal

On	O
her	O
examination	O
today	B-temporal
,	O
she	O
had	O
a	O
few	O
crackles	O
at	B-bodyloc
her	I-bodyloc
right	I-bodyloc
base	I-bodyloc
.	O

CARDIOLOGY	O

Name	O
:	O

15	O
.	O
)	O
Warfarin	O
2	B-strength
mg	I-strength
daily	B-frequency

2	O
.	O

nadolol	O
(	O
Corgard	O
)	O
(	O
NADOLOL	O
20	B-strength
MG	I-strength
TABLET	B-form
)	O
,	O
20	B-strength
mg	I-strength
,	O
Tab	B-form
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Routine	O
,	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

Lasix	O
40	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

Cultures	O
were	O
drawn	O
and	O
were	O
negative	O
upon	O
discharge	O
.	O

NPH	O
30	B-strength
units	I-strength
q	B-frequency
.	I-frequency
a	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency
,	O
5	B-dosage
to	I-dosage
6	I-dosage
units	I-dosage
q	B-frequency
.	I-frequency
p	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency

Follow	O
-	O
up	O
with	O
Dr	O
.	O
Michael	O
,	O
his	O
psychiatrist	O
,	O
on	O
Wednesday	B-temporal
,	O
09	B-temporal
-	I-temporal
08	I-temporal
.	O

The	O
patient	O
was	O
exacerbated	O
when	O
eating	O
and	O
when	O
lying	O
flat	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O
R	O

DEATH	O
SUMMARY	O

Communicating	O
by	O
speech	O
s	O
/	O
p	O
PMV	O
placement	O
.	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

7	O
.	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

The	O
patient	O
failed	O
the	O
conservative	O
therapy	O
and	O
is	O
admitted	O
for	O
a	O
spinal	O
cord	O
stimulator	O
trial	O
.	O

6	O
.	O

Medications	O
on	O
Admission	O
:	O

*	O
*	O
CARBON	O
-	O
COPY	O

Medications	O
per	O
medication	O
reconciliation	O
sheet	O
.	O

Temp	O
:	O

Is	O
called	O
out	O
of	O
the	O
FICU	O
as	O
has	O
been	O
been	O
HD	O
and	O
stable	O
HCT	O
.	O

Job	O
ID	O
:	O

A	O
Holter	O
monitor	O
showed	O
ventricular	B-bodyloc
ectopy	O
.	O

13	O
.	O

GENERAL	O
:	O

He	O
had	O
no	O
growth	O
x	O
1	O
day	O
.	O

HAs	O
noted	O
periods	O
of	O
palpitations	O
off	O
and	O
on	O
-	O
the	O
longest	O
time	O
frame	O
was	O
prior	O
to	O
PCP	O
visit	O
.	O

ASSESSMENT	O
:	O

EVALUATION	O
DATE	O
:	O

6	O
.	O

Abs	O
Eos	O
,	O
auto	O
0	B-labvalue
.	I-labvalue
0	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

7	O
.	O

To	O
hold	O
metoprololxl	O
for	O
now	O
.	O

-	O
Continue	O
lopressor	O

Temperature	O
Site	O
Oral	O

sodium	O
bicarbonate	O
,	O
1300	B-strength
mg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
TID	B-frequency
meals	I-frequency
,	O
Drug	O
Form	O
:	O
Tab	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
7:00:00	B-temporal

Bili	O
,	O
Total	O
0	B-labvalue
.	I-labvalue
2	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

Klonopin	O
2	B-strength
mg	I-strength
tid	B-frequency

Plan	O

On	O
bactrim	O
BID	B-frequency
Day	B-temporal
4	I-temporal
,	O

She	O
showed	O
no	O
interest	O
in	O
changing	O
her	O
overall	O
approach	O
to	O
life	O
in	O
terms	O
of	O
polysubstance	O
drug	O
abuse	O
.	O

ATTENDING	O
*	O
*	O
NAME	O
[	O
WWW	O
:	O

She	O
denies	O
cigarette	O
use	O
and	O
ethanol	O
use	O
as	O
well	O
as	O
a	O
recreational	O
drug	O
use	O
.	O

The	O
patient	O
was	O
transfused	O
platelets	O
one	O
time	O
on	O
the	O
second	O
hospital	O
day	O
.	O

The	O
patient	O
was	O
ambulatory	O
by	O
postoperative	O
day	O
5	O
with	O
physical	O
therapy	O
.	O

-	O
resumed	O
coumadin	O
as	O
her	O
home	O
dose	O
:	O

Pulm	O
-	O
White	O
count	O
is	O
normal	B-labvalue
(	O
6	B-labvalue
.	I-labvalue
6	I-labvalue
)	O
.	O

-	O
Protonix	O
40	B-strength
mg	I-strength
daily	B-frequency

On	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
9	I-temporal
]	O
,	O
Neurology	O
noted	O
,	O
discussed	O
with	O
the	O
radiologist	O
and	O
agreed	O
that	O
the	O
myelogram	O
was	O
unlikely	O
to	O
help	O
.	O

*	O
*	O
DATE	O
[	O
Oct	B-temporal
28	I-temporal
2007	I-temporal
]	O

2	O
.	O

-	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
RRR	O
M	O
]	O
.	O

Hct	O
30	B-labvalue
.	I-labvalue
8	I-labvalue
%	I-labvalue
Low	B-labvalue

We	O
have	O
advised	O
a	O
BRAT	O
diet	O
.	O

At	O
the	O
same	O
time	O
,	O
we	O
insured	O
adequate	O
oxygenation	O
on	O
the	O
patient	O
and	O
we	O
continued	O
with	O
the	O
therapy	O
with	O
moxifloxacin	O
IV	B-route
.	O

RECTAL	O
:	O

Report	O
:	O

NORMAL	O
RIGHT	O
VENTRICULAR	O
DIMENSION	O
AND	O
CONTRACTILITY	O
.	O

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

PATIENT	O
NAME	O
:	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

4	O
.	O

CONDITION	O
:	O

Today	O
'	O
s	O
results	O
:	O

2014-10-21	B-temporal
09	B-temporal
:	I-temporal
35	I-temporal
AM	I-temporal
URINE	O

Acute	B-course
renal	B-bodyloc
failure	O
.	O

Renal	O
ultrasound	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
4	I-temporal
2007	I-temporal
]	O
,	O
showed	O
echogenic	O
kidneys	B-bodyloc
consistent	O
with	O
renal	B-bodyloc
parenchymal	O
disease	O
.	O

Multivitamin	O
1	B-dosage
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

Discharge	O
Condition	O
:	O
Good	O
.	O

*	O
*	O
NAME	O
[	O
SSS	O
]	O
:	O

Patient	O
will	O
be	O
admitted	O
to	O
psychiatry	O
service	O

*	O
*	O
INSTITUTION	O
and	O
Rehab	O
.	O

YEAST	O
-	O
NONE	B-labvalue
EPI	O
-	O
<	B-labvalue
1	I-labvalue

In	O
addition	O
,	O
his	O
cyclosporin	O
levels	O
were	O
checked	O
.	O

Well	O
-	O
profused	O
.	O

Discharged	O
:	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Trazadone	O
200	B-strength
mg	I-strength
po	B-route
qhs	B-frequency

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
9:00:00	B-temporal

(	O
End	O
of	O
Report	O
)	O

The	O
patient	O
states	O
that	O
she	O
continues	O
to	O
feel	O
dizzy	O
when	O
she	O
stands	O
up	O
.	O

ETOH	O
:	O
according	O
to	O
her	O
POA	O
,	O
she	O
is	O
not	O
heavy	O
drinker	O
.	O

Exercise	O
stress	O
test	O
(	O
+	B-labvalue
)	O
pos	O
wall	O
function	O
-	O
suggestive	O
of	O
ischemia	O
.	O

The	O
patient	O
had	O
an	O
uneventful	O
night	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

ASA	O
-	O
NEG	B-labvalue
ETHANOL	O
-	O
NEG	B-labvalue
ACETMNPHN	O
-	O
NEG	B-labvalue
bnzodzpn	O
-	O
NEG	B-labvalue
barbitrt	O
-	O
NEG	B-labvalue
tricyclic	O
-	O
POS	B-labvalue

Abdominal	B-bodyloc
distension	O
with	O
a	O
+	O
fluid	O
wave	O
.	O

Her	O
left	O
lower	O
extremity	O
remained	O
distally	O
neurovascularly	O
intact	O
.	O

.	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Discharge	O
Date	O
:	O

General	O
results	O

Disposition	O

Prednisone	O
10	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
1	B-dosage
-	I-dosage
2	I-dosage
Tablets	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
for	O
4	B-duration
days	I-duration
:	O
Please	O
take	O
two	B-dosage
pills	I-dosage
for	O
one	B-duration
day	I-duration
starting	O
11	B-temporal
-	I-temporal
17	I-temporal
,	O
then	O
take	O
one	B-dosage
pill	I-dosage
for	O
three	B-duration
days	I-duration
.	O

Patient	O
:	O

*	O
*	O
NAME	O
[	O
UUU	O
]	O
:	O

Narcissism	O

5	O
.	O

Her	O
creatine	O
kinases	O
climbed	O
;	O
reaching	O
a	O
peak	O
of	O
3523	O
,	O
which	O
was	O
down	O
to	O
1500	O
at	O
the	O
time	O
of	O
discharge	O
.	O

Sputum	O
cultures	O
done	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
29	I-temporal
2007	I-temporal
]	O
,	O
that	O
showed	O
light	O
Gram	O
-	O
positive	O
cocci	O
in	O
pairs	O
,	O
rare	O
(	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
)	O
,	O
very	O
rare	O
yeast	O
.	O

Mass	O
effect	O
was	O
considered	O
,	O
although	O
no	B-negation
focal	O
deficits	O
were	O
ever	O
noted	O
on	O
examination	O
and	O
due	O
to	O
the	O
fluctuating	O
sensorium	O
,	O
it	O
was	O
determined	O
that	O
there	O
was	O
no	B-negation
severe	B-severity
underlying	O
structural	O
abnormality	O
.	O

Attending	O
:	O
Dona	O
J	O
.	O

NEUTS	O
-	O
73	B-labvalue
.	I-labvalue
0	I-labvalue
*	O
LYMPHS	O
-	O
21	B-labvalue
.	I-labvalue
8	I-labvalue
MONOS	O
-	O
3	B-labvalue
.	I-labvalue
8	I-labvalue
EOS	O
-	O
1	B-labvalue
.	I-labvalue
1	I-labvalue
BASOS	O
-	O
0	B-labvalue
.	I-labvalue
3	I-labvalue

Medicine	O
Progress	O

2014-04-28	B-temporal

F	O

Normal	B-labvalue
first	O
heart	O
sounds	O
and	O
second	O
heart	O
sounds	O
.	O

17	O
.	O

Dict	O
:	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
15:34:50	B-temporal

Protonix	O
40	B-strength
mg	I-strength
qd	B-frequency

T	O
:	O

*	O
*	O
DATE	O
[	O
Oct	B-temporal
7	I-temporal
1944	I-temporal
]	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
23	I-temporal
07	I-temporal
]	O

Perform	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
M	O

The	O
patient	O
continues	O
with	O
ARDS	O
,	O
respiratory	O
failure	O
with	O
a	O
chest	O
x	O
-	O
ray	O
which	O
is	O
compatible	O
with	O
ARDS	O
.	O

Injury	O
VS	O
hallucination	O
.	O

There	O
was	O
apparent	O
loss	O
of	O
consciousness	O
at	O
the	O
scene	O
and	O
significant	O
deformity	O
of	O
the	O
anterior	O
portion	O
of	O
the	O
motorvehicle	O
with	O
positive	O
starring	O
of	O
the	O
windshield	O
.	O

None	O
.	O

13	O
.	O
)	O
Actos	O
15	B-strength
mg	I-strength
daily	B-frequency

358453	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

Facility	O
:	O

As	O
a	O
matter	O
of	O
fact	O
,	O
she	O
improved	O
consistently	O
during	O
this	O
hospitalization	O
.	O

recheck	O
VS	O
again	O
.	O

1	O
.	O

7	O
.	O

In	O
currently	O
in	O
a	O
relationship	O
with	O
a	O
man	O
whom	O
she	O
met	O
during	O
a	O
previous	O
inpt	O
admission	O
.	O

3	O
.	O

MCH	O
29	B-labvalue
.	I-labvalue
5	I-labvalue
pg	I-labvalue

Paraplegia	O
status	O
post	O
thoracic	O
aortic	O
aneurysm	O
repair	O
.	O

Plastic	O
did	O
not	O
feel	O
that	O
patient	O
had	O
any	O
compartment	O
syndrome	O
and	O
recommended	O
aggresive	O
upper	O
extremity	O
elevation	O
for	O
swelling	O
reduction	O
.	O

Ventricular	B-bodyloc
ectopy	O
.	O

Social	O
History	O
:	O

Her	O
initial	O
white	O
blood	O
cell	O
count	O
was	O
11	B-labvalue
.	I-labvalue
3	I-labvalue
,	O
with	O
a	O
normal	B-labvalue
differential	O
.	O

Eosinophils	O
1	B-labvalue
%	I-labvalue

*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
YYY	O
]	O

-	O
Continue	O
lopressor	O

He	O
does	O
have	O
pink	O
tinge	O
to	O
urine	O
.	O

Stable	O
appearance	O
of	O
left	B-bodyloc
adrenal	I-bodyloc
fat	O
-	O
containing	O
lesion	O
consistent	O
with	O
a	O
myelolipoma	O
.	O

At	O
the	O
time	O
of	O
this	O
dictation	O
,	O
the	O
CT	O
of	O
her	O
chest	O
was	O
still	O
pending	O
.	O

Protonix	O
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

Magnesium	O
Hydroxide	O
400	B-strength
mg	I-strength
/	I-strength
5	I-strength
mL	I-strength
Suspension	B-form
Sig	O
:	O
Thirty	B-dosage
(	I-dosage
30	I-dosage
)	I-dosage
ML	I-dosage
PO	B-route
Q6H	B-frequency
(	O
every	B-frequency
6	I-frequency
hours	I-frequency
)	O
as	O
needed	O
for	O
consitpation	O
.	O

ECI	O
JESCSLAND	O
,	O
M	O
.	O
D	O
.	O

Service	O
:	O

Weight	O
Method	O
Bedscale	O

2	O
.	O

7	O
.	O

6	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

S1	O
,	O
S2	O
,	O
no	B-negation
gallop	O
.	O

In	O
TSICU	O
,	O
developed	O
MRSA	O
pneumonia	O
with	O
question	O
of	O
aspiration	O
,	O
treated	O
Zosyn	O
-	O
-	O
>	O
vanc	O
/	O
levo	O
-	O
-	O
>	O
then	O
2	B-duration
week	I-duration
course	O
of	O
Linazolid	O
with	O
resolution	O
of	O
fevers	O
and	O
decreased	B-course
pulmonary	B-bodyloc
secretions	O
.	O

Service	O
:	O

Service	O
:	O

Left	O
lumbar	O
sympathetic	O
block	O
*	O
*	O
DATE	O
[	O
Apr	B-temporal
25	I-temporal
2007	I-temporal
]	O
.	O

HTN	O

Monocytes	O
10	B-labvalue
%	I-labvalue

2	O
.	O

K	O
4	B-labvalue
.	I-labvalue
2	I-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

"	O

He	O
had	O
a	O
predischarge	O
biopsy	O
.	O

4	O
.	O

She	O
also	O
received	O
aggressive	O
deep	O
venous	O
thrombosis	O
prophylaxis	O
with	O
pneumatic	O
sequential	O
compression	O
device	O
on	O
the	O
nonoperative	O
leg	O
during	O
the	O
surgery	O
and	O
on	O
both	O
lower	O
extremities	O
postoperative	O
anytime	O
sedentary	O
continue	O
throughout	O
her	O
hospital	O
course	O
.	O

In	O
addition	O
,	O
the	O
patient	O
received	O
the	O
above	O
-	O
described	O
diagnostic	O
procedures	O
,	O
which	O
demonstrated	O
injuries	O
limited	O
to	O
a	B-bodyloc
posterior	I-bodyloc
scalp	I-bodyloc
laceration	O
,	O
left	O
fractured	O
clavicle	B-bodyloc
,	O
left	O
fractured	O
radius	B-bodyloc
,	O
right	B-bodyloc
thigh	I-bodyloc
hematoma	O
,	O
and	O
right	B-bodyloc
leg	I-bodyloc
laceration	O
.	O

Observe	O
.	O

We	O
will	O
continue	O
with	O
vancomycin	O
and	O
Unasyn	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
.	O

Discharge	O
Diagnosis	O
:	O

Family	O
History	O
:	O

Signed	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
18	I-temporal
2007	I-temporal
]	O

Sevelamer	O
2400	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Oriented	O
x	O
3	O
.	O

*	O
*	O
INSTITUTION	O

CONJUNCTIVITIS	O
,	O
UNSPECIFIED	O
(	O
ICD9	O
372	O
.	O
30	O
,	O
Working	O
,	O
Problem	O
)	O

HR	O
is	O
blow	O
60	B-labvalue
.	O

2	O
.	O

Discharge	O
Summary	O

The	O
patient	O
tolerated	O
this	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O
regular	O
nursing	O
floor	O
postoperatively	O
.	O

DICTATED	O
BY	O
:	O

36814	O

Spiriva	O
1	B-dosage
puff	B-form
daily	B-frequency
.	O

Systolic	O
BP	O
127	B-labvalue
mmHg	I-labvalue

ABS	O
Lymphs	O
2	B-labvalue
.	I-labvalue
1	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

Plaquenil	O
started	O
.	O

4	O
.	O

We	O
have	O
set	O
up	O
to	O
just	O
be	O
seen	O
at	O
the	O
*	O
*	O
INSTITUTION	O
prior	O
to	O
discharge	O
.	O

Normal	O
bowel	O
sounds	O
.	O

Hepatitis	O
B	O
.	O

DO	O
,	O
Attending	O
Physician	O

We	O
felt	O
that	O
the	O
patient	O
'	O
s	O
shortness	O
of	O
breath	O
was	O
either	O
likely	O
due	O
to	O
CHF	O
and	O
/	O
or	O
COPD	O
exacerbation	O
.	O

Attend	O
:	O

Allergy	O
profile	O
:	O

Dr	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
and	O
Dr	O
*	O
*	O
NAME	O
[	O
QQQ	O
]	O
from	O
Cardiology	O
.	O

Lungs	O
are	O
clear	B-labvalue
to	O
auscultation	O
and	O
percussion	O
.	O

No	B-negation
lymphadenopathy	O
,	O
no	B-negation
JVD	O
.	O

The	O
only	O
other	O
complaints	O
from	O
Mr	O
.	O
Mackey	O
during	O
his	O
stay	O
were	O
:	O

MEDICATIONS	O
:	O

Comparison	O
is	O
made	O
to	O
a	O
previous	O
study	O
from	O
2014-10-27	B-temporal
.	O

The	O
patient	O
was	O
admitted	O
on	O
*	O
*	O
DATE	O
[	O
Oct	O
29	O
07	O
]	O
and	O
underwent	O
elective	O
left	O
total	O
hip	O
arthroplasty	O
without	O
complication	O
.	O

HS	O
Job	O
#	O
653103	O
/	O
38374	O
/	O
36132	O

Past	O
Medical	O
History	O
:	O

T	O
:	O
2016-06-19	B-temporal

Keith	O
,	O
M	O
.	O
D	O
.	O

Patient	O
was	O
intubated	O
in	O
John	O
for	O
airway	O
protection	O
and	O
administation	O
of	O
charcoal	O
.	O

She	O
is	O
scheduled	O
to	O
be	O
transferred	O
today	O
*	O
*	O
DATE	O
[	O
Apr	B-temporal
30	I-temporal
2007	I-temporal
]	O
.	O

T	O
/	O
C	O
study	O
of	O
sleep	O
apnea	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
16	I-temporal
2008	I-temporal
]	O
17	B-temporal
:	I-temporal
01	I-temporal
)	O

Lungs	O
were	O
clear	B-labvalue
to	O
auscultation	O
anteriorly	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

FOLLOW	O
-	O
UP	O
CARE	O
:	O

For	O
further	O
specifics	O
on	O
this	O
patient	O
'	O
s	O
care	O
,	O
please	O
refer	O
to	O
the	O
patient	O
'	O
s	O
chart	O
.	O

TIBC	O
89	B-labvalue
ug	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

Heart	O
rate	O
was	O
77	B-labvalue
.	O

Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
will	O
be	O
happy	O
to	O
follow	O
the	O
patient	O
at	O
*	O
*	O
INSTITUTION	O
.	O

ATTENDING	O
*	O
*	O
NAME	O
[	O
UUU	O
:	O
YYY	O
M	O
ZZZ	O
]	O

The	O
patient	O
had	O
an	O
EKG	O
on	O
admission	O
which	O
showed	O
sinus	B-bodyloc
bradycardia	O
,	O
nonspecific	O
T	O
-	O
wave	O
abnormalities	O
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

7	O
.	O

Date	O
of	O
Birth	O
:	O

RHIM	O
,	O
M	O
.	O
D	O
.	O

Possible	O
aspiration	O
pneumonia	O
.	O

5	O
.	O

*	O
*	O
NAME	O
[	O
VVV	O
WWW	O
]	O
,	O
D	O
.	O
O	O
.	O

*	O
*	O
DATE	O
[	O
Oct	B-temporal
25	I-temporal
2007	I-temporal
]	O
05:34:08	B-temporal
/	I-temporal
pc	I-temporal

Sign	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O

Pulse	O
82	B-labvalue
BPM	I-labvalue

MRI	O
of	O
the	O
cervical	O
spine	O
revealed	O
mild	B-severity
protrusion	O
of	O
C5	B-bodyloc
-	I-bodyloc
C6	I-bodyloc
,	O
C6	B-bodyloc
-	I-bodyloc
C7	I-bodyloc
,	O
disk	O
barely	O
touching	O
cord	O
.	O

Patient	O
tolerated	O
decreasing	O
ventillary	O
support	O
.	O

The	O
patient	O
also	O
complained	O
of	O
fatigue	O
and	O
headache	O
upon	O
admission	O
.	O

repaglinide	O
(	O
Prandin	O
0	B-strength
.	I-strength
5	I-strength
mg	I-strength
oral	B-route
tablet	B-form
)	O
(	O
REPAGLINIDE	O
0	B-strength
.	I-strength
5	I-strength
MG	I-strength
TAB	B-form
)	O
,	O
0	B-strength
.	I-strength
5	I-strength
mg	I-strength
,	O
Tab	B-form
,	O
By	B-route
Mouth	I-route
,	O
TIDAC	B-frequency
,	O
Routine	O
,	O

The	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
in	O
no	B-negation
apparent	O
distress	O
.	O

16	O
.	O

Overdose	O
:	O

2	O
.	O

(	O
End	O
of	O
Report	O
)	O

PAIN	O
IN	O
JOINT	B-bodyloc
INVOLVING	O
SHOULDER	B-bodyloc
REGION	O
(	O
ICD9	O
719	O
.	O
41	O
,	O
Working	O
,	O
Problem	O
)	O

Clozapine	O
300	B-strength
mg	I-strength
po	B-route
qhs	B-frequency

Sinus	O
tachycardia	O
.	O

crystalloid	O
and	O
four	O
units	O
packed	O
red	O
blood	O
cells	O
with	O
good	O
response	O
.	O

Hypertension	O
.	O

Klonopin	O
0	B-strength
.	I-strength
5	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
nightly	B-frequency
.	O

There	O
is	O
no	O
evidence	O
of	O
surrounding	O
edema	O
.	O

Acute	B-course
renal	B-bodyloc
failure	O
.	O

-	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
VVV	O
M	O
]	O
.	O

Addendum	O
to	O
transfer	O
summary	O
that	O
was	O
dictated	O
on	O
*	O
*	O
DATE	O
[	O
Apr	B-temporal
29	I-temporal
2007	I-temporal
]	O
.	O

This	O
is	O
an	O
*	O
*	O
AGE	O
[	O
in	O
80s	O
]	O
-	O
year	O
-	O
old	O
female	O
with	O
past	O
medical	O
history	O
of	O
depression	O
,	O
atrial	B-bodyloc
fibrillation	O
,	O
and	O
COPD	O
who	O
was	O
transferred	O
to	O
the	O
MICU	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
12	I-temporal
2007	I-temporal
]	O
,	O
from	O
*	O
*	O
INSTITUTION	O
with	O
respiratory	O
distress	O
.	O

3	O
Ditropan	O
5	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Sex	O
:	O

Multiple	O
myeloma	O
.	O

2	O
.	O

EVALUATION	O
DATE	O
:	O

Sex	O
:	O

Regular	B-labvalue
rate	O
.	O

9	O
.	O

ASA	O
and	O
Ace	O
started	O
-	O
noBEta	O
blocker	O
secondary	O
to	O
Asthma	O
.	O

He	O
has	O
some	O
stress	O
ulcer	O
and	O
DVT	O
prophylaxis	O
.	O

STERNAL	O
WOUND	O
INFECTION	O
.	O

History	O
of	O
Present	O
Illness	O
:	O

DIS	O

8	O
.	O

Diagnosis	O
peritoneum	O
lavage	O
times	O
two	O
was	O
negative	B-negation
for	O
any	O
signs	O
of	O
intra	B-bodyloc
-	I-bodyloc
abdominal	I-bodyloc
bleeding	O
.	O

2	O
.	O

Continue	O
to	O
monitor	O
him	O
.	O

The	O
location	O
was	O
variable	O
.	O

2	O
.	O

PPX	O
:	O
SC	B-route
heparin	O
,	O
bowel	O
regimen	O
,	O
nicotine	O
patch	B-form

Reveiwed	O
her	O
BS	O
level	O
,	O
it	O
looks	O
good	O
in	O
early	O
morning	O
,	O
getting	O
,	O
higher	O
in	O
Evening	O
.	O

1	O
.	O

I	O
informed	O
him	O
that	O
work	O
is	O
not	O
an	O
exuse	O
as	O
if	O
he	O
does	O
not	O
qiut	O
etoh	O
and	O
go	O
to	O
all	O
his	O
appts	O
and	O
check	O
his	O
sugars	O
regularly	O
-	O
he	O
will	O
not	O
be	O
alive	O
to	O
go	O
to	O
work	O
.	O

I	O
have	O
started	O
him	O
on	O
some	O
glycemic	O
control	O
.	O

1	O
.	O

Hypertension	O
.	O

-	O
SW	O
consult	O
for	O
deposition	O
.	O

No	B-negation
abdominal	B-bodyloc
pain	O
,	O
nausea	O
or	O
vomiting	O
.	O

1963-12-03	B-temporal

Problems	O
and	O
management	O
are	O
as	O
follows	O
:	O

9	O
.	O

Resolved	O
hold	O
IV	B-route
abx	O
per	O
GI	O
cult	O
neg	B-labvalue
so	O
far	O

*	O
*	O
ID	O
-	O
NUM	O

DISCHARGE	O
DISPOSITION	O
:	O

5	O
.	O

Chest	O
:	O

He	O
denies	B-negation
any	O
chest	B-bodyloc
pain	O
or	O
dyspnea	O
.	O

Nicotine	O
21	B-strength
mg	I-strength
patch	B-form
topically	B-route
daily	B-frequency
for	O
nicotine	O
withdrawal	O
.	O

Tylenol	O
once	B-condition
his	O
delirium	O
had	O
resolved	B-course
.	O

Impression	O
and	O
Plan	O

The	O
patient	O
was	O
not	O
transferred	O
on	O
*	O
*	O
DATE	O
[	O
Apr	B-temporal
29	I-temporal
2007	I-temporal
]	O
,	O
because	O
her	O
bed	O
was	O
not	O
ready	O
.	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O

He	O
does	O
have	O
some	O
signs	O
of	O
volume	O
overload	O
with	O
pulmonary	B-bodyloc
vascular	I-bodyloc
congestion	O
on	O
the	O
ventilator	O
right	O
now	B-temporal
.	O

Completed	O
by	O
:	O
John	O
Konderla	O
MD	O
01	O
-	O
196	O
2012-06-09	B-temporal
@	O
1707	O

LUNGS	O
:	O

Gastrointestinal	O
:	O
soft	O
non	O
tender	O
-	O
obese	O
.	O

Alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
and	O
date	O
.	O

ICU	O
Prophylaxis	O
:	O

13	O
.	O

SECONDARY	O
DIAGNOSES	O
:	O

*	O
*	O
CARBON	O
-	O
COPY	O

1	O
.	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
27	I-temporal
2007	I-temporal
]	O
20:29:40	B-temporal
/	O
drl	O

ALT	O
/	O
SGPT	O
66	B-labvalue
IntUnit	I-labvalue
/	I-labvalue
L	I-labvalue
High	B-labvalue

what	O
day	O
is	O
today	O
?	O

For	O
the	O
last	O
two	O
days	O
,	O
we	O
have	O
tried	O
to	O
optimize	O
this	O
as	O
best	O
we	O
can	O
and	O
we	O
have	O
not	O
been	O
able	O
to	O
effectively	O
make	O
much	O
difference	O
.	O

He	O
will	O
need	O
to	O
be	O
put	O
on	O
low	O
molecular	O
weight	O
heparin	O
in	O
preparation	O
for	O
his	O
surgical	O
procedure	O
as	O
he	O
does	O
have	O
an	O
artifical	O
valve	O
.	O

Chest	O
x	O
-	O
ray	O
today	B-temporal
shows	O
some	O
decrease	O
in	O
his	O
bilateral	O
infiltrates	O
.	O

8	O
.	O

Heart	O
rate	O
90	B-labvalue
.	O

CT	O
of	O
the	O
head	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
3	I-temporal
2007	I-temporal
]	O
,	O
showed	O
increasing	B-course
microvascular	B-bodyloc
ischemic	O
change	O
.	O

She	O
denied	O
any	O
chest	B-bodyloc
pain	O
or	O
shortness	O
of	O
breath	O
.	O

Miriam	O
C	O
Hebert	O
,	O
M	O
.	O
D	O
.	O

Extremities	B-bodyloc
were	O
without	B-negation
edema	O
.	O

Persistent	O
complaints	O
of	O
SOB	O
/	O
orthopnia	O
/	O
(	O
-	O
)	O
CP	O
.	O

M	O

There	O
is	O
decreased	B-course
intraventricular	B-bodyloc
blood	O
,	O
compared	O
to	O
the	O
previous	O
study	O
,	O
and	O
there	O
are	O
no	B-negation
signs	O
of	O
hydrocephalus	O
.	O

No	B-negation
known	O
drug	O
allergies	O
.	O

Mental	O
status	O

2	O
.	O

Systolic	O
BP	O
106	B-labvalue
mmHg	I-labvalue

His	O
blood	O
pressure	O
is	O
unchanged	O
from	O
previous	O
recordings	O
.	O

Mg	O
1	B-labvalue
.	I-labvalue
6	I-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

.	O
.	O

Signed	O
electronically	O
by	O
:	O

Warfarin	O
Sodium	O
3	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
at	B-frequency
bedtime	I-frequency
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

Group	O
home	O
states	O
that	O
patient	O
"	O
may	O
have	O
taken	O
too	O
many	O
Xanax	O
.	O

Urinalysis	O
cultures	O
showed	O
no	B-negation
growth	O
,	O
however	O
,	O
the	O
patient	O
was	O
placed	O
on	O
Cipro	O
for	O
prophylaxis	O
especially	O
with	O
regards	O
to	O
the	O
fact	O
that	O
she	O
has	O
a	O
ureteral	O
stent	O
on	O
the	O
right	O
side	O
.	O

Evaluated	O
by	O
orthopedic	O
spine	O
surgeons	O
with	O
recommendations	O
for	O
soft	O
c	O
-	O
collar	O
for	O
comfort	O
.	O

DOB	O
:	O

Creatinine	O
2	B-labvalue
.	I-labvalue
2	I-labvalue
to	I-labvalue
2	I-labvalue
.	I-labvalue
5	I-labvalue
.	O

Her	B-bodyloc
abdomen	I-bodyloc
was	O
obese	O
and	O
had	O
positive	B-labvalue
bowel	O
sounds	O
.	O

Pericarditis	O
.	O

Matebolic	O
:	O

2014-04-23	B-temporal
08	B-temporal
:	I-temporal
13	I-temporal
AM	I-temporal
URINE	O
bnzodzpn	O
-	O
POS	B-labvalue
barbitrt	O
-	O
NEG	B-labvalue
opiates	O
-	O
NEG	B-labvalue
cocaine	O
-	O
NEG	B-labvalue
amphetmn	O
-	O
NEG	B-labvalue
mthdone	O
-	O
NEG	B-labvalue

Hypothyroidism	O
.	O

1	O
.	O

DIAGNOSIS	O
:	O

Hydrocortisone	O
10	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

1930-12-19	B-temporal

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

He	O
is	O
1800	O
-	O
calorie	O
diabetic	O
,	O
1000	O
mL	O
fluid	O
restriction	O
,	O
2	O
g	O
sodium	O
diet	O
.	O

An	O
ultrasound	O
was	O
done	O
to	O
R	B-uncertain
/	I-uncertain
O	I-uncertain
cholestasis	O
or	O
cholangitis	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

371899	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

Course	O

PULMONARY	O
SYSTEM	O
:	O

ADMISSION	O
DATE	O
:	O

PLT	O
COUNT	O
-	O
207	B-labvalue

Platelets	O
265	B-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

5	O
.	O

ADMISSION	O
DATE	O
:	O

He	O
continues	O
to	O
diurese	O
nicely	O
.	O

Heart	O
:	O
heart	O
sounds	O
:	O

Job	O
ID	O
:	O

Fentanyl	O
patch	B-form
25	B-strength
mcg	I-strength
an	O
hour	O
,	O
change	O
patch	O
every	O
72	O
hours	O
.	O

CK	O
(	O
CPK	O
)	O
-	O
4713	B-labvalue
*	O

On	O
2/22/00	B-temporal
,	O
the	O
patient	O
had	O
fevers	O
to	O
103	O
.	O
5	O
.	O

Folic	O
Acid	O
1	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

MRN	O
:	O

Mg	O
1	B-labvalue
.	I-labvalue
5	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

*	O
*	O
DATE	O
[	O
Oct	B-temporal
19	I-temporal
2007	I-temporal
]	O
14:11:43	B-temporal

She	O
was	O
started	O
on	O
nystatin	O
swish	O
and	O
swallow	O
QID	B-frequency
.	O

An	O
echocardiogram	O
showed	O
global	O
hypokinesis	O
.	O

TECHNIQUE	O
:	O
Non	O
-	O
contrast	O
head	O
CT	O
.	O

UCG	O
-	O
NEGATIVE	B-labvalue

Membranoproliferative	O
glomerulonephritis	O
.	O

2	O
.	O
)	O
CABG	O
2003	B-temporal

-	O
Gentamicin	O
oniment	B-form
q8	B-frequency
,	O
per	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
'	O
s	O
recommendation	O

JOB	O
#	O
:	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

A	O
spinal	O
tap	O
was	O
done	O
at	O
that	O
time	O
.	O

The	O
patient	O
was	O
admitted	O
and	O
was	O
initially	O
started	O
on	O
intravenous	B-route
ampicillin	O
,	O
gentamicin	O
and	O
clindamycin	O
.	O

2	O
.	O

Questionable	O
acute	B-course
right	O
heart	B-bodyloc
failure	O
versus	O
pulmonary	B-bodyloc
embolism	O
.	O

Cardiac	O
:	O

COPD	O

Upon	O
waking	O
on	O
the	O
morning	O
of	O
admission	O
,	O
she	O
had	O
10	B-severity
/	I-severity
10	I-severity
chest	B-bodyloc
pain	O
associated	O
with	O
nausea	O
.	O

CO2	O
28	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Kevin	O
Sineath	O
on	O
:	O
Andrea	O
2016-06-30	B-temporal
1	B-temporal
:	I-temporal
09	I-temporal
PM	I-temporal

His	O
initial	O
BP	O
was	O
60	B-labvalue
/	I-labvalue
P	I-labvalue
with	O
a	O
pulse	O
in	O
the	O
60	B-labvalue
s	I-labvalue
.	I-labvalue

MCH	O
-	O
28	B-labvalue
.	I-labvalue
9	I-labvalue
MCHC	O
-	O
34	B-labvalue
.	I-labvalue
3	I-labvalue
RDW	O
-	O
15	B-labvalue
.	I-labvalue
7	I-labvalue
*	I-labvalue

NON	O
-	O
CONTRAST	O
HEAD	O
CT	O
:	O
There	O
is	O
a	O
small	O
amount	O
of	O
hemorrhage	O
within	O
the	B-bodyloc
occipital	I-bodyloc
horns	I-bodyloc
of	I-bodyloc
both	I-bodyloc
lateral	I-bodyloc
ventricles	I-bodyloc
,	O
right	O
greater	O
than	O
left	O
.	O

8	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
18	I-temporal
2007	I-temporal
]	O
5	B-temporal
:	I-temporal
40	I-temporal
AM	I-temporal

2	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

17	O
.	O

ABS	O
Lymphs	O
2	B-labvalue
.	I-labvalue
4	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

General	O
results	O

Stenosis	O
of	O
thoracic	O
aorta	B-bodyloc
(	O
SNMCT	O
*	O
*	O
ID	O
-	O
NUM	O
,	O
Working	O
,	O
Problem	O
)	O

Clinically	O
stable	O
at	O
this	O
time	O
.	O

The	O
patient	O
also	O
reports	O
blood	O
-	O
streaked	O
diarrhea	O
for	O
two	B-temporal
days	I-temporal
.	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

Service	O
:	O

UTI	O
[	O
Urinary	B-bodyloc
tract	I-bodyloc
infection	O
]	O
(	O
ICD9	O
599	O
.	O
0	O
,	O
Working	O
,	O
Problem	O
)	O

diarrhea	O
:	O
The	O
patient	O
has	O
been	O
having	O
loose	O
stools	O
at	O
night	B-temporal
and	O
was	O
guiac	O
pos	O
x	O
2	O
.	O

TRANSPLANT	O
SURGERY	O

No	B-negation
acute	B-course
intracranial	B-bodyloc
hemorrhages	O
or	O
midline	O
shifts	O
were	O
noted	O
,	O
although	O
a	O
soft	O
tissue	O
mass	O
was	O
noted	O
at	O
the	B-bodyloc
level	I-bodyloc
of	I-bodyloc
C2	I-bodyloc
.	O

Swan	O
showed	O
a	O
PA	O
of	O
29	B-labvalue
/	I-labvalue
11	I-labvalue
,	O
SVR	O
of	O
14	B-labvalue
/	I-labvalue
9	I-labvalue
,	O
cardiac	O
output	O
of	O
3	B-labvalue
.	I-labvalue
86	I-labvalue
,	O
cardiac	O
index	O
of	O
2	B-labvalue
.	I-labvalue
14	I-labvalue
.	O

His	O
albumin	O
level	O
was	O
2	B-labvalue
.	I-labvalue
1	I-labvalue
today	O
,	O
prealbumin	O
is	O
still	O
pending	O
.	O

TYPE	O
-	O
ART	O
TEMP	O
-	O
36	B-labvalue
.	I-labvalue
6	I-labvalue
RATES	O
-	O
14	B-labvalue
/	O
TIDAL	O
VOL	O
-	O
550	B-labvalue
PEEP	O
-	O
5	B-labvalue
O2	O
-	O
100	O
PO2	O
-	O
416	B-labvalue
*	O
PCO2	O
-	O
39	B-labvalue
PH	O
-	O
7	B-labvalue
.	I-labvalue
41	I-labvalue
TOTAL	O
CO2	O
-	O
26	B-labvalue
BASE	O
XS	O
-	O
0	B-labvalue
AADO2	O
-	O
279	B-labvalue
REQ	O
O2	O
-	O
52	B-labvalue
-	O
ASSIST	O
/	O
CON	O
INTUBATED	O
-	O
INTUBATED	O

4	O
.	O

-	O
Consult	O
skin	O
care	O
for	O
heels	B-bodyloc
sore	O
.	O

Physical	O
examination	O
revealed	O
temperature	O
was	O
99	B-labvalue
.	I-labvalue
3	I-labvalue
,	O
heart	O
rate	O
was	O
66	B-labvalue
in	O
a	O
normal	B-labvalue
sinus	O
rhythm	O
,	O
blood	O
pressure	O
was	O
132	B-labvalue
/	I-labvalue
51	I-labvalue
,	O
respiratory	O
rate	O
was	O
22	B-labvalue
,	O
and	O
oxygen	O
saturation	O
was	O
100	B-labvalue
%	I-labvalue
on	O
3	O
liters	O
nasal	O
cannula	O
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O

-	O
-	O
t	O
/	O
c	O
inject	O
adhesive	O
capsulits	O
of	O
Rt	O
Shoulder	B-bodyloc

EVALUATION	O
DATE	O
:	O

Isosorbide	O
mononitrate	O
TR	O
30	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

D	O
/	O
C	O
Ambienm	O
today	B-temporal

*	O
*	O
INSTITUTION	O
.	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
10	I-temporal
07	I-temporal
]	O

Bowel	O
sounds	O
were	O
present	B-labvalue
.	O

Folate	O
1	B-strength
mg	I-strength
qd	B-frequency

Patient	O
lives	O
at	O
home	O
with	O
his	O
mother	O
,	O
father	O
and	O
brother	O
.	O

pneumothorax	O
.	O

Cholelithiasis	O
.	O

371871	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

Disp	O
:	O
*	O
240	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
2	O
*	O

The	O
patient	O
had	O
a	O
CT	O
scan	O
,	O
which	O
revealed	O
a	O
mass	O
in	O
the	O
gallbladder	B-bodyloc
neck	I-bodyloc
,	O
but	O
no	B-negation
biliary	B-bodyloc
dilatation	O
.	O

Course	O

HOSPITAL	O
COURSE	O
:	O

Patient	O
is	O
an	O
unreliable	O
historian	O
in	O
regards	O
to	O
his	O
alcohol	O
dependence	O
therefore	O
we	O
will	O
increase	O
his	O
Librium	O
to	O
50	B-strength
mg	I-strength
PO	B-route
PRN	B-frequency
as	O
this	O
is	O
Day	B-temporal
2	I-temporal
of	O
his	O
hospital	O
stay	O
.	O

662179752	O

-	O
suicide	O
precautions	O

An	O
endotracheal	O
tube	O
terminates	O
just	O
above	O
the	O
thoracic	O
inlet	O
approximately	O
6	O
.	O
5	O
cm	O
above	O
the	O
carina	O
.	O

Possible	B-uncertain
left	B-bodyloc
atrial	I-bodyloc
deformity	O
and	O
no	B-negation
other	O
changes	O
as	O
compared	O
to	O
the	O
previous	O
one	O
done	O
in	O
*	O
*	O
DATE	O
[	O
Aug	B-temporal
]	I-temporal
of	I-temporal
2006	I-temporal
.	O

The	O
patient	O
was	O
anticoagulated	O
with	O
Coumadin	O
for	O
DVT	O
prophylaxis	O
postoperatively	O
.	O

She	O
was	O
admitted	O
to	O
the	O
ICU	O
for	O
close	O
neurosurgical	O
and	O
neurological	O
observation	O
.	O

Lantoprost	O
0	B-strength
.	I-strength
005	I-strength
ophthalmic	O
solution	B-form
one	B-dosage
drop	I-dosage
O	B-route
.	I-route
U	I-route
.	I-route
q	B-duration
.	I-duration
h	I-duration
.	I-duration
s	I-duration
.	I-duration

Musculoskeletal	O
:	O

MOPAIGEIT	O
S	O
.	O

Soft	O
,	O
nd	O
,	O
hypoactive	O
bowel	O
sounds	O

Prilosec	O
20	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency

STUDIES	O
DONE	O
DURING	O
THIS	O
HOSPITALIZATION	O
:	O

Cor	O
:	O

Sign	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

ALLERGIES	O
:	O

Lescol	O
40	B-strength
qd	B-frequency

SocHx	O
:	O
Mr	O
Peres	O
generally	O
lives	O
with	O
his	O
wife	O
but	O
has	O
spent	O
a	O
great	O
deal	O
of	O
time	O
recently	O
at	O
rehab	O
.	O

3	O
.	O

343152	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

The	O
patient	O
needs	O
to	O
have	O
another	O
chest	O
x	O
-	O
ray	O
within	O
1	O
to	O
2	O
days	O
after	O
her	O
discharge	O
to	O
evaluate	O
the	O
progression	O
of	O
the	O
pleural	B-bodyloc
effusion	O
and	O
the	O
worsening	B-course
of	O
the	O
infiltrate	O
.	O

15	O
.	O

She	O
is	O
alert	O
and	O
oriented	O
x	O
2	O
;	O
although	O
,	O
she	O
did	O
think	O
that	O
she	O
was	O
at	O
*	O
*	O
INSTITUTION	O
.	O

After	O
discussing	O
this	O
with	O
his	O
PCP	O
,	O
Leon	O
was	O
clear	O
that	O
the	O
patient	O
had	O
had	O
recurrent	O
DVTs	O
and	O
ultimately	O
a	O
PE	O
and	O
his	O
PCP	O
felt	O
strongly	O
that	O
he	O
required	O
long	B-duration
-	I-duration
term	I-duration
anticoagulation	O
.	O

2016-03-30	B-temporal

His	O
PCP	O
had	O
recently	O
started	O
ciprofloxacin	O
for	O
a	O
UTI	O
.	O

MRN	O
:	O

folowwing	O
the	O
commeds	O
for	O
physical	O
exam	O
.	O

Today	O
'	O
s	O
results	O
:	O

DIS	O

D	O
:	O

Call	O
887	O
415	O
4220	O
to	O
schedule	O
an	O
appointment	O
with	O
Orthopedics	O
for	O
late	O
November	O
.	O

The	O
patient	O
is	O
to	O
continue	O
with	O
her	O
normal	O
preoperative	O
diet	O
.	O

Signed	O

Sex	O
:	O

In	O
the	O
Rita	O
,	O
the	O
patient	O
was	O
intubated	O
and	O
given	O
activated	O
charcoal	O
.	O

ALCOHOLIC	O
LIVER	B-bodyloc
DAMAGE	O
,	O
UNSPECIFIED	O
(	O
ICD9	O
571	O
.	O
3	O
,	O
Working	O
,	O
Diagnosis	O
)	O
possibly	O
Non	O
-	O
alcoholic	O
liver	B-bodyloc
ds	O
as	O
well	O
Probable	O
cirrhosis	O
s	O
/	O
p	O
2	O
.	O
5	O
L	O
removed	O
via	O
paracenthesis	O
see	O
Dr	O
*	O
*	O
NAME	O
[	O
VVV	O
]	O
detailed	O
note	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
06	I-temporal
]	O

Initially	O
she	O
was	O
admitted	O
to	O
3	O
-	O
B	O
,	O
but	O
had	O
to	O
be	O
transferred	O
to	O
the	O
stepdown	O
unit	O
because	O
her	O
pulmonary	B-bodyloc
status	O
showed	O
substantial	O
deterioration	O
.	O

An	O
*	O
*	O
AGE	O
[	O
in	O
80s	O
]	O
-	O
year	O
-	O
old	O
man	O
with	O
a	O
history	O
of	O
dementia	O
,	O
aspiration	O
pneumonia	O
,	O
ARDS	O
,	O
and	O
respiratory	O
failure	O
.	O

Left	O
ventriculography	O
.	O

The	O
patient	O
was	O
instructed	O
on	O
absolutely	O
no	O
alcohol	O
use	O
.	O

2012-06-07	B-temporal
09	B-temporal
:	I-temporal
55	I-temporal
PM	I-temporal
BLOOD	O
Neuts	O
-	O
49	B-labvalue
.	I-labvalue
9	I-labvalue
*	O
Lymphs	O
-	O
42	B-labvalue
.	I-labvalue
4	I-labvalue
*	O
Monos	O
-	O
5	B-labvalue
.	I-labvalue
5	I-labvalue
Eos	O
-	O
1	B-labvalue
.	I-labvalue
6	I-labvalue
Baso	O
-	O
0	B-labvalue
.	I-labvalue
6	I-labvalue

There	O
were	O
139	B-labvalue
WBC	O
s	O
,	O
there	O
were	O
99	B-labvalue
RBC	O
s	O
,	O
1	B-labvalue
neutrophil	O
,	O
2	B-labvalue
lymphs	O
,	O
48	B-labvalue
monos	O
,	O
and	O
37	B-labvalue
mesothelial	O
cells	O
,	O
12	B-labvalue
macrophages	O
.	O

It	O
did	O
not	O
radiate	O
.	O

1	O
.	O

Coronary	B-bodyloc
artery	I-bodyloc
disease	O
.	O

TSH	O
wnl	B-labvalue
,	O
and	O
B12	O
and	O
Folic	O
pending	O
.	O

Consider	O
EP	O
consult	O
in	O
future	O
.	O

2	O
.	O

Alert	O
,	O
oriented	O
x	O
3	O
.	O

2	O
Neurontin	O
1200	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
nightly	B-frequency
.	O

gGTP	O
47	B-labvalue
IU	I-labvalue
/	I-labvalue
L	I-labvalue
High	B-labvalue

Dict	O
:	O

2012-10-31	B-temporal
05	B-temporal
:	I-temporal
47PM	I-temporal
URINE	O

*	O
*	O
AGE	O
[	O
in	O
40s	O
]	O
years	O

A	O
fever	O
,	O
NO	B-negation
elevation	O
of	O
WBC	O
,	O
On	O
bactrim	O
BID	B-frequency
,	O
Urine	O
look	O
clear	O
.	O

This	O
is	O
a	O
20	O
-	O
year	O
-	O
old	O
female	O
with	O
no	O
significant	O
past	O
medical	O
history	O
,	O
who	O
was	O
the	O
unrestrained	O
passenger	O
in	O
a	O
high	O
speed	O
rollover	O
motor	O
vehicle	O
accident	O
on	O
2010-06-27	B-temporal
.	O

2	O
.	O

CT	O
ABDOMEN	O
W	O
/	O
CONTRAST	O

Discharge	O
Medications	O
:	O

Timoptic	O
0	B-strength
.	I-strength
25	I-strength
one	B-dosage
drop	I-dosage
O	B-route
.	I-route
U	I-route
.	I-route
b	B-duration
.	I-duration
i	I-duration
.	I-duration
d	I-duration
.	I-duration

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Her	O
phosphorous	O
rose	O
appropriately	O
to	O
3	B-labvalue
.	I-labvalue
6	I-labvalue
at	O
the	O
time	O
of	O
discharge	O
.	O

*	O
*	O
ROOM	O

pantoprazole	O
(	O
Protonix	O
)	O
(	O
PANTOPRAZOLE	O
)	O
,	O
40	B-strength
mg	I-strength
,	O
IV	B-route
,	O
Q24H	B-frequency
,	O
Routine	O
,	O

Hematologic	O
/	O
Lymphatic	O
:	O

Meds	O
on	O
Admission	O
:	O

Patient	O
to	O
followup	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
.	O

Chronic	B-course
low	B-bodyloc
back	I-bodyloc
pain	O
.	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
15	I-temporal
2007	I-temporal
]	O
17:20:05	B-temporal
/	O
ja	O

The	O
culture	O
of	O
the	O
pleural	O
fluid	O
showed	O
no	B-labvalue
growth	I-labvalue
after	O
4	O
days	O
of	O
culture	O
.	O

Inferior	B-bodyloc
myocardial	I-bodyloc
infarction	O
and	O
right	B-bodyloc
ventricular	I-bodyloc
infarction	O
.	O

12	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Nonfocal	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Radiographic	O
studies	O
demonstrated	O
an	O
inferior	O
displaced	O
left	B-bodyloc
midclavicular	I-bodyloc
fracture	O
,	O
no	O
evidence	O
of	O

He	O
continues	O
to	O
also	O
show	O
poor	O
cardiac	B-bodyloc
perfusion	O
and	O
poor	O
peripheral	O
perfusion	O
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O

EVALUATION	O
DATE	O
:	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
30	I-temporal
2006	I-temporal
]	O

GI	O
bleeding	O
NOS	O
(	O
ICD9	O
578	O
.	O
9	O
,	O
Working	O
,	O
Problem	O
)	O

*	O
*	O
ID	O
-	O
NUM	O

LIPASE	O
-	O
66	B-labvalue
*	O

6	O
.	O

WBC	O
6	B-labvalue
.	I-labvalue
6	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

Her	O
admission	O
orders	O
were	O
all	O
written	O
.	O

Her	O
renal	B-bodyloc
failure	O
began	O
to	O
improve	O
and	O
her	O
last	O
dialysis	O
session	O
occurred	O
six	O
days	O
prior	O
to	O
her	O
admission	O
to	O
*	O
*	O
INSTITUTION	O
.	O

On	O
the	O
day	O
of	O
discharge	O
,	O
the	O
patient	O
is	O
denying	B-negation
any	O
abdominal	B-bodyloc
pain	O
,	O
diarrhea	O
resolving	O
,	O
denies	B-negation
nausea	O
or	O
vomiting	O
,	O
tolerating	O
diet	O
.	O

There	O
are	O
numerous	O
areas	O
of	O
decreased	O
attenuation	O
in	O
the	B-bodyloc
periventricular	I-bodyloc
and	O
subcortical	B-bodyloc
white	I-bodyloc
matter	I-bodyloc
of	O
both	O
cerebral	O
hemispheres	O
,	O
indicating	O
chronic	B-course
microvascular	O
infarction	O
.	O

Ulcerative	O
Colitis	O
w	O
/	O
colostomy	O

Warm	O
and	O
dry	O
.	O

Facility	O
:	O

PATIENT	O
NAME	O
:	O

Hemoglobin	O
and	O
hematocrit	O
have	O
remained	O
stable	O
.	O

By	O
postoperative	O
day	O
two	O
the	O
patient	O
was	O
successfully	O
transitioned	O
from	O
narcotic	O
PCA	O
to	O
oral	B-route
analgesics	O
with	O
morphine	O
IV	B-route
backup	O
for	O
breakthrough	O
pain	O
.	O

Date	O
of	O
Birth	O
:	O

1	O
.	O

ATTENDING	O
PHYSICIAN	O
:	O

Right	O
foot	O
and	O
femur	O
series	O
demonstrated	O
no	B-negation
evidence	O
of	O
fracture	O
displacement	O
.	O

VERIFY	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O
(	O
on	O
*	O
*	O
DATE	O
[	O
Dec	O
07	O
2007	O
]	O
15	B-temporal
:	I-temporal
16	I-temporal
)	O

Dictated	O
By	O
:	O
Michael	O
S	O
Bonham	O
,	O
M	O
.	O
D	O
.	O

Bili	O
,	O
Conjugated	O
&	O
lt	O
;	O
0	B-labvalue
.	I-labvalue
1	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

4	O
.	O

Platelets	O
266	B-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

Note	O
:	O
you	O
have	O
had	O
a	O
cardiac	O
stent	O
placed	O
during	O
this	O
admission	O
.	O

It	O
was	O
0	O
.	O
49	O
.	O

The	O
patient	O
was	O
admitted	O
from	O
2016-01-21	B-temporal
to	O
2016-02-03	B-temporal
;	O
at	O
which	O
time	O
she	O
was	O
ruled	B-negation
out	I-negation
for	O
a	O
myocardial	B-bodyloc
infarction	O
.	O

She	O
is	O
to	O
continue	O
taking	O
her	O
Coumadin	O
as	O
prescribed	O
.	O

insulin	O
regular	O
,	O
1	O
See	O
Notes	O
,	O
subQ	B-route
,	O
ACandHS	B-frequency
,	O
Drug	O
Form	O
:	O
Solution	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
6:00:00	B-temporal

Docusate	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
twice	B-frequency
per	I-frequency
day	I-frequency
.	O

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

WBC	O
-	O
9	B-labvalue
.	I-labvalue
4	I-labvalue
#	O
RBC	O
-	O
4	B-labvalue
.	I-labvalue
75	I-labvalue
HGB	O
-	O
14	B-labvalue
.	I-labvalue
7	I-labvalue
HCT	O
-	O
42	B-labvalue
.	I-labvalue
2	I-labvalue
MCV	O
-	O
89	B-labvalue
MCH	O
-	O
30	B-labvalue
.	I-labvalue
9	I-labvalue
MCHC	O
-	O
34	B-labvalue
.	I-labvalue
8	I-labvalue
RDW	O
-	O
13	B-labvalue
.	I-labvalue
6	I-labvalue

History	O
of	O
renal	B-bodyloc
lithiasis	O
.	O

The	O
patient	O
was	O
alert	O
and	O
oriented	O
x3	O
.	O

GENERAL	O
:	O

Cc	O
:	O

He	O
had	O
good	O
hemodynamics	O
.	O

Librium	O
for	O
DT	O
proph	O

He	O
also	O
has	O
a	O
history	O
of	O
hypertension	O
and	O
diabetes	O
mellitus	O
.	O

Patient	O
was	O
exubated	O
after	O
1	O
day	O
in	O
ICU	O
after	O
waking	O
up	O
.	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

ACCOUNT	O
#	O
:	O

Dr	O
.	O
Streeter	O
from	O
Cardiothoracic	O
Surgery	O
will	O
follow	O
up	O
with	O
the	O
patient	O
for	O
further	O
management	O
in	O
approximately	O
one	O
month	O
as	O
an	O
outpatient	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

MEDQUIST36	O

Temperature	O
97	B-labvalue
.	I-labvalue
9	I-labvalue
Deg	I-labvalue
F	I-labvalue

Calcification	O
is	O
seen	O
at	O
both	O
carotid	B-bodyloc
bifurcations	I-bodyloc
.	O

Mrs	O
.	O
*	O
*	O
NAME	O
[	O
AAA	O
]	O
is	O
a	O
very	O
nice	O
*	O
*	O
AGE	O
[	O
in	O
30s	O
]	O
-	O
year	O
-	O
old	O
white	O
female	O
,	O
right	O
handed	O
with	O
significant	O
past	O
medical	O
history	O
for	O
asthma	O
,	O
migraine	O
,	O
fibromyalgia	O
,	O
panic	O
attacks	O
,	O
hypertension	O
,	O
hypothyroidism	O
,	O
eating	O
disorder	O
,	O
appendectomy	O
,	O
cholecystectomy	O
,	O
tonsillectomy	O
,	O
and	O
kidney	B-bodyloc
stones	O
.	O

CALCIUM	O
-	O
9	B-labvalue
.	I-labvalue
7	I-labvalue
PHOSPHATE	O
-	O
3	B-labvalue
.	I-labvalue
7	I-labvalue
MAGNESIUM	O
-	O
2	B-labvalue
.	I-labvalue
1	I-labvalue

and	O
Cockup	O
splitper	O
ortho	O
.	O

406231	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Melody	O
PARKS	O
on	O
:	O
WED	B-temporal
2012-11-21	B-temporal
6	B-temporal
:	I-temporal
22	I-temporal
PM	I-temporal

O	O
.	O

Allergies	O
:	O

She	O
was	O
afebrile	O
at	O
all	O
times	O
and	O
she	O
did	O
not	O
have	O
any	O
significant	O
dyspnea	O
during	O
this	O
hospitalization	O
.	O

14	O
.	O
)	O
Folate	O
1	B-strength
mg	I-strength
daily	B-frequency

*	O
*	O
INSTITUTION	O

1	O
.	O

14	O
.	O

The	O
patient	O
had	O
a	O
spinal	O
cord	O
stimulator	O
trial	O
on	O
07/21/99	B-temporal
,	O
the	O
patient	O
had	O
an	O
epidural	O
trial	O
on	O
07/24/99	B-temporal
.	O

2	O
.	O

Acetaminophen	O
325	B-strength
mg	I-strength
Tablet	O
Sig	O
:	O
1	B-dosage
-	I-dosage
2	I-dosage
Tablets	B-form
PO	B-route
Q4	B-frequency
-	I-frequency
6H	I-frequency
(	O
every	B-frequency
4	I-frequency
to	I-frequency
6	I-frequency
hours	I-frequency
)	O
as	B-frequency
needed	I-frequency
.	O

Today	O
'	O
s	O
results	O
:	O

No	B-negation
w	O
/	O
r	O
/	O
r	O
/	O
appreciated	O
.	O
.	O

2	O
.	O

PRINCIPAL	O
TESTS	O
AND	O
PROCEDURES	O
:	O

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

HOSPITAL	O
COURSE	O
:	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Oct	B-temporal
14	I-temporal
2007	I-temporal
]	O
20	B-temporal
:	I-temporal
15	I-temporal
)	O

Ca	O
9	B-labvalue
.	I-labvalue
4	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

-	O
PT	O
/	O
OP	O

D	O
:	O

*	O
*	O
ID	O
-	O
NUM	O

Hct	O
30	B-labvalue
.	I-labvalue
5	I-labvalue
%	I-labvalue
Low	B-labvalue

Xanax	O
0	B-strength
.	I-strength
5	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

11	O
.	O

The	O
nasogastric	O
tube	O
terminates	O
within	O
the	O
stomach	O
.	O

Therefore	O
,	O
he	O
was	O
admitted	O
for	O
C4	O
-	O
C5	O
and	O
C5	O
-	O
C6	O
anterior	O
diskectomy	O
with	O
autologous	O
bone	O
graft	O
and	O
instrumented	O
fusion	O
.	O

*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
YYY	O
]	O

Author	O
:	O

3	O
.	O

Alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
and	O
date	O
.	O

Intake	O
/	O
Output	O
=	O
480	B-labvalue
/	I-labvalue
100	I-labvalue
+	O
BR	O
.	O

Stable	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

22849	O
/	O
871n	O

2009-04-03	B-temporal

She	O
has	O
not	B-negation
had	O
any	O
periods	O
of	O
somnolence	O
.	O

The	O
patient	O
agreed	O
that	O
she	O
was	O
at	O
her	O
baseline	O
.	O

Discharge	O
Diagnosis	O
:	O

Facility	O
:	O

Neutrophils	O
87	B-labvalue
%	I-labvalue

Less	O
red	O
and	O
have	O
less	O
discharge	O
.	O

Service	O
is	O
actually	O
Medicine	O
,	O
Newburyport	O
Firm	O
not	O
C	O
-	O
CMED	O
.	O

Please	O
continue	O
to	O
take	O
antibiotics	O
as	O
directed	O
for	O
urinary	B-bodyloc
tract	I-bodyloc
infection	O
for	O
3	O
more	O
days	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
29	I-temporal
2007	I-temporal
]	O
19:54:24	B-temporal

*	O
*	O
AGE	O
[	O
in	O
60s	O
]	O
years	O

We	O
have	O
instructed	O
the	O
patient	O
the	O
importance	O
of	O
alcohol	O
cessation	O
.	O

9	O
.	O

He	O
was	O
,	O
however	O
,	O
extubted	O
without	O
difficulty	O
and	O
after	O
that	O
did	O
quite	O
well	O
.	O

Irritable	O
bowel	O
syndrome	O
.	O

08/02/93	B-temporal
:	O

A	O
CT	O
and	O
MRI	O
scan	O
corroborated	O
multiple	O
cerebral	B-bodyloc
infarcts	O
.	O

1	O
.	O

D	O
:	O

8	O
.	O

7/20/1999	B-temporal
12:00:00	B-temporal
AM	I-temporal

History	O
of	O
Present	O
Illness	O
:	O

Completed	O
by	O
:	O
Russell	O
Anthony	O
Conner	O
MD	O
87	O
-	O
672	O
2014-11-21	B-temporal
@	O
1110	O

-	O
Protonix	O
40	B-strength
mg	I-strength
daily	B-frequency

He	O
has	O
made	O
an	O
appointment	O
and	O
the	O
following	O
week	O
he	O
should	O
follow	O
up	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
and	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
as	O
needed	O
.	O

Activity	O
:	O
OOB	O
with	O
assist	O

Decreased	O
breath	O
sounds	O
on	O
the	O
left	B-bodyloc
base	I-bodyloc
with	O
coarse	O
rales	O
on	O
the	O
left	B-bodyloc
base	I-bodyloc
.	O

She	O
was	O
given	O
IV	B-route
normal	O
saline	O
500	B-dosage
cc	I-dosage
bolus	I-dosage
,	O
and	O
IV	B-route
Dilaudid	O
1	B-strength
mg	I-strength
IV	B-route
,	O
and	O
Valium	O
4	B-strength
mg	I-strength
IV	B-route
.	O

His	O
LFTs	O
showed	O
total	O
protein	O
of	O
7	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
total	O
bilirubin	O
of	O
4	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
direct	O
bilirubin	O
of	O
2	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
ALT	O
of	O
78	B-labvalue
,	O
AST	O
of	O
213	B-labvalue
,	O
alkaline	O
phosphatase	O
of	O
113	B-labvalue
with	O
a	O
lipase	O
of	O
242	B-labvalue
.	O

Please	O
consider	O
this	O
note	O
linked	O
to	O
the	O
resident	O
note	O
.	O

She	O
had	O
no	O
specific	O
complaints	O
for	O
me	O
.	O

Trental	O
400	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

He	O
agree	O
to	O
transfer	O
her	O
to	O
heartlant	O
NH	O
for	O
short	O
term	O
rehab	O
.	O

*	O
*	O
INSTITUTION	O

976113	O

Unfortunately	O
the	O
patient	O
is	O
impulsive	O
and	O
therapeutically	O
non	O
-	O
compliant	O
.	O

He	O
had	O
occasional	O
atrial	B-bodyloc
and	I-bodyloc
ventricular	I-bodyloc
premature	O
beats	O
.	O

Cesarean	O
section	O
x	O
2	O
,	O
spontaneous	O
abortion	O
x	O
1	O
.	O

JOB	O
#	O
:	O

He	O
is	O
to	O
see	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
on	O
Tuesday	B-temporal
at	O
1	B-temporal
:	I-temporal
30	I-temporal
p	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal

She	O
noted	O
increasing	B-course
abdominal	B-bodyloc
pain	O
two	O
days	O
prior	O
to	O
admission	O
,	O
which	O
became	O
more	O
severe	O
on	O
the	O
day	O
prior	O
to	O
admission	O
.	O

901751538	O

Pertinent	O
Results	O
:	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Denies	O
.	O

Physical	O
Exam	O
:	O

Otherwise	O
,	O
she	O
has	O
been	O
breathing	O
well	O
and	O
has	O
no	O
complaints	O
to	O
me	O
today	O
.	O

He	O
was	O
strongly	O
encouraged	O
to	O
come	O
in	O
by	O
his	O
mother	O
and	O
was	O
admitted	O
through	O
the	O
emergency	O
room	O
.	O

.	O
.	O

#	O
DM	O
-	O
2	O
-	O
-	O
The	O
patient	O
was	O
maintained	O
on	O
his	O
home	O
insulin	O
regimen	O
.	O

Eye	O
:	O
bilateral	O
:	O

On	O
admission	O
revealed	O
a	O
white	O
blood	O
cell	O
count	O
of	O
9	B-labvalue
.	I-labvalue
46	I-labvalue
with	O
89	B-labvalue
%	I-labvalue
polys	O
,	O
2	B-labvalue
%	I-labvalue
bands	O
,	O
7	B-labvalue
%	I-labvalue
lymphocytes	O
,	O
2	B-labvalue
%	I-labvalue
monocytes	O
.	O

Lower	O
extremity	O
Dopplers	O
negative	B-labvalue
for	O
deep	O
venous	O
thrombosis	O
in	O
either	O
leg	B-bodyloc
bilaterally	O
.	O

However	O
,	O
by	O
day	O
three	O
he	O
required	O
no	B-negation
additional	O
insulin	O
coverage	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

Addendum	O
to	O
hospital	O
course	O
.	O

F	O

Sign	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O
(	O
on	O
*	O
*	O
DATE	O
[	O
Dec	O
07	O
2007	O
]	O
15	B-temporal
:	I-temporal
16	I-temporal
)	O

He	O
will	O
need	O
q	B-temporal
.	I-temporal
i	I-temporal
.	I-temporal
d	I-temporal
.	I-temporal
glucose	O
monitoring	O
,	O
sliding	O
scale	O
,	O
and	O
close	O
follow	O
up	O
with	O
PCP	O
or	O
endocrine	O
.	O

She	O
will	O
have	O
an	O
IVP	O
repeated	O
in	O
one	O
week	O
at	O
which	O
time	O
she	O
should	O
have	O
cleared	O
the	O
residual	O
contrast	O
in	O
her	O
colon	O
.	O

DM	O
II	O
[	O
Diabetes	O
mellitus	O
type	O
II	O
]	O
(	O
ICD9	O
250	O
.	O
00	O
,	O
Working	O
,	O
Problem	O
)	O

Breath	O
sounds	O
were	O
of	O
good	B-labvalue
intensity	I-labvalue
.	O

9	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

CAUSE	O
OF	O
DEATH	O
:	O

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

Patient	O
was	O
splinted	O
and	O
UE	O
were	O
kept	O
elevated	O
.	O

2	O
.	O

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

No	B-negation
redness	O
,	O
dno	O
discharge	O
.	O

1	O
)	O
Rapid	O
atrial	O
fibrillation	O
with	O
demand	O
ischemia	O

Pantopraozle	O
40	B-strength
mg	I-strength
po	B-route
qd	B-frequency

Admitted	O
to	O
TSICU	O
for	O
subarachnoid	B-bodyloc
hemorrhage	O
and	O
multiple	O
spinal	B-bodyloc
fractures	O
.	O

Folic	O
acid	O
1	B-strength
mg	I-strength
p	B-form
.	I-form
o	I-form
.	I-form
daily	B-frequency
.	O

Spider	O
angioma	O
-	O
right	B-bodyloc
side	I-bodyloc
of	I-bodyloc
his	I-bodyloc
chest	I-bodyloc
-	I-bodyloc
near	I-bodyloc
his	I-bodyloc
subclavicular	I-bodyloc
area	I-bodyloc
.	O
.	O

Glucose	O
(	O
bedside	O
)	O
127	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
High	B-labvalue

She	O
has	O
never	O
been	O
married	O
.	O

The	O
patient	O
is	O
a	O
65	O
year	O
old	O
female	O
with	O
post	O
thoracotomy	O
syndrome	O
that	O
occurred	O
on	O
the	O
site	O
of	O
her	O
thoracotomy	O
incision	O
.	O

*	O
*	O
CARBON	O
-	O
COPY	O

Status	O
post	O
deep	O
venous	B-bodyloc
thrombosis	O
.	O

*	O
*	O
INSTITUTION	O

341298	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

139391631	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Delusional	O
hyponatremia	O
.	O

Throat	B-bodyloc
cancer	O
status	O
post	O
right	O
neck	O
dissection	O
and	O
XRT	O
in	O
2004	B-temporal
.	O

9	O
.	O

PRIMARY	O
DIAGNOSIS	O
:	O

Labile	O
hypertension	O
.	O

Neutrophils	O
71	B-labvalue
%	I-labvalue

Her	O
dialysis	O
catheter	O
has	O
been	O
removed	O
.	O

The	O
vehicle	O
was	O
noted	O
to	O
be	O
extensively	O
damaged	O
.	O

On	O
06	O
-	O
30	O
,	O
the	O
patient	O
was	O
evaluated	O
by	O
Occupational	O
Therapy	O
and	O
fitted	O
for	O
a	O
left	O
upper	O
extremity	O
splint	O
.	O

Propanolol	O
20	B-strength
mg	I-strength
tid	B-frequency

Patient	O
:	O

5	O
.	O

Glucose	O
99	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

Heart	O
:	O

*	O
*	O
ID	O
-	O
NUM	O

They	O
were	O
taken	O
off	O
two	O
at	O
a	O
time	O
.	O

On	O
coumadin	O
which	O
being	O
off	O
for	O
a	O
while	O
before	O
this	O
hospitalization	O
?	O

Course	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

RY93	O
KE526	O
/	O
9219	O

RDW	O
16	B-labvalue
.	I-labvalue
9	I-labvalue
%	I-labvalue
High	B-labvalue

Right	O
lung	O
is	O
clear	O
.	O

R	O
.	O

2	O
.	O

check	O
INR	O
daily	O
.	O

DISCHARGE	O
FOLLOW	O
-	O
UP	O
:	O

Status	O
post	O
myocardial	O
infarction	O
.	O

Glucose	O
(	O
bedside	O
)	O
80	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

*	O
*	O
DATE	O
[	O
Aug	B-temporal
16	I-temporal
1930	I-temporal
]	O

1	O
)	O
Please	O
follow	O
up	O
with	O
your	O
PCP	O
and	O
cardiologist	O
,	O
David	O
,	O
Larry	O
Robinson	O
(	O
771	O
)	O
937	O
-	O
5400	O
,	O
upon	O
discharge	O
.	O

MEDQUIST36	O

R	O
:	O

It	O
was	O
thought	O
,	O
by	O
Internal	O
Medicine	O
,	O
the	O
patient	O
was	O
to	O
be	O
transferred	O
to	O
rehab	O
unit	O
,	O
after	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
okays	O
for	O
transfer	O
.	O

6	O
.	O

Diabetes	O
mellitus	O
type	O
2	O
in	O
obese	O
male	O
-	O
controlled	O
.	O

K	O
4	B-labvalue
.	I-labvalue
4	I-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

The	O
cefotaxime	O
was	O
discontinued	O
since	O
no	B-negation
infection	O
was	O
identified	O
.	O

DIAGNOSIS	O
:	O

ALLRESLTSECT	O

Fibroid	O
uterus	B-bodyloc
status	O
post	O
embolization	O
on	O
2009-01-07	B-temporal
.	O

Pacemaker	O

NO	B-negation
wheeze	O
/	O
sputum	O
production	O
.	O

After	O
surgery	O
he	O
had	O
a	O
ongoing	O
sinus	O
tachycardia	O
.	O

Pressure	O
,	O
dermal	O
ulcer	O
care	O
b	O
.	O
i	O
.	O
d	O
.	O
dressing	O
change	O
with	O
antibiotic	O
solution	B-form
.	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
18	I-temporal
2007	I-temporal
]	O

On	O
hospital	O
day	O
#	O
2	O
,	O
she	O
started	O
passing	O
gas	O
and	O
stools	O
through	O
her	O
ileostomy	O
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

She	O
works	O
as	O
a	O
nursing	O
assistant	O
in	O
a	O
nursing	O
home	O
.	O

It	O
was	O
recommend	O
to	O
continue	O
current	B-temporal
treatment	O
.	O

-	O
check	O
A1c	O
:	O

Progressed	O
adequately	O
with	O
physical	O
/	O
occupational	O
therapy	O
,	O
however	O
was	O
noted	O
to	O
develop	O
an	B-bodyloc
early	I-bodyloc
bilateral	I-bodyloc
upper	I-bodyloc
extermity	I-bodyloc
contracture	O
at	O
the	O
elbows	O
and	O
wrists	O
.	O

5	O
.	O

*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
YYY	O
]	O

Patient	O
was	O
known	O
to	O
neurologist	O
.	O

4	O
.	O

No	B-negation
clubbing	O
.	O

*	O
*	O
CARBON	O
-	O
COPY	O

Family	O
History	O
:	O

Report	O
Status	O
:	O

Her	O
PE	O
was	O
unlikely	O
due	O
to	O
the	O
fact	O
the	O
patient	O
was	O
on	O
Coumadin	O
as	O
an	O
outpatient	O
,	O
and	O
had	O
been	O
anticoagulated	O
for	O
some	O
amount	O
of	O
time	O
.	O

Past	O
Medical	O
History	O
:	O

ADMISSION	O
DATE	O
:	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
29	I-temporal
07	I-temporal
]	O

Creatinine	O
showed	O
substantial	O
improvement	O
all	O
the	O
way	O
through	O
her	O
hospitalization	O
and	O
at	O
the	O
time	O
of	O
discharge	O
her	O
BUN	O
and	O
creatinine	O
had	O
practically	O
normalized	O
with	O
a	O
BUN	O
of	O
25	B-labvalue
and	O
a	O
creatinine	O
of	O
1	B-labvalue
.	I-labvalue
3	I-labvalue
.	O

Amlodipine	O
5	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

Other	O
recommendations	O
are	O
the	O
patient	O
will	O
have	O
a	O
paracentesis	O
with	O
cell	O
count	O
,	O
C	O
and	O
S	O
,	O
and	O
total	O
protein	O
which	O
has	O
been	O
done	O
,	O
2	O
.	O
5	O
L	O
was	O
removed	O
from	O
the	O
patient	O
.	O

Physical	O
Examination	O

Hgb	O
stable	B-labvalue
.	O

Age	O
:	O

MD	O

7	O
:	O
16	O
A	O
mm	O

BASOS	O
-	O
0	B-labvalue
.	I-labvalue
4	I-labvalue

2014-10-21	B-temporal
08	B-temporal
:	I-temporal
10	I-temporal
PM	I-temporal

Lymphs	O
20	B-labvalue
%	I-labvalue

Hypercholesterolemia	O
.	O

*	O
*	O
INSTITUTION	O
when	O
stable	O
.	O

CALCIUM	O
-	O
8	B-labvalue
.	I-labvalue
2	I-labvalue
*	O
PHOSPHATE	O
-	O
2	B-labvalue
.	I-labvalue
1	I-labvalue
*	O
MAGNESIUM	O
-	O
1	B-labvalue
.	I-labvalue
9	I-labvalue

*	O
*	O
*	O
Dictated	O
By	O
:	O

CODE	O
:	O
full	O

Diabetes	O
mellitus	O
.	O

DIS	O

Cholecystitis	O
.	O

2	O
.	O

Diabetes	O
mellitus	O
type	O
2	O
in	O
obese	O
(	O
SNMCT	O
*	O
*	O
ID	O
-	O
NUM	O
,	O
Working	O
,	O
Diagnosis	O
)	O
on	O
actos	O
at	O
home	O
-	O
hgba1c	O
nl	O
range	O
glu	O
low	O
this	O
am	O
watch	O
pt	O
off	O
prandin	O

Do	O
not	O
take	O
while	O
continuing	O
to	O
smoke	O
.	O

On	O
physical	O
examination	O
,	O
his	O
temperature	O
is	O
99	B-labvalue
.	I-labvalue
5	I-labvalue
.	O

He	O
was	O
also	O
discharged	O
home	O
with	O
Visiting	O
Nurse	O
Association	O
for	O
Physical	O
Therapy	O
evaluation	O
of	O
home	O
safety	O
.	O

The	O
patient	O
was	O
a	O
*	O
*	O
AGE	O
[	O
in	O
30s	O
]	O
-	O
year	O
-	O
old	O
male	O
with	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
.	O

She	O
receives	O
this	O
medication	O
by	O
mail	O
from	O
her	O
relatives	O
in	O
Jill	O
.	O

XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

Coronary	O
artery	O
bypass	O
grafting	O
x	O
4	O
.	O

1942-03-10	B-temporal

R	O
:	O

*	O
*	O
ID	O
-	O
NUM	O

We	O
placed	O
an	O
NG	O
tube	O
and	O
kept	O
the	O
patient	O
n	O
.	O
p	O
.	O
o	O
.	O
with	O
hydration	O
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

*	O
*	O
ROOM	O

*	O
*	O
INSTITUTION	O

T	O
:	O

4	O
.	O

His	O
hemoglobin	O
was	O
roughly	O
near	O
his	O
recent	O
baseline	O
.	O

Albuterol	O
neb	B-route
2	B-strength
.	I-strength
5	I-strength
mg	I-strength
every	B-frequency
six	I-frequency
hours	I-frequency
,	O
30	O
minutes	O
before	O
Colistin	O
.	O

Respiratory	O
code	O
was	O
called	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
17	I-temporal
2007	I-temporal
]	O
19	B-temporal
:	I-temporal
42	I-temporal

TOTAL	O
CRITICAL	O
CARE	O
TIME	O
EQUALS	O
40	O
MINUTES	O

TD	O
:	O

Acct	O
#	O
:	O

07/30/93	B-temporal
:	O

Her	O
INR	O
was	O
therapeutic	O
at	O
the	O
time	O
of	O
her	O
discharge	O
.	O

R	O
:	O

Ultimately	O
we	O
had	O
a	O
discussion	O
with	O
family	O
and	O
the	O
family	O
has	O
decided	O
to	O
extubate	O
the	O
patient	O
and	O
make	O
him	O
comfortable	O
with	O
morphine	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
01	I-temporal
2007	I-temporal
]	O
22:42:59	B-temporal

3	O
.	O

Abdomen	B-bodyloc
:	O
contour	O
:	O
generalized	O
distention	O
,	O
soft	O
,	O

3	O
.	O

Patient	O
was	O
gradually	O
put	O
back	O
on	O
her	O
outpatient	O
xanax	O
dose	O
of	O
1	B-strength
mg	I-strength
qid	B-frequency
and	O
clozaril	O
was	O
restarted	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
19	I-temporal
2007	I-temporal
]	O
10	B-temporal
:	I-temporal
00	I-temporal
)	O

There	O
is	O
continued	O
to	O
be	O
large	O
oozing	O
sores	O
on	O
her	O
legs	B-bodyloc
,	O
buttocks	B-bodyloc
,	O
under	O
her	O
breast	B-bodyloc
.	O

folic	O
acid	O
,	O
1	B-strength
mg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
Daily	O
,	O
Drug	O
Form	O
:	O
Tab	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
9:00:00	B-temporal

2012-10-31	B-temporal
12	B-temporal
:	I-temporal
20PM	I-temporal

2012-06-07	B-temporal
09	B-temporal
:	I-temporal
55	I-temporal
PM	I-temporal
BLOOD	O
Glucose	O
-	O
108	B-labvalue
*	O
UreaN	O
-	O
13	B-labvalue
Creat	O
-	O
0	B-labvalue
.	I-labvalue
7	I-labvalue
Na	O
-	O
146	B-labvalue
*	O
K	O
-	O
3	B-labvalue
.	I-labvalue
7	I-labvalue
Cl	O
-	O
109	B-labvalue
*	O
HCO3	O
-	O
30	B-labvalue
*	O
AnGap	O
-	O
11	B-labvalue

The	O
patient	O
was	O
taken	O
to	O
the	O
cardiac	O
catheterization	O
laboratory	O
,	O
where	O
he	O
was	O
noted	O
initially	O
to	O
have	O
a	O
pulmonary	O
wedge	O
pressure	O
of	O
45	B-labvalue
with	O
a	O
pulmonary	O
artery	O
pressure	O
of	O
82	B-labvalue
/	I-labvalue
40	I-labvalue
.	O

Index	O
No	O
.	O

The	O
patient	O
did	O
progress	O
slowly	O
with	O
physical	O
therapy	O
throughout	O
her	O
hospital	O
stay	O
and	O
it	O
was	O
deemed	O
appropriate	O
for	O
her	O
to	O
go	O
to	O
inpatient	O
Rehab	O
at	O
*	O
*	O
PLACE	O
Rehab	O
under	O
the	O
care	O
of	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
02	I-temporal
07	I-temporal
]	O
.	O

His	O
respiratory	O
rate	O
was	O
30	B-labvalue
on	O
face	O
mask	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
19	I-temporal
2007	I-temporal
]	O

2014-11-12	B-temporal
9	B-temporal
:	I-temporal
10	I-temporal
AM	I-temporal

Lungs	O
:	O
normal	O

61261	O

Continue	O
with	O
steroids	O
.	O

Weight	O
:	O

Chart	O
reviewed	O
,	O
including	O
36	O
-	O
hr	O
rounding	O
report	O
.	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Stable	O

There	O
is	O
no	B-negation
evidence	O
of	O
reflux	O
.	O

Plan	O

CHEST	O
(	O
PORTABLE	O
AP	O
)	O

I	O
would	O
like	O
to	O
try	O
and	O
to	O
keep	O
him	O
off	O
BiPAP	O
tonight	O
if	O
possible	O
.	O

He	O
was	O
given	O
Lasix	O
to	O
continue	O
to	O
diurese	O
the	O
excess	O
volume	O
.	O

Past	O
Medical	O
History	O
:	O

FiberCon	O
1250	B-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Dict	O
:	O

Motor	O
,	O
sensory	O
,	O
and	O
vascular	O
examinations	O
were	O
intact	B-labvalue
in	O
all	O
distributions	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

+	O
1	O
pedal	O
edema	O
.	O

Dictated	O
By	O
:	O
Caroline	O
D	O
Dempsey	O
,	O
M	O
.	O
D	O
.	O

Will	O
continue	O
to	O
monitor	O
his	O
BS	O
.	O

PATIENT	O
NAME	O
:	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
13	I-temporal
07	I-temporal
]	O

Asthma	O

Abdomen	O
was	O
benign	O
.	O

Status	O
post	O
right	O
total	O
knee	O
arthroplasty	O
.	O

Provider	O
:	O
Lucio	O
Y	O
.	O

Mental	O
Status	O
:	O

Decreased	O
breath	O
sounds	O
in	O
her	B-bodyloc
right	I-bodyloc
lower	I-bodyloc
lobe	I-bodyloc
and	O
no	B-negation
wheezes	O
or	O
crackles	O
.	O

Results	O
Review	O

PHYSICAL	O
EXAMINATION	O
:	O

MCH	O
36	B-labvalue
.	I-labvalue
6	I-labvalue
pg	I-labvalue
High	B-labvalue

Renal	B-bodyloc
insufficiency	O
syndrome	O
NOS	O
(	O
ICD9	O
586	O
,	O
Working	O
,	O
Problem	O
)	O

Hgb	O
10	B-labvalue
.	I-labvalue
7	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

Docusate	O
Sodium	O
100	B-strength
mg	I-strength
Capsule	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Capsule	B-form
PO	B-route
BID	B-frequency
(	O
2	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
.	O

Channel	O
1	O
was	O
negative	O
,	O
2	O
was	O
neutral	O
,	O
3	O
was	O
neutral	O
,	O
4	O
was	O
positive	O
.	O

She	O
did	O
have	O
some	O
blurry	O
vision	O
and	O
chest	B-bodyloc
pain	O
on	O
admission	O
.	O

Currently	B-temporal
denies	B-negation
CP	O
,	O
SOB	O
,	O
abd	B-bodyloc
pain	O
or	O
continued	O
BRBPR	O
.	O

OPERATIONS	O
AND	O
DATES	O
:	O

1	O
.	O

ABS	O
Neutrophils	O
7	B-labvalue
.	I-labvalue
2	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

Heart	O

Discharge	O
Disposition	O
:	O

Diastolic	O
BP	O
56	B-labvalue
mmHg	I-labvalue

There	O
were	O
no	B-negation
electrolytes	O
or	O
mineral	O
abnormalities	O
that	O
could	O
explain	O
his	O
delirium	O
.	O

multivitamin	O
,	O
1	B-dosage
cap	B-form
(	O
s	O
)	O
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Drug	O
Form	O
:	O
Cap	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
9:00:00	B-temporal

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
07	I-temporal
2008	I-temporal
]	O
12:45:40	B-temporal
/	O
rms	O

She	O
remained	O
afebrile	O
throughout	O
her	O
hospital	O
course	O
.	O

4	O
.	O

NOTE	O
:	O
This	O
study	O
was	O
initially	O
performed	O
on	O
the	O
morning	B-temporal
of	O
10	B-temporal
-	I-temporal
21	I-temporal
,	O
and	O
is	O
being	O
dictated	O
on	O
the	O
morning	B-temporal
of	O
10	B-temporal
-	I-temporal
22	I-temporal
due	O
to	O
PACS	O
malfunction	O
.	O

The	O
patient	O
is	O
diuresing	O
well	O
,	O
negative	O
2	O
liters	O
again	O
per	O
day	O
.	O

MCHC	O
33	B-labvalue
.	I-labvalue
7	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue

A	O
diabetic	O
educator	O
has	O
been	O
consulted	O
for	O
patient	O
,	O
they	O
have	O
instructed	O
the	O
patient	O
.	O

The	O
patient	O
'	O
s	O
paracentesis	O
results	O
are	O
already	O
dictated	O
as	O
above	O
.	O

Temperature	O
35	B-labvalue
.	I-labvalue
4	I-labvalue
Celsius	I-labvalue
,	O
blood	O
pressure	O
116	B-labvalue
/	I-labvalue
63	I-labvalue
,	O
pulse	O
105	B-labvalue
,	O
respiratory	O
rate	O
18	B-labvalue
,	O
oxygen	O
saturation	O
98	B-labvalue
%	I-labvalue
on	O
room	O
air	O
.	O

He	O
was	O
awake	O
,	O
alert	O
,	O
uncomfortable	O
secondary	O
to	O
incisional	O
tenderness	O
at	O
neck	B-bodyloc
site	O
as	O
well	O
as	O
right	B-bodyloc
iliac	I-bodyloc
graft	O
site	O
.	O

X	O
-	O
rays	O
showed	O
chest	O
x	O
-	O
ray	O
with	O
some	O
minor	B-severity
right	B-bodyloc
lower	I-bodyloc
lobe	I-bodyloc
atelectasis	O
.	O

2011-11-22	B-temporal

VS	O
95	B-labvalue
.	I-labvalue
4	I-labvalue
HR	O
62	B-labvalue
BP	O
99	B-labvalue
/	I-labvalue
70	I-labvalue
RR	O
20	B-labvalue
O2Sat	O
100	B-labvalue
%	I-labvalue

Type	O
1	O
diabetes	O
mellitus	O
with	O
triopathy	O
,	O
retinopathy	O
,	O
neuropathy	O
,	O
nephropathy	O
.	O

Neurological	O
:	O

Constitutional	O
:	O
hydration	O
:	O
normal	O
,	O
nutritional	O
status	O
:	O
normal	O
.	O

18	B-labvalue
breaths	I-labvalue
/	I-labvalue
min	I-labvalue
.	O

Respiratory	O
.	O

She	O
has	O
moist	O
mucous	O
membranes	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Abdomen	O
soft	O
and	O
nontender	O
.	O

Pulse	O
:	O

Liver	B-bodyloc
Ds	O

2012-10-31	B-temporal

The	O
severity	O
and	O
persistent	O
of	O
the	O
patient	O
&apos;s	O
epigastric	B-bodyloc
pain	O
was	O
concerning	O
for	O
a	O
pancreatic	B-bodyloc
complication	O
such	O
as	O
necrosis	O
or	O
abscess	O
.	O

15	O
.	O

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

Kristie	O
R	O
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

Multiple	O
myeloma	O
.	O

There	O
is	O
also	O
an	O
old	O
right	B-bodyloc
frontal	I-bodyloc
lobe	I-bodyloc
cortical	I-bodyloc
infarction	O
.	O

Ischemic	O
heart	O
disease	O
and	O
status	O
post	O
mitral	O
valve	O
repair	O
:	O

HOSPITAL	O
COURSE	O
:	O

All	O
of	O
this	O
occurred	O
in	O
the	O
setting	O
of	O
aggressive	O
BP	O
management	O
with	O
metoprolol	O
25	B-strength
BID	B-frequency
,	O
HCTZ	O
/	O
Triampterene	O
(	O
as	O
a	O
replacment	O
for	O
lasix	O
due	O
to	O
recurrent	B-course
hypokalemia	O
)	O
,	O
Benicar	O
20	B-strength
mg	I-strength
QD	B-frequency
,	O
and	O
Imdur	O
30	B-strength
mg	I-strength
QD	B-frequency
.	O

RIGHT	O
HYDRONEPHROSIS	O
ON	O
CT	O
SCAN	O
.	O

HEENT	O
:	O

Discharge	O
Condition	O
:	O

1	O
.	O

2012-06-07	B-temporal
09	B-temporal
:	I-temporal
55	I-temporal
PM	I-temporal
BLOOD	O
ALT	O
-	O
44	B-labvalue
*	O
AST	O
-	O
31	B-labvalue
AlkPhos	O
-	O
36	B-labvalue
*	O
TotBili	O
-	O
0	B-labvalue
.	I-labvalue
2	I-labvalue

On	O
coumadin	O
which	O
being	O
off	O
for	O
a	O
while	O
before	O
this	O
hospitalization	O
?	O

T	O
:	O

Pupils	O
were	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
at	O
approximately	O
4	O
mm	O
.	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

She	O
is	O
to	O
continue	O
with	O
sequential	O
compression	O
devices	O
on	O
the	O
lower	O
extremities	O
while	O
sedentary	O
and	O
standard	O
hip	O
precautions	O
.	O

T	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

Librium	O
25	B-strength
mg	I-strength
one	B-dosage
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
as	B-frequency
needed	I-frequency
for	O
alcohol	O
withdrawal	O
.	O

Subjective	O

Congestive	O
heart	B-bodyloc
failure	O
,	O
diabetes	O
,	O
hypertension	O
,	O
end	B-severity
-	I-severity
stage	I-severity
renal	B-bodyloc
disease	O
,	O
dialysis	O
dependent	O
,	O
depression	O
,	O
malnutrition	O
,	O
adherence	O
/	O
compliance	O
difficulty	O
,	O
decreased	O
albumin	O
,	O
dyslipidemia	O
,	O
psychiatric	O
issues	O
,	O
GERD	O
,	O
and	O
hypokalemia	O
.	O

Basophils	O
1	B-labvalue
%	I-labvalue

Today	O
'	O
s	O
results	O

xray	O
of	O
R	O
wrist	O
final	O
reading	O
Pending	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Cr	O
1	B-labvalue
.	I-labvalue
1	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

A	O
Urology	O
consultation	O
was	O
obtained	O
,	O
and	O
it	O
was	O
recommended	O
that	O
an	O
IVP	O
be	O
obtained	O
.	O

HEENT	O
:	O
NCAT	O
,	O
PERRL	O
,	O
EOMI	O
,	O
no	B-negation
icterus	O
,	O
OP	O
clear	O
,	O
MMM	O
,	O
no	B-negation
tongue	B-bodyloc
fasciculations	O

Asthma	O
.	O

Author	O
:	O

Therefore	O
,	O
he	O
had	O
a	O
repeat	O
colonoscopy	O
on	O
11	B-temporal
-	I-temporal
06	I-temporal
which	O
showed	O
expected	O
mucosal	B-bodyloc
signs	O
of	O
moderate	B-severity
ulcerative	O
colitis	O
,	O
no	B-negation
polyps	O
,	O
w	O
/	O
8	O
mm	O
ulcer	O
at	O
junction	O
of	O
distal	B-bodyloc
descending	I-bodyloc
colon	I-bodyloc
and	O
sigmoid	B-bodyloc
colon	I-bodyloc
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
19	I-temporal
2007	I-temporal
]	O
07:32:11	B-temporal
PM	I-temporal

Lisinopril	O
5	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency

SECONDARY	O
DIAGNOSES	O
:	O

DISCHARGE	O
MEDICATIONS	O
:	O

6	O
.	O

She	O
had	O
been	O
receiving	O
electroconvulsive	O
therapy	O
,	O
her	O
last	O
treatment	O
being	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
11	I-temporal
2007	I-temporal
]	O
.	O

The	O
culture	O
is	O
currently	B-temporal
no	B-labvalue
growth	I-labvalue
times	O
2	O
days	O
.	O

MCHC	O
34	B-labvalue
.	I-labvalue
7	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue

Clear	B-labvalue
to	O
auscultation	O
on	O
the	O
right	O
.	O

Hypertension	O
.	O

DISCHARGE	O
STATUS	O
:	O

Reducible	O
left	O
inguinal	O
hernia	O
.	O

This	O
was	O
determined	O
to	O
be	O
within	O
the	O
normal	O
expected	O
changes	O
post	O
surgery	O
.	O

Renal	O
.	O

Basophils	O
0	B-labvalue
%	I-labvalue

MCH	O
36	B-labvalue
.	I-labvalue
5	I-labvalue
pg	I-labvalue
High	B-labvalue

She	O
underwent	O
a	O
pelvic	O
ultrasound	O
and	O
an	O
abdomen	O
and	O
pelvis	O
CT	O
,	O
which	O
revealed	O
continued	O
air	O
in	O
the	O
endometrial	B-bodyloc
cavity	O
vs	O
.	O
in	O
the	O
fundal	B-bodyloc
fibroid	O
.	O

3	O
.	O

abd	B-bodyloc
-	O
soft	O
,	O
minimally	O
distended	O
,	O
nt	O
,	O
no	B-negation
rebound	O
/	O
guarding	O
,	O
nabs	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
12:18:00	B-temporal

*	O
*	O
INITIALS	O

Cardiac	O
-	O
Htn	O
-	O
continue	O
lisnopril	O
.	O

Throat	O
culture	O
that	O
showed	O
no	B-negation
B	O
-	O
hemolytic	O
streptococci	O
isolated	O
.	O

The	O
infection	O
has	O
been	O
well	O
controlled	O
and	O
improving	B-course
.	O

*	O
*	O
ID	O
-	O
NUM	O

Patient	O
is	O
in	O
NAD	O
.	O

The	O
patient	O
was	O
treated	O
with	O
Pepcid	O
and	O
heparin	O
for	O
GIT	O
and	O
DVT	O
prophylaxis	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
01	I-temporal
2007	I-temporal
]	O
22:25:53	B-temporal

#	O
BRBPR	O
-	O
-	O
The	O
patient	O
was	O
in	O
the	O
intensive	O
care	O
unit	O
given	O
his	O
lower	B-bodyloc
GI	I-bodyloc
bleed	O
.	O

ASCITES	O
(	O
ICD9	O
789	O
.	O
5	O
,	O
Working	O
,	O
Diagnosis	O
)	O
on	O
spironalactone	O

Cardiac	O
and	O
mediastinal	O
contours	O
are	O
within	O
normal	O
limits	O
.	O

An	O
echocardiogram	O
status	O
post	O
percutaneous	O
coronary	O
intervention	O
revealed	O
an	O
akinetic	O
inferior	B-bodyloc
wall	I-bodyloc
and	O
right	B-bodyloc
ventricle	I-bodyloc
,	O
mild	B-severity
mitral	B-bodyloc
regurgitation	O
,	O
and	O
ascending	O
aorta	O
measuring	O
5	O
cm	O
.	O

The	O
patient	O
had	O
24	O
-	O
hour	O
urine	O
protein	O
which	O
was	O
7	B-labvalue
.	I-labvalue
22	I-labvalue
gm	I-labvalue
per	I-labvalue
day	I-labvalue
.	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Melissa	O
Higuera	O
on	O
:	O
SUN	O
2014-11-23	B-temporal
6	B-temporal
:	I-temporal
13	I-temporal
PM	I-temporal

ADMISSION	O
DATE	O
:	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

2012-04-30	B-temporal

2012-10-31	B-temporal
3	B-temporal
:	I-temporal
27	I-temporal
PM	I-temporal

Service	O
:	O

11	O
.	O

Job	O
ID	O
:	O

Impression	O
and	O
Plan	O

SOLID	O
,	O
M	O
.	O
D	O
.	O

Sex	O
:	O

2012-10-31	B-temporal
02	B-temporal
:	I-temporal
32PM	I-temporal

She	O
did	O
have	O
a	O
tracheal	O
aspirate	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
12	I-temporal
2006	I-temporal
]	O
,	O
which	O
showed	O
moderate	O
gram	O
-	O
positive	O
cocci	O
.	O

She	O
is	O
instructed	O
to	O
resume	O
activity	O
as	O
tolerated	O
and	O
also	O
to	O
resume	O
a	O
cardiac	O
healthy	O
diet	O
.	O

At	O
that	O
point	O
,	O
it	O
was	O
normal	B-labvalue
for	O
protein	O
and	O
glucose	O
.	O

8	O
.	O

Lantus	O
,	O
Neurontin	O
,	O
Effexor	O
,	O
Nicomide	O
,	O
loratadine	O
as	O
stated	O
,	O
Nexium	O
,	O
Lupron	O
,	O
Lopid	O
,	O
Lipitor	O
,	O
sodium	O
bicarbonate	O
,	O
Renal	O
Caps	O
,	O
Cardizem	O
,	O
and	O
Humalog	O
sliding	B-dosage
scale	I-dosage
.	O

Admission	O
Date	O
:	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
M	O
]	O

D	O
:	O

Admission	O
Date	O
:	O

Examination	O
of	O
the	O
sternal	B-bodyloc
wound	O
showed	O
an	O
opened	O
area	O
in	O
the	O
mid	O
region	O
of	O
the	O
wound	O
with	O
serosanguineous	O
drainage	O
and	O
a	O
scant	O
amount	O
of	O
thick	O
,	O
yellow	O
pus	O
.	O

*	O
*	O
ROOM	O

Discharge	O
Instructions	O
:	O

Hematologic	O
-	O
-	O
anemia	O
-	O
-	O
the	O
patient	O
'	O
s	O
anemia	O
was	O
treated	O
with	O
transfusion	O
upon	O
admission	O
and	O
fatigue	O
was	O
improved	B-course
.	O

Venlafaxine	O
XR	O
75	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
a	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency

There	O
was	O
no	B-negation
infiltrates	O
or	O
consolidation	O
.	O

1	O
.	O

Colace	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

ALLERGIES	O
:	O

Followup	O
Instructions	O
:	O

Coherent	O
.	O

Dilaudid	O
IV	B-route
was	O
continued	O
for	O
the	O
remainder	O
of	O
the	O
patient	O
&apos;s	O
hospitalization	O
.	O

10	O
.	O

I	O
am	O
seeing	O
him	O
for	O
management	O
of	O
these	O
issues	O
.	O

PLT	O
COUNT	O
-	O
330	B-labvalue

(	O
on	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
16	I-temporal
2008	I-temporal
]	O
17	B-temporal
:	I-temporal
01	I-temporal
)	O

ADMISSION	O
DATE	O
:	O

-	O
Hold	O
Metformin	O
due	O
to	O
MS	O
unstable	O
and	O
renal	O
function	O
not	O
optimal	O
.	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Margarita	O
Martin	O
on	O
:	O
TUE	O
2012-06-05	B-temporal
8	B-temporal
:	I-temporal
08	I-temporal
AM	I-temporal

A	O
bone	O
marrow	O
biopsy	O
was	O
performed	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
4	I-temporal
2007	I-temporal
]	O
,	O
which	O
showed	O
a	B-labvalue
less	I-labvalue
than	I-labvalue
10	I-labvalue
%	I-labvalue
plasma	O
cell	O
level	O
.	O

She	O
can	O
call	O
*	O
*	O
PHONE	O
to	O
confirm	O
this	O
appointment	O
.	O

Lisinopril	O
40	B-strength
mg	I-strength
p	B-form
.	I-form
o	I-form
.	I-form
daily	B-frequency
.	O

This	O
is	O
an	O
unusual	O
finding	O
for	O
a	O
parapneumonic	O
effusion	O
.	O

-	O
check	O
Stool	O
occult	O
:	O
pending	O

The	O
patient	O
is	O
a	O
20	O
year	O
old	O
black	O
female	O
who	O
was	O
a	O
pedestrian	O
when	O
struck	O
by	O
a	O
car	O
at	O
apparent	O
high	O
speed	O
.	O

10	O
.	O

Temperature	O
normal	B-labvalue

Ultimately	O
,	O
he	O
will	O
need	O
to	O
have	O
his	O
prostate	O
removed	O
by	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
and	O
arrangements	O
are	O
being	O
made	O
for	O
that	O
at	O
this	O
time	O
.	O

Delirium	O
NOS	O
(	O
ICD9	O
780	O
.	O
09	O
,	O
Working	O
,	O
Problem	O
)	O

Denies	O
alcohol	O
use	O
.	O

3	O
.	O

BUN	O
33	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
High	B-labvalue

The	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
with	O
active	O
bowel	O
sounds	O
.	O

-	O
appreciate	O
CMED	O
consult	O
;	O
patient	O
to	O
be	O
discharged	O
to	O
inpatient	O
CMED	O
facility	O
once	O
stable	O

Infection	O
/	O
sepsis	O
was	O
not	O
likely	O
given	O
she	O
was	O
afebrile	O
and	O
had	O
no	B-negation
localizing	O
sx	O
with	O
an	O
improving	O
lung	O
exam	O
and	O
02	O
requirement	O
.	O

Left	B-bodyloc
T1	I-bodyloc
transverse	I-bodyloc
process	I-bodyloc
fracture	O

Chest	O
tube	O
was	O
in	O
place	O
in	O
left	O
internal	O
jugular	O
an	O
pulmonary	O
artery	O
catheter	O
.	O

I	O
discussed	O
the	O
case	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
VVV	O
]	O
.	O

He	O
was	O
also	O
placed	O
on	O
Vasotec	O
.	O

SHY	O
#	O
*	O
*	O
ID	O
-	O
NUM	O

Laboratories	O
revealed	O
white	O
blood	O
cell	O
count	O
was	O
12	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
hematocrit	O
was	O
32	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
platelets	O
were	O
140	B-labvalue
,	O
and	O
mean	O
cell	O
volume	O
was	O
80	B-labvalue
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
CCC	O
]	O

*	O
*	O
DATE	O
[	O
May	B-temporal
01	I-temporal
2007	I-temporal
]	O
23:15:19	B-temporal

Sex	O
:	O

F	O

On	O
the	O
day	O
of	O
discharge	O
,	O
she	O
was	O
tolerating	O
diet	O
and	O
had	O
a	O
normal	B-labvalue
bowel	O
movement	O
.	O

Positioning	O
limits	O
assessment	O
of	O
alignment	O
due	O
to	O
extreme	O
head	B-bodyloc
tilting	O
to	O
the	O
right	O
,	O
but	O
this	O
is	O
likely	O
the	O
best	O
obtainable	O
secondary	O
to	O
intubation	O
and	O
nasogastric	O
tube	O
placement	O
.	O

-	O
watch	O
for	O
BZD	O
withdrawal	O
,	O
agitation	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Tympanic	O
membranes	O
were	O
noted	O
to	O
be	O
clear	O
.	O

She	O
neurologically	O
,	O
she	O
had	O
a	O
nonfocal	O
neurologic	O
examination	O
.	O

*	O
*	O
CARBON	O
-	O
COPY	O

If	B-condition
bleeding	O
continues	O
to	O
occur	O
,	O
consider	O
V	O
.	O

At	O
9am	O
the	O
morning	O
of	O
admission	O
he	O
passed	O
a	O
large	O
,	O
bloody	O
bowel	B-bodyloc
movement	O
and	O
came	O
to	O
the	O
Michael	O
.	O

Mr	O
.	O
Mackey	O
also	O
had	O
signs	O
and	O
symptoms	O
consistent	O
with	O
cervical	B-bodyloc
myelopathy	O
;	O
a	O
cervical	O
MRI	O
scan	O
showed	O
very	O
impressive	O
disc	O
herniations	O
at	B-bodyloc
C5	I-bodyloc
-	I-bodyloc
C6	I-bodyloc
,	O
less	O
so	O
at	B-bodyloc
C4	I-bodyloc
-	I-bodyloc
C5	I-bodyloc
,	O
with	O
clear	O
cut	O
cord	B-bodyloc
compression	O
,	O
particularly	O
on	O
the	O
right	B-bodyloc
side	I-bodyloc
C5	I-bodyloc
-	I-bodyloc
C6	I-bodyloc
.	O

Cardiovascular	O
:	O

ADMISSION	O
DATE	O
:	O

Subjective	O

The	O
patient	O
is	O
a	O
49	O
-	O
year	O
-	O
old	O
gravida	O
III	O
,	O
para	O
II	O
,	O
who	O
was	O
sent	O
from	O
her	O
primary	O
care	O
physician	O
'	O
s	O
office	O
secondary	O
to	O
lower	B-bodyloc
abdominal	I-bodyloc
pain	O
.	O

A	O
&	O
amp	O
;	O
Ox3	O
.	O

*	O
*	O
NAME	O
[	O
XXX	O
M	O
ZZZ	O
YYY	O
]	O

ASSESSMENT	O
AND	O
PLANS	O
:	O

I	O
have	O
seen	O
and	O
examined	O
the	O
patient	O
and	O
reviewed	O
his	O
laboratory	O
,	O
radiographic	O
and	O
EMTEK	O
data	O
and	O
discussed	O
the	O
management	O
with	O
the	O
surgeons	O
and	O
Critical	O
Care	O
Team	O
.	O

Cl	O
108	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

Lipitor	O
10	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

SHY	O
#	O
*	O
*	O
ID	O
-	O
NUM	O

-	O
Consult	O

Her	O
lungs	O
remained	O
clear	O
to	O
auscultation	O
bilaterally	O
throughout	O
the	O
remainder	O
of	O
her	O
hospital	O
course	O
.	O

Attend	O
:	O

DISCHARGE	O
MEDICATIONS	O
:	O

No	O
dictation	O
.	O

*	O
*	O
ROOM	O

Cc	O
:	O

Protonix	O
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency

14	O
.	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
06	I-temporal
2007	I-temporal
]	O
00:00:00	B-temporal

Fluticasone	O
2	O
puffs	O
inhaled	B-route
twice	B-frequency
per	I-frequency
day	I-frequency
.	O

She	O
did	O
receive	O
intravenous	B-route
K	O
-	O
Phos	O
for	O
a	O
low	O
phosphorous	O
of	O
1	O
.	O
5	O
.	O

Report	O
Status	O
:	O

4	O
.	O

No	B-negation
murmurs	O
auscultated	O
.	O

WBC	O
-	O
5	B-labvalue
.	I-labvalue
6	I-labvalue
RBC	O
-	O
4	B-labvalue
.	I-labvalue
35	I-labvalue
*	I-labvalue
HGB	O
-	O
12	B-labvalue
.	I-labvalue
6	I-labvalue
*	I-labvalue
HCT	O
-	O
36	B-labvalue
.	I-labvalue
7	I-labvalue
*	I-labvalue
MCV	O
-	O
84	B-labvalue

Sulfa	O
(	O
Sulfonamides	O
)	O
/	O
Penicillins	O
/	O
Macrodantin	O
/	O
Ivp	O
Dye	O
,	O
Iodine	O
Containing	O

Sex	O
:	O

2/17/2000	B-temporal
12:00:00	B-temporal
AM	I-temporal

The	O
restraints	O
were	O
weaned	O
off	O
overnight	O
although	O
he	O
became	O
acutely	B-course
agitated	O
and	O
they	O
were	O
replaced	O
early	O
on	O
08	B-temporal
-	I-temporal
31	I-temporal
.	O

Tylenol	O
650	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q4	B-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
pain	O
.	O

Stable	O

Eddings	O
,	O
M	O
.	O
D	O
.	O

None	O
.	O

-	O
-	O
suspect	O
MID	O
that	O
worsens	B-course
after	O
no	B-negation
anticoag	O
for	O
weeks	B-duration
/	I-duration
months	I-duration
.	O

*	O
*	O
INSTITUTION	O

ACCOUNT	O
#	O
:	O

Attend	O
:	O

During	O
hospitalization	O
her	O
dialysis	O
catheter	O
was	O
removed	O
by	O
Dr	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
.	O

His	O
iron	O
was	O
123	B-labvalue
.	O

She	O
stated	O
that	O
she	O
was	O
feeling	O
better	O
.	O

*	O
*	O
INITIALS	O

ASSESSMENT	O
AND	O
PLAN	O
:	O

Please	O
continue	O
to	O
take	O
coumadin	O
as	O
directed	O
by	O
your	O
doctors	O
until	O
told	O
to	O
stop	O
for	O
clots	O
found	O
in	O
your	O
lungs	B-bodyloc
.	O

His	O
glycemic	O
control	O
has	O
been	O
adequate	O
.	O

Paxil	O
30	B-strength
mg	I-strength
qd	B-frequency

Weight	O
159	B-labvalue
.	I-labvalue
90	I-labvalue
lb	I-labvalue

HS	O
Job	O
#	O
158744	O
/	O
33103	O
/	O
38218	O

Weight	O
270	B-labvalue
.	I-labvalue
40	I-labvalue
lb	I-labvalue

No	B-negation
known	O
drug	O
allergies	O
.	O

She	O
was	O
given	O
prescription	O
for	O
pain	O
control	O
medicines	O
.	O

MIld	B-course
lt	O
atrial	B-bodyloc
enlarge	O
/	O
norm	O
lv	O
size	O
/	O
function	O
/	O
stress	O
induced	O
chest	B-bodyloc
pain	O
/	O
EF	O
55	B-labvalue
-	I-labvalue
60	I-labvalue
%	I-labvalue
.	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
27	I-temporal
2007	I-temporal
]	O
17:09:05	B-temporal

8	O
.	O
)	O
Atorvastatin	O
40	B-strength
mg	I-strength
daily	B-frequency

On	O
the	O
first	O
day	O
of	O
admission	O
,	O
her	O
blood	O
pressure	O
became	O
under	O
control	O
with	O
a	O
systolic	O
134	B-labvalue
/	I-labvalue
85	I-labvalue
.	O

Mg	O
1	B-labvalue
.	I-labvalue
6	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

Neck	O
:	O

BUN	O
6	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

LABORATORY	O
EXAMINATION	O
:	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

GI	B-bodyloc
bleeding	O
NOS	O
(	O
ICD9	O
578	O
.	O
9	O
,	O
Working	O
,	O
Problem	O
)	O

Chief	O
Complaint	O
:	O

PHYSICAL	O
EXAMINATION	O
:	O

By	O
report	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
awake	O
,	O
but	O
confused	O
at	O
the	O
scene	O
of	O
the	O
accident	O
with	O
no	O
memory	O
of	O
the	O
incident	O
.	O

pt	O
denied	O
inpt	O
auth	O
by	O
his	O
insurance	O
company	O
-	O
dr	O
to	O
dr	O
review	O
req	O
'	O
ed	O
pt	O
needs	O
at	O
least	O
1	O
-	O
2	O
days	O
in	O
pt	O
at	O
least	O

She	O
was	O
maintained	O
on	O
Bumex	O
,	O
but	O
developed	O
shortness	O
of	O
breath	O
and	O
was	O
transferred	O
to	O
*	O
*	O
STREET	O
-	O
ADDRESS	O
*	O
*	O
INSTITUTION	O
early	O
on	O
the	B-temporal
morning	I-temporal
of	O
*	O
*	O
DATE	O
[	O
Apr	B-temporal
19	I-temporal
2007	I-temporal
]	O
.	O

Male	O

R	O
:	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
23:31:43	B-temporal
/	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
07	I-temporal
08	I-temporal
]	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

R	O
:	O

1945-09-15	B-temporal

She	O
had	O
no	B-negation
significant	O
complaints	O
.	O

History	O
and	O
physical	O
exam	O
were	O
reviewed	O
.	O

History	O
of	O
Present	O
Illness	O

Fluid	O
glucose	O
was	O
98	B-labvalue
.	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

ADMISSION	O
DATE	O
:	O

NG	O
tube	O

If	O
you	O
experience	O
CP	O
,	O
SOB	O
,	O
dizzyness	O
,	O
or	O
any	O
other	O
symptoms	O
that	O
concern	O
you	O
please	O
call	O
your	O
PCP	O
or	O
return	O
to	O
the	O
ER	O
.	O

Total	O
Protein	O
6	B-labvalue
.	I-labvalue
3	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

HEART	O
:	O

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

His	O
non	O
-	O
essential	O
medications	O
that	O
may	O
have	O
been	O
contributing	O
to	O
his	O
change	O
in	O
mental	O
status	O
were	O
discontinued	O
;	O
those	O
included	O
Temocillin	O
,	O
Nortriptyline	O
,	O
Haldol	O
,	O
Lorazepam	O
,	O
Venlafaxine	O
,	O
Bupropion	O
,	O
and	O
Gabapentin	O
.	O

She	O
should	O
have	O
q	O
.	O

She	O
denies	B-negation
any	O
pain	O
or	O
discomfort	O
,	O
shortness	O
of	O
breath	O
.	O

EMG	O
nerve	O
conduction	O
studies	O
confirm	O
neuropathy	O
.	O

CORONARY	B-bodyloc
ARTERY	I-bodyloc
DISEASE	O
.	O

At	O
that	O
time	O
,	O
he	O
was	O
noted	O
to	O
have	O
massive	O
secretions	O
in	O
his	B-bodyloc
pharynx	I-bodyloc
.	O

Extended	O
Care	O

Left	B-bodyloc
midclavicular	I-bodyloc
fracture	O
managed	O
nonoperatively	O
.	O

21	B-temporal
:	I-temporal
48	I-temporal

HS	O
Job	O
#	O
788312	O
/	O
38142	O
/	O

She	O
was	O
without	O
the	O
ability	O
to	O
move	O
her	O
left	B-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
with	O
decreased	B-course
sensation	O
in	O
the	O
left	B-bodyloc
leg	I-bodyloc
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

He	O
had	O
been	O
at	O
home	O
drinking	O
fluids	O
trying	O
to	O
flush	O
his	O
system	O
.	O

ADMISSION	O
DATE	O
:	O

The	O
patient	O
also	O
was	O
started	O
on	O
her	O
Tenoretic	O
which	O
is	O
in	O
a	O
combination	O
of	O
atenolol	O
and	O
chlorthalidone	O
.	O

He	O
'	O
d	O
been	O
having	O
lower	B-bodyloc
abdominal	I-bodyloc
pain	O
for	O
approximately	O
the	B-temporal
past	I-temporal
week	I-temporal
,	O
a	O
symptom	O
for	O
which	O
he	O
'	O
s	O
been	O
admitted	O
in	O
the	O
past	O
.	O

Head	O
,	O
neck	O
:	O

the	O
right	O
inguinal	O
region	O
.	O

Thrombocytopenia	O
.	O

Dictator	O
:	O

Abdominal	O
CT	O
was	O
negative	B-labvalue
except	O
for	O
right	O
hydronephrosis	O
with	O
mild	B-severity
right	O
hydroureter	O
.	O

Chief	O
Complaint	O
:	O

8	O
.	O

ABS	O
Monocytes	O
0	B-labvalue
.	I-labvalue
3	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

CT	O
C	O
-	O
SPINE	O
W	O
/	O
O	O
CONTRAST	O

Reason	O
:	O
bleed	O
?	B-uncertain

Allergies	O
:	O

*	O
*	O
ID	O
-	O
NUM	O

Colonoscopy	O
.	O

At	O
this	O
point	O
,	O
the	B-bodyloc
left	I-bodyloc
ventricular	I-bodyloc
thrombus	O
(	O
for	O
which	O
she	O
was	O
initially	O
started	O
therapy	O
for	O
)	O
was	O
no	O
longer	O
present	O
.	O

ASA	O
-	O
NEG	B-labvalue
ETHANOL	O
-	O
NEG	B-labvalue
ACETMNPHN	O
-	O
NEG	B-labvalue
bnzodzpn	O
-	O
NEG	B-labvalue
barbitrt	O
-	O
NEG	B-labvalue
tricyclic	O
-	O
NEG	B-labvalue

Stable	O
condition	O
.	O

A	O
paraphimosis	O
was	O
noted	O
and	O
treated	O
by	O
Dr	O
.	O
Ryna	O
Jescdrig	O
.	O

History	O
of	O
Present	O
Illness	O

She	O
is	O
to	O
be	O
transferred	O
to	O
*	O
*	O
INSTITUTION	O
when	O
a	O
bed	O
is	O
available	O
.	O

Course	O

Minoxidil	O
10	B-strength
mg	I-strength
twice	B-frequency
a	I-frequency
day	I-frequency
.	O

Sex	O
:	O

Her	O
cardiovascular	O
was	O
regular	B-labvalue
rate	O
and	O
rhythm	O
.	O

DATE	O
OF	O
ADMISSION	O
:	O

Admission	O
Date	O
:	O

2	O
.	O

Teary	O
eye	B-bodyloc
,	O
crying	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

This	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
30s	O
]	O
-	O
year	O
-	O
old	O
male	O
who	O
presented	O
with	O
increased	B-course
abdominal	B-bodyloc
girth	O
associated	O
with	O
no	B-negation
shortness	O
of	O
breath	O
.	O

DISPOSITION	O
:	O

Nonoperative	O
treatment	O
was	O
elected	O
for	O
the	O
patient	O
'	O
s	O
left	B-bodyloc
clavicular	I-bodyloc
fracture	O
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
demonstrated	O
a	O
postoperative	O
hematocrit	O
of	O
40	B-labvalue
.	I-labvalue
9	I-labvalue
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
20	I-temporal
1928	I-temporal
]	O

Extremities	O
:	O

7	O
.	O

3	O
.	O

She	O
should	O
follow	O
up	O
with	O
the	O
results	O
as	O
an	O
outpatient	O
.	O

Glucose	O
90	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

At	O
their	O
request	O
,	O
a	O
CT	O
scan	O
of	O
the	O
chest	O
with	O
contrast	O
was	O
performed	O
on	O
the	O
day	O
of	O
discharge	O
.	O

BACK	O
:	O

Alprazolam	O
1	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
QID	B-frequency
(	O
4	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
.	O

ACCOUNT	O
#	O
:	O

12	O
.	O
)	O
Carafate	O
1	B-strength
gm	I-strength
bid	B-frequency

Extensive	O
carotid	B-bodyloc
arterial	I-bodyloc
calcifications	O
are	O
present	O
in	O
the	O
bulb	B-bodyloc
regions	I-bodyloc
bilaterally	I-bodyloc
.	O

I	O
believe	O
his	O
bleeding	O
is	O
minor	O
,	O
relative	O
to	O
his	O
procedure	O
.	O

*	O
*	O
INSTITUTION	O

D	O
/	O
C	O
Celebrex	O
today	B-temporal
,	O
due	O
to	O
Cr	O
.	O
up	O
to	O
2	B-labvalue
.	I-labvalue
1	I-labvalue

Nsaids	O
/	O
Anti	O
-	O
Inflammatory	O
Classifier	O
/	O
Vancomycin	O

PT	O
live	O
alon	O
at	O
home	O
has	O
a	O
male	O
partner	O
?	O
or	O
POA	O
.	O

DIAGNOSIS	O
ON	O
DISCHARGE	O
:	O

There	O
is	O
no	O
evidence	O
of	O
subarachnoid	B-bodyloc
hemorrhage	O
or	O
acute	B-course
major	O
vascular	O
territorial	O
infarction	O
.	O

Extremities	O
:	O
normal	O

*	O
*	O
CARBON	O
-	O
COPY	O

As	O
stated	O
above	O
,	O
the	O
patient	O
self	O
-	O
extubated	O
herself	O
.	O

3	O
.	O

Lungs	O
clear	O
.	O

1	O
.	O

No	B-negation
organisms	O
seen	O
.	O

Still	O
confused	O
,	O
sounds	O
a	O
lot	O
better	O
.	O

PT	O
-	O
15	B-labvalue
.	I-labvalue
0	I-labvalue
*	O
PTT	O
-	O
31	B-labvalue
.	I-labvalue
3	I-labvalue
INR	O
(	O
PT	O
)	O
-	O
1	B-labvalue
.	I-labvalue
5	I-labvalue

Temperature	O
of	O
37	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
pulse	O
80	B-labvalue
,	O
respirations	O
18	B-labvalue
,	O
and	O
blood	O
pressure	O
110	B-labvalue
/	I-labvalue
60	I-labvalue
.	O

proper	O
use	O
.	O

He	O
denies	B-negation
increased	B-course
urinary	O
frequent	O
or	O
urgency	O
.	O

1/23/1992	B-temporal
12:00:00	B-temporal
AM	I-temporal

ALTERED	O
MENTAL	O
STATUS	O
(	O
ICD9	O
780	O
.	O
97	O
,	O
Working	O
,	O
Problem	O
)	O

Point	O
tenderness	O
at	O
the	O
left	B-bodyloc
costovertebral	I-bodyloc
angle	O
.	O

5	O
.	O
)	O
LBBB	O

This	O
patient	O
had	O
a	O
chest	O
x	O
-	O
ray	O
during	O
the	O
hospitalization	O
that	O
showed	O
unilateral	O
pleural	B-bodyloc
effusion	O
.	O

Fever	O
,	O
f	O
/	O
u	O
infiltrte	O

Tamsulosin	O
0	B-strength
.	I-strength
4	I-strength
mg	I-strength
Capsule	B-form
,	I-form
Sust	I-form
.	I-form

Neuro	O
:	O
no	B-negation
asterixis	O
,	O
CN	O
II	O
-	O
XII	O
intact	O
,	O
5	O
/	O
5	O
strength	O
throughout	O
,	O
sensation	O
to	O
LT	O
intact	O
throughout	O
,	O
gait	O
deferred	O

1	O
.	O

Course	O

Hypertension	O
.	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Victoria	O
Williams	O
on	O
:	O
MON	O
2010-11-08	O
3	O
:	O
18	O
PM	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
12	I-temporal
2008	I-temporal
]	O
04:32:44	B-temporal
/	O
fp	O

RR	O
-	O
20	B-labvalue
.	O

General	O
:	O

Pertinent	O
Results	O
:	O

4	O
.	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O
,	O
D	O
.	O
O	O
.	O

Regular	B-labvalue
rhythm	O
.	O

GENERAL	O
MEDICINE	O

to	O
those	O
ten	O
days	O
for	O
a	O
total	O
of	O
14	O
days	O
postoperative	O
therapy	O
;	O
ferrous	O
sulfate	O
300	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
Lasix	O
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
a	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency
;	O
Humulin	O
insulin	O
sliding	B-form
scale	I-form
;	O
metformin	O
1000	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
sertraline	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
;	O
Tylenol	O
650	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
4	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
fever	O
greater	O
than	O
100	O
-	O
degrees	O
Fahrenheit	O
,	O
caution	O
not	O
to	O
exceed	O
total	O
Tylenol	O
dosage	O
of	O
4	B-dosage
grams	I-dosage
per	B-frequency
24	I-frequency
hours	I-frequency
when	O
combined	O
with	O
the	O
also	O
ordered	O
Vicodin	O
;	O
Vicodin	O
5	B-strength
/	I-strength
500	I-strength
one	B-dosage
to	O
two	B-dosage
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
4	I-frequency
to	I-frequency
6	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
pain	O
with	O
food	O
,	O
again	O
caution	O

1	O
.	O
)	O
Spironolactone	O
/	O
hctz	O
25	B-strength
/	I-strength
25	I-strength
daily	B-frequency

Coronary	B-bodyloc
artery	I-bodyloc
disease	O
;	O
3	B-bodyloc
-	I-bodyloc
vessel	I-bodyloc
disease	O
.	O

Resp	O
:	O

ALLERGIES	O
:	O

Notations	O
below	O
.	O

It	O
was	O
thought	O
to	O
be	O
possibly	O
due	O
to	O
worsening	B-course
multiple	O
myeloma	O
.	O

Evans	O
,	O
M	O
.	O
D	O
.	O

4373	O

Sucralfate	O
1	B-strength
g	I-strength
via	O
nasogastric	B-route
tube	I-route
q	B-frequency
.	I-frequency
6h	I-frequency
.	I-frequency

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

Respiratory	O
:	O

MCHC	O
34	B-labvalue
.	I-labvalue
7	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue

2009-03-27	B-temporal

Left	O
buttock	O
area	O
has	O
a	O
dressing	O
over	O
the	B-bodyloc
sacral	I-bodyloc
decubitus	O
ulcer	O
.	O

Folic	O
Acid	O
1	B-strength
mg	I-strength
Tablet	O
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Ext	O
:	O
no	B-negation
c	O
/	O
c	O
/	O
e	O
,	O
no	B-negation
edema	O

Temperature	O
Conversion	O
36	O
.	O
6	O
Deg	O
C	O

ABS	O
Lymphs	O
1	B-labvalue
.	I-labvalue
40	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

On	O
the	O
arrival	O
,	O
the	O
Critical	O
Care	O
Medicine	O
Service	O
found	O
the	O
patient	O
in	O
bradycardia	O
rhythm	O
.	O

SB	O
/	O
rms	O

1961-06-26	B-temporal

SECONDARY	O
DIAGNOSES	O
:	O

In	O
the	O
ER	O
,	O
her	O
labs	O
were	O
obtained	O
.	O

She	O
has	O
no	O
current	O
romantic	O
relationship	O
.	O

-	O
*	O
*	O
NAME	O
[	O
WWW	O
,	O
UUU	O
]	O
*	O
*	O
*	O

Chief	O
Complaint	O
:	O

*	O
*	O
INSTITUTION	O
Resident	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O

Mr	O
.	O
Robert	O
Mackey	O
is	O
a	O
49	O
year	O
old	O
gentleman	O
with	O
a	O
22	O
year	O
history	O
of	O
diabetes	O
mellitus	O
.	O

The	O
patient	O
'	O
s	O
electrolytes	O
sere	O
managed	O
daily	O
and	O
repleted	O
on	O
an	O
as	O
needed	O
basis	O
.	O

So	O
,	O
an	O
epidural	O
catheter	O
was	O
placed	O
on	O
07/23/99	B-temporal
.	O

2	O
.	O

You	O
must	O
continue	O
to	O
wear	O
your	O
cervical	O
collar	O
for	O
the	O
next	O
4	B-temporal
weeks	I-temporal
(	O
through	O
12	B-temporal
-	I-temporal
11	I-temporal
)	O
.	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
25	I-temporal
2007	I-temporal
]	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
9:28:00	B-temporal

Dictator	O
:	O

XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

2	O
.	O

THERE	O
HAS	O
BEEN	O
A	O
FURTHER	O
REDUCTION	O
IN	O
SYSTOLIC	O
FUNCTION	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

Sensation	O
was	O
intact	O
in	O
the	O
median	O
,	O
radius	O
,	O
and	O
ulnar	O
-	O
nerve	O
distributions	O
.	O

Rosemary	O
D	O
Mccluskey	O
,	O
M	O
.	O
D	O
.	O
39	O
-	O
696	O

She	O
seems	O
to	O
have	O
just	O
some	O
very	O
mild	B-severity
proximal	B-bodyloc
muscle	I-bodyloc
weakness	O
on	O
her	B-bodyloc
upper	I-bodyloc
and	I-bodyloc
lower	I-bodyloc
extremities	I-bodyloc
,	O
but	O
there	O
was	O
no	B-negation
distal	B-bodyloc
extremity	I-bodyloc
weakness	O
,	O
and	O
she	O
had	O
some	O
mild	B-severity
numbness	O
in	O
her	B-bodyloc
feet	I-bodyloc
bilaterally	I-bodyloc
and	O
on	O
the	O
lateral	O
aspect	O
of	O
her	O
left	O
leg	O
to	O
light	O
touch	O
.	O

Her	O
pulmonary	O
:	O

NECK	O
:	O

Body	O
fluid	O
culture	O
showed	O
few	B-labvalue
WBCs	I-labvalue
on	O
Gram	O
-	O
stain	O
.	O

Lupron	O
x	O
three	B-duration
months	I-duration
prior	O
to	O
embolization	O
.	O

3	O
.	O

Warm	O
to	O
touch	O
,	O
no	B-negation
clubbing	O
,	O
cyanosis	O
,	O
or	O
edema	O
.	O

Iron	O
sulfate	O
325	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Bili	O
,	O
Total	O
4	B-labvalue
.	I-labvalue
3	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
High	B-labvalue

The	O
headache	O
was	O
rated	O
as	O
*	O
*	O
DATE	O
[	O
Dec	B-temporal
10	I-temporal
]	O
with	O
radiation	O
to	O
her	O
right	B-bodyloc
neck	I-bodyloc
and	O
right	B-bodyloc
nuchal	I-bodyloc
area	I-bodyloc
.	O

4	O
.	O

2	O
.	O

Heart	O
:	O
heart	O
sounds	O
:	O

B	O
/	O
L	O
LE	O
LENIs	O
-	O
negative	B-labvalue

S1	O
:	O
normal	B-labvalue
,	O
S2	O
:	O
normal	B-labvalue
.	O

2	O
.	O

Platelets	O
162	B-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

REASON	O
FOR	O
ADMISSION	O
:	O

Discharge	O
Summary	O

On	O
admission	O
,	O
the	O
patient	O
was	O
diagnosed	O
with	O
acute	B-course
pancreatitis	O
.	O

01/23/1992	B-temporal

Her	O
UA	O
did	O
not	B-negation
show	O
any	O
signs	O
of	O
infection	O
.	O

Follow	O
up	O
with	O
:	O

*	O
*	O
DATE	O
[	O
May	B-temporal
01	I-temporal
07	I-temporal
]	O

ALLERGIES	O
:	O

BP	O
is	O
not	O
optimal	O
controlled	O
.	O

Ramipril	O
1	B-strength
.	I-strength
25	I-strength
mg	I-strength
Capsule	B-form
Sig	O
:	O
Two	B-dosage
(	I-dosage
2	I-dosage
)	I-dosage
Capsule	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Although	O
she	O
had	O
a	O
good	O
response	O
to	O
diuretic	O
therapy	O
it	O
was	O
felt	O
that	O
she	O
would	O
require	O
one	O
more	O
dialysis	O
session	O
to	O
try	O
to	O
pull	O
off	O
fluid	O
from	O
the	O
lungs	B-bodyloc
and	O
allow	O
her	O
to	O
breath	O
more	O
comfortably	O
.	O

Discharge	O
Summary	O

Anemia	O
is	O
likely	O
of	O
chronic	B-course
disease	O
.	O

*	O
*	O
DATE	O
[	O
May	B-temporal
02	I-temporal
2007	I-temporal
]	O
01:02:07	B-temporal

JOB	O
#	O
:	O

Glucose	O
171	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
High	B-labvalue

Afebrile	O
.	O

4	O
Fentanyl	O
patch	O
50	B-strength
mcg	I-strength
every	B-frequency
72	I-frequency
hours	I-frequency
.	O

He	O
has	O
a	O
family	O
history	O
of	O
hypertension	O
as	O
well	O
.	O

Lopressor	O
25	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

1	O
.	O

1	O
.	O

Anion	O
Gap	O
5	B-labvalue
.	I-labvalue
0	I-labvalue
Low	B-labvalue

No	B-negation
audible	O
extra	O
heart	B-bodyloc
sounds	O
.	O

The	O
patient	O
was	O
reportedly	O
alert	O
at	O
scene	O
,	O
and	O
then	O
became	O
unresponsive	O
in	O
route	O
to	O
the	O
hospital	O
.	O

Name	O
:	O

-	O
The	O
patient	O
underwent	O
a	O
flex	O
sigmoidoscopy	O
on	O
Friday	B-temporal
,	O
11	B-temporal
-	I-temporal
02	I-temporal
,	O
which	O
showed	O
old	O
blood	O
in	O
the	O
rectal	B-bodyloc
vault	O
but	O
no	B-negation
active	O
source	O
of	O
bleeding	O
.	O

The	O
patient	O
was	O
recently	O
admitted	O
to	O
*	O
*	O
INSTITUTION	O
for	O
CHF	O
.	O

Endo	O
-	O
DM	O
-	O
Patient	O
on	O
Prandin	O
.	O

Protonix	O
40	B-strength
mg	I-strength
daily	B-frequency

1	O
.	O
)	O
DM	O
-	O
2	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

3rd	O
floor	O
Henderson	O
Building	O
with	O
Dr	O
.	O
Black	O
(	O
650	O
)	O
866	O
-	O
1361	O

His	O
INR	O
is	O
2	B-labvalue
.	I-labvalue
2	I-labvalue
and	O
he	O
is	O
to	O
remain	O
in	O
the	O
therapeutic	O
range	O
.	O

Senna	O
8	B-strength
.	I-strength
6	I-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
BID	B-frequency
(	O
2	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
.	O

TSH	O
was	O
within	B-labvalue
normal	I-labvalue
limits	I-labvalue
as	O
was	O
B12	O
and	O
folate	O
.	O

*	O
*	O
NAME	O
[	O
SSS	O
RRR	O
]	O
,	O
D	O
.	O
O	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
12:19:00	B-temporal

Right	O
coronary	O
artery	O
stent	O
in	O
2008	B-temporal
;	O
ejection	O
fraction	O
60	B-labvalue
to	I-labvalue
65	I-labvalue
%	I-labvalue
.	O

Sodium	O
140	B-labvalue
,	O
potassium	O
4	B-labvalue
.	I-labvalue
0	I-labvalue
,	O
chloride	O
104	B-labvalue
,	O
CO2	O
28	B-labvalue
,	O
BUN	O
14	B-labvalue
,	O
creatinine	O
1	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
glucose	O
243	B-labvalue
.	O

Course	O

Given	O
the	O
patient	O
'	O
s	O
recent	O
RP	O
bleed	O
,	O
there	O
was	O
concern	O
for	O
a	O
recurrent	B-course
bleed	O
.	O

It	O
was	O
soft	O
and	O
nontender	O
.	O

3	O
.	O

R	O
:	O

MPV	O
6	B-labvalue
.	I-labvalue
5	I-labvalue
fL	I-labvalue
Low	B-labvalue

CT	O
HEAD	O
W	O
/	O
O	O
CONTRAST	O

CTA	O
-	O
B	O
.	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
Richard	O
,	O
Kevin	O
Robinson	O
(	O
771	O
)	O
937	O
-	O
5400	O
upon	O
discharge	O
.	O

The	O
patient	O
became	O
agitated	O
with	O
both	O
tent	O
and	O
Bi	O
-	O
PAP	O
machine	O
,	O
although	O
continued	O
to	O
saturate	O
well	O
.	O

SERVICE	O
:	O

This	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
30s	O
]	O
-	O
year	O
-	O
old	O
female	O
patient	O
with	O
history	O
of	O
paraplegia	O
secondary	O
to	O
a	O
motor	O
vehicle	O
accident	O
and	O
multiple	O
exploratory	O
laparotomies	O
for	O
small	O
bowel	B-bodyloc
perforation	O
in	O
the	B-temporal
past	I-temporal
.	O

-	O
Thomas	O
D	O
.	O
*	O
*	O
*	O

SHY	O
#	O
*	O
*	O
ID	O
-	O
NUM	O

4	O
.	O

Darbepoetin	O
alfa	O
100	B-strength
mcg	I-strength
subcu	B-route
weekly	B-frequency
.	O

Sign	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
L	O

If	O
pt	O
has	O
recurrence	O
of	O
SVT	O
-	O
may	O
be	O
amenable	O
to	O
ablation	O
?	O

Neurological	O
:	O

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

cipro	O
and	O
Pepcid	O
have	O
been	O
off	O
4	O
days	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
26	I-temporal
2007	I-temporal
]	O
09:05:44	B-temporal
AM	I-temporal

IMPRESSION	O
:	O

.	O
.	O

4	O
.	O

Pleasant	O
SWM	O
in	O
NAD	O
.	O

PhosLo	O
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Zithropren	O
50	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
day	I-frequency
.	O

There	O
was	O
swelling	O
of	O
the	O
body	B-bodyloc
and	I-bodyloc
tail	I-bodyloc
of	I-bodyloc
the	I-bodyloc
pancreas	I-bodyloc
.	O

4	O
.	O

T	O
:	O

Methylphenidate	O
10	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
Two	B-dosage
(	I-dosage
2	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

There	O
were	O
no	B-negation
complications	O
associated	O
with	O
the	O
procedure	O
.	O

Plan	O

She	O
presented	O
to	O
Charlton	O
Memorial	O
Hospital	O
Hospital	O
Emergency	O
Department	O
with	O
inferior	O
ST	O
elevations	O
;	O
at	O
which	O
time	O
she	O
became	O
acutely	B-bodyloc
hypotensive	O
to	O
a	O
systolic	O
blood	O
pressure	O
of	O
70	B-labvalue
to	I-labvalue
80	I-labvalue
after	O
receiving	O
one	B-dosage
ublingual	B-route
nitroglycerin	O
.	O

Portal	O
Hypertension	O
-	O
continue	O
Nadolol	O

ADMISSION	O
DIAGNOSIS	O
:	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
11:00:00	B-temporal

2	O
.	O

023928	O

Tenoretic	O
100	B-strength
/	I-strength
25	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

Normal	O
Saline	O
Flush	O
(	O
SODIUM	O
CHLORIDE	O
0	B-strength
.	I-strength
9	I-strength
%	I-strength
FLUSH	B-form
10	B-dosage
ML	I-dosage
SYR	O
)	O
,	O
3	B-dosage
mL	I-dosage
,	O
Solution	B-form
,	O
IV	B-route
,	O
Q8H	B-frequency
,	O
Routine	O
,	O

Neller	O
,	O
M	O
.	O
D	O
.	O

Pulm	B-bodyloc
-	O
COPD	O
:	O

ATTENDING	O
PHYSICIAN	O
:	O

GI	O
-	O
.	O

Monocytes	O
4	B-labvalue
%	I-labvalue

HS	O
Job	O
#	O
757448	O
/	O
38640	O
/	O
33455	O

-	O
*	O
*	O
NAME	O
[	O
WWW	O
,	O
QQQ	O
]	O
*	O
*	O
*	O

Neurontin	O
600	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

EVALUATION	O
DATE	O
:	O

On	O
discharge	O
included	O
tetracycline	O
,	O
250	B-strength
mg	I-strength
po	B-route
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
cyclosporin	O
,	O
325	B-strength
mg	I-strength
po	B-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
prednisone	O
,	O
30	B-strength
mg	I-strength
po	B-route
q	B-frequency
day	I-frequency
;	O
Bactrim	O
DS	O
,	O
one	B-dosage
po	B-route
q	B-frequency
.	I-frequency
o	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
diltiazem	O
,	O
30	B-strength
mg	I-strength
po	B-route
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
Mycostatin	O
,	O
15	B-dosage
cc	I-dosage
swish	B-route
and	I-route
swallow	I-route
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
Lasix	O
,	O
40	B-strength
mg	I-strength
po	B-route
q	B-frequency
day	I-frequency
;	O
Colace	O
,	O
100	B-strength
mg	I-strength
po	B-route
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
Carafate	O
,	O
1	B-strength
gram	I-strength
po	B-route
q	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
Imuran	O
,	O
50	B-strength
mg	I-strength
po	B-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
NPH	O
insulin	O
,	O
44	B-dosage
units	I-dosage
and	I-dosage
10	I-dosage
units	I-dosage
of	O
regular	O
q	B-frequency
a	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency
;	O
NPH	O
,	O
22	B-dosage
units	I-dosage
and	I-dosage
8	I-dosage
units	I-dosage
of	O
regular	O
q	B-frequency
p	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency

Percocet	O
5	B-strength
/	I-strength
325	I-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
6h	I-frequency
.	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
severe	O
pain	O
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
started	O
on	O
Wellbutrin	O
for	O
smoking	O
cessation	O
.	O

The	O
hypotension	O
was	O
likely	O
due	O
to	O
volume	O
depletion	O
caused	O
by	O
her	O
diarrhea	O
/	O
loose	O
stools	O
in	O
addition	O
to	O
decreased	O
PO	O
intake	O
secondary	O
to	O
her	O
GERD	O
and	O
thrush	O
.	O

Will	O
follow	O
his	O
K	O
+	O
levels	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

R	O
:	O

elevate	O
R	O
hand	O
and	O
celebrex	O
200	B-strength
mg	I-strength
daily	B-frequency
.	O

Failed	O
swallow	O
study	O
x	O
2	O
in	O
early	B-temporal
November	I-temporal
.	O

2	O
.	O

Admission	O
Date	O
:	O

He	O
denies	B-negation
nausea	O
and	O
vomiting	O
.	O

HS	O
Job	O
#	O
152958	O
/	O
38997	O
/	O

02/27/92	B-temporal

nicotine	O
(	O
NICOTINE	O
21	B-strength
MG	I-strength
PATCH	B-form
)	O
,	O
21	B-strength
mg	I-strength
,	O
Film	O
,	O
extended	B-form
release	I-form
,	O
Topically	B-route
,	O
Daily	B-frequency
,	O
Routine	O
,	O

I	O
am	O
seeing	O
him	O
for	O
management	O
of	O
these	O
issues	O
.	O

CONJUNCTIVITIS	O
,	O
UNSPECIFIED	O
(	O
ICD9	O
372	O
.	O
30	O
,	O
Working	O
,	O
Problem	O
)	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
30	I-temporal
2007	I-temporal
]	O
14	B-temporal
:	I-temporal
15	I-temporal

Credentials	O
and	O
Title	O
of	O
Author	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
Signing	O
this	O
Document	O
:	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
did	O
not	O
complain	O
of	O
any	O
significantly	O
new	O
shortness	O
of	O
breath	O
.	O

Phillips	O
,	O
M	O
.	O
D	O
.	O

The	O
patient	O
was	O
started	O
on	O
Zosyn	O
and	O
vancomycin	O
.	O

She	O
is	O
on	O
oral	B-route
antibiotics	O
and	O
denies	B-negation
any	O
symptoms	O
.	O

CRITICAL	O
CARE	O
MEDICINE	O

The	O
pain	O
was	O
subsequently	O
relieved	B-course
with	O
high	O
dose	O
Dilaudid	O
.	O

bilateral	O
cardiac	O
catheterization	O
.	O

Results	O
Review	O

The	O
patient	O
was	O
continued	O
on	O
aspirin	O
,	O
Plavix	O
,	O
and	O
statin	O
.	O

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

DISCHARGE	O
DATE	O
:	O

Name	O
:	O

He	O
was	O
also	O
noted	O
to	O
have	O
a	O
questionable	O
right	B-bodyloc
lower	I-bodyloc
lobe	I-bodyloc
infiltrate	O
and	O
chest	O
x	O
-	O
ray	O
.	O

CC	O
:	O

PATIENT	O
NAME	O
:	O

CONSULTS	O
:	O

1	O
.	O

PT	O
-	O
20	B-labvalue
.	I-labvalue
5	I-labvalue
*	I-labvalue
PTT	O
-	O
29	B-labvalue
.	I-labvalue
4	I-labvalue
INR	O
(	O
PT	O
)	O
-	O
3	B-labvalue
.	I-labvalue
0	I-labvalue

8	O
.	O

The	O
patient	O
currently	O
lives	O
in	O
Son	O
Wooda	O
with	O
his	O
wife	O
.	O

-	O
Check	O
Echo	O
:	O

5	O
.	O

If	O
her	O
temporary	O
biopsy	O
is	O
negative	B-labvalue
and	O
her	O
EMG	O
is	O
positive	B-labvalue
,	O
then	O
we	O
would	O
biopsy	O
her	O
leg	O
;	O
and	O
if	O
that	O
is	O
negative	O
,	O
then	O
consider	O
bone	O
marrow	O
biopsy	O
.	O

Spironolactone	O
25	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Reason	O
:	O
72	O
male	O
s	O
/	O
p	O
fall	O
down	O
20	O
stairs	O

*	O
*	O
INSTITUTION	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
27	I-temporal
07	I-temporal
]	O

PHYSICAL	O
EXAMINATION	O
:	O

Fluticasone	O
110	B-strength
mcg	I-strength
/	O
Actuation	B-form
Aerosol	I-form
Sig	O
:	O
Two	B-dosage
(	I-dosage
2	I-dosage
)	I-dosage
Puff	O
Inhalation	B-route
BID	B-frequency
(	O
2	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
.	O

Left	O
prosthetic	O
CMED	O
CCU	O
.	O

CRITICAL	O
CARE	O
TIME	O
30	O
MINUTES	O
.	O

9	O
.	O

*	O
*	O
AGE	O
[	O
in	O
70s	O
]	O
y	O
/	O
o	O
male	O
with	O
pmh	O
of	O
CAD	O
,	O
s	O
/	O
p	O
MI	O
,	O
HTN	O
,	O
COPD	O
and	O
pneumonia	O
.	O

R	O
:	O

71	O
y	O
/	O
o	O
male	O
with	O
dm2	O
,	O
cad	O
,	O
chf	O
,	O
uc	O
presents	O
with	O
one	B-temporal
week	I-temporal
of	O
lower	B-bodyloc
abdominal	I-bodyloc
pain	O
and	O
2	O
episodes	O
of	O
brpbr	O
on	O
the	O
day	O
of	O
admission	O
.	O

MEDQUIST36	O

*	O
*	O
INSTITUTION	O

12	O
.	O

Female	O

Course	O

General	O
Plan	O

Name	O
:	O

Multiple	O
left	B-bodyloc
-	I-bodyloc
sided	I-bodyloc
rib	I-bodyloc
fractures	O
are	O
seen	O
.	O

Heart	O

SERVICE	O
OF	O
:	O

Discharge	O
Instructions	O
:	O

Tylenol	O
provided	O
no	O
relief	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
02	I-temporal
2007	I-temporal
]	O
/	O
8	B-temporal
:	I-temporal
19	I-temporal
A	I-temporal

8	O
.	O

Disp	O
:	O
*	O
30	O
Cap	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
2	O
*	O

Shirley	O
H	O
.	O
Q	O
.	O

Sex	O
:	O

7	O
.	O
)	O
Flomax	O

1	O
.	O

Please	O
consider	O
my	O
note	O
linked	O
to	O
his	O
note	O
.	O

It	O
was	O
thought	O
that	O
it	O
was	O
not	O
likely	O
related	O
to	O
TTP	O
.	O

Lamotrigine	O
100	B-strength
mg	I-strength
Tablet	O
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
BID	B-frequency
(	O
2	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
.	O

NOTE	O
:	O
This	O
study	O
was	O
initially	O
performed	O
on	O
2014-10-21	B-temporal
.	O

Neuro	O
:	O

060514276	O
SC	O

BUN	O
7	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

CT	O
HEAD	O
W	O
/	O
O	O
CONTRAST	O

Signed	O
electronically	O
by	O
:	O
DR	O
.	O
Felix	O
Garcia	O
on	O
:	O
FRI	O
2012-06-15	B-temporal
4	B-temporal
:	I-temporal
29	I-temporal
PM	I-temporal

Her	O
stool	O
on	O
Hemoccult	O
was	O
found	O
to	O
be	O
negative	B-labvalue
.	O

In	O
the	O
office	O
of	O
*	O
*	O
NAME	O
[	O
RRR	O
M	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

s	O
/	O
p	O
Fall	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
13	I-temporal
2007	I-temporal
]	O
07:00:11	B-temporal
/	I-temporal
gn	I-temporal

AST	O
/	O
SGOT	O
167	B-labvalue
IntUnit	I-labvalue
/	I-labvalue
L	I-labvalue
High	B-labvalue

He	O
had	O
been	O
on	O
respiratory	O
support	O
for	O
that	O
.	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
13	I-temporal
2007	I-temporal
]	O

1	O
Intestinal	B-bodyloc
obstruction	O
.	O

It	O
was	O
not	O
felt	O
to	O
be	O
postobstructive	O
and	O
not	O
prerenal	O
but	O
somehow	O
related	O
to	O
her	O
multiple	O
myeloma	O
.	O

Wellbutrin	O
100	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
day	I-frequency
.	I-frequency

Followup	O
Instructions	O
:	O

She	O
had	O
lab	O
work	O
yesterday	B-temporal
morning	B-temporal
that	O
showed	O
a	O
sodium	O
of	O
138	B-labvalue
,	O
potassium	O
3	B-labvalue
.	I-labvalue
8	I-labvalue
,	O
chloride	O
103	B-labvalue
,	O
bicarbonate	O
20	B-labvalue
,	O
BUN	O
and	O
creatinine	O
10	B-labvalue
and	O
1	B-labvalue
.	I-labvalue
6	I-labvalue
,	O
calcium	O
8	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
magnesium	O
1	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
phosphorus	O
3	B-labvalue
.	I-labvalue
9	I-labvalue
,	O
total	O
bilirubin	O
0	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
ALT	O
47	B-labvalue
,	O
AST	O
33	B-labvalue
,	O
alkaline	O
phosphatase	O
128	B-labvalue
,	O
lactate	O
1	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
amylase	O
less	B-labvalue
than	I-labvalue
30	I-labvalue
,	O
and	O
lipase	O
21	B-labvalue
.	O

She	O
smokes	O
approximately	O
one	O
and	O
a	O
half	O
packs	O
of	O
cigarettes	O
per	O
day	O
for	O
the	O
last	O
30	O
years	O
.	O

Laboratory	O
tests	O
were	O
reviewed	O
.	O

MCV	O
87	B-labvalue
.	I-labvalue
4	I-labvalue
fL	I-labvalue

Dictator	O
:	O

None	O
.	O

A	O
CT	O
scan	O
of	O
the	O
head	O
showed	O
microvascular	O
ischemic	O
changes	O
.	O

Perform	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
R	O

Moxifloxacin	O
400	B-strength
mg	I-strength
by	B-route
mouth	I-route
daily	B-frequency
for	O
5	B-duration
more	I-duration
days	I-duration
.	O

Summary	O
of	O
Hospitalization	O
:	O

DM	O
?	B-uncertain
Arthritis	O

Discharge	O
Instructions	O
:	O

He	O
had	O
dressing	O
changes	O
twice	O
a	O
day	O
.	O

I	O
discussed	O
disposition	O
with	O
patient	O
who	O
says	O
she	O
would	O
need	O
at	O
least	O
1	O
-	O
1	O
.	O
5	O
days	O
to	O
prepare	O
her	O
home	O
for	O
d	O
/	O
c	O
.	O

Follow	O
up	O
with	O
Trauma	O
in	O
3	O
-	O
4	O
weeks	O
after	O
your	O
discharge	O
.	O

D	O
:	O

Noncontributory	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

*	O
*	O
NAME	O
[	O
ZZZ	O
YYY	O
XXX	O
]	O

5	O
.	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
02	I-temporal
2007	I-temporal
]	O

6	O
.	O

Soreness	O
at	O
his	O
operative	O
sites	O
,	O
for	O
which	O
he	O
was	O
given	O
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency

Intramuscular	B-route
as	O
well	O
as	O
intravenous	B-route
Haldol	O
were	O
ordered	O
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
emergency	O
use	O
should	O
he	O
become	O
acutely	B-course
agitated	O
.	O

Lives	O
with	O
wife	O
;	O
+	O
ETOH	O
use	O

INR	O
/	O
PT	O
/	O
BMP	O
weekly	O
via	O
home	O
care	O
,	O
oxygen	O
at	O
home	O
care	O
.	O

Likewise	O
,	O
on	O
04	B-temporal
-	I-temporal
01	I-temporal
,	O
the	O
patient	O
was	O
weaned	O
off	O
surgery	O
without	O
difficulty	O
.	O

Denies	O
use	O
of	O
AA	O
/	O
NA	O
.	O

ICU	O
prophylaxis	O
:	O

+	B-labvalue
BS	O
,	O
nondistended	O
,	O
nontender	O
.	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

Admission	O
Date	O
:	O

3	O
.	O

#	O
h	O
/	O
o	O
DVT	O
/	O
PE	O
:	O

His	O
hepatitis	O
panel	O
was	O
nonreactive	B-labvalue
.	O

RBC	O
4	B-labvalue
.	I-labvalue
19	I-labvalue
X10E	I-labvalue
+	I-labvalue
12	I-labvalue
/	I-labvalue
L	I-labvalue
Low	B-labvalue

Lashonda	O
Christopher	O
MD	O
48	O
-	O
669	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
13	I-temporal
2007	I-temporal
]	O
07:00:11	B-temporal

7	O
.	O

LITHIUM	O
-	O
LESS	B-labvalue
THAN	I-labvalue

5	O
.	O

Dr	O
.	O
*	O
*	O
NAME	O
[	O
VVV	O
]	O
was	O
also	O
there	O
&	O
amp	O
;	O
he	O
agreed	O
with	O
the	O
above	O
management	O
.	O

Na	O
134	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

2	O
.	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

:	O

History	O
of	O
multiple	O
urinary	B-bodyloc
tract	I-bodyloc
infections	O
.	O

THE	O
LEFT	B-bodyloc
VENTRICLE	I-bodyloc
IS	O
DILATED	O
WITH	O
GLOBAL	O
HYPOKINESIS	O
WITH	O
A	O
RESIDUAL	O
EJECTION	O
FRACTION	O
OF	O
25	B-labvalue
-	I-labvalue
30	I-labvalue
%	I-labvalue
.	O

1	O
.	O

-	O
Hold	O
Metformin	O
due	O
to	O
MS	O
unstable	O
and	O
renal	O
function	O
not	B-labvalue
optimal	I-labvalue
.	O

Has	O
BM	O
daily	O
.	O

Systolic	O
BP	O
107	B-labvalue
mmHg	I-labvalue

His	O
blood	O
cultures	O
no	B-labvalue
growth	I-labvalue
x	O
2	B-temporal
days	I-temporal
and	O
urine	O
cultures	O
no	B-labvalue
growth	I-labvalue
x	O
2	B-temporal
days	I-temporal
and	O
this	O
is	O
the	O
final	O
report	O
.	O

BLOOD	O
-	O
NEG	B-labvalue
NITRITE	O
-	O
NEG	B-labvalue
PROTEIN	O
-	O
NEG	B-labvalue
GLUCOSE	O
-	O
NEG	B-labvalue
KETONE	O
-	O
TR	B-labvalue
BILIRUBIN	O
-	O
NEG	B-labvalue
UROBILNGN	O
-	O
NEG	B-labvalue
PH	O
-	O
6	B-labvalue
.	I-labvalue
5	I-labvalue
LEUK	O
-	O
NEG	B-labvalue

2	O
.	O

3	O
.	O

02/03/1992	B-temporal

Positive	B-labvalue
bowel	O
sounds	O
.	O

Pioglitazone	O
15	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Tablet	B-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
as	B-frequency
needed	I-frequency
for	O
DM	O
.	O

FOLLOWUP	O
:	O

Job	O
#	O
:	O

lactulose	O
,	O
20	B-strength
gm	I-strength
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Drug	O
Form	O
:	O
Syrup	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
4:00:00	B-temporal

coronary	O
artery	O
bypass	O
grafting	O
x	O
3	O
.	O

Prilosec	O
20	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
day	I-frequency
.	O

As	O
volume	O
depletion	O
was	O
thought	O
to	O
be	O
the	O
cause	O
of	O
her	O
low	O
BP	O
,	O
only	O
the	O
BBlocker	O
was	O
restarted	O
.	O

The	O
patient	O
described	O
the	O
pain	O
as	O
&	O
quot	O
;	O
knife	O
-	O
like	O
&	O
quot	O
;	O
with	O
a	O
severity	O
of	O
1	B-temporal
/	I-temporal
25	I-temporal
at	O
its	O
worse	B-severity
.	O

There	O
is	O
no	B-negation
evidence	O
of	O
right	O
pleural	O
effusion	O
or	O
right	O
pneumothorax	O
.	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
11	I-temporal
2008	I-temporal
]	O
18:31:10	B-temporal

Dispo	O
-	O
recommend	O
an	O
alcohol	O
rehab	O
treatment	O
program	O
upon	O
discharge	O
.	O

Dict	O
:	O

Spironolactone	O
100	B-strength
mg	I-strength
p	B-frequency
.	I-frequency
o	I-frequency
.	I-frequency
daily	I-frequency
.	O

The	O
patient	O
'	O
s	O
blood	O
pressure	O
was	O
within	O
normal	O
limits	O
,	O
and	O
she	O
was	O
hemodynamically	O
stable	O
.	O

No	B-negation
sign	O
or	O
indication	O
of	O
wound	O
infection	O
.	O

No	B-negation
history	O
of	O
abnormal	O
Pap	O
smears	O
.	O

The	O
patient	O
does	O
not	O
have	O
his	O
driver	O
'	O
s	O
license	O
currently	O
.	O

Dictated	O
By	O
:	O
Barbara	O
B	O
.	O

Concur	O
with	O
assessment	O
and	O
plan	O
.	O

1	O
.	O

Ca	O
7	B-labvalue
.	I-labvalue
6	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

*	O
*	O
DATE	O
[	O
Jul	B-temporal
16	I-temporal
2007	I-temporal
]	O

Phone	O
:	O
(	O
967	O
)	O
675	O
1641	O
Date	O
/	O
Time	O
:	O
2012-12-28	B-temporal
2	B-temporal
:	I-temporal
30	I-temporal

2014-10-21	B-temporal
09	B-temporal
:	I-temporal
35	I-temporal
AM	I-temporal

Abd	O
:	O
normal	B-labvalue
size	O
,	O
nd	O
,	O
no	B-negation
scars	O
,	O
nl	B-labvalue
bs	O
,	O
soft	O
,	O
nt	O
,	O
palp	O
liver	O

MEDICATIONS	O
:	O

Cranial	O
nerves	O

2	O
.	O

Vital	O
signs	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

While	O
on	O
the	O
floor	O
patient	O
'	O
s	O
urinalysis	O
suggestive	O
of	O
UTI	O
and	O
was	O
put	O
on	O
6	B-duration
day	I-duration
course	O
of	O
levofloxacin	O
.	O

The	O
patient	O
should	O
be	O
able	O
to	O
be	O
discharged	O
to	O
home	O
today	B-temporal
with	O
a	O
Foley	O
in	O
place	O
to	O
continue	O
on	O
present	O
therapy	O
with	O
anticoagulation	O
and	O
fluconazole	O
.	O

1	O
.	O

9	O
.	O

378736	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

She	O
was	O
discharged	O
to	O
home	O
on	O
hospital	O
day	O
number	O
eight	O
,	O
on	O
oral	B-route
antibiotics	O
.	O

Quality	O
Measures	O

Hypertension	O
.	O

Sedated	O
,	O
DTRs	O
:	O

VERIFY	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
M	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
19	I-temporal
2007	I-temporal
]	O
10	B-temporal
:	I-temporal
00	I-temporal
)	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

I	O
do	O
not	O
feel	O
that	O
this	O
is	O
of	O
any	O
implication	O
.	O

*	O
*	O
CARBON	O
-	O
COPY	O

COMPARISON	O
:	O
None	O
.	O

The	O
patient	O
had	O
a	O
spinal	O
cord	O
stimulator	O
placed	O
on	O
07/21/99	B-temporal
.	O

She	O
received	O
an	O
amiodarone	O
bolus	O
of	O
150	B-strength
mg	I-strength
intravenously	B-route
and	O
was	O
continued	O
on	O
an	O
amiodarone	O
drip	B-route
while	O
CMED	O
CSRU	O
-	O
flighted	O
to	O
Boston	O
Regional	O
Medical	O
Centerr	O
where	O
she	O
underwent	O
a	O
catheterization	O
.	O

The	O
patient	O
should	O
follow	O
up	O
with	O
her	O
PCP	O
in	O
2	O
weeks	O
and	O
have	O
a	O
stress	O
test	O
as	O
an	O
outpatient	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
as	O
well	O
as	O
follow	O
up	O
for	O
some	O
oral	B-bodyloc
lesions	O
which	O
she	O
complained	O
of	O
while	O
in	O
the	O
hospital	O
.	O

Lymphs	O
30	B-labvalue
%	I-labvalue

She	O
has	O
not	O
been	O
out	O
of	O
bed	O
since	O
admission	O
and	O
we	O
will	O
get	O
PT	O
/	O
OT	O
to	O
evaluate	O
her	O
home	O
safety	O
.	O

Regular	O
10	O
units	O
intravenously	O
q	O
.	O
6h	O
.	O
as	O
needed	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

CMED	O
:	O
A	O
+	O
Ox3	O
,	O
mood	O
"	O
great	O
,	O
"	O
affect	O
approp	O
,	O
speech	O
stuttering	O
,	O
linear	O
TP	O
,	O
no	B-negation
SI	O
or	O
HI	O

Fine	O
hand	B-bodyloc
tremor	O
.	O
.	O

M	O

what	O
year	O
,	O
and	O
what	O
mont	O
?	O

See	O
Delirium	O
in	O
below	O
.	O

COURSE	O
:	O

-	O
*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
XXX	O
M	O
]	O
.	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

CRM	O
/	O
gn	O

nystatin	O
topical	O
,	O
1	O
Application	O
,	O
Topically	B-route
,	O
Q8HRS	B-frequency
,	O
Drug	O
Form	O
:	O
Powder	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
22:00:00	B-temporal

Constitutional	O

Benzo	O
overdose	O

On	O
2/23/00	B-temporal
,	O
the	O
high	O
grade	O
fever	O
persisted	O
.	O

Please	O
call	O
White	O
,	O
Leslie	O
L	O
.	O
at	O
(	O
602	O
)	O
743	O
8709	O
to	O
schedule	O
an	O
appointment	O
with	O
him	O
in	O
1	O
week	O
.	O

Steroids	O
are	O
a	O
double	O
-	O
edged	O
sword	O
,	O
however	O
,	O
and	O
we	O
need	O
to	O
be	O
vigilant	O
regarding	O
infection	O
control	O
and	O
with	O
this	O
patient	O
'	O
s	O
glucose	O
control	O
as	O
he	O
is	O
diabetic	O
.	O

CC	O
:	O

Dict	O
:	O

extrm	O
-	O
trace	B-severity
edema	O
at	O
ankles	B-bodyloc
,	O
no	B-negation
cyanosis	O
,	O
warm	O
/	O
dry	O

Respiratory	O
failure	O
:	O

Cooperative	O
with	O
the	O
interview	O
.	O
.	O

She	O
was	O
at	O
her	O
baseline	O
shortness	O
of	O
breath	O
at	O
home	O
.	O

DISCHARGE	O
SUMMARY	O

Temperature	O
97	B-labvalue
.	I-labvalue
6	I-labvalue
Deg	I-labvalue
F	I-labvalue

PRIMARY	O
DIAGNOSIS	O
:	O

The	O
patient	O
was	O
evaluated	O
by	O
the	O
Trauma	O
Service	O
in	O
the	O
emergency	O
room	O
,	O
where	O
she	O
received	O
four	O
liters	O

D	O
:	O

Extremities	O
were	O
2	O
+	O
pedal	B-bodyloc
edema	O
to	O
the	B-bodyloc
knees	I-bodyloc
.	O

She	O
was	O
promptly	O
intubated	O
for	O
airway	O
protection	O
and	O
in	O
order	O
to	O
administer	O
charcoal	O
.	O

Bili	O
,	O
Total	O
3	B-labvalue
.	I-labvalue
8	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
High	B-labvalue

M	O

She	O
was	O
immobilized	O
in	O
the	O
C	O
-	O
spine	O
collar	O
at	O
the	O
scene	O
of	O
the	O
accident	O
and	O
subsequently	O
transported	O
by	O
EMS	O
to	O
the	O
New	O
England	O
Sinai	O
Hospital	O
&	O
Rehab	O
Center	O
Emergency	O
Department	O
for	O
further	O
management	O
.	O

Admission	O
Date	O
:	O

K	O
3	B-labvalue
.	I-labvalue
8	I-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

Left	O
humerus	O
film	O
series	O
demonstrated	O
no	B-negation
evidence	O
of	O
fracture	O
or	O
displacement	O
.	O

Abdominal	O
CT	O
scan	O
on	O
2/21/00	B-temporal
-	O
Study	O
revealed	O
a	O
prominent	O
pancreas	B-bodyloc
with	O
associated	O
mesenteric	B-bodyloc
stranding	O
.	O

POIKILOCY	O
-	O
1	B-labvalue
+	I-labvalue
MICROCYT	O
-	O
1	B-labvalue
+	I-labvalue

guiac	O
pos	O
stool	O
:	O
Given	O
the	O
patient	O
'	O
s	O
sx	O
of	O
GERD	O
,	O
current	O
PO	B-route
steroid	O
regimen	O
,	O
and	O
ASA	O
for	O
her	O
stents	O
,	O
the	O
ddx	O
for	O
her	O
guiac	O
positive	O
stools	O
would	O
include	O
gastritis	O
/	O
gastric	O
ulcer	O
in	O
addition	O
to	O
lower	O
GI	O
pathology	O
.	O

R	O
:	O

neck	B-bodyloc
-	O
jvd	O
flat	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
M	O
]	O

6	O
.	O

2	O
.	O

Cc	O
:	O

He	O
was	O
started	O
on	O
aspirin	O
.	O

6	O
.	O

52108	O

It	O
is	O
characterized	O
by	O
Patient	O
reports	O
no	O
overnight	O
events	O
.	O

Probable	O
ateletasis	O
of	O
lingula	B-bodyloc
,	O
consistent	O
with	O
pneumonitis	O

Service	O
:	O

INDICATIONS	O
:	O
Fall	O
down	O
20	O
stairs	O
.	O

After	O
treatment	O
for	O
CHF	O
and	O
COPD	O
exacerbation	O
,	O
the	O
patient	O
'	O
s	O
shortness	O
of	O
breath	O
improved	B-course
.	O

STUDIES	O
:	O

95	O
-	O
182	O

pul	B-bodyloc
-	O
CTAB	O
without	B-negation
rales	O

(	O
658	O
)	O
842	O
-	O
8661	O
.	O

He	O
subsequently	O
was	O
able	O
to	O
be	O
intubated	O
and	O
given	O
full	O
cardiac	O
resuscitation	O
attempts	O
.	O

Her	O
CBC	O
was	O
normal	B-labvalue
.	O

The	O
size	O
and	O
shape	O
of	O
the	O
ventricles	O
is	O
unchanged	O
.	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
29	I-temporal
2007	I-temporal
]	O

(	O
End	O
of	O
Report	O
)	O

Signed	O
Discharge	O

DATE	O
OF	O
ADMISSION	O
:	O

CO2	O
28	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

Left	B-bodyloc
hemidiaphragmatic	I-bodyloc
paralysis	O
,	O
history	O
of	O
recurrent	B-course
lung	B-bodyloc
infections	O
.	O

-	O
SSI	O
cover	O

WNK	O
/	O
ss	O

(	O
End	O
of	O
Report	O
)	O

3	O
.	O

42266	O

Coumadin	O
resumed	O
2	B-temporal
days	I-temporal
ago	I-temporal
,	O
Check	O
INR	O
daily	O

D	O
:	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

Discussion	O
was	O
had	O
at	O
this	O
time	O
with	O
the	O
patient	O
regarding	O
whether	O
or	O
not	O
this	O
represented	O
an	O
infected	O
abscess	O
vs	O
.	O
post	O
-	O
surgical	O
change	O
.	O

2010-09-02	B-temporal

.	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
*	O
*	O
INSTITUTION	O
Harmarville	O
on	O
*	O
*	O
DATE	O
[	O
Apr	B-temporal
16	I-temporal
2007	I-temporal
]	O
with	O
BUN	O
and	O
creatinine	O
the	O
following	O
day	O
of	O
35	B-labvalue
and	O
5	B-labvalue
.	I-labvalue
6	I-labvalue
.	O

I	O
told	O
him	O
we	O
will	O
set	O
him	O
up	O
with	O
rehab	O
and	O
it	O
will	O
be	O
up	O
to	O
him	O
.	O

He	O
had	O
a	B-bodyloc
right	I-bodyloc
bundle	I-bodyloc
branch	I-bodyloc
block	O
.	O

The	O
Jewish	O
Memorial	O
Hospital	O
hospital	O
course	O
over	O
the	O
1	O
-	O
day	O
addendum	O
is	O
improving	O
.	O

*	O
*	O
INITIALS	O

*	O
*	O
*	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
30	I-temporal
2007	I-temporal
]	O
00:36:28	B-temporal
/	O
klf	O

Status	O
post	O
fem	O
-	O
pop	O
bypass	O
bilaterally	O
x	O
3	O
.	O

3	O
.	O

STATUS	O
POST	O
ORTHOTOPIC	O
CARDIAC	O
TRANSPLANT	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
12	I-temporal
2007	I-temporal
]	O

The	O
patient	O
was	O
conscious	O
on	O
the	O
scene	O
when	O
evaluated	O
by	O
EMT	O
&apos;s	O
but	O
at	O
the	O
scene	O
,	O
the	O
patient	O
was	O
apparently	O
paraplegic	O
below	O
the	O
umbilicus	B-bodyloc
with	O
absence	O
of	O
movement	O
and	O
sensation	O
below	O
the	O
umbilicus	B-bodyloc
.	O

T	O
:	O
2010-06-30	B-temporal
17	B-temporal
:	I-temporal
39	I-temporal

Subarachnoid	B-bodyloc
hemorrhage	O
w	O
/	O
bilateral	B-bodyloc
intraventricular	I-bodyloc
hemorrhage	O

Ca	O
(	O
adjusted	O
)	O
9	B-labvalue
.	I-labvalue
8	I-labvalue
(	O
Modified	O
)	O

T	O
:	O
2009-04-03	B-temporal
01	B-temporal
:	I-temporal
26	I-temporal

Bili	O
,	O
Direct	O
2	B-labvalue
.	I-labvalue
3	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
High	B-labvalue

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O

Continue	O
O2	O
supplement	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

14	O
.	O

Tran	O
:	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
23:31:43	B-temporal

T	O
:	O
2010-09-07	B-temporal
16	B-temporal
:	I-temporal
04	I-temporal

DM	O
II	O
[	O
Diabetes	O
mellitus	O
type	O
II	O
]	O
(	O
ICD9	O
250	O
.	O
00	O
,	O
Working	O
,	O
Problem	O
)	O

Clonidine	O
0	B-strength
.	I-strength
1	I-strength
mg	I-strength
q	B-frequency
2	I-frequency
hours	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
systolic	O
blood	O
pressure	O
greater	O
than	O
160	B-labvalue
.	O

DOB	O
:	O

1	O
.	O

Lasix	O
and	O
was	O
diuresed	O
.	O

The	O
patient	O
was	O
transfused	O
from	O
a	O
Hct	O
29	B-labvalue
to	I-labvalue
34	I-labvalue
on	O
the	O
day	O
of	O
discharge	O
.	O

The	O
patient	O
'	O
s	O
condition	O
on	O
discharge	O
was	O
stable	O
and	O
improved	O
.	O

ACCOUNT	O
#	O
:	O

4	O
.	O

He	O
had	O
significant	O
past	O
medical	O
history	O
of	O
pulmonary	B-bodyloc
hypertension	O
and	O
right	B-bodyloc
heart	I-bodyloc
failure	O
.	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
05	I-temporal
2007	I-temporal
]	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

Her	O
electrolytes	O
were	O
within	B-labvalue
normal	I-labvalue
limits	I-labvalue
.	O

oxycodone	O
,	O
2	B-strength
.	I-strength
5	I-strength
mg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
Q6HRS	B-frequency
,	O
Drug	O
Form	O
:	O
Tab	B-form
,	O
PRN	B-frequency
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
14	I-temporal
08	I-temporal
]	O
14:58:00	B-temporal

Pt	O
may	O
not	O
be	O
good	O
candidate	O
for	O
Surgery	O
.	O

History	O
of	O
Present	O
Illness	O
:	O

Dictator	O
:	O

She	O
did	O
receive	O
perioperative	O
antibiotic	O
prophylaxis	O
in	O
the	O
form	O
of	O
a	O
gram	O
of	O
Ancef	O
administered	O
IV	B-route
within	O
a	O
half	O
hour	O
prior	O
to	O
incision	O
and	O
the	O
same	O
medicine	O
at	O
same	O
dose	O
administered	O
q	B-frequency
.	I-frequency
8	I-frequency
hours	I-frequency
IV	B-route
x	O
24	B-duration
hours	I-duration
postoperatively	O
.	O

Secondary	O
unspecified	O
mononeuritis	O
of	B-bodyloc
lower	I-bodyloc
extremities	I-bodyloc
.	O

Pravastatin	O
20	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

2012-06-07	B-temporal
09	B-temporal
:	I-temporal
55	I-temporal
PM	I-temporal
BLOOD	O
WBC	O
-	O
8	B-labvalue
.	I-labvalue
9	I-labvalue
RBC	O
-	O
4	B-labvalue
.	I-labvalue
94	I-labvalue
Hgb	O
-	O
15	B-labvalue
.	I-labvalue
8	I-labvalue
Hct	O
-	O
45	B-labvalue
.	I-labvalue
3	I-labvalue
MCV	O
-	O
92	B-labvalue
MCH	O
-	O
31	B-labvalue
.	I-labvalue
9	I-labvalue
MCHC	O
-	O
34	B-labvalue
.	I-labvalue
8	I-labvalue
RDW	O
-	O
12	B-labvalue
.	I-labvalue
4	I-labvalue
Plt	O
Ct	O
-	O
175	B-labvalue

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

She	O
was	O
admitted	O
to	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
YYY	O
]	O
'	O
s	O
service	O
under	O
the	O
impression	O
of	O
intestinal	B-bodyloc
obstruction	O
.	O

Patient	O
remains	O
afebrile	O
.	O

The	O
patient	O
had	O
a	O
lumbar	O
spine	O
MRI	O
and	O
x	O
-	O
ray	O
which	O
was	O
an	O
unremarkable	O
lumbar	O
spine	O
MRI	O
,	O
probable	B-uncertain
left	O
paravertebral	B-bodyloc
dilated	O
vascular	O
structure	O
versus	O
lymph	O
node	O
.	O

Sputum	O
and	O
blood	O
cultures	O
are	O
pending	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

If	O
he	O
continues	O
to	O
bleed	O
,	O
I	O
will	O
be	O
obligated	O
to	O
turn	O
off	O
the	O
Heparin	O
,	O
at	O
this	O
point	O
.	O

Social	O
Service	O
and	O
Case	O
Management	O
consulted	O
for	O
discharge	O
planning	O
and	O
placement	O
.	O

02/29/2000	B-temporal

Please	O
conitnue	O
to	O
keep	O
hands	O
elevated	O
in	O
bed	O
until	O
follow	O
up	O
appointment	O
with	O
plastic	O
surgery	O
.	O

Date	O
of	O
Birth	O
:	O

D	O
:	O

K	O
4	B-labvalue
.	I-labvalue
1	I-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

He	O
had	O
no	B-negation
chest	B-bodyloc
pain	O
or	O
shortness	O
of	O
breath	O
.	O

The	O
patient	O
remained	O
stable	O
through	O
2010-06-29	B-temporal
at	O
which	O
point	O
she	O
was	O
sent	O
to	O
the	O
operating	O
room	O
to	O
undergo	O
a	O
left	O
radial	O
fracture	O
open	O
reduction	O
and	O
internal	O
fixation	O
procedure	O
.	O

Rehab	O
&	O
Nursing	O
Center	O
-	O
Westwood	O
Lodge	O
Hospital	O

On	O
2011-11-21	B-temporal
,	O
the	O
patient	O
experienced	O
atypical	O
chest	B-bodyloc
pain	O
which	O
was	O
made	O
worse	O
with	O
inspiration	O
and	O
movement	O
.	O

Dictated	O
By	O
:	O
David	O
GA	O
Crane	O
,	O
M	O
.	O
D	O
.	O

*	O
*	O
AGE	O
[	O
in	O
40s	O
]	O
YO	O
female	O
admitted	O
with	O
Palpitations	O
.	O

Albumin	O
was	O
1	B-labvalue
.	I-labvalue
5	I-labvalue
.	O

magnesium	O
hydroxide	O
(	O
Milk	O
of	O
Magnesia	O
8	B-strength
%	I-strength
oral	B-route
suspension	B-form
)	O
(	O
MAGNESIUM	O
HYDROXIDE	O
SUSP	B-form
30	B-dosage
ML	I-dosage
)	O
,	O
30	B-dosage
mL	I-dosage
,	O
Susp	O
,	O
By	B-route
Mouth	I-route
,	O
At	B-frequency
Bedtime	I-frequency
,	O
PRN	B-frequency
,	O
For	O
Constipation	O
,	O
Routine	O
,	O

We	O
would	O
like	O
to	O
see	O
that	O
the	O
patient	O
is	O
at	O
least	O
willing	O
to	O
follow	O
up	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
before	O
starting	O
prednisone	O
therapy	O
.	O

Monocytes	O
11	B-labvalue
%	I-labvalue

Stable	O
during	O
his	O
course	O
on	O
the	O
surgical	O
Beth	O
Israel	O
Deaconess	O
Hospital	O
-	O
Needham	O
.	O

GENERAL	O
MEDICINE	O

1933-02-05	B-temporal

Heparin	O
,	O
consisting	O
of	O
thrombocytopenia	O
;	O
Pronestyl	O
,	O
consisting	O
of	O
nausea	O
.	O

1	O
.	O

Iodine	O
;	O
Iodine	O
Containing	O

At	O
this	O
time	O
,	O
an	O
Infectious	O
Disease	O
consult	O
was	O
obtained	O
,	O
and	O
the	O
recommendation	O
was	O
to	O
discontinue	O
the	O
ampicillin	O
,	O
gentamicin	O
and	O
clindamycin	O
,	O
and	O
start	O
her	O
on	O
intravenous	B-route
Unasyn	O
.	O

2012-10-31	B-temporal
05	B-temporal
:	I-temporal
47PM	I-temporal
URINE	O

D	O
:	O

Afebrile	O
,	O
BP	O
stable	B-labvalue
.	O

Past	O
Medical	O
History	O
:	O

XXX	O
]	O
,	O
D	O
.	O
O	O
.	O

5	O
.	O

Lymphs	O
18	B-labvalue
%	I-labvalue

Neuro	O
:	O

3	O
.	O

Trazodone	O
HCl	O
100	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
Two	B-dosage
(	O
2	O
)	O
Tablet	B-form
PO	B-route
HS	B-frequency
(	O
at	B-frequency
bedtime	I-frequency
)	O
as	O
needed	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
12	I-temporal
2007	I-temporal
]	O
08:02:32	B-temporal
AM	I-temporal

Appreciate	O
Ortho	O
input	O
:	O
concerning	O
R	B-bodyloc
wrist	I-bodyloc
synovitis	O
/	O
psudo	O
gout	O
.	O

The	O
patient	O
was	O
continued	O
on	O
her	O
outpatient	O
antihypertensive	O
medications	O
throughout	O
her	O
hospital	O
course	O
.	O

DATE	O
OF	O
DISCHARGE	O
:	O

1	O
.	O

*	O
*	O
*	O
PATH	O
-	O
NUMBER	O
[	O
1	O
]	O
%	O
on	O
4lit	O
.	O

Nitroglycerin	O
sublingual	O
0	B-strength
.	I-strength
3	I-strength
mg	I-strength
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency

Of	O
note	O
,	O
the	B-bodyloc
scalp	I-bodyloc
and	O
right	B-bodyloc
lower	I-bodyloc
leg	I-bodyloc
lacerations	O
were	O
closed	O
primarily	O
by	O
the	O
trauma	O
team	O
on	O
admission	O
and	O
on	O
hospital	O
day	O
#	O
1	O
were	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
.	O

It	O
is	O
due	O
to	O
a	O
normal	O
postsurgical	O
pain	O
.	O

Date	O
of	O
Birth	O
:	O

what	O
year	O
,	O
and	O
what	O
mont	O
?	O

6	O
.	O

Studies	O
on	O
admission	O
revealed	O
the	O
following	O
:	O

General	O
Appearance	O
:	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
24	I-temporal
1969	I-temporal
]	O

Patient	O
conitnued	O
to	O
have	O
SI	O
while	O
on	O
floor	O
and	O
was	O
transferred	O
to	O
psychiatry	O
.	O

Subsequently	O
,	O
in	O
the	B-temporal
early	I-temporal
morning	I-temporal
of	O
*	O
*	O
DATE	O
[	O
Dec	B-temporal
6	I-temporal
2007	I-temporal
]	O
,	O
he	O
was	O
found	O
unresponsive	O
on	O
the	O
floor	O
.	O

Index	O
No	O
.	O

Status	O
post	O
aborted	O
coronary	O
artery	O
bypass	O
graft	O
due	O
to	O
mobile	O
aortic	B-bodyloc
atheroma	O
.	O

D	O
:	O

-	O
-	O
*	O
*	O
NAME	O
[	O
PPP	O
]	O
Psych	O
(	O
Groff	O
)	O
consult	O

Dicatated	O
By	O
:	O

Initial	O
electrocardiogram	O
showed	O
a	B-labvalue
normal	I-labvalue
sinus	I-labvalue
rhythm	I-labvalue
at	O
65	B-labvalue
,	O
normal	O
axis	O
,	O
2	O
-	O
mm	O
ST	O
elevations	O
in	O
lead	O
III	O
,	O
1	O
-	O
mm	O
ST	O
elevations	O
in	O
aVF	O
and	O
V1	O
,	O
1	O
-	O
mm	O
ST	O
depressions	O
in	O
I	O
and	O
aVL	O
;	O
consistent	O
with	O
an	O
inferior	B-bodyloc
and	I-bodyloc
right	I-bodyloc
ventricular	I-bodyloc
infarction	O
.	O

In	O
the	O
Emergency	O
Department	O
she	O
was	O
given	O
Lasix	O
with	O
success	O
and	O
diuresed	O
a	O
good	O
amount	O
of	O
fluid	O
.	O

He	O
had	O
a	O
GI	O
evaluation	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
who	O
consulted	O
the	O
hepatologist	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
SSS	O
RRR	O
]	O
at	O
*	O
*	O
PHONE	O
regarding	O
Mr	O
.	O
*	O
*	O
NAME	O
[	O
AAA	O
]	O
.	O

SECONDARY	O
DIAGNOSES	O
:	O

37707	O

Troponin	O
I	O
&	O
lt	O
;	O
0	B-labvalue
.	I-labvalue
04	I-labvalue
ng	I-labvalue
/	I-labvalue
mL	I-labvalue

HISTORY	O
:	O

MRSA	O
screen	O
showed	O
no	B-negation
MRSA	O
isolated	O
at	O
1	O
day	O
.	O

6	O
.	O

Rheumatoid	O
arthritis	O
.	O

Temperature	O
Conversion	O
36	B-labvalue
.	I-labvalue
9	I-labvalue
Deg	I-labvalue
C	I-labvalue

PT	O
states	O
that	O
she	O
feel	O
better	O
but	O
not	O
much	O
.	O

I	O
do	O
not	O
believe	O
that	O
she	O
requires	O
the	O
standard	O
routine	O
daily	O
antihypertensive	O
medication	O
at	O
this	B-temporal
time	I-temporal
.	O

The	O
patient	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
50s	O
]	O
-	O
year	O
-	O
old	O
patient	O
of	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
with	O
right	B-bodyloc
knee	I-bodyloc
DJD	O
.	O

Briefly	O
,	O
this	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
70s	O
]	O
-	O
year	O
-	O
old	O
female	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
congestive	O
heart	B-bodyloc
failure	O
,	O
COPD	O
,	O
and	O
history	O
of	O
DVT	O
,	O
who	O
presented	O
with	O
right	O
calf	B-bodyloc
swelling	O
and	O
increased	B-course
shortness	O
of	O
breath	O
x	O
3	B-temporal
days	I-temporal
.	O

GERD	O
and	O
PUD	O
.	O

Job	O
ID	O
:	O

This	O
was	O
attributed	O
to	O
postoperative	O
swelling	O
and	O
changes	O
from	O
his	O
diskectomy	O
performed	O
2010-08-27	B-temporal
.	O

Temperature	O
Site	O
Oral	O

Regarding	O
her	B-bodyloc
aortic	I-bodyloc
ascending	I-bodyloc
aneurysm	O
,	O
Cardiothoracic	O
Surgery	O
was	O
consulted	O
regarding	O
further	O
workup	O
.	O

I	O
personally	O
manage	O
Mr	O
.	O
*	O
*	O
NAME	O
[	O
AAA	O
]	O
in	O
the	O
ICU	O
.	O

Ortiz	O
V	O
Baugher	O
,	O
M	O
.	O
D	O
.	O

289	B-labvalue
.	O

Will	O
f	O
/	O
u	O
on	O
.	O

Pain	O
control	O
was	O
initiated	O
with	O
morphine	O
but	O
was	O
then	O
changed	O
to	O
Demerol	O
,	O
which	O
gave	O
the	O
patient	O
better	O
relief	O
of	O
his	O
epigastric	B-bodyloc
pain	O
.	O

-	O
-	O
ophtho	O
as	O
outpt	O
after	O
Abx	O
done	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
30	I-temporal
2007	I-temporal
]	O
00:36:28	B-temporal

Job	O
ID	O
:	O

Progress	O
Note	O

Glucose	O
68	B-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

The	O
patient	O
needs	O
to	O
have	O
PT	O
/	O
OT	O
during	O
her	O
stay	O
at	O
the	O
nursing	O
home	O
.	O

Depression	O

Assess	O
for	O
hemorrhage	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

He	O
has	O
not	O
shown	O
any	O
substantial	O
improvement	O
.	O

D	O
:	O
2010-06-30	B-temporal
17	B-temporal
:	I-temporal
18	I-temporal

Heart	O
:	O

15	O
.	O

7	O
.	O

Dr	O
.	O
Falccouette	O
would	O
like	O
to	O
perform	O
an	O
excision	O
and	O
closure	O
flap	O
of	O
her	O
left	B-bodyloc
ischial	I-bodyloc
decubitusin	O
the	O
near	O
future	O
.	O

With	O
this	O
in	O
mind	O
,	O
when	O
obtaining	O
a	O
CT	O
scan	O
it	O
was	O
determined	O
that	O
contrast	O
would	O
not	O
be	O
the	O
best	O
option	O
.	O

18	B-labvalue
breaths	I-labvalue
/	I-labvalue
min	I-labvalue
.	O

Patient	O
was	O
4	O
.	O
4	O
,	O
blood	O
urea	O
nitrogen	O
was	O
14	B-labvalue
,	O
creatinine	O
was	O
0	B-labvalue
.	I-labvalue
6	I-labvalue
,	O
and	O
glucose	O
was	O
147	B-labvalue
.	O

Patient	O
is	O
to	O
have	O
his	O
ascites	O
tapped	O
today	O
.	O

14	O
.	O

Patient	O
was	O
transferred	O
to	O
floor	O
after	O
spending	O
1	O
day	O
in	O
the	O
ICU	O
.	O

Right	O
tibial	O
-	O
fibular	O
film	O
series	O
demonstrated	O
no	B-negation
evidence	O
of	O
fracture	O
displacement	O
.	O

No	B-negation
evidence	O
of	O
colitis	O
or	O
other	O
bowel	B-bodyloc
pathology	O
present	O
to	O
explain	O
the	O
patient	O
'	O
s	O
bright	O
red	O
blood	O
per	O
rectum	B-bodyloc
.	O

-	O
remove	O
foley	O
.	O

2014-10-21	B-temporal
08	B-temporal
:	I-temporal
10	I-temporal
PM	I-temporal

Hypercholesterolemia	O
.	O

Perform	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
L	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
17	I-temporal
1929	I-temporal
]	O

CT	O
Chest	O
-	O
shows	O
bilateral	O
segmental	O
,	O
subsegmental	O
PEs	O

The	O
patient	O
is	O
a	O
64	O
-	O
year	O
-	O
old	O
female	O
with	O
3	B-bodyloc
-	I-bodyloc
vessel	I-bodyloc
disease	O
who	O
was	O
admitted	O
to	O
the	O
Coronary	O
Care	O
Unit	O
Service	O
for	O
Western	O
Mass	O
.	O

PROCEDURE	O
PERFORMED	O
:	O

.	O
.	O

Name	O
:	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
24	I-temporal
1969	I-temporal
]	O

Patient	O
should	O
follow	O
up	O
with	O
at	O
plastic	O
surgery	O
clinic	O
in	O
2	O
weeks	O
.	O

F	O

The	O
patient	O
at	O
the	O
time	O
of	O
admission	O
was	O
not	O
giving	O
much	O
history	O
.	O

Patient	O
had	O
no	B-negation
acute	B-course
overnight	O
events	O
.	O

+	B-labvalue
BS	O
,	O
soft	O
,	O
*	O
*	O
INITIALS	O
.	O

ALLERGIES	O
:	O

*	O
*	O
NAME	O
[	O
PPP	O
]	O
Family	O
Endowed	O
Professor	O
of	O
*	O
*	O
NAME	O
[	O
CCC	O
]	O
Chief	O
,	O
The	O
Heart	O
,	O
Lung	O
and	O
*	O
*	O
INSTITUTION	O

4	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Complaints	O
abdominal	B-bodyloc
swelling	O
-	O
much	O
improved	B-course
s	O
/	O
p	O
paracenthesis	O
/	O
minimal	O
leak	O
of	O
serous	O
fliud	O
overnight	O
d	O
/	O
w	O
pt	O
at	O
length	O
regarding	O
treatment	O
and	O
need	O
for	O
close	O
follow	O
up	O
-	O
he	O
understands	O
and	O
is	O
aggreeable	O
however	O
,	O
he	O
is	O
not	O
agreeable	O
to	O
Acute	O
ETOH	O
rehab	O
as	O
it	O
has	O
not	O
helped	O
in	O
the	O
past	O
and	O
hearing	O
about	O
other	O
peoples	O
'	O
problems	O
only	O
makes	O
him	O
anxious	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O

No	B-negation
cyanosis	O
,	O
clubbing	O
,	O
or	O
edema	O
.	O

Current	O
medications	O
reviewed	O

Troponin	O
I	O
&	O
lt	O
;	O
0	B-labvalue
.	I-labvalue
10	I-labvalue
ng	I-labvalue
/	I-labvalue
mL	I-labvalue

Repeat	O
EKG	O
today	B-temporal
.	O

After	O
evaluation	O
and	O
a	O
discussion	O
with	O
Dr	O
.	O
Gunter	O
,	O
it	O
was	O
determined	O
that	O
the	O
patient	O
no	B-negation
longer	I-negation
needed	O
anticoagulation	O
since	O
there	O
was	O
no	B-negation
aortic	B-bodyloc
thrombus	O
but	O
only	O
an	O
aortic	B-bodyloc
plaque	O
,	O
and	O
there	O
was	O
no	B-negation
anterior	B-bodyloc
/	I-bodyloc
apical	I-bodyloc
akinesis	O
noted	O
.	O

DISPO	O
:	O
transfer	O
to	O
inpatient	O
CMED	O
likely	O
tomorrow	O

Prilosec	O
20	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency
;	O
Percocet	O
1	B-dosage
-	I-dosage
2	I-dosage
tabs	B-form
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
6	I-frequency
-	I-frequency
8h	I-frequency
.	I-frequency
x5	B-duration
days	I-duration
;	O
MVI	O
1	B-dosage
tab	B-form
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency

*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
YYY	O
]	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
examination	O
was	O
without	B-negation
bruits	O
.	O

It	O
was	O
felt	O
that	O
the	O
patient	O
'	O
s	O
mildly	O
elevated	O
BMP	O
was	O
secondary	O
to	O
pulmonary	B-bodyloc
hypertension	O
seen	O
on	O
the	O
patient	O
'	O
s	O
last	O
echocardiogram	O
at	O
last	O
admission	O
.	O

She	O
was	O
also	O
to	O
obtain	O
a	O
second	O
opinion	O
regarding	O
the	O
question	O
of	O
possible	O
surgical	O
management	O
.	O

8	O
.	O
)	O
Ulcerative	O
colitis	O

Degenerative	O
osteoarthritis	O
.	O

NEUTS	O
-	O
80	B-labvalue
.	I-labvalue
5	I-labvalue
*	I-labvalue
LYMPHS	O
-	O
13	B-labvalue
.	I-labvalue
1	I-labvalue
*	I-labvalue
MONOS	O
-	O
3	B-labvalue
.	I-labvalue
5	I-labvalue
EOS	O
-	O
2	B-labvalue
.	I-labvalue
5	I-labvalue

A	O
Cardiology	O
consult	O
was	O
also	O
obtained	O
to	O
rule	O
out	O
any	O
cardiac	O
causes	O
of	O
the	O
patient	O
'	O
s	O
shortness	O
of	O
breath	O
.	O

7	O
.	O

normal	O
axis	O
,	O
and	O
normalizing	O
of	O
the	O
inferior	O
ST	O
segments	O
,	O
with	O
Q	O
waves	O
evolving	O
in	O
leads	O
III	O
and	O
aVF	O
.	O

Cardiology	O
.	O

Lungs	O

There	O
is	O
some	O
fluid	O
or	O
mucosal	O
thickening	O
in	O
the	B-bodyloc
ethmoid	I-bodyloc
and	O
sphenoid	B-bodyloc
sinuses	I-bodyloc
.	O

Diabetes	O
.	O

His	O
lactate	O
is	O
less	O
than	O
2	B-labvalue
.	O

Her	O
case	O
is	O
discussed	O
in	O
detail	O
with	O
the	O
house	O
staff	O
.	O

FY2	O
Resident	O

He	O
said	O
that	O
I	O
am	O
24	O
hours	O
with	O
her	O
.	O

XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

Acct	O
#	O
:	O

She	O
did	O
receive	O
a	O
transfusion	O
of	O
two	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
1	I-temporal
2007	I-temporal
]	O
.	O

Coronary	B-bodyloc
artery	I-bodyloc
disease	O
.	O

He	O
had	O
an	O
80	O
%	O
distal	O
left	O
main	O
,	O
a	O
90	O
%	O
proximal	O
circumflex	O
,	O
and	O
multiple	O
significant	O
lesions	O
in	O
the	O
LAD	O
.	O

Sex	O
:	O

Ms	O
.	O
Franklin	O
is	O
a	O
34	O
-	O
year	O
-	O
old	O
woman	O
with	O
Bipolar	O
disorder	O
and	O
group	O
home	O
resident	O
who	O
by	O
way	O
of	O
EMS	O
for	O
apparent	O
alprazolam	O
overdose	O
.	O

13	O
.	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

1	O
.	O

Posttraumatic	O
stress	O
disorder	O
.	O

Na	O
137	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

Medications	O
on	O
Admission	O
:	O

-	O
monitor	O
on	O
tele	O
overnight	O

*	O
*	O
PLACE	O
,	O
PA	O
*	O
*	O
ZIP	O
-	O
CODE	O

Flonase	O
2	B-dosage
puffs	B-form
twice	B-frequency
per	I-frequency
day	I-frequency
.	O

Acct	O
#	O
:	O

His	O
gas	O
exchange	O
is	O
good	O
at	O
40	O
%	O
FIO2	O
and	O
5	B-labvalue
of	O
PEEP	O
the	O
current	O
assist	O
control	O
settings	O
.	O

HOSPITAL	O
COURSE	O
:	O

Trauma	O
CT	O
demonstrated	O
mild	B-severity
pulmonary	B-bodyloc
contusions	O
,	O
but	O
no	B-negation
pelvic	B-bodyloc
fracture	O
.	O

Blood	O
and	O
urine	O
cultures	O
were	O
sent	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

DISCHARGE	O
SUMMARY	O

LIST	O
OF	O
DISCHARGE	O
MEDICATIONS	O
:	O

The	O
patient	O
will	O
schedule	O
with	O
the	O
Pain	O
Clinic	O
regarding	O
upcoming	O
epidural	O
pump	O
placement	O
.	O

5	O
.	O

D	O
:	O

1	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
10	I-temporal
2007	I-temporal
]	O
20:09:51	B-temporal

He	O
also	O
had	O
multifocal	O
ventricular	B-bodyloc
ectopy	O
at	O
that	O
time	O
.	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
15	I-temporal
2007	I-temporal
]	O
15:16:41	B-temporal
/	O
np	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Findings	O
were	O
called	O
to	O
Dr	O
.	O
Leanne	O
Vazquez	O
on	O
the	B-temporal
morning	I-temporal
of	O
10	B-temporal
-	I-temporal
21	I-temporal
.	O

LFT	O
s	O
Normal	B-labvalue
at	O
this	O
addmison	O
.	O

10	O
.	O

He	O
remains	O
on	O
Meropenem	O
as	O
well	O
as	O
linezolid	O
for	O
treatment	O
of	O
his	O
infection	O
.	O

ACCOUNT	O
#	O
:	O

IDDM	O

I	O
think	O
from	O
our	O
exam	O
she	O
likely	O
has	O
benign	B-severity
positional	O
vertigo	O
may	O
be	O
triggered	O
by	O
her	O
fall	O
.	O

10	O
.	O

We	O
appreciate	O
Dermatology	O
'	O
s	O
help	O
await	O
the	O
results	O
of	O
their	O
cultures	O
.	O

Discharged	O
:	O

MAE	O
s	O
.	O

AST	O
/	O
SGOT	O
36	B-labvalue
IU	I-labvalue
/	I-labvalue
L	I-labvalue

The	O
patient	O
has	O
a	O
history	O
of	O
membranoproliferative	O
glomerulonephritis	O
which	O
has	O
been	O
worked	O
in	O
the	O
past	O
,	O
and	O
all	O
other	O
etiologies	O
were	O
negative	O
and	O
was	O
thought	O
to	O
be	O
due	O
to	O
her	O
multiple	O
myeloma	O
.	O

4	O
.	O

FAMILY	O
HISTORY	O
:	O

Depressed	O

11	O
.	O

Bipolar	O
Disorder	O

TR	O
:	O

3	O
.	O

Her	O
groin	O
exam	O
was	O
unchanged	O
.	O

She	O
tolerated	O
these	O
meds	O
with	O
SBP	O
s	O
in	O
the	O
high	O
90	B-labvalue
s	I-labvalue
to	I-labvalue
100	I-labvalue
s	I-labvalue
and	O
was	O
therefore	O
discharged	O
on	O
this	O
regimen	O
.	O

In	O
addition	O
she	O
showed	O
evidence	O
for	O
anasarca	O
.	O

Consult	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O

3	O
.	O

An	O
EEG	O
was	O
also	O
considered	O
to	O
rule	O
out	O
non	O
-	O
convulsive	O
status	O
epilepticus	O
,	O
although	O
again	O
this	O
did	O
not	O
seem	O
to	O
be	O
a	O
likely	O
cause	O
.	O

Disp	O
:	O
*	O
5	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
0	O
*	O

He	O
is	O
starting	O
to	O
developed	O
a	O
little	O
bit	O
of	O
the	O
decubitus	O
of	O
the	O
bridge	O
of	O
his	O
nose	O
.	O

Case	O
was	O
discussed	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
ZZZ	O
]	O
.	O

Oak	O
Bluffs	O
Of	O
Greenfield	O

6	O
.	O

2014-10-21	B-temporal
02	B-temporal
:	I-temporal
56	I-temporal
PM	I-temporal

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

Cc	O
:	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
22	I-temporal
2007	I-temporal
]	O
09	B-temporal
:	I-temporal
00	I-temporal
)	O

DISCHARGE	O
SUMMARY	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
19	I-temporal
2007	I-temporal
]	O
10	B-temporal
:	I-temporal
00	I-temporal
)	O

*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
also	O
fitted	O
with	O
a	O
figure	O
-	O
of	O
-	O
eight	O
clavicular	O
splint	O
and	O
instructed	O
in	O
its	O

Carotids	O
normal	O
.	O

7	O
.	O

This	O
is	O
a	O
very	O
nice	O
patient	O
.	O

Also	O
,	O
at	O
the	O
time	O
of	O
discharge	O
,	O
for	O
increased	O
afterload	O
reduction	O
,	O
she	O
was	O
started	O
on	O
lisinopril	O
5	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
d	I-frequency
.	I-frequency

heent	O
-	O
anicteric	O
sclera	B-bodyloc
,	O
op	O
clear	O
with	O
mmm	O

She	O
also	O
received	O
Lovenox	O
30	B-strength
mg	I-strength
subcutaneously	B-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
beginning	O
12	O
hours	O
postoperatively	O
and	O
continued	O
through	O
her	O
hospital	O
course	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Batch	O
:	O

Neutrophils	O
52	B-labvalue
%	I-labvalue

6	O
.	O

Examination	O
on	O
admission	O
to	O
the	O
Coronary	O
Care	O
Unit	O
revealed	O
blood	O
pressure	O
was	O
100	B-labvalue
/	I-labvalue
57	I-labvalue
,	O
with	O
a	O
mean	O
arterial	O
pressure	O
of	O
75	B-labvalue
,	O
heart	O
rate	O
was	O
sinus	B-labvalue
rhythm	I-labvalue
at	O
75	B-labvalue
,	O
temperature	O
was	O
97	B-labvalue
.	I-labvalue
6	I-labvalue
,	O
oxygen	O
saturation	O
was	O
99	B-labvalue
%	I-labvalue
on	O
assist	O
control	O
with	O
a	O
tidal	O
volume	O
of	O
600	B-labvalue
on	O
60	B-labvalue
%	I-labvalue
FIO2	O
,	O
5	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
.	O

The	O
prednisone	O
will	O
be	O
started	O
with	O
his	O
PCP	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
.	O

His	O
office	O
will	O
contact	O
her	O
to	O
make	O
that	O
appointment	O
.	O

Alan	O
John	O
MD	O
54	O
-	O
745	O

13	O
.	O

﻿Admission	O
Date	O
:	O

Report	O
Status	O
:	O

WWP	O
,	O
multiple	O
linear	O
scars	O
and	O
burns	O
on	O
hands	B-bodyloc
and	I-bodyloc
arms	I-bodyloc

Progress	O
*	O
*	O
INSTITUTION	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
19	I-temporal
2007	I-temporal
]	O
16	B-temporal
:	I-temporal
43	I-temporal
)	O

Subjective	O
/	O
Events	O
Overnight	O
:	O

Blood	O
pressure	O
is	O
150	B-labvalue
/	I-labvalue
90	I-labvalue
,	O
heart	O
rate	O
of	O
90	B-labvalue
,	O
respiratory	O
rate	O
20	B-labvalue
with	O
saturation	O
of	O
98	B-labvalue
%	I-labvalue
.	O

2	O
)	O
Patchy	B-bodyloc
left	I-bodyloc
retrocardiac	I-bodyloc
opacity	O
which	O
may	O
be	O
due	O
to	O
patchy	O
atelectasis	O
,	O
aspiration	O
,	O
or	O
early	O
pneumonia	O
.	O

The	O
patient	O
reportedly	O
living	O
in	O
third	O
floor	O
apartment	O
with	O
mother	O
.	O

Sex	O
:	O

Cyclosporin	O
A	O
level	O
on	O
admission	O
was	O
179	B-labvalue
.	O

Neurontin	O
800	B-strength
mg	I-strength
tid	B-frequency

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

Postoperative	O
from	O
Nissen	O
fundoplication	O
.	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
.	O

Portable	O
supine	O
chest	O
radiograph	O
shows	O
improvement	O
in	O
edema	O
compared	O
to	O
studies	O
from	O
four	O
and	O
five	O
days	O
earlier	O
with	O
no	B-negation
significant	O
radiographic	O
change	O
in	O
right	B-bodyloc
upper	I-bodyloc
lobe	I-bodyloc
consolidation	O
consistent	O
with	O
pneumonia	O
.	O

None	O
.	O

Ct	O
scan	O
the	O
head	O
r	O
/	O
o	O
ICH	O
.	O

The	O
patient	O
was	O
continued	O
on	O
her	O
home	O
dose	O
of	O
Synthroid	O
.	O

THE	O
AORTIC	B-bodyloc
VALVE	I-bodyloc
APPEARS	O
MILDLY	O
SCLEROTIC	O
HOWEVER	O
,	O
THE	O
DOPPLER	O
ASSESSMENT	O
OF	O
DEGREE	O
OF	O
AORTIC	B-bodyloc
STENOSIS	O
IS	O
INACCURATE	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

DOB	O
:	O

haldol	O
as	O
well	O
as	O
the	O
restraints	O
were	O
not	B-negation
required	I-negation
after	O
the	B-temporal
morning	I-temporal
of	I-temporal
the	I-temporal
23rd	I-temporal
.	O

Neutrophils	O
69	B-labvalue
%	I-labvalue

Examination	O
on	O
presentation	O
to	O
the	O
emergency	O
room	O
revealed	O
the	O
following	O
:	O

Prevertebral	B-bodyloc
soft	O
tissue	O
swelling	O
cannot	O
be	O
excluded	O
secondary	O
to	O
intubation	O
.	O

DIGOXIN	O
-	B-labvalue
<	I-labvalue
0	I-labvalue
.	I-labvalue
2	I-labvalue
*	O

MCV	O
was	O
85	B-labvalue
.	O

ESRD	O
on	O
HD	O

Exacerbation	O
of	O
congestive	O
heart	B-bodyloc
failure	O
.	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

M	O

PM296	O
/	O
2413	O
RI	O
SEEN	O
,	O
M	O
.	O
D	O
.	O

GENERAL	O
MEDICINE	O

Major	O
depression	O
.	O

Afever	O
,	O

6	O
.	O

Discharge	O
Date	O
:	O

what	O
day	O
is	O
today	O
?	O

Danvers	O
T	O
Sharp	O
,	O
M	O
.	O
D	O
.	O

Soft	O
,	O
non	O
-	O
distended	O
.	O

Status	O
post	O
cardiac	O
catheterization	O
and	O
stents	O
times	O
three	O
of	O
the	O
right	O
coronary	O
artery	O
.	O

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

Valtrex	O
500	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

His	O
PT	O
was	O
21	B-labvalue
.	I-labvalue
2	I-labvalue
with	O
an	O
INR	O
of	O
1	B-labvalue
.	I-labvalue
8	I-labvalue
and	O
his	O
PTT	O
was	O
42	B-labvalue
.	I-labvalue
8	I-labvalue
.	O

Acetaminophen	O
500	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
Two	B-dosage
(	O
2	O
)	O
Tablet	B-form
PO	B-route
Q6H	B-frequency
(	O
every	B-frequency
6	I-frequency
hours	I-frequency
)	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

POTASSIUM	O
-	O
3	B-labvalue
.	I-labvalue
7	I-labvalue
CHLORIDE	O
-	O
105	B-labvalue
TOTAL	O
CO2	O
-	O
22	B-labvalue
ANION	O
GAP	O
-	O
18	B-labvalue

Thrush	O
:	O
This	O
is	O
likely	O
secondary	O
to	O
her	O
steroid	O
inhalers	O
and	O
PO	B-route
prednisone	O
for	O
COPD	O
exacerbation	O
.	O

The	O
left	O
forearm	O
dressing	O
was	O
noted	O
to	O
be	O
in	O
place	O
,	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
no	B-negation
saturation	O
.	O

3	O
.	O

Prednisone	O
10	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
day	I-frequency
.	O

Allergies	O
:	O

ALLRESLTSECT	O

2	O
.	O

Results	O
Review	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
15	I-temporal
2007	I-temporal
]	O
17:20:05	B-temporal

She	O
will	O
be	O
discharged	O
to	O
home	O
with	O
followup	O
with	O
Dr	O
.	O
Wilson	O
in	B-temporal
two	I-temporal
weeks	I-temporal
with	O
a	O
repeat	O
head	O
CT	O
.	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
24	I-temporal
2007	I-temporal
]	O
02:26:22	B-temporal
/	I-temporal
sk	I-temporal

bilateral	O
coronary	O
angiography	O
.	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

His	O
weekly	O
labs	O
will	O
include	O
a	O
CBC	O
,	O
LFT	O
s	O
,	O
PT	O
,	O
INR	O
,	O
lytes	O
,	O
BUN	O
,	O
creatinine	O
,	O
and	O
glucose	O
.	O

Atraumatic	O
,	O
normocephalic	O
.	O
.	O

The	O
patient	O
had	O
hemodynamic	O
instability	O
and	O
was	O
then	O
later	O
transferred	O
back	O
to	O
the	O
intensive	O
care	O
unit	O
for	O
which	O
the	O
patient	O
had	O
a	O
Condition	O
called	O
.	O

She	O
has	O
approximately	O
one	O
glass	O
of	O
wine	O
every	O
day	O
.	O

5	O
.	O

Plan	O

I	O
hope	O
that	O
he	O
can	O
be	O
compliant	O
.	O

Appointment	O
setup	O
for	O
Tues	O
.	O
05	B-temporal
-	I-temporal
13	I-temporal
at	O
10	B-temporal
am	I-temporal
.	O

Warm	O
and	O
well	O
perfused	O
.	O

2	O
)	O
Retroperitoneal	O
bleed	O

PERTINENT	O
LABORATORY	O
VALUES	O
ON	O
PRESENTATION	O
:	O

The	O
patient	O
will	O
follow	O
up	O
with	O
Dr	O
.	O
Falccouette	O
to	O
schedule	O
for	O
excision	O
and	O
closure	O
of	O
her	O
left	B-bodyloc
ischial	I-bodyloc
sacral	I-bodyloc
decubitus	O
.	O

#	O
Code	O
-	O
-	O
full	O

Selective	O
coronary	O
angiography	O
showed	O
an	O
occluded	O
right	B-bodyloc
coronary	I-bodyloc
artery	I-bodyloc
in	O
its	O
midportion	O
.	O

We	O
removed	O
her	O
NG	O
tube	O
on	O
hospital	O
day	O
#	O
2	O
and	O
we	O
were	O
able	O
to	O
start	O
diet	O
.	O

Therefore	O
,	O
he	O
does	O
have	O
a	O
thrombocytopenic	O
reaction	O
to	O
Heparin	O
.	O

Neurology	O
noted	O
immune	O
studies	O
would	O
take	O
several	O
days	O
to	O
be	O
done	O
.	O

86	B-labvalue
beats	I-labvalue
per	I-labvalue
min	I-labvalue
.	O

Alk	O
Phos	O
108	B-labvalue
IntUnit	I-labvalue
/	I-labvalue
L	I-labvalue

The	O
patient	O
presents	O
with	O
complaint	O
of	O
.	O
.	O

She	O
also	O
was	O
able	O
to	O
resume	O
normal	O
p	O
.	O
o	O
.	O
intake	O
of	O
food	O
and	O
liquid	O
.	O

She	O
was	O
brought	O
into	O
the	O
day	O
of	O
admission	O
surgery	O
unit	O
at	O
*	O
*	O
INSTITUTION	O
for	O
elective	O
total	O
knee	O
arthroplasty	O
on	O
the	O
right	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
10	I-temporal
2007	I-temporal
]	O
.	O

16	O
-	O
530	O

Patient	O
was	O
put	O
on	O
coumadin	O
that	O
was	O
bridged	O
with	O
lovenox	O
unti	O
lINR	O
theraputic	O
01	O
-	O
23	O
.	O

R	O
:	O

She	O
has	O
had	O
continuing	O
vaginal	B-bodyloc
discharge	O
,	O
and	O
was	O
diagnosed	O
with	O
bacterial	O
vaginosis	O
one	O
day	O
prior	O
to	O
admission	O
,	O
and	O
was	O
given	O
a	O
prescription	O
for	O
Flagyl	O
.	O

1	O
.	O

6	O
.	O

Patient	O
denies	B-negation
N	O
/	O
V	O
,	O
fever	O
/	O
chills	O
and	O
chest	B-bodyloc
pain	O
.	O

We	O
will	O
start	O
her	O
on	O
steroid	O
therapy	O
30	B-strength
mg	I-strength
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Alcohol	O
abuse	O
.	O

T	O
:	O

She	O
was	O
maintained	O
on	O
intravenous	B-route
antibiotics	O
.	O

RBC	O
4	B-labvalue
.	I-labvalue
31	I-labvalue
X10E	I-labvalue
+	I-labvalue
12	I-labvalue
/	I-labvalue
L	I-labvalue

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

not	O
to	O
exceed	O
total	O
of	O
4	B-strength
grams	I-strength
of	O
Tylenol	O
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
24	I-frequency
hours	I-frequency
when	O
combined	O
with	O
regular	O
Tylenol	O
dosage	O
also	O
ordered	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O
D	O
.	O
O	O
.	O
,	O
RESIDENT	O

*	O
*	O
*	O

ATTENDING	O
PHYSICIAN	O
:	O

Waiting	O
for	O
a	O
subsidized	O
apartment	O
.	O

A5B	O
/	O
549	O

Medication	O
:	O

D	O
:	O

Bili	O
,	O
Direct	O
2	B-labvalue
.	I-labvalue
0	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue
High	B-labvalue

She	O
was	O
admitted	O
for	O
blood	O
pressure	O
management	O
and	O
pain	O
control	O
.	O

The	O
fluid	O
albumin	O
was	O
0	B-labvalue
.	I-labvalue
6	I-labvalue
and	O
total	O
protein	O
of	O
0	B-labvalue
.	I-labvalue
7	I-labvalue
.	O

6	O
.	O
)	O
Sinus	B-bodyloc
node	I-bodyloc
dysfunction	O
s	O
/	O
p	O
pacemaker	O

Dictator	O
:	O

*	O
*	O
NAME	O
[	O
BBB	O
AAA	O
]	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
50s	O
]	O
-	O
year	O
-	O
old	O
female	O
who	O
presented	O
to	O
the	O
emergency	O
room	O
with	O
a	O
complaint	O
of	O
a	O
right	O
-	O
sided	O
headache	O
of	O
gradual	O
onset	O
as	O
well	O
as	O
hypertension	O
.	O

PERTINENT	O
LABORATORY	O
DATA	O
ON	O
PRESENTATION	O
:	O

FAMILY	O
HISTORY	O
:	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

T	O
:	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
12	I-temporal
2007	I-temporal
]	O
09	B-temporal
:	I-temporal
12	I-temporal

The	O
patient	O
presented	O
with	O
3	B-temporal
to	I-temporal
4	I-temporal
days	I-temporal
worth	O
of	O
diarrhea	O
.	O

*	O
*	O
ROOM	O

PHYSICAL	O
EXAMINATION	O
:	O

Anderson	O
,	O
M	O
.	O
D	O
.	O

He	O
is	O
at	O
increased	O
risk	O
for	O
future	O
events	O
because	O
of	O
his	O
low	B-bodyloc
left	I-bodyloc
ventricular	I-bodyloc
ejection	O
fraction	O
,	O
but	O
he	O
is	O
clinically	O
stable	O
on	O
ACE	O
inhibitors	O
,	O
Digoxin	O
,	O
Coumadin	O
,	O
and	O
aspirin	O
.	O

Age	O
:	O

Kenneth	O
Jeffrey	O
,	O
MD	O
89	O
-	O
808	O

1	O
.	O

Delirium	O
NOS	O
(	O
ICD9	O
780	O
.	O
09	O
,	O
Working	O
,	O
Problem	O
)	O

Ca	O
(	O
adjusted	O
)	O
10	B-labvalue
.	I-labvalue
1	I-labvalue
(	O
Modified	O
)	O

GLUCOSE	O
-	O
126	B-labvalue
*	O
UREA	O
N	O
-	O
9	B-labvalue
CREAT	O
-	O
0	B-labvalue
.	I-labvalue
8	I-labvalue
SODIUM	O
-	O
135	B-labvalue
POTASSIUM	O
-	O
3	B-labvalue
.	I-labvalue
4	I-labvalue
CHLORIDE	O
-	O
99	B-labvalue
TOTAL	O
CO2	O
-	O
25	B-labvalue
ANION	O
GAP	O
-	O
14	B-labvalue

9	O
.	O

She	O
was	O
continued	O
on	O
her	O
antibiotics	O
,	O
and	O
was	O
afebrile	O
until	O
hospital	O
day	O
number	O
five	O
,	O
when	O
she	O
had	O
a	O
temperature	O
spike	O
to	O
102	O
.	O
3	O
.	O

On	O
hospital	O
day	O
number	O
three	O
,	O
her	O
blood	O
cultures	O
came	O
back	O
positive	B-labvalue
in	O
the	O
anaerobic	O
culture	O
for	O
gram	O
-	O
positive	O
cocci	O
in	O
pairs	O
and	O
clusters	O
.	O

2	O
.	O

Discharge	O
Date	O
:	O

He	O
was	O
transferred	O
to	O
Medicine	O
the	B-temporal
morning	I-temporal
of	O
2010-08-30	B-temporal
,	O
for	O
continued	O
medical	O
management	O
post	O
surgery	O
.	O

*	O
*	O
INSTITUTION	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
06	I-temporal
07	I-temporal
]	O

Attending	O
:	O
Louie	O
A	O
.	O

His	O
white	O
blood	O
cell	O
count	O
is	O
4	B-labvalue
.	I-labvalue
9	I-labvalue
and	O
he	O
has	O
been	O
afebrile	O
.	O

Cr	O
0	B-labvalue
.	I-labvalue
6	I-labvalue
mg	I-labvalue
/	I-labvalue
dL	I-labvalue

07/26/99	B-temporal

*	O
*	O
NAME	O
[	O
VVV	O
WWW	O
]	O
,	O
D	O
.	O
O	O
.	O

Diabetes	O
.	O

*	O
*	O
DATE	O
[	O
Apr	B-temporal
30	I-temporal
2007	I-temporal
]	O
14	B-temporal
:	I-temporal
38	I-temporal

Report	O
:	O

PT	O
refused	O
to	O
answere	O
my	O
questions	O
:	O
where	O
we	O
are	O
at	O
?	O

The	O
patient	O
is	O
a	O
47	O
year	O
old	O
patient	O
of	O
Dr	O
.	O
Laymie	O
Fournier	O
and	O
Dr	O
.	O
Leebjescobe	O
in	O
Co	O
In	O
Saorlirv	O
Frea	O
,	O
West	O
Virginia	O
who	O
was	O
well	O
until	O
a	O
bout	O
of	O
double	O
pneumonia	O
in	O
May	B-temporal
1992	I-temporal
,	O
at	O
which	O
time	O
he	O
was	O
hospitalized	O
at	O
Centdick	O
Naco	O
Hospital	O
Medical	O
Center	O
.	O

10	O
.	O
)	O
Ramipril	O
2	B-strength
.	I-strength
5	I-strength
mg	I-strength
daily	B-frequency

*	O
*	O
DATE	O
[	O
Nov	B-temporal
01	I-temporal
2007	I-temporal
]	O
22:42:59	B-temporal
/	O
drl	O

2012-11-07	B-temporal

Depression	O
.	O

7	O
.	O

A	O
Neurosurgery	O
consultation	O
was	O
obtained	O
,	O
and	O
it	O
was	O
their	O
impression	O
that	O
the	O
patient	O
&apos;s	O
paraplegia	O
might	O
possibly	B-uncertain
represent	I-uncertain
a	O
cord	B-bodyloc
concussion	O
,	O
and	O
recommended	O
treatment	O
with	O
intravenous	B-route
steroids	O
for	B-duration
24	I-duration
hours	I-duration
.	O

*	O
*	O
INITIALS	O

Phosphate	O
was	O
3	B-labvalue
.	I-labvalue
6	I-labvalue
and	O
magnesium	O
was	O
2	B-labvalue
.	I-labvalue
2	I-labvalue
.	O

Her	O
heart	O
rates	O
are	O
sinus	O
and	O
in	O
the	O
90s	B-labvalue
.	O

She	O
did	O
not	O
have	O
any	O
further	O
episodes	O
of	O
blurry	O
vision	O
or	O
chest	B-bodyloc
pain	O
.	O

Cesarean	O
section	O
x	O
2	O
,	O
dilatation	O
and	O
curettage	O
x	O
1	O
,	O
neck	O
fusion	O
after	O
motor	O
vehicle	O
accident	O
,	O
shoulder	O
surgery	O
after	O
motor	O
vehicle	O
accident	O
.	O

72	O
year	O
old	O
man	O
with	O
intraparenchymal	B-bodyloc
bleed	O
s	O
/	O
p	O
fall	O

Release	I-form
24HR	I-form
Sig	O
:	O
One	B-dosage
(	I-dosage
1	I-dosage
)	I-dosage
Capsule	B-form
,	I-form
Sust	I-form
.	I-form

-	O
*	O
*	O
NAME	O
[	O
ZZZ	O
,	O
VVV	O
M	O
]	O
.	O

6	O
.	O

12	O
.	O

She	O
has	O
had	O
a	O
biopsy	O
today	B-temporal
.	O

Discharge	O
Summary	O

Gastrointestinal	O
:	O

Extensive	O
discussion	O
was	O
held	O
,	O
and	O
second	O
opinion	O
was	O
obtained	O
regarding	O
the	O
need	O
for	O

Leukocytosis	O
-	O
resolved	B-course
.	O

*	O
*	O
INSTITUTION	O

D	O
:	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
her	O
pain	O
managed	O
by	O
the	O
postoperative	O
pain	O
service	O
using	O
nerve	O
block	O
catheters	O
,	O
IV	B-route
,	O
and	O
oral	B-route
pain	O
medications	O
.	O

AST	O
/	O
SGOT	O
176	B-labvalue
IntUnit	I-labvalue
/	I-labvalue
L	I-labvalue
High	B-labvalue

prep	O
was	O
inadequate	O
.	O

5	O
.	O

She	O
was	O
admitted	O
to	O
*	O
*	O
INSTITUTION	O
in	O
*	O
*	O
PLACE	O
,	O
PA	O
with	O
severe	B-severity
rhabdomyolysis	O
which	O
led	O
to	O
acute	B-course
tubular	O
necrosis	O
and	O
renal	B-bodyloc
failure	O
which	O
itself	O
required	O
several	O
dialysis	O
sessions	O
.	O

*	O
*	O
INSTITUTION	O
Intern	O

Insulin	O
-	O
sliding	O
scale	O
as	O
well	O
as	O
40	B-dosage
units	I-dosage
of	O
Humalog	O
in	O
the	B-frequency
a	I-frequency
.	I-frequency
m	I-frequency
.	I-frequency
and	O
20	B-dosage
at	B-frequency
night	I-frequency
.	O

SECONDARY	O
DIAGNOSIS	O
:	O

Nephrology	O
,	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
QQQ	O
]	O
.	O

CO2	O
23	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

*	O
*	O
DATE	O
[	O
Sep	B-temporal
26	I-temporal
2007	I-temporal
]	O

Follow	O
-	O
up	O
with	O
Dr	O
.	O
Williams	O
on	O
Tuesday	B-temporal
,	O
09	B-temporal
-	I-temporal
07	I-temporal
,	O
at	O
noon	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
excessive	O
alcohol	O
use	O
.	O

There	O
are	O
times	O
during	O
this	O
hospitalization	O
when	O
she	O
left	O
the	O
floor	O
against	O
medical	O
advice	O
in	O
order	O
to	O
smoke	O
cigarettes	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

The	O
patient	O
was	O
found	O
out	O
of	O
bed	O
but	O
no	B-negation
signs	O
of	O
head	B-bodyloc
trauma	O
,	O
no	B-negation
loss	O
of	O
consciousness	O
.	O

Brief	O
Hospital	O
Course	O
:	O

2010-06-28	B-temporal

This	O
could	O
represent	O
either	O
an	O
atypically	O
located	O
blood	O
clot	O
or	O
an	O
intraventricular	B-bodyloc
mass	O
,	O
and	O
further	O
evaluation	O
with	O
contrast	O
-	O
enhanced	O
MRI	O
of	O
the	O
brain	O
,	O
when	O
clinically	O
feasible	O
,	O
is	O
recommended	O
.	O

Her	O
answere	O
to	O
my	O
question	O
make	O
more	O
sense	O
.	O

380771	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

LACTATE	O
-	O
1	B-labvalue
.	I-labvalue
8	I-labvalue

EVALUATION	O
DATE	O
:	O

CV	O
:	O
RRR	O
,	O
nl	B-labvalue
s1	O
s2	O
,	O
no	B-negation
m	O
/	O
g	O
/	O
r	O

D	O
/	O
C	O
the	O
celebrex	O
.	O

She	O
is	O
weightbearing	O
as	O
tolerated	O
on	O
the	O
left	O
lower	O
extremity	O
with	O
a	O
walker	O
.	O

She	O
is	O
afebrile	O
.	O

Diabetes	O
mellitus	O
.	O

7	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
/	O
FOLLOWUP	O
:	O

Credentials	O
and	O
Title	O
of	O
Author	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
Signing	O
this	O
Document	O
:	O

She	O
is	O
being	O
returned	O
to	O
*	O
*	O
INSTITUTION	O
Harmarville	O
for	O
rehabilitation	O
training	O
given	O
her	B-bodyloc
lower	I-bodyloc
extremity	I-bodyloc
weakness	O
and	O
pain	O
.	O

Patient	O
:	O

7	O
.	O

Hct	O
36	B-labvalue
.	I-labvalue
6	I-labvalue
%	I-labvalue
Low	B-labvalue

D	O
:	O

She	O
should	O
continue	O
physical	O
therapy	O
while	O
at	O
rehabilitation	O
,	O
be	O
weightbearing	O
as	O
tolerated	O
on	O
her	O
right	O
lower	O
extremity	O
.	O

Discharge	O
Date	O
:	O

TRANSFER	O
MEDICATIONS	O
:	O

Follow	O
up	O
with	O
Dr	O
.	O
Topping	O
after	O
your	O
discharge	O
from	O
rehabilitation	O

The	O
patient	O
'	O
s	O
right	B-bodyloc
anterior	I-bodyloc
tibial	I-bodyloc
wound	O
was	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
sutures	O
intact	O
and	O
no	B-negation
erythema	O
or	O
purulence	O
noted	O
.	O

Hypo	O
or	O
hyperglycemia	O
:	O

Upon	O
discharge	O
the	O
patient	O
was	O
changed	O
to	O
a	O
BID	B-frequency
protonix	O
regimen	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

MRN	O
:	O

5	O
.	O

Muslce	O
strength	O
+	B-labvalue
4	I-labvalue
/	I-labvalue
5	I-labvalue

The	O
patient	O
was	O
advised	O
to	O
follow	O
-	O
up	O
with	O
Dr	O
.	O
Edwards	O
in	O
clinic	O
in	O
one	O
week	O
.	O

1	O
)	O
Endotracheal	O
tube	O
is	O
slightly	O
proximal	O
in	O
location	O
,	O
and	O
could	O
be	O
advanced	O
approximately	O
1	O
.	O
5	O
cm	O
for	O
more	O
optimal	O
placement	O
.	O

The	O
results	O
from	O
this	O
exam	O
are	O
as	O
follows	O
:	O

Dictator	O
:	O

AD	O
/	O
an	O
/	O
353412	O
/	O
*	O
*	O
ID	O
-	O
NUM	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

Sex	O
:	O

Drug	O
overdose	O
and	O
immobility	O
.	O

Need	O
carefully	O
to	O
investigae	O
her	O
home	O
meds	O
to	O
see	O
if	O
there	O
any	O
she	O
has	O
been	O
taking	O
but	O
we	O
did	O
not	O
give	O
to	O
her	O
.	O

GASTROESOPHAGEAL	B-bodyloc
REFLUX	O
DISEASE	O
.	O

Incidentally	O
,	O
an	O
aortogram	O
during	O
the	O
catheterization	O
revealed	O
a	O
Debakey	O
class	O
I	O
aortic	O
ascending	O
aneurysm	O
,	O
and	O
the	O
patient	O
had	O
a	O
pulmonary	O
capillary	O
wedge	O
pressure	O
of	O
20	B-labvalue
at	O
the	O
time	O
of	O
catheterization	O
.	O

Others	O
:	O

His	O
UA	O
showed	O
bilirubin	O
,	O
trace	B-severity
ketones	O
,	O
positive	O
nitrites	O
,	O
and	O
positive	O
protein	O
.	O

Eye	O
:	O
bilateral	O
:	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

Saturations	O
were	O
100	B-labvalue
%	I-labvalue
on	O
6	O
L	O
of	O
nasal	O
cannula	O
.	O

Synthroid	O
50	B-strength
mcg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
day	I-frequency
.	O

T	O
:	O

Total	O
protein	O
in	O
the	O
fluid	O
was	O
3	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
and	O
amylase	O
was	O
less	O
than	O
30	B-labvalue
,	O
and	O
LDH	O
was	O

The	O
family	O
was	O
contacted	O
early	O
in	O
the	B-temporal
morning	I-temporal
of	O
*	O
*	O
DATE	O
[	O
Dec	B-temporal
6	I-temporal
2007	I-temporal
]	O
.	O

She	O
was	O
asymptomatic	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

0	O
.	O

3	O
-	O
mm	O
noncalcified	O
pulmonary	O
nodule	O
within	O
the	O
right	B-bodyloc
lower	I-bodyloc
lobe	I-bodyloc
.	O

MRSA	O
conjunctivitis	O
,	O
*	O
*	O
DATE	O
[	O
Jan	O
]	O
attribute	O
to	O
chronic	B-course
dry	O
eyes	B-bodyloc
(	O
eyelid	B-bodyloc
problems	O
and	O
tear	B-bodyloc
duct	I-bodyloc
problem	O
)	O
PT	O
can	O
close	O
her	O
eyes	O
normally	O
.	O

Constitutional	O

Job	O
ID	O
:	O

9	O
.	O

Follow	O
up	O
with	O
*	O
*	O
INSTITUTION	O
.	O

Dict	O
:	O

Stable	O
.	O

The	O
patient	O
lives	O
in	O
Napro	O
with	O
her	O
husband	O
who	O
is	O
her	O
primary	O
caregiver	O
.	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
07	I-temporal
2008	I-temporal
]	O
12:45:40	B-temporal

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Polysubstance	O
drug	O
abuse	O
.	O

2012-06-08	B-temporal
09	B-temporal
:	I-temporal
30	I-temporal
AM	I-temporal
BLOOD	O
Calcium	O
-	O
10	B-labvalue
.	I-labvalue
4	I-labvalue
*	O
Phos	O
-	O
2	B-labvalue
.	I-labvalue
8	I-labvalue
Mg	O
-	O
1	B-labvalue
.	I-labvalue
8	I-labvalue

He	O
is	O
adamant	O
against	O
acute	O
inpatient	O
rehabilitation	O
.	O

2	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
9:46:00	B-temporal

David	O
Thomas	O
MD	O
60	O
-	O
008	O

Hypertension	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

MEDICINE	O

Head	O
CT	O
demonstrated	O
no	B-negation
evidence	O
of	O
intracranial	B-bodyloc
bleeding	O
.	O

*	O
*	O
ROOM	O

After	O
approximately	O
20	O
to	O
30	O
minutes	O
,	O
the	O
patient	O
developed	O
an	O
agonal	O
respiration	O
and	O
was	O
declared	O
dead	O
.	O

The	O
patient	O
was	O
kept	O
in	O
the	O
hospital	O
and	O
the	O
following	O
issues	O
were	O
addressed	O
:	O

REASON	O
FOR	O
ADMISSION	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
,	O
and	O
she	O
will	O
follow	O
up	O
with	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
TTT	O
]	O
as	O
instructed	O
.	O

4	O
.	O

*	O
*	O
NAME	O
[	O
AAA	O
,	O
BBB	O
]	O

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

ACCOUNT	O
#	O
:	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

Mental	O
Status	O
.	O

Her	O
bowel	O
regimen	O
is	O
prn	O
.	O

3	O
.	O

Abdomen	O
:	O

s	O
/	O
p	O
Fall	O

D	O
:	O

ABS	O
Basophils	O
0	B-labvalue
.	I-labvalue
0	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

DISCHARGE	O
INSTRUCTIONS	O
:	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
.	O

54818584	O

The	O
left	O
clavicle	O
was	O
noted	O
to	O
have	O
continued	O
ecchymosis	O
decreased	O
from	O
prior	B-temporal
examination	O
with	O
a	O
minor	O
stepoff	O
and	O
mild	B-severity
tenderness	O
to	O
palpation	O
decreased	O
from	O
prior	B-temporal
examinations	O
.	O

No	B-negation
abdominal	B-bodyloc
pain	O
.	O

Heart	O
was	O
regular	B-labvalue
in	O
rate	O
and	O
rhythm	O
.	O

Female	O

No	B-negation
LE	B-bodyloc
edema	O
.	O

I	O
agree	O
with	O
their	O
note	O
as	O
written	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

*	O
*	O
ID	O
-	O
NUM	O

Progress	O
*	O
*	O
INSTITUTION	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

.	O
.	O

2	O
.	O

Patient	O
was	O
started	O
on	O
heparin	O
drip	B-route
and	O
bilateral	O
lower	O
extremeties	O
were	O
done	O
which	O
were	O
negative	B-labvalue
for	O
DVT	O
.	O

T	O
:	O

Discharge	O
Medications	O
:	O

The	O
patient	O
fell	O
well	O
on	O
the	O
day	O
of	O
discharge	O
.	O

Continue	O
Sliding	B-dosage
scale	I-dosage
insulin	O
as	B-frequency
needed	I-frequency
.	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
27	I-temporal
2007	I-temporal
]	O
20:29:40	B-temporal

2	O
.	O
)	O
CAD	O
s	O
/	O
p	O
3v	O
-	O
CABG	O
2003	O
and	O
subsequent	O
stenting	O
of	O
SVG	O
and	O
LIMA	O

For	O
detail	O
description	O
of	O
this	O
procedure	O
please	O
see	O
the	O
operative	O
note	O
dated	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
10	I-temporal
2007	I-temporal
]	O
.	O

The	O
patient	O
'	O
s	O
lung	O
examination	O
revealed	O
the	O
lungs	O
to	O
be	O
clear	B-labvalue
to	O
auscultation	O
bilaterally	O
,	O
no	B-negation
crepitus	O
,	O
and	O
a	O
left	B-bodyloc
clavicular	I-bodyloc
deformity	O
was	O
grossly	O
apparent	O
on	O
examination	O
.	O

The	O
patient	O
was	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
(	O
Dr	O
.	O
Desmet	O
)	O
,	O
as	O
well	O
as	O

He	O
received	O
cardizem	O
,	O
loressorxl	O
,	O
lisinopril	O
today	B-temporal
.	O

*	O
*	O
NAME	O
[	O
VVV	O
WWW	O
]	O
,	O
R	O
.	O
N	O
.	O

CONSULTANTS	O
DURING	O
THIS	O
HOSPITALIZATION	O
:	O

At	O
surgery	O
,	O
the	B-bodyloc
descending	I-bodyloc
aorta	I-bodyloc
was	O
noted	O
to	O
be	O
calcified	O
,	O
and	O
an	O
intraoperative	O
transesophageal	O
echocardiogram	O
revealed	O
an	O
irregular	O
intra	B-bodyloc
-	I-bodyloc
aortic	I-bodyloc
pedunculated	O
lesion	O
.	O

Alcohlic	O
liver	B-bodyloc
disease	O

It	O
was	O
negative	O
for	O
malignant	O
cells	O
,	O
mild	B-severity
chronic	B-course
inflammation	O
.	O

GERD	O
L	O
knee	O
arthroscopy	O
2005	B-temporal

One	O
dialysis	O
session	O
to	O
draw	O
off	O
fluid	O
from	O
her	O
lungs	B-bodyloc
.	O

The	O
patient	O
was	O
started	O
on	O
cefotaxime	O
1	B-strength
gm	I-strength
IV	B-route
for	O
empiric	O
antibiotic	O
treatment	O
.	O

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

The	O
patient	O
was	O
worked	O
up	O
for	O
acute	B-course
renal	B-bodyloc
failure	O
.	O

He	O
was	O
instructed	O
not	O
to	O
restart	O
these	O
until	O
seen	O
by	O
Dr	O
.	O
Ercek	O
.	O

His	O
BUN	O
is	O
15	B-labvalue
,	O
creatinine	O
1	B-labvalue
.	I-labvalue
1	I-labvalue
.	O

He	O
also	O
was	O
having	O
agonal	O
respirations	O
.	O

The	O
highest	O
fever	O
she	O
had	O
was	O
on	O
*	O
*	O
DATE	O
[	O
Oct	B-temporal
29	I-temporal
07	I-temporal
]	O
,	O
which	O
was	O
102	O
.	O
1	O
.	O

Results	O
Review	O

Release	I-form
24HR	I-form
PO	B-route
HS	B-frequency
(	O
at	B-frequency
bedtime	I-frequency
)	O
.	O

On	O
2/28/00	B-temporal
,	O
the	O
patient	O
&apos;s	O
diet	O
was	O
advanced	O
to	O
a	O
low	O
fat	O
solids	O
(	O
per	O
pancreatitis	O
study	O
)	O
,	O
which	O
the	O
patient	O
tolerated	O
well	O
.	O

recheck	O
VS	O
again	O
.	O

There	O
was	O
no	B-negation
significant	O
erythema	O
and	O
after	O
postoperative	O
day	B-temporal
two	I-temporal
no	B-negation
drainage	O
of	O
the	B-bodyloc
left	I-bodyloc
hip	I-bodyloc
wound	O
.	O

2	O
.	O

Hep	O
C	O

3	O
.	O
)	O
R	O
intracerebral	O
hemorrhage	O
drainage	O

She	O
received	O
three	O
stents	O
to	O
the	O
right	O
coronary	O
artery	O
which	O
was	O
complicated	O
by	O
a	O
proximal	O
dissection	O
.	O

1	O
.	O
)	O
C4	O
-	O
7	O
anterior	O
discectomies	O

VERIFY	O
by	O
*	O
*	O
NAME	O
[	O
VVV	O
,	O
UUU	O
]	O

*	O
*	O
INITIALS	O

A5B	O
/	O
1	O

While	O
the	O
patient	O
was	O
in	O
restraints	O
,	O
gentle	O
hydration	O
was	O
initiated	O
since	O
p	O
.	O
o	O
.	O
intake	O
was	O
not	O
adequate	O
.	O

Age	O
:	O

On	O
08	O
/	O
05	O
it	O
was	O
noted	O
that	O
his	O
platelet	O
count	O
had	O
fallen	O
from	O
171	B-labvalue
,	I-labvalue
000	I-labvalue
to	I-labvalue
54	I-labvalue
,	I-labvalue
000	I-labvalue
;	O
this	O
was	O
thought	O
to	O
be	O
associated	O
with	O
intravenous	B-route
Heparin	O
and	O
indeed	O
,	O
when	O
Heparin	O
was	O
discontinued	O
,	O
since	O
it	O
had	O
been	O
restarted	O
after	O
surgery	O
,	O
his	O
platelet	O
count	O
rebounded	O
to	O
normal	B-labvalue
.	O

General	O
Plan	O

10	B-temporal
:	I-temporal
46	I-temporal

*	O
*	O
INSTITUTION	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
16	I-temporal
2008	I-temporal
]	O
17	B-temporal
:	I-temporal
01	I-temporal
)	O

During	O
her	O
hospitalization	O
,	O
the	O
patient	O
was	O
also	O
seen	O
by	O
the	O
Plastic	O
Service	O
.	O

She	O
was	O
pain	O
free	O
on	O
the	O
day	O
of	O
discharge	O
.	O

Health	O
Status	O

Progress	O
*	O
*	O
INSTITUTION	O

Hypertension	O

disease	O
.	O

See	O
Delirium	O
in	O
below	O
.	O

She	O
denies	B-negation
any	O
fever	O
or	O
chills	O
or	O
shortness	O
of	O
breath	O
.	O

Talked	O
to	O
her	O
nurse	O
,	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
27	I-temporal
07	I-temporal
]	O

Coronary	B-bodyloc
artery	I-bodyloc
disease	O
.	O

HOSPITAL	O
COURSE	O
:	O

CTA	O
.	O

Heparin	O
(	O
Porcine	O
)	O
5	B-strength
,	I-strength
000	I-strength
unit	I-strength
/	I-strength
mL	I-strength
Solution	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Injection	B-route
TID	B-frequency
(	O
3	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
.	O

Sex	O
:	O

General	O
Exam	O

2012-06-07	B-temporal
09	B-temporal
:	I-temporal
55	I-temporal
PM	I-temporal
BLOOD	O
PT	O
-	O
12	B-labvalue
.	I-labvalue
8	I-labvalue
PTT	O
-	O
25	B-labvalue
.	I-labvalue
7	I-labvalue
INR	O
(	O
PT	O
)	O
-	O
1	B-labvalue
.	I-labvalue
0	I-labvalue

4	O
.	O

Vital	O
signs	O
:	O

Albumin	O
1	B-labvalue
.	I-labvalue
4	I-labvalue
gm	I-labvalue
/	I-labvalue
dL	I-labvalue
Low	B-labvalue

Anasarca	O

Folate	O
1	B-strength
mg	I-strength
po	B-route
qd	B-frequency

Acct	O
#	O
:	O

Stenosis	O
of	O
thoracic	B-bodyloc
aorta	I-bodyloc
(	O
SNMCT	O
*	O
*	O
ID	O
-	O
NUM	O
,	O
Working	O
,	O
Problem	O
)	O

On	O
08/02/93	B-temporal
,	O
an	O
intra	O
-	O
aortic	O
balloon	O
pump	O
was	O
placed	O
;	O
then	O
,	O
Dr	O
.	O
Thorebreutz	O
took	O
him	O
to	O
the	O
operating	O
room	O
,	O
where	O
he	O
had	O
quadruple	O
coronary	O
artery	O
bypass	O
grafting	O
.	O

Zantac	O
150	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-duration
.	I-duration
i	I-duration
.	I-duration
d	I-duration
.	I-duration

The	O
patient	O
was	O
seen	O
at	O
*	O
*	O
INSTITUTION	O
ER	O
about	O
2	O
days	O
prior	O
to	O
this	O
admission	O
and	O
left	O
AMA	O
when	O
she	O
was	O
told	O
that	O
she	O
will	O
be	O
admitted	O
.	O

Indication	O
with	O
a	O
cardiac	O
catheterization	O
showed	O
that	O
the	O
patient	O
had	O
a	O
severe	B-course
coronary	B-bodyloc
artery	I-bodyloc
disease	O
,	O
and	O
therefore	O
,	O
a	O
consult	O
was	O
placed	O
for	O
the	O
cardiothoracic	O
surgeon	O
for	O
a	O
coronary	O
artery	O
bypass	O
graft	O
.	O

FY2	O
Resident	O

An	O
electrocardiogram	O
was	O
checked	O
which	O
revealed	O
no	B-negation
ST	O
changes	O
,	O
and	O
there	O
was	O
no	O
increase	O
in	O
her	O
downward	O
trending	O
creatine	O
phosphokinases	O
.	O

*	O
*	O
PLACE	O
,	O
PA	O
*	O
*	O
ZIP	O
-	O
CODE	O

3	O
.	O

Provider	O
:	O
Lucio	O
F	O
.	O

STRUCTURALLY	O
NORMAL	O
MITRAL	O
AND	O
TRICUSPID	O
VALVE	O
.	O

INSULIN	O
DEPENDENT	O
DIABETES	O
MELLITUS	O
.	O

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

gen	O
-	O
lying	O
in	O
bed	O
,	O
NAD	O

T	O
:	O

11	O
.	O

Coumadin	O
resumed	O
2	O
days	O
ago	O
,	O
Coumadin	O
reach	O
therapuetic	O
,	O
D	O
/	O
C	O
heparin	O
SQ	O

While	O
his	O
vital	O
signs	O
were	O
been	O
taken	O
,	O
he	O
was	O
complaining	O
of	O
acute	B-course
shortness	O
of	O
breath	O
and	O
inability	O
to	O
breath	O
.	O

She	O
underwent	O
the	O
procedure	O
and	O
tolerated	O
the	O
procedure	O
very	O
well	O
.	O

Coumadin	O
2	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
at	I-frequency
night	I-frequency
.	O

IMPRESSION	O
:	O
No	B-negation
new	B-bodyloc
cortical	I-bodyloc
territorial	O
infarction	O
or	O
hemorrhage	O
is	O
identified	O
.	O

Respiratory	O
failure	O
:	O

1	O
.	O

4	O
.	O

QQQ	O
]	O
,	O
M	O
.	O
D	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Clear	O
.	O

*	O
*	O
INSTITUTION	O
ADMISSION	O
:	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

T	O
:	O

Milk	O
of	O
magnesia	O
by	B-route
mouth	I-route
daily	B-frequency
suspension	B-form
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency
for	O
constipation	O
.	O

ABDOMEN	O
:	O

Thiamine	O
100	B-strength
mg	I-strength
p	B-form
.	I-form
o	I-form
.	I-form
daily	B-frequency
.	O

O8919E48	O

ATE	O
OF	O
DEATH	O
:	O

4	B-labvalue
/	I-labvalue
5	I-labvalue
motor	O
strength	O
in	O
the	O
upper	O
extremities	O
bilaterally	O
.	O

Sensation	O
was	O
intact	B-labvalue
to	O
pain	O
and	O
light	O
touch	O
.	O

She	O
did	O
hit	O
her	O
head	O
she	O
states	O
when	O
she	O
passed	O
out	O
recently	O
at	O
home	O
.	O

Evaluated	O
by	O
neurosurgery	O
and	O
deemed	O
stable	O
on	O
2014-10-22	B-temporal
.	O

It	O
was	O
felt	O
to	O
be	O
pain	O
secondary	O
to	O
her	O
self	O
-	O
extubation	O
and	O
noncardiac	O
chest	B-bodyloc
pain	O
.	O

2014-04-23	B-temporal
03	B-temporal
:	I-temporal
45	I-temporal
PM	I-temporal
URINE	O

5	O
.	O

3	O
.	O

Although	O
an	O
initial	O
DRE	O
showed	O
only	O
clot	O
,	O
he	O
later	O
passed	O
a	O
large	O
,	O
bloody	O
bowel	B-bodyloc
movement	O
,	O
and	O
his	O
bp	O
nadired	O
to	O
the	O
low	O
90	O
'	O
s	O
but	O
rested	O
there	O
only	O
transiently	O
and	O
easily	O
rebounded	O
to	O
the	O
130	O
'	O
s	O
-	O
140	O
'	O
s	O
with	O
fluid	O
;	O
he	O
then	O
went	O
to	O
angiography	O
for	O
a	O
tagged	O
RBC	O
scan	O
where	O
they	O
found	O
and	O
embolized	O
two	O
vessels	O
to	O
the	O
sigmoid	O
colon	O
.	O

Date	O
of	O
Birth	O
:	O

3	O
.	O
)	O
CHF	O
with	O
EF	O
30	B-labvalue
-	I-labvalue
35	I-labvalue
%	I-labvalue
on	O
07	B-temporal
-	I-temporal
10	I-temporal
echo	O

Margaret	O
'	O
s	O
Center	O
for	O
Women	O
&	O
Infants	O
,	O
the	O
patient	O
was	O
lethargic	O
and	O
unable	O
to	O
give	O
a	O
history	O
.	O

9	O
.	O

7	O
.	O

425615	O

thiamine	O
,	O
100	B-strength
mg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Drug	O
Form	O
:	O
Tab	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
9:00:00	B-temporal

She	O
also	O
complained	O
of	O
some	O
loose	O
stools	O
on	O
the	O
day	O
of	O
admission	O
,	O
no	B-negation
nausea	O
or	O
vomiting	O
.	O

PAST	O
OBSTETRICAL	O
HISTORY	O
:	O

Hypercholesterolemia	O
.	O

ACCOUNT	O
#	O
:	O

Continue	O
accuchecks	O
+	O
SSI	O
and	O
Lantus	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
19	I-temporal
2007	I-temporal
]	O
16	B-temporal
:	I-temporal
43	I-temporal
)	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
10	B-temporal
:	I-temporal
00	I-temporal
AM	I-temporal

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

2013-11-04	B-temporal

*	O
*	O
DATE	O
[	O
Aug	B-temporal
07	I-temporal
2007	I-temporal
]	O
01:19:40	B-temporal

He	O
felt	O
well	O
at	O
home	O
without	B-negation
fevers	O
,	O
chills	O
or	O
rigors	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
11	B-temporal
:	I-temporal
34	I-temporal
)	O

MRN	O
-	O
*	O
*	O
ID	O
-	O
NUM	O
-	O
MPACCOMMMRN	O

ABS	O
Neutrophils	O
5	B-labvalue
.	I-labvalue
7	I-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

*	O
*	O
DATE	O
[	O
Nov	B-temporal
18	I-temporal
2007	I-temporal
]	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

Attending	O
:	O

Family	O
History	O
:	O

Abdomen	O
:	O
bowel	O
sounds	O
:	O
normal	B-labvalue
.	O

Asthma	O
.	O

His	O
preoperative	O
fluid	O
management	O
has	O
been	O
difficulty	O
and	O
postoperatively	O
he	O
was	O
transferred	O
to	O
the	O
intensive	O
care	O
,	O
intubated	O
,	O
sedated	O
and	O
mechanically	O
ventilated	O
.	O

Tran	O
:	O

He	O
was	O
admitted	O
to	O
12D	O
.	O

2012-06-09	B-temporal

2014-04-23	B-temporal
08	B-temporal
:	I-temporal
00	I-temporal
AM	I-temporal
URINE	O

-	O
check	O
A1c	O
:	O
6	B-labvalue
.	I-labvalue
3	I-labvalue
on	O
*	O
*	O
DATE	O
[	O
Sep	B-temporal
15	I-temporal
07	I-temporal
]	O

Stable	O
-	O
Swelling	O
in	O
hands	B-bodyloc
reduced	O
and	O
range	O
of	O
motion	O
continue	O
to	O
improve	O
.	O

Milk	O
of	O
Magnesia	O
30	B-dosage
cc	I-dosage
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
day	I-frequency
constipation	O
.	O

He	O
noted	O
that	O
the	O
patient	O
had	O
history	O
of	O
normal	B-labvalue
MRI	O
s	O
of	O
the	O
brain	O
,	O
thoracic	O
spine	O
,	O
lumbar	O
spine	O
,	O
and	O
cervical	O
spine	O
.	O

Dictator	O
:	O

Asked	O
me	O
to	O
leave	O
her	O
alone	O
.	O

The	O
etiology	O
for	O
his	O
congestive	O
heart	B-bodyloc
failure	O
was	O
determined	O
likely	O
to	O
be	O
diastolic	O
dysfunction	O
from	O
increased	O
heart	B-bodyloc
rate	O
as	O
well	O
as	O
excess	O
volume	O
.	O

MRN	O
-	O
*	O
*	O
ID	O
-	O
NUM	O
-	O
MPACCOMMMRN	O

-	O
Hold	O
her	O
lisinopril	O
due	O
to	O
renal	B-bodyloc
fuction	O
getting	O
bad	O
.	O

albuterol	O
-	O
ipratropium	O
(	O
DuoNeb	O
)	O
(	O
ALBUTEROL	O
/	O
IPRATROP	O
3	B-strength
MG	I-strength
/	O
0	B-strength
.	I-strength
5	I-strength
MG	I-strength
/	O
3	B-dosage
ML	I-dosage
)	O
,	O
3	B-dosage
mL	I-dosage
,	O
Solution	B-form
,	O
Inhalation	B-route
,	O
QID	B-frequency
,	O
PRN	B-frequency
,	O
For	O
Dyspnea	O
,	O
Routine	O
,	O

Her	O
heart	O
was	O
regular	O
.	O

*	O
*	O
INSTITUTION	O

*	O
*	O
CARBON	O
-	O
COPY	O

INSTRUCTIONS	O
:	O

Chest	O
x	O
-	O
ray	O
done	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
28	I-temporal
2007	I-temporal
]	O
,	O
that	O
showed	O
no	O
change	O
compared	O
to	O
the	O
previous	B-temporal
exam	O
.	O

ADDENDUM	O
:	O

General	O
results	O

The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
slight	O
hematocrit	O
drop	O
and	O
was	O
transfused	O
one	O
unit	O
of	O
packed	O
red	O
blood	O
cells	O
for	O
a	O
goal	O
hematocrit	O
of	O
greater	B-labvalue
than	I-labvalue
30	I-labvalue
.	O

She	O
was	O
then	O
admitted	O
again	O
on	O
2016-03-30	B-temporal
for	O
an	O
elective	O
coronary	O
artery	O
bypass	O
graft	O
.	O

He	O
stabilized	O
over	O
the	O
weekend	O
.	O

Prophylaxis	O
.	O

The	O
patient	O
was	O
then	O
followed	O
in	O
the	O
cardiac	O
critical	O
care	O
unit	O
where	O
he	O
had	O
evidence	O
of	O
anoxic	O
encephalopathy	O
.	O

Sertraline	O
20	B-strength
mg	I-strength
/	I-strength
mL	I-strength
Concentrate	B-form
Sig	O
:	O
Two	B-dosage
(	I-dosage
2	I-dosage
)	I-dosage
PO	B-route
at	B-frequency
bedtime	I-frequency
.	O

There	O
is	O
no	B-negation
evidence	O
of	O
obstruction	O
on	O
AXR	O
.	O

ALT	O
(	O
SGPT	O
)	O
-	O
21	B-labvalue
AST	O
(	O
SGOT	O
)	O
-	O
40	B-labvalue
ALK	O
PHOS	O
-	O
70	B-labvalue
AMYLASE	O
-	O
59	B-labvalue
TOT	O
BILI	O
-	O
0	B-labvalue
.	I-labvalue
4	I-labvalue

8	O
.	O

DEATH	O
SUMMARY	O

Sign	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
M	O

*	O
*	O
INITIALS	O

Job	O
ID	O
:	O

The	O
epidural	O
was	O
discontinued	O
on	O
07/26/99	B-temporal
and	O
was	O
considered	O
a	O
successful	O
trial	O
.	O

Stable	O

Pt	O
home	O
regimen	O
as	O
Lopressor	O
and	O
Lisinopril	O
.	O

Monday	O
and	O
Thursday	O
blood	O
draws	O
for	O
PT	O
and	O
INR	O
.	O

Arterial	O
blood	O
gas	O
at	O
3	B-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal
demonstrated	O
7	B-labvalue
.	I-labvalue
4/45/125	I-labvalue
.	O

H	O
/	O
O	O
GI	O
bleeding	O
.	O

The	O
patient	O
continued	O
to	O
do	O
well	O
on	O
the	O
medical	O
regimen	O
and	O
was	O
without	B-negation
chest	B-bodyloc
pain	O
,	O
shortness	O
of	O
breath	O
,	O
or	O
any	O
other	O
symptoms	O
.	O

The	O
problems	O
and	O
management	O
are	O
as	O
follows	O
:	O

The	O
situation	O
was	O
reviewed	O
with	O
his	O
wife	O
,	O
Sligh	O
.	O

These	O
results	O
should	O
be	O
called	O
at	O
*	O
*	O
ID	O
-	O
NUM	O
by	O
2	O
p	O
.	O
m	O
.	O
on	O
the	O
day	O
of	O
draw	O
.	O

She	O
is	O
on	O
metformin	O
and	O
will	O
remain	O
on	O
metformin	O
.	O

Benign	B-severity
prostatic	O
hypertrophy	O
status	O
post	O
transurethral	O
resection	O
of	O
the	O
prostate	O
;	O
self	O
catheterization	O
.	O

Platelets	O
167	B-labvalue
X10E	I-labvalue
+	I-labvalue
09	I-labvalue
/	I-labvalue
L	I-labvalue

Matthews	O
,	O
M	O
.	O
D	O
.	O

Physical	O
Examination	O

Dictator	O
:	O

*	O
*	O
ID	O
-	O
NUM	O

VERIFY	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

Lactulose	O
decreased	O
from	O
TID	O
to	O
daily	B-frequency
.	O

SLE	O
.	O

2014-04-23	B-temporal

SON	O
RHALT	O
,	O
SUBINTERN	O
.	O

For	O
completeness	O
,	O
the	O
patient	O
'	O
s	O
complete	O
past	O
medical	O
history	O
:	O

She	O
is	O
afebrile	O
.	O

The	O
patient	O
finally	O
expired	O
on	O
*	O
*	O
DATE	O
[	O
Aug	B-temporal
27	I-temporal
2007	I-temporal
]	O
.	O

Others	O
:	O

She	O
is	O
currently	B-temporal
on	O
Vicodin	O
,	O
one	O
to	O
two	B-dosage
tablets	B-form
every	B-frequency
four	I-frequency
hours	I-frequency
p	O
.	O
r	O
.	O
n	O
.	O
,	O
Fentanyl	O
patch	B-form
25	B-strength
mcg	I-strength
an	I-strength
hour	I-strength
,	O
change	O
of	O
patch	B-form
every	B-frequency
72	I-frequency
hours	I-frequency
,	O
Elavil	O
50	B-strength
mgq	I-strength
.	B-frequency
h	I-frequency
.	I-frequency
s	I-frequency
.	I-frequency
,	O
Neurontin	O
600	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
with	O
still	O
what	O
she	O
reports	O
as	O
stabbing	O
left	O
-	O
sided	O
chest	B-bodyloc
pain	O
that	O
can	O
be	O
as	O
severe	B-severity
as	O
a	O
7	B-severity
/	I-severity
10	I-severity
.	I-severity

Clozapine	O
25	B-strength
mg	I-strength
Tablet	B-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
HS	B-frequency
(	O
at	B-frequency
bedtime	I-frequency
)	O
.	O

*	O
*	O
NAME	O
[	O
WWW	O
XXX	O
]	O

Electronically	O
Signed	O
by	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O

8	O
.	O

Dr	O
.	O
Valerio	O
office	O
was	O
notified	O
about	O
the	O
patient	O
'	O
s	O
discharge	O
plans	O
and	O
status	O
.	O

EVALUATION	O
DATE	O
:	O

36	B-labvalue
.	I-labvalue
7	I-labvalue
degrees	I-labvalue
Celsius	I-labvalue
.	O

Na	O
140	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

FOLLOWUP	O
INSTRUCTIONS	O
:	O

Vital	O
signs	O
:	O
normal	B-labvalue

She	O
states	O
that	O
her	O
dizziness	O
did	O
start	O
after	O
that	O
fall	O
.	O

XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

The	O
patient	O
did	O
well	O
postoperatively	O
,	O
however	O
,	O
she	O
did	O
have	O
a	O
small	O
amount	O
of	O
drainage	O
from	O
her	O
incision	O
site	O
which	O
was	O
serous	O
in	O
nature	O
.	O

There	O
is	O
a	O
patchy	O
area	O
of	O
increased	B-course
opacity	O
in	O
the	O
left	B-bodyloc
retrocardiac	I-bodyloc
region	I-bodyloc
,	O
which	O
was	O
not	O
seen	O
on	O
the	O
earlier	O
study	O
.	O

Congestive	O
heart	B-bodyloc
failure	O
.	O

He	O
was	O
subsequently	O
given	O
supplemental	O
oxygen	O
.	O

HOSPITAL	O
COURSE	O
:	O

There	O
was	O
no	B-negation
induration	O
.	O

Hypoxia	O
:	O

*	O
*	O
INSTITUTION	O

1	O
Temporal	B-bodyloc
arteritis	O
.	O

DATE	O
OF	O
ADMISSION	O
:	O

It	O
was	O
felt	O
that	O
she	O
could	O
be	O
followed	O
up	O
on	O
an	O
outpatient	O
basis	O
for	O
her	O
renal	B-bodyloc
insufficiency	O
,	O
and	O
her	O
creatinine	O
was	O
at	O
her	O
baseline	O
in	O
2006	B-temporal
,	O
at	O
1	B-labvalue
.	I-labvalue
5	I-labvalue
.	O

Discharge	O
Summary	O

She	O
is	O
a	O
*	O
*	O
AGE	O
[	O
in	O
30s	O
]	O
-	O
year	O
-	O
old	O
white	O
female	O
with	O
a	O
history	O
of	O
diabetes	O
and	O
end	B-severity
-	I-severity
stage	I-severity
renal	B-bodyloc
disease	O
,	O
dialysis	O
dependent	O
on	O
Mondays	B-temporal
,	I-temporal
Wednesdays	I-temporal
,	I-temporal
Fridays	I-temporal
,	I-temporal
and	I-temporal
Saturdays	I-temporal
,	O
who	O
comes	O
in	O
with	O
a	O
3	B-temporal
-	I-temporal
to	I-temporal
4	I-temporal
-	I-temporal
day	I-temporal
history	O
of	O
diarrhea	O
.	O

The	O
patient	O
'	O
s	O
CBC	O
showed	O
a	O
WBC	O
count	O
of	O
21	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
hemoglobin	O
12	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
hematocrit	O
of	O
36	B-labvalue
.	I-labvalue
8	I-labvalue
,	O
and	O
MCV	O
of	O
105	B-labvalue
,	O
MCH	O
of	O
36	B-labvalue
.	I-labvalue
3	I-labvalue
with	O
platelets	O
of	O
177	B-labvalue
.	O

Family	O
health	O
clinic	O
service	O
.	O

9	O
.	O

*	O
*	O
DATE	O
[	O
Dec	B-temporal
11	I-temporal
2007	I-temporal
]	O
04:51:51	B-temporal
PM	I-temporal

SOCIAL	O
HISTORY	O
:	O

Discharge	O
Date	O
:	O

unremarkable	O
.	O

07/30/93	B-temporal
:	O

NORMAL	O
RIGHT	O
VENTRICULAR	O
DIMENSION	O
AND	O
CONTRACTILITY	O
.	O

RDW	O
16	B-labvalue
.	I-labvalue
4	I-labvalue
%	I-labvalue
High	B-labvalue

BLOOD	O
-	O
LG	B-labvalue
NITRITE	O
-	O
NEG	B-labvalue
PROTEIN	O
-	O
NEG	B-labvalue

No	B-negation
chest	B-bodyloc
pain	O
.	O

Age	O
:	O

I	O
am	O
managing	O
this	O
critically	O
ill	O
,	O
*	O
*	O
AGE	O
[	O
in	O
40s	O
]	O
-	O
year	O
-	O
old	O
male	O
,	O
who	O
is	O
recovering	O
from	O
pancreatitis	O
.	O

87	B-labvalue
.	I-labvalue
2	I-labvalue
kgs	I-labvalue
.	O

Chest	O
(	O
PA	O
and	O
lateral	O
)	O
on	O
2/25/00	B-temporal
-	O
Lungs	O
were	O
clear	O
.	O

Endocrine	O
-	O
h	O
/	O
o	O
DM	O
.	O

Plan	O

Cardiac	O
examination	O
demonstrated	O
regular	B-labvalue
rate	O
and	O
rhythm	O
,	O
no	B-negation
murmurs	O
,	O
rubs	O
,	O
or	O
gallops	O
.	O

2/3/1992	B-temporal
12:00:00	B-temporal
AM	I-temporal

Current	O
weight	O
conversion	O
72	B-labvalue
.	I-labvalue
7	I-labvalue
kg	I-labvalue

Her	O
BNP	O
was	O
checked	O
and	O
found	O
to	O
be	O
347	B-labvalue
.	O

Acute	B-course
tubular	O
necrosis	O
secondary	O
to	O
#	O
4	O
.	O

Clopidogrel	O
75	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

Levofloxacin	O
250	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
24h	I-frequency
.	I-frequency
x3	B-duration
days	I-duration
.	O

Chest	O
x	O
-	O
ray	O
showed	O
a	O
large	O
pleural	O
-	O
based	O
opacity	O
in	O
the	B-bodyloc
right	I-bodyloc
mid	I-bodyloc
lung	I-bodyloc
consistent	O
with	O
atelectasis	O
and	O
no	B-negation
pneumonia	O
.	O

A	O
nasal	O
swab	O
,	O
which	O
has	O
been	O
done	O
.	O

Coronary	B-bodyloc
artery	I-bodyloc
disease	O
status	O
post	O
stenting	O
.	O

I	O
have	O
seen	O
and	O
examined	O
the	O
patient	O
,	O
reviewed	O
his	O
laboratory	O
,	O
radiographic	O
,	O
and	O
EMTEK	O
data	O
and	O
discussed	O
the	O
management	O
with	O
the	O
general	O
surgeons	O
.	O

Ascites	O
status	O
post	O
paracentesis	O
of	O
2	O
.	O
5	O
L	O
.	O

Author	O
:	O

SOCIAL	O
HISTORY	O
:	O

Metoprolol	O
Succinate	O
25	B-strength
mg	I-strength
Tablet	B-form
Sustained	I-form
Release	I-form
24HR	I-form
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
Sustained	I-form
Release	I-form
24HR	I-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
.	O

Supporting	O
tubes	O
and	O
lines	O
are	O
in	O
unchanged	O
position	O
and	O
the	O
patient	O
has	O
a	O
single	O
lead	O
pacemaker	O
projected	O
on	O
the	O
left	O
.	O

*	O
*	O
NAME	O
[	O
YYY	O
M	O
ZZZ	O
]	O

*	O
*	O
ID	O
-	O
NUM	O

Her	O
lungs	O
are	O
clear	O
and	O
she	O
is	O
doing	O
well	O
.	O

Professional	O
Services	O

Home	O
oxygen	O
at	O
two	O
liters	O
a	O
minute	O
when	O
she	O
is	O
at	O
home	O
;	O
she	O
does	O
not	O
use	O
the	O
oxygen	O
when	O
she	O
is	O
in	O
a	O
wheelchair	O
or	O
is	O
out	O
of	O
the	O
house	O
.	O

5	O
.	O

On	O
the	O
day	O
prior	O
to	O
discharge	O
,	O
his	O
intravenous	B-route
antibiotics	O
were	O
discontinued	O
and	O
he	O
was	O
begun	O
on	O
tetracycline	O
.	O

DISCHARGE	O
CONDITION	O
:	O

The	O
patient	O
was	O
discharged	O
on	O
09	B-temporal
-	I-temporal
02	I-temporal
.	O

*	O
*	O
ID	O
-	O
NUM	O

PSH	O
:	O

A	O
consult	O
was	O
placed	O
to	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
.	O

Perform	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

T	O
:	O

Name	O
:	O

Course	O

She	O
is	O
at	O
approximately	O
40	O
%	O
risk	O
of	O
having	O
hyperglycemia	O
.	O

HEMATOLOGY	O
-	O
ONCOLOGY	O

S1	O
and	O
S2	O
heard	O
.	O

She	O
stated	O
that	O
her	O
blood	O
pressure	O
have	O
been	O
running	O
above	O
140	B-labvalue
a	O
week	O
and	O
when	O
it	O
was	O
checked	O
in	O
the	O
ED	O
,	O
it	O
was	O
over	O
200	B-labvalue
systolic	O
,	O
100	B-labvalue
diastolic	O
.	O

Extended	O
Care	O

She	O
did	O
report	O
having	O
some	O
pain	O
and	O
was	O
reluctant	O
to	O
participate	O
fully	O
with	O
physical	O
therapy	O
until	O
postoperative	O
day	B-temporal
5	I-temporal
.	O

5	O
.	O

XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

2014-10-21	B-temporal
9	B-temporal
:	I-temporal
59	I-temporal
AM	I-temporal

Patient	O
:	O

2014-04-23	B-temporal
07	B-temporal
:	I-temporal
56	I-temporal
AM	I-temporal

During	O
this	O
hospitalization	O
she	O
was	O
seen	O
in	O
consultation	O
by	O
Cardiology	O
who	O
did	O
not	O
feel	O
that	O
the	O
patient	O
had	O
intrinsic	O
heart	B-bodyloc
disease	O
despite	O
the	B-bodyloc
elevated	I-bodyloc
BNP	O
.	O

The	O
ventricles	O
do	O
not	O
appear	O
dilated	O
relative	O
to	O
the	O
sulci	O
,	O
and	O
there	O
is	O
no	B-negation
shift	O
of	O
normally	O
midline	O
structures	O
.	O

No	B-negation
murmur	O
or	O
gallop	O
.	O

levothyroxine	O
,	O
100	B-strength
mcg	I-strength
,	O
By	B-route
Mouth	I-route
,	O
Daily	B-frequency
,	O
Drug	O
Form	O
:	O
Tab	B-form
,	O
Start	O
:	O
*	O
*	O
DATE	O
[	O
Jan	B-temporal
13	I-temporal
08	I-temporal
]	O
9:00:00	B-temporal

Ziprasidone	O
bid	B-frequency

Patient	O
was	O
being	O
evaluated	O
for	O
weakness	O
and	O
numbness	O
in	B-bodyloc
arms	I-bodyloc
and	I-bodyloc
legs	I-bodyloc
and	O
incontinence	O
.	O

Biapical	B-bodyloc
lung	I-bodyloc
scarring	O
and	O
mild	B-severity
bronchiectasis	O
are	O
present	O
.	O

The	O
patient	O
also	O
stated	O
that	O
her	O
headaches	O
declined	B-course
and	O
responded	O
well	O
to	O
Tylenol	O
.	O

He	O
had	O
been	O
discharged	O
24	O
hours	O
prior	O
to	O
presenting	O
again	O
to	O
the	O
emergency	O
room	O
complaining	O
of	O
pain	O
uncontrolled	O
by	O
his	O
home	O
regimen	O
of	O
methadone	O
and	O
Dilaudid	O
.	O

Continued	O
in	O
Melrose	O
-	O
J	O
for	O
comfort	O
per	O
orthopedics	O
.	O

Last	O
night	O
I	O
rested	O
him	O
on	O
BiPAP	O
.	O

Dopamine	O
drip	B-route
at	O
3	O
.	O

03/01/00	B-temporal

1	O
.	O

2	O
.	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
16	I-temporal
2008	I-temporal
]	O
6	B-temporal
:	I-temporal
16	I-temporal
AM	I-temporal

Improving	O
a	O
lot	O
today	O
.	O

3	O
.	O

MEDICATIONS	O
:	O

He	O
also	O
had	O
sigmoid	B-bodyloc
diverticula	O
without	B-negation
evidence	O
for	O
acute	B-course
diverticulitis	O
.	O

Professional	O
Services	O

Dictator	O
:	O

The	O
plan	O
,	O
at	O
that	O
time	O
,	O
was	O
a	O
myelogram	O
,	O
cerebrospinal	O
fluid	O
analysis	O
.	O

His	O
post	O
transplant	O
course	O
was	O
initially	O
complicated	O
by	O
hyperglycemia	O
and	O
seizure	O
on	O
postoperative	O
day	O
number	O
one	O
.	O

XXX	O
]	O
,	O
M	O
.	O
D	O
.	O

Discharge	O
Instructions	O
:	O

Professional	O
Services	O

Ferritin	O
272	B-labvalue
ng	I-labvalue
/	I-labvalue
mL	I-labvalue

Consult	O
Endocrine	O
to	O
follow	O
glucose	O
with	O
initiation	O
of	O
prednisone	O
for	O
ETOH	O

*	O
*	O
INSTITUTION	O
STAY	O
:	O

SOCIAL	O
HISTORY	O
:	O

Intravenous	O
fluids	O
.	O

Panic	O
disorder	O

Alprazolam	O
1	B-strength
mg	I-strength
po	B-route
qid	B-frequency

The	O
patient	O
has	O
improved	O
.	O

2	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

He	O
is	O
in	O
a	O
primarily	O
narcotic	O
based	O
sedative	O
regimen	O
over	O
the	O
course	O
of	O
the	O
evening	O
with	O
no	O
plans	O
on	O
ventilatory	O
weaning	O
until	O
after	O
we	O
have	O
a	O
better	O
feel	O
for	O
his	O
hemodynamics	O
.	O

Talked	O
to	O
her	O
POA	O
yesterday	O
.	O

No	B-negation
definite	O
evidence	O
for	O
significant	O
myocardial	B-bodyloc
ischemia	O
,	O
although	O
cardiac	O
enzymes	O
were	O
sent	O
and	O
he	O
ruled	O
out	O
for	O
myocardial	B-bodyloc
infarction	O
.	O

He	O
was	O
given	O
a	O
script	O
for	O
blood	O
work	O
.	O

The	O
patient	O
was	O
treated	O
with	O
Tylenol	O
orally	B-route
as	O
well	O
as	O
Ativan	O
for	O
anxiety	O
that	O
she	O
had	O
about	O
going	O
home	O
.	O

Chem	O
-	O
7	O
-	O
Na	O
139	B-labvalue
,	O
K	O
3	B-labvalue
.	I-labvalue
7	I-labvalue
,	O
Cl	O
99	B-labvalue
,	O
bicarb	O
28	B-labvalue
,	O
BUN	O
15	B-labvalue
,	O
creatinine	O
0	B-labvalue
.	I-labvalue
9	I-labvalue
,	O
glucose	O
89	B-labvalue
.	O

Atenolol	O
25	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
once	B-frequency
per	I-frequency
day	I-frequency
.	O

Within	O
the	O
next	O
couple	O
of	O
days	O
,	O
the	O
patient	O
noticed	O
a	O
significant	O
improvement	B-course
in	O
her	O
pain	O
pattern	O
.	O

Attend	O
:	O

He	O
has	O
no	O
h	O
/	O
o	O
ETOH	O
/	O
IVDA	O
but	O
quit	O
tob	O
15	O
years	O
ago	O
.	O

-	O
Continue	O
coumadin	O
4	B-strength
mg	I-strength
daily	B-frequency
and	O
check	O
INR	O
daily	O
until	O
INR	O
stable	O
.	O

*	O
*	O
NAME	O
[	O
WWW	O
M	O
.	O

GLUCOSE	O
-	O
197	B-labvalue
*	I-labvalue
UREA	O
N	O
-	O
25	O
*	O
CREAT	O
-	O
0	B-labvalue
.	I-labvalue
8	I-labvalue
SODIUM	O
-	O
141	B-labvalue

LABS	O
:	O

*	O
*	O
DATE	O
[	O
Jan	B-temporal
16	I-temporal
2008	I-temporal
]	O
4	B-temporal
:	I-temporal
00	I-temporal
AM	I-temporal

The	O
patient	O
was	O
instructed	O
to	O
have	O
blood	O
work	O
drawn	O
for	O
lab	O
work	O
once	O
a	O
week	O
.	O

He	O
understands	O
that	O
he	O
does	O
have	O
significant	O
left	B-bodyloc
ventricle	I-bodyloc
dysfunction	O
and	O
requires	O
monitoring	O
of	O
his	O
prothrombin	O
times	O
and	O
his	O
arrhythmias	O
;	O
these	O
will	O
be	O
done	O
in	O
Grovea	O
Co	O
Terburgperv	O
Portnew	O
.	O

Ionized	O
Calcium	O
1	B-labvalue
.	I-labvalue
13	I-labvalue
mMol	I-labvalue
/	I-labvalue
L	I-labvalue
Low	B-labvalue

(	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
11	B-temporal
:	I-temporal
34	I-temporal
)	O

ADMISSION	O
DATE	O
:	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Jul	B-temporal
19	I-temporal
2007	I-temporal
]	O
11	B-temporal
:	I-temporal
34	I-temporal
)	O

ATTENDING	O
PHYSICIAN	O
PROGRESS	O
NOTE	O

Head	O

Furosemide	O
20	B-strength
mg	I-strength
q	B-frequency
.	I-frequency
o	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

03326	O

-	O
-	O
d	O
/	O
c	O
ambien	O
prn	B-frequency
qhs	B-frequency

TSH	O
wnl	B-labvalue
,	O
and	O
B12	O
and	O
Folic	O
pending	O
.	O

Absolutely	O
no	O
driving	O
.	O

3	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
4:00:00	B-temporal

367138	O
/	O
*	O
*	O
ID	O
-	O
NUM	O

FALCCOUETTE	O
,	O
M	O
.	O
D	O
.	O

The	O
patient	O
will	O
get	O
rehabilitation	O
and	O
continue	O
to	O
get	O
care	O
for	O
his	O
fluid	O
status	O
.	O

10	O
.	O

6	O
.	O

*	O
*	O
DATE	O
[	O
Mar	B-temporal
15	I-temporal
2007	I-temporal
]	O
15:16:41	B-temporal

6	O
.	O

TRANSFER	O
DIAGNOSIS	O
:	O

1	O
.	O

He	O
was	O
referred	O
to	O
the	O
Surgical	O
Clinic	O
where	O
the	O
wound	O
was	O
opened	O
and	O
the	O
patient	O
was	O
admitted	O
for	O
intravenous	B-route
antibiotics	O
.	O

Nifedipine	O
XL	O
90	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

Disp	O
:	O
*	O
30	O
Tablet	O
(	O
s	O
)	O
*	O
Refills	O
:	O
*	O
2	O
*	O

Will	O
follow	O
up	O
on	O
to	O
r	O
/	O
o	O
SBP	O
.	O

Physical	O
Exam	O

Job	O
ID	O
:	O

Dict	O
:	O

HOSPITAL	O
COURSE	O
:	O

BS	O
is	O
not	O
well	O
controoled	O
:	O
beside	O
Lantus	O
22	B-dosage
units	I-dosage
daily	B-frequency
,	O
she	O
also	O
had	O
14	O
units	O
covered	O
by	O
ISS	O
.	O

Regular	B-labvalue
rate	O
and	O
rhythm	O
.	O

3	O
.	O

Following	O
the	O
commend	O
,	O
and	O
talk	O
makes	O
kind	O
of	O
sense	O
.	O

The	O
patient	O
admits	O
to	O
smoking	O
one	O
pack	O
of	O
cigarettes	O
per	O
day	O
.	O

Dictator	O
:	O

*	O
*	O
NAME	O
[	O
ZZZ	O
]	O

The	O
patient	O
with	O
no	B-negation
new	O
events	O
.	O

-	O
if	O
HR	O
drops	O
,	O
restart	O
glucagon	O
gtt	O

Labetalol	O
300	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

*	O
*	O
DATE	O
[	O
Oct	B-temporal
19	I-temporal
2007	I-temporal
]	O
19:10:31	B-temporal

LABORATORY	O
DATA	O

He	O
developed	O
epigastric	O
pain	O
on	O
07	B-temporal
/	I-temporal
31	I-temporal
which	O
previously	O
had	O
been	O
ignored	O
but	O
in	O
retrospect	O
was	O
probably	O
his	O
anginal	O
equivalent	O
.	O

Physical	O
Exam	O

Heart	O
:	O
normal	O

*	O
*	O
*	O

I	O
reviewed	O
her	O
vital	O
signs	O
.	O

*	O
*	O
DATE	O
[	O
Jul	B-temporal
17	I-temporal
07	I-temporal
]	O
9:00:00	B-temporal

-	O
Gentamicin	O
oniment	B-form
q8	B-frequency
,	O
per	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
'	O
s	O
recommendation	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

11	O
.	O

Lungs	O
:	O

72	O
year	O
old	O
man	O
with	O

*	O
*	O
DATE	O
[	O
Feb	B-temporal
10	I-temporal
2007	I-temporal
]	O
4	B-temporal
:	I-temporal
00	I-temporal
AM	I-temporal

14	O
.	O

Clear	B-labvalue
to	O
auscultation	O
bilaterally	O
.	O

Course	O

Doxycycline	O
100	B-strength
mg	I-strength
1	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency
x	O
7	B-duration
days	I-duration
.	O

11	O
.	O

Intake	O
:	O

Discharge	O
Condition	O
:	O

The	O
patient	O
was	O
then	O
transferred	O
to	O
the	O
Coronary	O
Care	O
Unit	O
Service	O
for	O
medical	O
management	O
in	O
anticipation	O
of	O
possible	O
percutaneous	O
coronary	O
intervention	O
later	O
in	O
the	O
admission	O
.	O

WBC	O
'	O
s	O
trending	O
down	O
.	O

(	O
on	O
*	O
*	O
DATE	O
[	O
Feb	B-temporal
10	I-temporal
2007	I-temporal
]	O
16	B-temporal
:	I-temporal
25	I-temporal
)	O

His	O
TIBC	O
was	O
greater	B-labvalue
than	I-labvalue
123	I-labvalue
,	O
but	O
less	O
than	O
143	O
.	O

Results	O
Review	O

Noncontributory	O
.	O

MCV	O
105	B-labvalue
.	I-labvalue
4	I-labvalue
fL	I-labvalue
High	B-labvalue

Sign	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
R	O

BP	O
is	O
not	O
optimal	O
controlled	O
.	O

Author	O
:	O

Deep	O
tendon	O
reflexes	O
were	O
equal	B-labvalue
and	O
adequate	O
in	O
upper	O
and	O
lower	O
extremities	O
.	O

Her	O
dopamine	O
was	O
weaned	O
off	O
the	O
following	O
day	O
,	O
and	O
her	O
heparin	O
was	O
discontinued	O
secondary	O
to	O
a	B-bodyloc
right	I-bodyloc
groin	I-bodyloc
hematoma	O
which	O
had	O
developed	O
after	O
the	O
sheath	O
had	O
been	O
pulled	O
out	O
by	O
the	O
fellow	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

C4	O
-	O
C5	O
,	O
C5	O
-	O
C6	O
,	O
anterior	O
microdiscectomy	O
and	O
fusion	O
with	O
right	O
iliac	O
bone	O
graft	O
.	O

On	O
the	O
day	O
of	O
transfer	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
confused	O
with	O
waxing	O
and	O
waning	O
sensorium	O
;	O
thus	O
,	O
a	O
delirium	O
work	O
-	O
up	O
was	O
initiated	O
looking	O
for	O
precipitants	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Cataracts	O
,	O
s	O
/	O
p	O
cataract	O
surgery	O

*	O
*	O
ROOM	O

02/07/1992	B-temporal

2014-11-11	B-temporal
:	O
Tracheostomy	O
performed	O
without	B-negation
complication	O
.	O

Discharge	O
Medications	O
:	O

She	O
remained	O
neurologically	O
stable	O
.	O

No	B-negation
new	B-course
hemorrhage	O
is	O
observed	O
.	O

*	O
*	O
*	O

She	O
said	O
these	O
things	O
again	O
?	O

Cerebrospinal	O
fluid	O
results	O
were	O
essentially	O
normal	B-labvalue
.	O

The	O
patient	O
presented	O
with	O
platelet	O
count	O
of	O
41	B-labvalue
upon	O
admission	O
with	O
bleeding	O
from	O
her	B-bodyloc
nose	I-bodyloc
.	O

*	O
*	O
INSTITUTION	O

D	O
-	O
DIMER	O
-	O
7998	B-labvalue
*	O

T	O
:	O
2011-11-23	B-temporal
11	B-temporal
:	I-temporal
59	I-temporal

2	O
.	O

02/17/2000	B-temporal

4	O
.	O

2	O
.	O

This	O
has	O
worked	O
well	O
.	O

Dementia	O
on	O
baseline	O
.	O

Clostridium	O
difficile	O
diarrhea	O
infection	O
.	O

*	O
*	O
ID	O
-	O
NUM	O

The	O
patient	O
also	O
had	O
lab	O
work	O
,	O
showed	O
acute	B-course
renal	B-bodyloc
failure	O
with	O
elevated	B-course
creatinine	O
.	O

Albumin	O
of	O
1	B-labvalue
.	I-labvalue
4	I-labvalue
,	O
total	O
protein	O
of	O
6	B-labvalue
.	I-labvalue
3	I-labvalue
,	O
total	O
bilirubin	O
of	O
3	B-labvalue
.	I-labvalue
8	I-labvalue
,	O
direct	O
bilirubin	O
2	B-labvalue
.	I-labvalue
0	I-labvalue
,	O
ALT	O
65	B-labvalue
,	O
AST	O
167	B-labvalue
,	O
and	O
alkaline	O
phosphatase	O
117	B-labvalue
.	O

Cerebral	B-bodyloc
aneurysm	O
.	O

After	O
this	O
surgery	O
,	O
she	O
was	O
stable	O
to	O
return	O
to	O
the	O
floor	O
for	O
continuance	O
of	O
care	O
.	O

5	O
.	O

ZZZ	O
]	O
,	O
M	O
.	O
D	O
.	O

Physical	O
Examination	O

T	O
:	O

Bisacodyl	O
5	B-strength
mg	I-strength
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
Sig	O
:	O
Two	B-dosage
(	O
2	O
)	O
Tablet	B-form
,	I-form
Delayed	I-form
Release	I-form
(	I-form
E	I-form
.	I-form
C	I-form
.	I-form
)	I-form
PO	B-route
DAILY	B-frequency
(	O
Daily	B-frequency
)	O
as	O
needed	O
.	O

-	O
check	O
Labs	O
in	O
am	B-temporal

MRN	O
:	O

Creatine	O
kinase	O
on	O
admission	O
was	O
309	B-labvalue
,	O
with	O
a	O
MB	O
of	O
19	B-labvalue
.	I-labvalue
6	I-labvalue
,	O
an	O
index	O
of	O
6	B-labvalue
.	I-labvalue
3	I-labvalue
,	O
and	O
an	O
initial	O
troponin	O
of	O
0	B-labvalue
.	I-labvalue
73	I-labvalue
.	O

Echo	O
results	O
show	O
normal	B-labvalue
left	O
and	O
right	O
ventricular	O
size	O
and	O
function	O
with	O
mild	B-severity
mitral	B-bodyloc
and	O
mild	B-severity
tricuspid	B-bodyloc
regurgitation	O
with	O
normal	O
pulmonary	O
artery	O
pressure	O
.	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
on	O
the	O
medications	O
as	O
listed	O
above	O
.	O

He	O
was	O
thought	O
to	O
be	O
a	O
candidate	O
for	O
steroid	O
therapy	O
and	O
Trental	O
.	O

She	O
will	O
follow	O
up	O
with	O
Dr	O
.	O
Perez	O
in	B-temporal
two	I-temporal
weeks	I-temporal
with	O
repeat	O
head	O
CT	O
.	O

MEDICINE	O

02/26/92	B-temporal

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

Should	O
this	O
become	O
available	O
,	O
an	O
addendum	O
will	O
be	O
issued	O
to	O
this	O
report	O
following	O
the	O
comparison	O
with	O
the	O
outside	O
examination	O
.	O

She	O
did	O
have	O
postoperative	O
anemia	O
,	O
which	O
on	O
*	O
*	O
DATE	O
[	O
Nov	B-temporal
01	I-temporal
07	I-temporal
]	O
showed	O
hemoglobin	O
of	O
8	B-labvalue
with	O
hematocrit	O
of	O
23	B-labvalue
.	I-labvalue
6	I-labvalue
.	O

He	O
was	O
seen	O
by	O
cardiology	O
,	O
and	O
toxicology	O
was	O
consulted	O
via	O
telephone	O
.	O

*	O
*	O
PLACE	O
,	O
PA	O
*	O
*	O
ZIP	O
-	O
CODE	O

Urinalysis	O
was	O
within	B-labvalue
normal	I-labvalue
limits	I-labvalue
with	O
6	B-labvalue
to	I-labvalue
10	I-labvalue
red	O
blood	O
cells	O
.	O

He	O
was	O
9	O
.	O
2	O
and	O
26	O
.	O
4	O
before	O
his	O
procedure	O
,	O
yesterday	B-temporal
.	O

There	O
was	O
no	B-negation
pleural	B-bodyloc
effusion	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

She	O
was	O
admitted	O
to	O
this	O
hospital	O
,	O
*	O
*	O
INSTITUTION	O
,	O
on	O
*	O
*	O
DATE	O
[	O
Mar	B-temporal
18	I-temporal
2007	I-temporal
]	O
,	O
by	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
YYY	O
ZZZ	O
]	O
for	O
Nissen	O
fundoplication	O
.	O

Phone	O
:	O
(	O
967	O
)	O
675	O
1641	O
Date	O
/	O
Time	O
:	O
2013-01-11	B-temporal
2	B-temporal
:	I-temporal
00	I-temporal

He	O
should	O
have	O
a	O
physician	O
visit	O
weekly	O
without	O
fail	O
between	O
his	O
PCP	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
UUU	O
]	O
and	O
the	O
hepatologist	O
Dr	O
.	O
*	O
*	O
NAME	O
[	O
RRR	O
]	O
.	O

Patient	O
:	O

10	O
.	O

Given	O
the	O
patient	O
'	O
s	O
right	O
thigh	O
hematoma	O
,	O
a	O
duplex	O
evaluation	O
of	O
the	O
right	O
lower	O
extremity	O
was	O
performed	O
on	O
2010-06-28	B-temporal
and	O
demonstrated	O
no	B-negation
evidence	O
of	O
major	O
arterial	B-bodyloc
or	O
venous	B-bodyloc
injury	O
in	O
the	O
level	O
of	O

My	O
note	O
should	O
be	O
considered	O
linked	O
to	O
theirs	O
.	O

VERIFY	O
by	O
*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O
R	O

This	O
was	O
most	O
likely	O
due	O
to	O
her	O
multiple	O
myeloma	O
with	O
hyperviscosity	O
.	O

Cl	O
103	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue

Senna	O
8	B-strength
.	I-strength
6	I-strength
mg	I-strength
Tablet	O
Sig	O
:	O
One	B-dosage
(	O
1	O
)	O
Tablet	B-form
PO	B-route
BID	B-frequency
(	O
2	B-frequency
times	I-frequency
a	I-frequency
day	I-frequency
)	O
as	B-frequency
needed	I-frequency
.	O

Hypothyroidism	O
.	O

*	O
*	O
*	O
Dictated	O
By	O
:	O

*	O
*	O
DATE	O
[	O
Nov	B-temporal
01	I-temporal
07	I-temporal
]	O

Admitted	O
:	O

*	O
*	O
DATE	O
[	O
Aug	B-temporal
06	I-temporal
07	I-temporal
]	O

We	O
also	O
checked	O
another	O
chest	O
x	O
-	O
ray	O
to	O
insure	O
that	O
the	O
effusion	O
was	O
not	O
progressing	O
or	O
infiltrates	O
at	O
the	O
same	O
time	O
.	O

Batch	O
:	O

2012-06-08	B-temporal
09	B-temporal
:	I-temporal
30	I-temporal
AM	I-temporal
BLOOD	O
Glucose	O
-	O
115	B-labvalue
*	O
UreaN	O
-	O
14	B-labvalue
Creat	O
-	O
0	B-labvalue
.	I-labvalue
8	I-labvalue
Na	O
-	O
142	B-labvalue
K	O
-	O
4	B-labvalue
.	I-labvalue
1	I-labvalue
Cl	O
-	O
112	B-labvalue
*	O
HCO3	O
-	O
26	B-labvalue
AnGap	O
-	O
8	B-labvalue

PRINCIPAL	O
DIAGNOSES	O
:	O

ACCOUNT	O
#	O
:	O

Respiratory	O
:	O
clear	O
bilat	O
.	O

oxygen	O
continue	O
02	O
at	O
1L	O
/	O
min	O
continuous	O
to	O
keep	O
sats	O
in	O
90	B-labvalue
'	I-labvalue
s	I-labvalue
.	I-labvalue

Sex	O
:	O

Dr	O
*	O
*	O
NAME	O
[	O
SSS	O
]	O
,	O
waiting	O
for	O
input	O
.	O

-	O
-	O
placement	O
issues	O

The	O
patient	O
has	O
otherwise	O
been	O
feeling	O
well	O
and	O
she	O
was	O
subsequently	O
transferred	O
to	O
the	O
medicine	O
floor	O
for	O
further	O
treatment	O
.	O

Age	O
:	O

Progress	O
*	O
*	O
INSTITUTION	O

1	O
.	O

ASSESSMENT	O
AND	O
PLAN	O
:	O

6	O
.	O
)	O
Zoloft	O
40	B-strength
mg	I-strength
qAM	B-frequency

Her	O
temperature	O
was	O
100	B-labvalue
.	I-labvalue
4	I-labvalue
in	O
the	O
office	O
,	O
and	O
she	O
had	O
no	B-negation
chills	O
.	O

He	O
had	O
a	O
left	O
internal	O
mammary	O
artery	O
graft	O
of	O
the	O
LAD	O
,	O
a	O
single	O
saphenous	O
vein	O
to	O
the	O
right	O
coronary	O
artery	O
with	O
280	O
cc	O
per	O
minute	O
flow	O
,	O
and	O
a	O
saphenous	O
vein	O
snake	O
graft	O
to	O
the	O
diagonal	O
and	O
circumflex	O
with	O
150	O
cc	O
per	O
minute	O
flow	O
.	O

CO2	O
34	B-labvalue
mEq	I-labvalue
/	I-labvalue
L	I-labvalue
High	B-labvalue

*	O
*	O
NAME	O
[	O
XXX	O
,	O
WWW	O
]	O

Cc	O
:	O

Throughout	O
her	O
stay	O
her	O
left	O
hip	B-bodyloc
wound	O
looked	O
very	O
good	O
.	O

3	O
.	O

Her	O
lungs	O
revealed	O
just	O
a	O
few	O
crackles	O
at	O
the	B-bodyloc
right	I-bodyloc
base	I-bodyloc
.	O

She	O
had	O
to	O
get	O
some	O
Xopenex	O
which	O
decreased	O
her	O
O2	O
requirement	O
.	O

Attend	O
:	O

07/20/1999	B-temporal

She	O
also	O
has	O
no	B-negation
gross	O
blood	O
per	O
rectum	O
and	O
her	O
hct	O
is	O
stable	O
.	O

*	O
*	O
DATE	O
[	O
Sep	B-temporal
30	I-temporal
2007	I-temporal
]	O
11	B-temporal
:	I-temporal
26	I-temporal

Synthroid	O
0	B-strength
.	I-strength
125	I-strength
mcg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
day	I-frequency
.	O

Bupropion	O
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
twice	B-frequency
per	I-frequency
day	I-frequency
(	O
for	O
smoking	O
cessation	O
)	O
.	O

Temperature	O
is	O
37	B-labvalue
.	I-labvalue
0	I-labvalue
,	O
heart	O
rate	O
is	O
80	B-labvalue
,	O
respiratory	O
rate	O
is	O
20	B-labvalue
,	O
she	O
is	O
saturating	O
96	B-labvalue
%	I-labvalue
on	O
room	O
air	O
,	O
and	O
blood	O
pressure	O
is	O
129	B-labvalue
/	I-labvalue
78	I-labvalue
.	O

4	O
.	O

Has	O
a	O
history	O
of	O
qualude	O
use	O
since	O
high	O
school	O
,	O
also	O
in	O
remission	O
.	O

*	O
*	O
INSTITUTION	O

6	O
.	O

She	O
had	O
biopsies	O
.	O

4	O
.	O

Benazepril	O
20	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

She	O
has	O
failed	O
conservative	O
therapy	O
and	O
is	O
admitted	O
for	O
a	O
spinal	O
cord	O
stimulator	O
trial	O
.	O

Her	O
case	O
was	O
discussed	O
in	O
detail	O
with	O
the	O
house	O
staff	O
.	O

2014-10-21	B-temporal
08	B-temporal
:	I-temporal
10	I-temporal
PM	I-temporal

Dictated	O
By	O
:	O
Harriet	O
E	O
.	O

Toxicology	O
screen	O
was	O
negative	B-labvalue
.	O

2	O
.	O

The	O
patient	O
has	O
been	O
in	O
*	O
*	O
INSTITUTION	O
since	O
*	O
*	O
DATE	O
[	O
Oct	B-temporal
20	I-temporal
2007	I-temporal
]	O
,	O
for	O
worsening	B-course
confusion	O
without	O
an	O
organic	O
cause	O
.	O

UTI	O
[	O
Urinary	O
tract	O
infection	O
]	O
(	O
ICD9	O
599	O
.	O
0	O
,	O
Working	O
,	O
Problem	O
)	O

Extremities	O
:	O

Percocet	O
as	B-frequency
needed	I-frequency
.	O

Dictator	O
:	O

*	O
*	O
*	O

Cardiovascular	O
:	O

Integrilin	O
drip	B-route
.	O

JOB	O
#	O
:	O

If	O
her	O
temporary	O
biopsy	O
is	O
negative	B-labvalue
,	O
we	O
may	O
be	O
able	O
to	O
proceed	O
with	O
further	O
evaluation	O
as	O
outpatient	O
after	O
her	O
EMG	O
nerve	O
conduction	O
tests	O
.	O

_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O
_	O

ALLRESLTSECT	O

Electrocardiogram	O
the	O
following	O
morning	O
revealed	O
normalization	O
of	O
her	O
ST	O
segments	O
with	O
evolution	O
of	O
Q	O
waves	O
.	O

1	O
Neurontin	O
900	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

Dictated	O
By	O
:	O

ADMISSION	O
DATE	O
:	O

During	O
the	O
first	O
two	O
days	O
,	O
he	O
required	O
14	O
and	O
22	O
units	O
of	O
additional	O
coverage	O
.	O

Cc	O
:	O

BENIGN	O
ESSENTIAL	O
HYPERTENSION	O
(	O
ICD9	O
401	O
.	O
1	O
,	O
Working	O
,	O
Diagnosis	O
)	O
on	O
ace	O

Eosinophils	O
6	B-labvalue
%	I-labvalue

Gout	O
s	O
/	O
p	O
appendectomy	O

2012-10-31	B-temporal
12	B-temporal
:	I-temporal
20PM	I-temporal

Lone	O
atrial	B-bodyloc
fibrillation	O
(	O
SNMCT	O
*	O
*	O
ID	O
-	O
NUM	O
,	O
Working	O
,	O
Diagnosis	O
)	O
by	O
history	O
current	O
NSR	O
on	O
Nadolol	O

